data_2my3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2my3 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 4.6 p90 -157.97 -179.59 8.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.219 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -102.65 144.27 13.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 40.4 t80 -101.97 124.96 48.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.525 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 3.8 mp -102.38 139.25 23.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.06 -169.78 46.29 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.124 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.4 ' HB2' ' NH2' ' A' ' 80' ' ' ARG . 11.6 m120 -45.51 112.23 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.63 0.772 . . . . 0.0 112.553 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.4 mt -104.42 168.9 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.201 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.17 140.31 58.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -64.55 -17.24 63.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.896 0.379 . . . . 0.0 110.561 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HB2' HD13 ' B' ' 217' ' ' LEU . 63.9 mm-40 -82.68 -11.6 58.23 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.93 128.27 34.55 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.8 p -110.43 176.56 5.0 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.489 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.42 -30.33 64.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.634 0.373 . . . . 0.0 111.137 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.64 94.96 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.644 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.402 ' CG ' ' HG ' ' B' ' 215' ' ' SER . 19.3 m-20 -67.83 -42.39 81.52 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.088 0.471 . . . . 0.0 109.866 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.08 -47.84 88.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.787 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.46 -32.57 74.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 109.874 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -63.71 -41.27 98.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.0 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.65 -46.81 93.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.031 0.443 . . . . 0.0 110.456 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.497 ' CG ' HD22 ' A' ' 57' ' ' LEU . 60.4 m-85 -73.81 -13.07 60.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.08 -16.48 63.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.395 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.46 -39.56 84.06 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.916 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -85.29 -16.02 41.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.669 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 27.44 73.47 Favored Glycine 0 N--CA 1.454 -0.155 0 CA-C-N 115.877 -0.602 . . . . 0.0 113.327 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.08 97.36 42.15 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.13 101.74 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.079 2.519 . . . . 0.0 112.564 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -137.13 -166.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.466 ' H ' HG11 ' A' ' 38' ' ' VAL . 17.4 m-20 -60.2 140.9 56.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.9 128.95 32.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.52 118.62 52.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.784 0.326 . . . . 0.0 111.065 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -109.11 128.69 55.21 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 23.9 m -70.03 108.24 3.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.972 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -126.71 143.3 51.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.693 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.7 138.47 35.05 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.763 0.665 . . . . 0.0 111.229 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.54 -13.93 62.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.25 -55.72 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.059 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -101.55 -5.34 25.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.02 18.71 76.6 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.892 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -56.28 134.18 53.17 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.916 0.358 . . . . 0.0 111.283 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.0 m -66.2 107.98 2.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -71.33 -19.17 62.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.661 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.88 -0.12 51.95 Favored Glycine 0 C--O 1.221 -0.67 0 C-N-CA 120.747 -0.74 . . . . 0.0 114.452 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 4.0 m-85 -108.99 129.83 55.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.551 0.675 . . . . 0.0 109.592 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.453 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -125.83 149.73 48.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.025 0.441 . . . . 0.0 111.365 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.488 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 20.3 m-85 -137.9 148.8 45.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.281 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.626 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.2 tp -140.66 115.23 9.47 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.531 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 12' ' ' TYR . 1.5 tmtp? -100.25 114.11 27.3 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.265 0.555 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 42.7 p90 -132.06 143.73 50.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.165 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -101.06 106.81 18.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.24 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 65' ' ' THR . 21.0 t70 175.27 109.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.599 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -64.07 -47.18 81.15 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.339 0.59 . . . . 0.0 110.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 m -67.37 -25.42 65.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.534 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.2 p -62.77 -61.2 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.12 -34.98 62.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.59 -61.01 2.83 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.131 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.84 91.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 73.7 t -58.95 -51.59 70.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 120.586 0.231 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.58 -36.77 68.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.828 0.347 . . . . 0.0 111.334 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.56 -43.83 72.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.88 -18.17 31.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 32.9 t-20 -65.06 109.49 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.069 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.9 -2.44 52.04 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -81.13 132.08 35.34 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -88.86 132.26 34.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.146 0.498 . . . . 0.0 112.214 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.1 mm -129.22 101.76 6.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.79 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.43 23.59 77.87 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.458 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 -15.78 60.5 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.043 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 17' ' ' ASN . 30.3 mmm180 -94.86 110.2 22.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.616 0.246 . . . . 0.0 111.596 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 83' ' ' LYS . . . -68.41 127.69 33.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.23 117.88 16.54 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.635 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 81' ' ' ALA . 10.8 mptt -100.84 110.75 22.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 20.5 mm -103.16 121.65 54.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.727 0.298 . . . . 0.0 111.423 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -116.53 166.6 11.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.858 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -96.35 136.43 36.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.3 t -161.24 160.8 30.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.758 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.53 138.99 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.911 0.386 . . . . 0.0 110.175 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 15.6 t80 -149.88 135.24 18.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -96.28 112.32 59.42 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.249 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.54 115.35 2.99 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -73.91 144.84 45.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.916 0.388 . . . . 0.0 110.376 178.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -72.94 -13.42 61.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.371 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -68.52 -17.08 64.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.112 0.482 . . . . 0.0 110.063 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 tp -123.01 24.83 8.8 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -58.7 -32.49 69.22 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.172 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.42 -32.63 71.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.531 0.205 . . . . 0.0 111.513 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.55 -55.69 16.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -64.49 -34.5 78.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.73 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 34.0 tt0 -65.6 -41.52 92.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.136 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.61 -30.24 70.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 110.019 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.23 -48.48 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -70.84 -12.74 61.72 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 25.5 mm-40 -61.26 -35.13 76.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -83.23 -26.16 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.58 -14.99 44.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.696 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -178.102 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 121.325 0.583 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 24.4 mt -134.55 117.22 23.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.482 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 3.1 mmt -114.54 117.95 42.02 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.35 133.65 37.05 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.191 2.594 . . . . 0.0 112.512 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -123.27 108.24 12.56 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.699 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -88.96 88.86 7.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 61.7 m -112.55 155.17 44.22 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.753 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -100.87 112.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.747 2.298 . . . . 0.0 112.044 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.402 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 95.3 p -78.89 -43.41 24.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 109.822 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.18 72.86 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.211 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 21' ' ' GLU . 42.4 mt -58.29 -36.39 73.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.13 -9.59 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.081 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.29 0.567 . . . . 0.0 110.558 -177.894 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.973 0 CA-C-O 121.123 0.487 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.525 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 33.4 m-85 -134.74 166.69 22.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 pt -141.92 138.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -85.47 116.81 24.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.477 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.48 130.92 35.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.42 -168.27 44.6 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.25 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 12.4 t30 -39.69 101.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.944 0.898 . . . . 0.0 112.964 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.3 mt -97.94 -173.8 2.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.08 139.58 35.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -64.89 -17.39 64.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.654 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.69 -6.38 58.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 0.0 110.517 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.2 tp -90.59 110.7 21.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.1 p -98.27 172.95 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -57.99 -32.18 67.64 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.986 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.16 98.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 29' ' ' THR . 6.2 t70 -74.83 -38.83 61.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.565 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 72.0 mt -58.32 -45.05 89.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.413 0.625 . . . . 0.0 109.581 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.06 -26.63 65.06 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.339 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.3 m -57.97 -54.06 51.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.03 -31.19 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 67.8 m-85 -79.26 -20.61 47.7 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.171 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.2 t -70.89 -17.69 62.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 109.892 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.13 -22.13 65.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.701 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.59 2.55 52.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.0 81.38 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.779 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -127.03 98.72 29.86 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 117.254 0.527 . . . . 0.0 111.687 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.14 120.08 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.936 2.424 . . . . 0.0 110.68 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -124.44 -167.4 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.788 -177.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.77 136.18 39.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 111.802 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.33 134.86 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 41' ' ' ILE . 4.1 mp -124.84 108.61 20.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.0 tp -88.13 139.4 30.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -83.68 109.55 17.55 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.506 ' NE ' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -121.79 145.5 47.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.294 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.11 131.48 50.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.088 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' B' ' 208' ' ' ILE . 29.3 mt-10 -75.08 -15.8 60.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.61 -61.39 1.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.1 t -108.06 -22.15 12.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.39 21.58 12.84 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.712 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -71.87 161.37 31.05 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 120.684 0.278 . . . . 0.0 111.162 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 t -81.22 130.97 35.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -80.07 -9.11 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 97.41 13.82 43.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.708 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -158.33 165.48 34.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.169 0.485 . . . . 0.0 110.732 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.73 14.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.983 0.42 . . . . 0.0 111.627 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.81 124.91 27.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.14 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 11.0 tp -110.32 136.52 49.38 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.55 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -114.62 120.38 39.96 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -140.99 -166.82 2.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.809 -176.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.69 179.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 65' ' ' THR . 14.9 m-20 -61.42 -174.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.868 -1.06 . . . . 0.0 113.421 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -49.8 -39.79 39.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.601 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -51.29 -52.79 41.97 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 m -70.81 -30.84 67.4 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.383 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.642 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 32.8 p -61.1 -47.48 86.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 110.757 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.76 -37.53 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.867 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.85 -57.76 10.58 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.147 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.69 82.22 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 65' ' ' THR . 60.4 t -56.47 -52.43 52.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.226 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.47 -37.57 88.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -77.27 -49.22 15.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.47 -29.97 57.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -66.59 110.27 3.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 0.0 109.967 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.76 -19.99 25.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.093 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -74.99 139.02 42.65 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 37.0 ttpt -109.86 135.74 50.27 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.924 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.22 119.29 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.64 30.38 76.55 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.626 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.75 1.44 68.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.494 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.558 ' C ' ' HG3' ' A' ' 76' ' ' LYS . 81.6 mtt180 -129.06 119.55 24.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.347 0.574 . . . . 0.0 111.494 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -68.96 137.27 53.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.637 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.93 125.79 30.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.067 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -108.11 105.34 15.04 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -99.21 109.81 25.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.034 0.445 . . . . 0.0 111.11 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -104.61 112.74 25.94 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.1 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.4 124.17 22.01 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.856 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -159.37 136.66 9.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -74.52 155.99 37.36 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.525 ' HB3' ' CG ' ' A' ' 12' ' ' TYR . 82.9 t80 -150.75 149.89 30.33 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -108.49 121.14 44.32 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.06 129.89 37.75 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.072 2.514 . . . . 0.0 112.442 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.42 128.69 39.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -80.22 -10.18 59.75 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.8 m -76.88 -22.74 53.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.205 0.526 . . . . 0.0 109.886 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 tp -110.9 26.67 10.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.79 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -57.64 -31.32 66.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.956 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -58.66 -38.13 77.5 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.584 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -64.64 -43.89 92.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.6 -47.71 80.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.977 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -59.06 -43.68 91.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.25 86.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.28 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.89 -45.7 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -60.37 -50.39 73.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.499 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.53 -38.64 91.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.69 -51.55 68.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.513 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.33 -30.02 69.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.713 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.104 0.478 . . . . 0.0 110.313 179.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.038 0.447 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -129.56 129.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.605 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 14.7 mmt -110.18 149.7 40.48 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.445 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.76 146.79 91.27 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.946 2.43 . . . . 0.0 111.557 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -120.14 88.88 3.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.461 0.648 . . . . 0.0 111.348 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.87 96.68 4.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.912 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.6 m -110.22 145.19 31.64 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.91 62.05 3.9 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.472 2.115 . . . . 0.0 111.216 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.571 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 34.4 m -59.12 -51.82 68.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.91 37.98 93.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.108 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.571 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 8.5 mp -68.06 -26.62 65.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.23 0.515 . . . . 0.0 111.245 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.98 -22.28 64.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 109.901 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.516 176.831 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 87' ' ' THR . 0.2 OUTLIER -55.88 155.83 5.74 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -109.94 152.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.722 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.43 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 39.2 t80 -99.92 137.8 37.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.779 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 51.6 mt -123.63 143.6 36.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.74 -168.76 45.2 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.79 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 9.2 t30 -55.22 117.86 3.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.3 0.572 . . . . 0.0 112.434 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.57 -168.4 1.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . 56.6 t30 -79.11 154.4 29.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.353 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -70.69 -31.83 68.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.77 -0.5 55.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.413 HD13 ' H ' ' A' ' 19' ' ' ASN . 16.8 mt -81.64 109.51 16.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.945 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -98.52 178.74 4.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.915 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.06 -25.17 65.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.36 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.35 -51.48 31.99 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 29' ' ' THR . 2.9 m-20 -64.0 -39.64 94.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.784 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.22 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.5 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.23 -35.47 80.91 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 36.9 m -59.01 -48.94 79.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.656 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG21 HD11 ' B' ' 218' ' ' LEU . 68.9 t -56.38 -51.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.542 ' CG ' HD23 ' A' ' 57' ' ' LEU . 95.7 m-85 -78.26 -17.75 56.25 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -20.0 64.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.07 -24.05 63.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.425 ' HH ' ' HG ' ' A' ' 72' ' ' LEU . 41.8 m-85 -81.45 -20.34 40.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.128 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.78 9.68 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.721 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.0 m -127.41 89.23 51.91 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 121.21 0.529 . . . . 0.0 111.95 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 84.32 1.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.88 2.387 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.8 t -124.78 -166.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' H ' HG11 ' A' ' 38' ' ' VAL . 7.0 m-20 -72.58 131.81 42.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.39 133.41 68.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.482 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.5 mp -130.43 124.96 58.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.603 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 43' ' ' SER . 2.0 tt -107.79 134.85 50.15 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.415 ' N ' HD22 ' A' ' 42' ' ' LEU . 51.3 p -61.21 114.77 3.34 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 51.4 mtp180 -134.72 137.52 43.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.755 0.312 . . . . 0.0 110.224 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.586 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 16.5 m-20 -68.62 156.02 38.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.032 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.92 -35.58 28.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.434 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -71.43 -70.51 0.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.796 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -85.7 -19.9 30.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 73.9 18.59 79.65 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.311 178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 44.0 mt-10 -93.02 164.55 13.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.739 0.304 . . . . 0.0 111.309 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -72.12 129.07 37.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -80.16 -13.59 59.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.583 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.42 -10.28 30.81 Favored Glycine 0 C--O 1.215 -1.058 0 C-N-CA 120.6 -0.81 . . . . 0.0 114.305 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.16 148.49 28.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.865 0.833 . . . . 0.0 109.853 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB1' ' HB ' ' A' ' 15' ' ' ILE . . . -124.77 153.15 42.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.991 0.424 . . . . 0.0 110.836 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.43 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 55.1 m-85 -138.54 136.4 36.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD23 ' CG ' ' A' ' 31' ' ' PHE . 16.5 tp -135.21 122.79 22.09 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.735 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.589 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 55.5 tttp -102.13 117.25 34.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.754 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 50.8 p90 -145.09 145.27 31.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.6 107.58 18.88 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.426 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.675 ' O ' HG22 ' A' ' 65' ' ' THR . 28.0 t70 177.22 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.536 0.522 . . . . 0.0 110.783 174.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -51.17 -39.39 56.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -65.25 -54.86 22.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.794 0.33 . . . . 0.0 111.565 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.44 ' HG ' ' HB3' ' A' ' 61' ' ' ASP . 31.9 p -67.24 -19.93 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.754 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.3 p -61.63 -49.13 77.79 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.757 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -65.23 -38.73 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.788 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.4 tp -58.77 -56.89 16.35 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.181 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.07 83.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.489 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' THR . 71.4 t -63.56 -53.06 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.909 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.93 -40.08 63.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.84 -37.81 87.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -95.62 -10.66 28.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 47.8 t-20 -64.84 109.73 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.0 110.578 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.25 3.65 65.06 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.514 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.06 132.78 39.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.0 mmtp -91.88 125.35 36.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.095 0.474 . . . . 0.0 112.221 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mt -134.61 115.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.051 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.44 72.41 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.627 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -3.71 86.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.42 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 mmt180 -102.37 150.13 23.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.94 126.31 51.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 45.4 mt -73.68 128.94 36.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.754 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 75.3 mmtt -122.4 115.14 21.75 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 3.4 mm -114.22 148.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.519 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.09 145.97 23.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.029 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.401 ' HE2' ' CB ' ' A' ' 65' ' ' THR . 27.6 m80 -74.4 136.75 42.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.539 HG21 ' CE1' ' A' ' 12' ' ' TYR . 10.2 t -159.24 159.85 34.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.819 0.343 . . . . 0.0 111.128 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -124.27 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.461 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 33.6 t80 -136.74 142.8 43.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.65 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -98.14 107.59 42.07 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.446 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.81 119.73 6.47 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.081 2.52 . . . . 0.0 112.839 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.15 150.65 31.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.456 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -70.66 -19.86 62.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.923 0.392 . . . . 0.0 110.73 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.1 m -75.94 -11.16 59.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.373 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp -114.96 18.65 16.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.215 0.531 . . . . 0.0 109.813 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -58.56 -42.12 87.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.942 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.78 -29.11 69.92 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.673 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 3.7 t80 -67.94 -52.54 34.97 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.728 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.29 -46.45 73.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.27 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.57 91.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.701 0.286 . . . . 0.0 111.241 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.1 t -64.5 -50.39 76.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.39 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -63.28 -40.61 97.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.884 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.31 -39.64 89.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.49 -35.13 78.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 90.7 mt -63.09 -48.54 78.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 CA--C 1.517 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.174 179.608 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 N--CA 1.443 -0.823 0 CA-C-O 120.877 0.37 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.99 99.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.145 0.498 . . . . 0.0 109.781 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 17.7 mmt -99.64 125.74 39.64 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.558 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.37 135.36 39.34 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.632 2.221 . . . . 0.0 112.369 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -109.31 104.37 13.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.35 87.39 6.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.2 m -112.42 117.97 46.3 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.629 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.31 100.85 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.05 1.833 . . . . 0.0 112.184 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -75.27 -44.18 47.24 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.2 27.98 38.43 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.294 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.51 -42.01 98.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.564 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.45 HD11 HG21 ' A' ' 30' ' ' VAL . 2.5 pt? -76.99 -11.58 59.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.481 -177.76 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.975 0.417 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 17.2 m-85 -138.48 147.94 43.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.101 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -124.5 137.56 56.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.725 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.2 t80 -91.66 129.97 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.275 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.5 142.39 16.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.97 -169.89 46.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.576 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -63.83 105.66 0.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.9 mt -97.73 -173.02 2.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -72.7 143.09 48.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -59.09 -31.83 69.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -84.91 9.73 13.61 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.617 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tt -96.59 121.03 37.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.107 0.48 . . . . 0.0 109.849 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -100.16 174.72 6.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.96 -22.7 65.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.148 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.03 -38.84 94.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.451 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.537 ' O ' ' HB ' ' A' ' 29' ' ' THR . 9.6 t70 -72.89 -38.57 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.36 -46.2 97.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.303 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.6 -34.74 78.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.0 m -56.96 -46.39 82.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.415 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.33 -46.92 91.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -72.52 -19.29 61.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -66.47 -21.34 66.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.459 0.171 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -68.07 -18.4 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.994 0.426 . . . . 0.0 110.587 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.69 3.77 40.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 71.44 44.35 51.25 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.74 89.93 20.52 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 120.821 0.343 . . . . 0.0 111.256 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 97.3 Cg_endo -103.22 47.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.742 2.961 . . . . 0.0 110.949 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.5 t -104.56 -166.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' H ' HG11 ' A' ' 38' ' ' VAL . 10.0 m-20 -67.07 120.02 12.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -116.78 115.33 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.957 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.8 106.66 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.053 0.454 . . . . 0.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.99 141.17 28.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 78.7 p -73.81 100.23 3.4 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.345 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -106.38 146.41 30.5 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD2' HG23 ' A' ' 48' ' ' THR . 18.7 t70 -58.89 137.53 57.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.94 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.04 -9.73 58.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.271 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -102.6 -65.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.4 HG23 ' OD2' ' A' ' 45' ' ' ASP . 12.1 t -93.91 -25.67 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.55 35.78 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.688 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.41 154.84 24.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.249 0.524 . . . . 0.0 110.355 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 m -66.34 133.65 50.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.049 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 74.8 mt-30 -89.17 -14.1 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.55 -29.33 8.31 Favored Glycine 0 C--O 1.219 -0.825 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.389 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -108.83 173.44 6.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.011 0.905 . . . . 0.0 111.039 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.44 167.84 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.484 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -131.69 123.36 27.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.945 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 tp -111.45 138.16 48.32 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.712 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 35.0 tttm -122.24 123.09 40.64 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.443 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.73 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.6 p90 -143.7 148.56 35.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.278 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.6 106.08 17.1 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.727 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' HG21 ' A' ' 65' ' ' THR . 14.7 t70 177.07 126.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.218 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -70.65 -48.12 56.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -63.49 -40.02 95.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -60.94 -32.85 72.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.831 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.73 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.1 p -59.28 -45.73 90.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.347 0.594 . . . . 0.0 110.938 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.78 -38.92 45.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.543 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.17 -56.1 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.604 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.92 78.8 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 88.6 t -65.97 -53.14 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.05 -29.11 66.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -81.25 -48.96 11.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.17 -18.38 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 38.1 t-20 -61.86 112.35 2.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.922 0.391 . . . . 0.0 110.047 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . 105.76 -11.33 45.77 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.755 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -67.13 133.13 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -81.37 115.74 20.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.931 0.395 . . . . 0.0 111.697 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -132.37 112.43 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.82 29.67 67.01 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.749 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.5 16.35 80.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.347 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.5 148.72 51.71 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 122.788 -0.242 . . . . 0.0 110.48 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . . . -84.87 128.59 34.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.457 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 77.8 mt -62.72 108.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -89.22 99.73 12.66 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.589 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 9.8 mm -105.83 138.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -151.41 148.28 27.91 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.194 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -72.06 118.63 15.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.616 0.246 . . . . 0.0 110.428 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -132.15 160.24 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -106.62 136.91 45.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -149.97 136.61 19.2 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 4.3 mpt_? -108.92 127.19 27.77 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.91 104.32 0.17 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.71 2.273 . . . . 0.0 111.901 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.67 134.34 33.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 15.1 ptm180 -60.02 -22.73 62.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -65.31 -19.34 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.118 0.485 . . . . 0.0 110.454 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.9 16.95 6.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 13.7 pt20 -64.94 -20.26 66.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.583 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.08 -41.44 78.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.765 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.474 ' O ' HG12 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -62.96 -45.3 93.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.594 -178.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.14 -41.56 92.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.076 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 35.7 tt0 -74.25 -43.15 58.13 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.478 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.1 84.85 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.266 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.557 ' O ' HD12 ' A' ' 106' ' ' LEU . 10.4 m -70.15 -34.6 59.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.858 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.24 -44.11 97.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 5.1 mm-40 -61.27 -41.11 96.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.114 0.483 . . . . 0.0 109.926 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -70.7 -32.41 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.132 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 102' ' ' VAL . 5.8 mp -84.16 -44.72 13.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.664 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.912 -176.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 121.046 0.451 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 53.4 mt -121.7 107.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.714 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.2 mmt -110.37 124.61 32.83 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-O 121.074 0.464 . . . . 0.0 111.907 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 58.9 Cg_endo -72.09 166.29 30.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.105 2.537 . . . . 0.0 112.289 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.74 102.99 4.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.666 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -81.05 85.87 6.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.258 0.551 . . . . 0.0 111.728 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 70.0 m -113.72 119.35 41.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.308 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 98.55 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.151 1.901 . . . . 0.0 111.034 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.45 ' OG ' ' HG ' ' B' ' 217' ' ' LEU . 11.3 t -63.86 -40.88 97.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.8 20.36 68.43 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.45 ' HG ' ' OG ' ' B' ' 215' ' ' SER . 57.4 mt -65.29 -40.32 93.67 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -61.55 -27.1 68.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.899 0.381 . . . . 0.0 110.72 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.765 179.8 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.1 p90 -159.31 -178.89 7.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.845 0.355 . . . . 0.0 110.835 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -112.91 144.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.471 . . . . 0.0 111.309 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 83.9 t80 -97.13 131.0 44.32 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 mp -109.7 136.37 45.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.36 -169.4 45.89 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.262 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.24 114.67 0.99 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.369 0.604 . . . . 0.0 112.595 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.17 -170.87 1.94 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.217 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -82.98 151.32 25.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.975 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -66.91 -20.05 65.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.709 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.51 10.59 40.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.812 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.7 mt -96.27 127.21 42.07 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.9 p -110.3 -179.13 3.69 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 38.1 mt-10 -64.62 -25.26 67.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.983 0.42 . . . . 0.0 110.916 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.96 -42.05 70.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.451 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 29' ' ' THR . 14.3 m-20 -66.08 -42.64 89.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 109.942 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.14 -45.81 95.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.194 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.6 -35.49 81.16 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.049 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 28.1 m -57.49 -47.03 83.01 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.684 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.04 -48.89 86.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -75.53 -17.17 60.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 t -64.74 -32.42 74.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 0.0 110.235 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.05 -22.2 63.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 110.287 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.4 ' HH ' ' CD2' ' A' ' 72' ' ' LEU . 70.9 m-85 -89.42 0.76 56.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.227 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.78 38.85 97.18 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.62 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.06 88.52 52.53 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.228 0.537 . . . . 0.0 112.266 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -93.57 70.26 0.41 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.133 2.556 . . . . 0.0 110.244 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -117.76 -166.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.043 -177.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.46 ' H ' HG11 ' A' ' 38' ' ' VAL . 5.6 m-20 -64.27 120.46 12.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.672 0.272 . . . . 0.0 111.431 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.02 138.2 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.7 130.37 49.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 54' ' ' PHE . 49.3 tp -109.95 133.12 53.52 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 26.9 m -67.8 106.62 2.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -117.84 151.95 36.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 12.9 t70 -66.85 135.89 54.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.648 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -81.95 -11.44 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -84.45 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.76 0.314 . . . . 0.0 111.292 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -104.41 -20.4 13.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.024 0.44 . . . . 0.0 111.117 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 91.86 32.3 8.63 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.96 165.22 13.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.996 0.398 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -67.5 128.05 35.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.695 0.283 . . . . 0.0 110.601 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.87 -17.62 27.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.84 -4.41 29.03 Favored Glycine 0 C--O 1.221 -0.69 0 C-N-CA 120.075 -1.059 . . . . 0.0 115.207 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.54 ' O ' HD11 ' A' ' 42' ' ' LEU . 5.0 m-85 -114.46 146.84 40.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.049 0.924 . . . . 0.0 109.533 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -133.35 148.37 51.86 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 32.8 m-85 -129.29 138.78 51.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 25.0 tp -138.18 118.68 13.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.177 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -105.43 106.1 16.45 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.711 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.701 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 26.9 p90 -124.79 145.93 49.49 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -103.35 106.21 16.67 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.768 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 65' ' ' THR . 33.4 t70 176.46 108.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.557 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.17 -36.39 72.98 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -66.99 -49.11 66.38 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.427 ' HG ' ' HB3' ' A' ' 61' ' ' ASP . 19.6 p -69.97 -20.72 63.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.701 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 72.4 p -58.36 -46.78 85.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.1 mt -74.26 -36.15 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.044 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.6 tt -61.97 -54.79 36.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.126 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.66 90.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.867 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 65' ' ' THR . 79.4 t -60.92 -52.16 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.03 -38.38 79.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -69.89 -50.02 46.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.931 0.396 . . . . 0.0 111.267 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 94.7 mt -78.13 -12.98 60.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.083 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.91 109.86 1.38 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.35 . . . . 0.0 110.497 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.47 76.85 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.382 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -78.82 129.66 34.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 3.2 tppp? -82.05 116.01 21.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.166 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.4 mm -125.02 101.68 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.468 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.4 42.39 93.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.289 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 20.64 79.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.7 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 51.5 mmm-85 -129.68 144.19 51.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.1 118.7 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.726 0.298 . . . . 0.0 110.242 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 94.7 mt -64.89 140.14 58.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.2 0.524 . . . . 0.0 111.502 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.14 116.51 21.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 5.6 mm -111.7 138.15 41.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.0 145.56 37.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.668 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.36 127.86 32.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 14' ' ' TYR . 1.8 t -147.65 160.37 42.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.575 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -126.94 135.45 50.92 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -150.48 124.09 9.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.311 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -81.64 128.87 67.76 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.13 142.37 96.65 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.09 2.527 . . . . 0.0 112.602 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -95.47 137.72 34.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.389 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -18.12 58.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.032 0.444 . . . . 0.0 109.833 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -66.81 -27.6 67.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.425 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.34 31.79 5.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.285 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.78 -32.51 67.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.28 -21.13 63.91 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.442 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -70.25 -51.51 30.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -64.15 -30.73 71.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.96 -46.49 71.24 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.28 74.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.359 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.582 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 34.4 m -60.19 -35.0 59.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -58.65 -57.62 12.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.51 -34.91 79.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.508 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -65.5 -51.46 59.89 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.513 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 89.4 mt -61.17 -40.51 94.16 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.872 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -178.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 N--CA 1.444 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 7.4 mm -93.1 107.04 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.026 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 93.9 mmm -121.72 125.12 26.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.458 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 77.0 Cg_exo -52.66 132.97 48.33 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.227 2.618 . . . . 0.0 113.576 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -126.13 103.69 7.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.863 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -88.63 96.02 10.48 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.391 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 36.1 t -110.56 139.12 21.27 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.932 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.83 79.1 0.41 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.079 1.853 . . . . 0.0 111.908 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -67.74 -39.14 84.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.67 36.0 62.19 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.456 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.715 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -95.52 -5.88 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.521 -176.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 120.999 0.428 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 87' ' ' THR . 99.0 m-85 -154.4 141.2 19.1 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.178 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.463 HG22 ' HH ' ' A' ' 59' ' ' TYR . 25.1 pt -116.4 142.13 31.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.407 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -93.16 122.53 35.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 71.7 mt -107.45 138.49 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.85 -169.54 46.0 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.277 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -50.24 119.28 3.54 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 112.489 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.5 mt -98.87 169.46 9.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.173 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.445 HD21 HD11 ' B' ' 217' ' ' LEU . 56.7 t30 -70.28 149.22 47.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -64.71 -24.93 67.73 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.044 0.449 . . . . 0.0 110.726 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.85 5.33 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.823 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tt -96.7 127.24 42.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -110.73 179.75 3.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.266 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.4 -23.17 66.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.055 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.13 -41.61 96.94 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' B' ' 215' ' ' SER . 6.1 m-20 -65.1 -39.86 93.74 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.24 -49.67 80.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.68 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.87 -35.6 81.09 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.436 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -57.35 -45.43 84.37 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.07 -46.46 45.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.74 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -76.1 -19.61 58.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -19.86 66.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.092 0.473 . . . . 0.0 110.574 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.26 -0.69 15.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.738 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -96.88 -1.21 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.968 0.413 . . . . 0.0 110.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.45 -21.25 24.24 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.819 -0.705 . . . . 0.0 114.563 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.08 129.51 3.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 117.93 0.865 . . . . 0.0 112.29 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.5 112.56 1.07 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.585 2.19 . . . . 0.0 111.458 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 2.2 t -103.06 -167.54 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.468 ' H ' HG11 ' A' ' 38' ' ' VAL . 28.4 t70 -68.2 144.47 54.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.02 133.23 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 111.391 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.31 134.89 61.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.828 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.9 tp -132.22 139.6 48.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.715 0.293 . . . . 0.0 111.053 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.6 p -77.06 125.24 28.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.97 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -121.82 142.75 49.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.176 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.28 138.52 43.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.181 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.37 -17.12 52.87 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.41 -67.87 0.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.879 0.371 . . . . 0.0 111.171 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' HG3' ' A' ' 50' ' ' GLU . 9.9 t -115.36 -31.45 5.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.978 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.82 43.65 0.79 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.194 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.44 ' HG3' HG22 ' A' ' 48' ' ' THR . 43.1 mt-10 -94.53 168.47 10.84 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -74.99 134.63 41.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -84.05 -9.47 58.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.142 0.496 . . . . 0.0 110.591 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.23 3.45 51.0 Favored Glycine 0 C--O 1.222 -0.635 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.772 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.94 130.0 54.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.494 0.647 . . . . 0.0 110.192 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -131.07 141.2 50.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -128.19 127.98 43.91 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.7 tp -116.91 142.4 46.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.665 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 42.3 tttp -122.66 125.74 46.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.889 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.707 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -146.76 147.47 30.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 105.33 16.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.407 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' HG21 ' A' ' 65' ' ' THR . 30.4 t70 176.04 137.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.416 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -75.91 -45.52 34.89 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.788 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -62.75 -43.07 99.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 m -58.98 -27.58 65.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.848 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.707 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.1 p -63.98 -40.17 95.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.597 0.713 . . . . 0.0 109.942 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.9 mt -76.64 -39.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.12 -58.32 8.95 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.535 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.63 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.592 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 76.7 t -65.4 -59.98 3.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.599 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 -36.66 78.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.97 -51.04 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.71 -8.99 45.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 20.0 t-20 -62.74 109.69 1.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.131 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.59 2.07 76.65 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.682 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -72.51 137.49 46.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -85.64 110.1 19.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.777 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' B' ' 218' ' ' LEU . 29.0 mm -119.13 108.4 23.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.296 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.97 13.77 80.68 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.693 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.76 -10.42 58.95 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.75 130.95 35.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD13 HG13 ' A' ' 77' ' ' ILE . 60.4 mt -84.74 128.3 34.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -104.91 111.43 24.19 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 13.8 mm -105.21 129.33 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -135.92 -179.77 5.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -111.84 129.36 56.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.1 t -155.14 160.96 41.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.123 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -110.52 121.67 45.88 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.86 148.73 41.02 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -113.15 116.01 47.28 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.466 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.13 110.24 0.98 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 112.038 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -94.79 147.24 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.79 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -78.13 -0.66 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.604 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 m -63.5 -22.95 67.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 0.0 110.018 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -122.54 34.36 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.634 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.542 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 29.1 pt20 -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.271 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 29.8 mmtp -58.11 -44.53 87.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.018 0.437 . . . . 0.0 110.737 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 102' ' ' VAL . 11.8 t80 -62.98 -46.66 86.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.514 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -48.19 82.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.565 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 49.2 mt-10 -57.81 -49.45 76.58 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.081 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -38.23 81.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 98' ' ' TYR . 68.4 t -63.1 -51.98 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.886 0.374 . . . . 0.0 110.139 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -54.78 -48.67 72.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.91 -30.16 66.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.958 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.65 -47.38 69.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.705 0.288 . . . . 0.0 110.299 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.86 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 178.716 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . 0.534 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 17.5 t70 . . . . . 0 C--O 1.237 0.404 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 58.0 mt -136.78 140.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.576 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.441 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 2.9 mmt -107.73 143.85 28.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -73.1 175.61 10.26 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.728 2.286 . . . . 0.0 111.921 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.03 93.0 2.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 0.0 111.064 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -90.48 86.19 6.36 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.962 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 11.0 p -113.08 141.79 26.25 Favored Pre-proline 0 N--CA 1.435 -1.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.579 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 13.6 Cg_exo -70.25 86.84 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.906 1.737 . . . . 0.0 111.476 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.432 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 13.8 t -78.03 -51.25 10.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.54 36.71 58.66 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.63 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 19' ' ' ASN . 57.1 mt -60.35 -39.91 88.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.12 0.486 . . . . 0.0 111.058 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.04 -18.13 63.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.961 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . . . . . . 0 C--O 1.241 0.621 0 CA-C-O 120.255 0.074 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.685 ' CE1' ' HB2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -157.07 178.76 9.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.226 0.328 . . . . 0.0 110.313 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -118.97 145.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 0.0 111.738 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -94.57 133.77 37.85 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.274 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 62.6 mt -111.59 135.05 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 83' ' ' LYS . . . -87.45 -167.32 43.48 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.933 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 26.2 t-20 -39.69 112.48 0.26 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.372 1.069 . . . . 0.0 113.583 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -107.54 171.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.119 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -87.96 142.52 27.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -60.51 -23.96 64.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.905 0.384 . . . . 0.0 111.396 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -88.07 -7.6 56.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.75 111.02 22.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.491 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 p -91.87 173.9 7.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' B' ' 212' ' ' PHE . 7.5 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.725 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' B' ' 212' ' ' PHE . . . -70.51 -43.1 62.3 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.63 -41.03 98.3 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.97 -53.04 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.761 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.28 -33.17 74.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.69 0.281 . . . . 0.0 110.603 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 m -59.89 -45.59 92.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.543 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.43 -41.36 92.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.639 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.407 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 70.5 m-85 -74.79 -22.65 58.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -72.78 -17.62 61.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.324 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.56 -33.52 76.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 121.219 0.533 . . . . 0.0 109.774 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -91.73 -15.42 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.801 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.29 44.99 6.02 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.546 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -137.51 88.28 16.87 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 121.528 0.68 . . . . 0.0 111.596 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -98.44 99.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.502 2.802 . . . . 0.0 111.723 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -130.7 -165.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.8 m-20 -64.42 116.09 5.76 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.2 129.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.57 106.24 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 57.0 tp -87.21 131.31 34.24 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -74.97 102.44 4.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 19.1 mtp85 -115.7 149.43 38.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.464 ' OD2' HG21 ' A' ' 48' ' ' THR . 25.5 t70 -67.72 135.16 52.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.794 0.33 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.99 -28.25 66.18 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.46 -56.23 2.67 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.464 HG21 ' OD2' ' A' ' 45' ' ' ASP . 10.3 t -84.82 -23.1 29.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 44' ' ' ARG . . . 82.02 -6.54 66.51 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.698 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -71.34 155.34 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.688 -0.301 . . . . 0.0 111.274 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -68.63 138.18 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.3 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -85.25 -5.23 59.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.987 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 106.93 7.63 33.08 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.383 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -152.07 167.97 26.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.785 0.793 . . . . 0.0 110.924 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.44 176.28 11.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.27 0.557 . . . . 0.0 111.998 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.466 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 50.8 m-85 -136.62 153.02 51.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.932 . . . . 0.0 108.972 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 HD22 ' CZ ' ' A' ' 31' ' ' PHE . 12.4 tp -142.04 125.87 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.1 tmtm? -116.15 113.21 22.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.687 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 15.6 p90 -125.18 158.83 33.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.867 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 40.2 mt-10 -103.09 105.54 15.87 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.962 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.455 ' O ' HG21 ' A' ' 65' ' ' THR . 14.6 t70 175.7 133.46 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.79 -37.3 30.47 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.654 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -71.32 -40.61 70.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.72 0.295 . . . . 0.0 110.513 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 26.1 t -58.09 -27.83 64.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.687 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.4 p -60.82 -52.52 64.74 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.518 0.675 . . . . 0.0 109.775 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.87 -36.35 63.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.086 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.05 -61.18 2.83 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.367 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.07 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.481 HG22 ' CD2' ' A' ' 86' ' ' HIS . 54.2 t -64.36 -47.47 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.4 -33.37 60.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.107 0.479 . . . . 0.0 111.154 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.69 -53.19 7.84 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -91.43 -23.61 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 t30 -67.76 109.31 3.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.65 -5.05 32.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.673 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -75.05 126.35 30.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -83.72 122.76 29.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.386 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -136.5 120.29 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.299 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.77 35.83 87.77 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.408 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.47 3.91 86.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.742 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -133.09 154.5 50.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.546 0.673 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.12 134.82 43.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.727 0.299 . . . . 0.0 111.224 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 75.9 mt -73.22 125.72 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.593 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 56.2 mtpt -108.11 122.42 46.85 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -120.46 129.65 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.621 0.248 . . . . 0.0 110.483 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -138.99 146.22 40.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.127 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.481 ' CD2' HG22 ' A' ' 69' ' ' VAL . 14.7 m-70 -79.57 130.48 35.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.676 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.624 HG22 ' CE1' ' A' ' 12' ' ' TYR . 3.5 t -156.27 162.52 40.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.825 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -109.68 143.12 39.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.685 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 47.5 t80 -128.65 136.64 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.893 0.378 . . . . 0.0 111.178 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -108.07 96.03 16.83 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.74 146.71 84.49 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.98 2.453 . . . . 0.0 113.506 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.67 136.71 46.96 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.937 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.66 -6.96 44.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.868 0.366 . . . . 0.0 111.41 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -74.74 -27.68 60.45 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 17.26 16.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.987 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -59.04 -28.61 66.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.637 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.39 -40.09 85.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.097 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -72.86 -46.77 51.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.65 -51.82 68.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 36.4 mm-40 -62.27 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.493 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.84 -49.38 77.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.945 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -47.38 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.592 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -56.02 -54.41 45.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.539 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.3 pt-20 -69.89 -26.63 64.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.23 -58.16 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 107' ' ' ASP . 4.1 pp -66.47 -28.33 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.423 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.446 ' N ' HD12 ' A' ' 106' ' ' LEU . 19.0 t70 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.426 -1.636 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 46.6 mt -134.22 144.39 35.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.6 mmt -127.19 139.93 36.48 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.854 0.359 . . . . 0.0 111.713 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.61 151.23 41.33 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.435 2.09 . . . . 0.0 111.203 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -158.02 76.22 0.78 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 24' ' ' GLU . 36.8 p90 -110.88 115.72 30.01 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.7 p -110.28 117.96 50.3 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.263 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.84 114.49 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.75 2.3 . . . . 0.0 113.001 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.414 ' HB2' HD12 ' B' ' 217' ' ' LEU . 37.7 m -78.89 -40.48 32.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.69 38.35 8.18 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.386 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.3 mp -63.69 -40.18 96.17 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.15 -20.31 66.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.16 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.351 179.163 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.257 0.551 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 74.2 m-85 -147.59 156.0 42.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.126 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.21 133.39 69.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.656 0.265 . . . . 0.0 110.498 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -85.49 126.06 33.53 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -105.9 137.02 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.71 -169.5 45.96 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.557 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -53.67 112.39 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.654 0.782 . . . . 0.0 112.239 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 HD23 ' A' ' 22' ' ' LEU . 67.6 mt -102.74 -173.42 2.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.405 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 16.4 m120 -79.31 148.19 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.08 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -65.43 -35.69 81.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.85 7.82 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.803 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 18' ' ' LEU . 26.8 tp -81.67 109.96 16.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -85.17 166.07 16.89 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.615 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 32.1 mt-10 -65.66 -22.4 66.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.53 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -45.76 78.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.581 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -64.26 -40.48 96.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 110.471 178.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.66 -46.39 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.582 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.42 -30.63 70.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.103 0.478 . . . . 0.0 109.733 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 30.8 m -62.57 -41.14 98.75 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG21 HD13 ' B' ' 218' ' ' LEU . 81.4 t -67.5 -46.86 82.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.26 -21.99 55.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -70.77 -14.31 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.784 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.45 -8.73 55.75 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.391 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.627 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 79.8 m-85 -92.15 -10.9 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.63 10.45 86.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -129.15 89.83 47.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.683 0.278 . . . . 0.0 110.737 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -88.01 114.66 0.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.963 2.442 . . . . 0.0 111.964 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.6 t -132.31 -167.42 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.485 ' H ' HG12 ' A' ' 38' ' ' VAL . 6.4 m-20 -62.0 144.23 55.43 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.24 140.28 46.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.864 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -137.32 110.33 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.668 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.52 136.42 42.38 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -79.36 112.38 16.53 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -123.29 149.62 44.58 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.72 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.63 142.45 42.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.557 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.52 -29.3 41.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.819 0.342 . . . . 0.0 111.424 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.74 -58.01 3.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 50' ' ' GLU . 3.7 t -91.79 -40.28 11.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.13 43.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.558 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 48' ' ' THR . 42.7 mt-10 -67.49 160.33 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.968 0.507 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.2 m -75.69 141.37 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.03 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.81 -12.96 57.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.03 -30.58 7.9 Favored Glycine 0 C--O 1.216 -0.997 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.969 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -109.36 161.81 14.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.775 0.788 . . . . 0.0 111.575 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.54 26.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -134.09 135.27 43.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.735 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.8 tp -119.15 143.43 47.21 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 31.6 tttm -124.37 118.54 26.95 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.207 0.527 . . . . 0.0 111.788 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.772 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 12.3 p90 -138.82 144.04 39.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.45 104.4 14.85 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.675 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HG ' ' A' ' 64' ' ' SER . 25.1 t70 175.46 141.88 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.433 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -80.83 -37.48 29.96 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.02 -43.19 71.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' A' ' 61' ' ' ASP . 8.6 p -63.86 -22.72 67.05 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.772 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.1 p -62.23 -50.71 70.66 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.337 0.589 . . . . 0.0 109.762 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mt -64.78 -37.05 79.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.072 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.83 -58.65 7.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.426 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.66 89.23 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 65' ' ' THR . 72.2 t -57.32 -58.98 3.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.44 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.3 -31.38 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -67.23 -46.73 72.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.316 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 72.5 mt -93.78 -20.49 20.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.12 109.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.52 7.97 58.79 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.061 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.06 138.46 31.5 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -86.32 127.58 34.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.407 HG13 HD11 ' A' ' 82' ' ' LEU . 23.7 mm -131.91 110.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.88 20.84 77.96 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.753 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.31 -12.57 65.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.359 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -107.47 150.88 26.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.269 0.534 . . . . 0.0 110.926 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.51 33.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 111.067 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 78.5 mt -80.14 130.62 35.37 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -114.81 108.86 17.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.31 141.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.656 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.26 155.27 38.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.662 0.268 . . . . 0.0 110.95 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -71.68 128.25 35.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.625 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.4 t -153.72 161.26 42.27 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -108.94 159.26 16.95 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -149.48 138.92 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.355 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -112.78 113.73 49.92 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.8 140.34 79.58 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.722 2.282 . . . . 0.0 111.823 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -94.15 128.39 40.53 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -71.8 -15.26 62.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.068 0.461 . . . . 0.0 110.478 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -66.8 -29.63 69.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.6 30.87 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.628 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -53.38 -33.39 53.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.328 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -71.06 -27.09 63.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -68.37 -49.85 57.26 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -64.64 -32.17 73.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.221 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -53.31 48.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.421 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.431 ' HB3' ' SD ' ' B' ' 209' ' ' MET . . . -63.03 -38.39 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.914 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 9.0 p -70.92 -27.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.451 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 tptt -76.68 -42.53 41.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.958 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.76 -26.39 67.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.87 -31.04 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.999 0.428 . . . . 0.0 110.206 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 12.7 tp -63.39 -64.7 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.467 0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.769 -178.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 62.4 mt -108.26 131.09 59.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.797 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 101' ' ' ALA . 20.5 mmt -107.22 134.74 19.79 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.4 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 29.6 Cg_endo -62.05 129.59 27.78 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.205 2.603 . . . . 0.0 111.829 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -103.26 102.4 12.36 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.699 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.28 83.38 3.57 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.548 0.689 . . . . 0.0 109.674 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.0 t -113.64 119.41 41.54 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.446 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.31 96.61 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.707 1.605 . . . . 0.0 111.227 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.444 ' HB2' HD11 ' B' ' 217' ' ' LEU . 17.2 m -81.39 -43.79 18.48 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 81.28 38.82 13.84 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.905 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' B' ' 215' ' ' SER . 5.6 mp -62.72 -37.76 87.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.584 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 30' ' ' VAL . 2.6 pt? -80.34 -22.7 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.517 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.224 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.848 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -139.2 137.73 36.26 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.338 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.139 0.495 . . . . 0.0 111.667 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 50.5 t80 -88.42 132.0 34.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.991 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 63.4 mt -106.9 132.69 53.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.44 -168.22 44.55 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.696 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 66.5 t30 -52.12 108.76 0.31 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -175.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.96 -165.6 1.33 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.647 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -101.15 149.03 24.39 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -72.0 -26.53 62.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.72 -19.05 62.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.765 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.1 tp -84.04 109.04 17.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.418 ' O ' HG12 ' A' ' 27' ' ' ILE . 80.4 p -91.12 178.12 6.08 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 120.927 0.394 . . . . 0.0 110.704 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.34 -9.81 58.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.466 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.77 -45.8 56.52 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.33 -39.22 85.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 23' ' ' THR . 46.7 mm -51.11 -51.62 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.636 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -67.7 -36.85 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.8 m -61.95 -42.24 98.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.652 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.04 -45.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -79.34 -21.97 45.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -75.8 -12.57 60.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.954 -0.466 . . . . 0.0 111.069 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.41 -24.53 56.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.878 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -75.2 -1.65 24.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.71 -21.3 45.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.355 -0.45 . . . . 0.0 114.096 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.99 107.2 15.1 Favored Pre-proline 0 C--N 1.313 -0.988 0 O-C-N 122.462 -0.434 . . . . 0.0 110.906 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.8 100.9 1.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.534 2.156 . . . . 0.0 110.718 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -101.05 -166.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.306 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.485 ' H ' HG13 ' A' ' 38' ' ' VAL . 34.9 t70 -63.16 129.0 38.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.929 0.395 . . . . 0.0 111.478 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.8 134.87 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.766 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 mt -131.52 106.42 11.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -93.03 127.4 38.54 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.6 t -75.74 91.58 2.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.16 0.505 . . . . 0.0 110.952 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.473 ' NH1' ' HB3' ' B' ' 211' ' ' ASP . 4.4 tpt180 -91.44 136.14 33.33 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p30 -80.75 147.16 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.093 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HB3' HD11 ' B' ' 208' ' ' ILE . 1.5 pm0 -81.59 -9.59 59.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.042 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -75.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 111.473 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -112.68 -18.93 12.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.216 0.532 . . . . 0.0 110.153 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 90.82 32.05 9.5 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.937 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -103.93 171.29 7.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.806 0.336 . . . . 0.0 111.626 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -73.3 130.85 41.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.59 -8.65 58.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.014 0.435 . . . . 0.0 110.894 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 105.95 -3.55 38.58 Favored Glycine 0 C--O 1.206 -1.63 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.673 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -137.22 163.09 31.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 117.962 0.881 . . . . 0.0 111.292 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.03 175.28 12.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.34 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 84.4 m-85 -138.87 147.99 43.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 tp -137.39 144.11 42.27 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.568 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 31.5 tttt -132.39 123.27 26.42 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.659 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 6.2 p90 -134.06 150.91 51.21 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -101.18 103.59 14.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.654 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 174.29 122.87 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.097 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -69.24 -33.36 73.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.04 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -68.04 -41.38 82.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 0.0 111.531 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.3 m -61.9 -26.32 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.659 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.7 p -61.57 -50.78 71.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.568 0.699 . . . . 0.0 109.955 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.6 mt -70.98 -34.77 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.182 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.36 -58.21 8.52 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.831 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.12 75.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 95.7 t -69.01 -30.14 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.154 0.502 . . . . 0.0 111.594 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.41 -31.9 18.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.275 0.56 . . . . 0.0 111.355 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.22 -45.23 9.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.006 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.04 -30.78 13.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 69' ' ' VAL . 8.8 t30 -67.42 109.89 3.37 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.816 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.78 31.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.185 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -72.71 132.22 43.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.21 116.85 21.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.305 0.574 . . . . 0.0 112.334 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.61 109.6 22.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.02 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.89 30.82 77.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.765 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 -13.61 65.43 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.238 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.72 148.7 35.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.925 0.363 . . . . 0.0 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.99 143.46 26.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.691 0.282 . . . . 0.0 111.307 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 87.7 mt -76.74 124.41 27.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.238 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 40.0 ttmt -104.64 117.06 33.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mm -114.96 117.22 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -127.32 146.13 50.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.738 0.304 . . . . 0.0 111.324 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -80.04 125.36 29.69 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -154.96 160.65 41.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -100.55 99.63 10.25 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -115.86 132.76 56.55 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.432 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -113.98 132.87 22.47 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.962 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.16 163.24 34.93 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 60.6 mttp -98.72 129.34 45.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.31 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.36 -11.82 60.13 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.872 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -75.08 -32.73 61.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.18 0.514 . . . . 0.0 110.236 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -89.53 33.46 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -51.4 -36.13 42.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.085 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -60.41 -49.36 77.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 111.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.82 -51.47 69.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.326 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.516 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 59.3 m-85 -61.58 -36.3 80.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.287 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 37.7 tt0 -66.5 -51.88 52.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.24 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.7 69.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.194 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HD12 ' A' ' 106' ' ' LEU . 74.4 t -69.52 -50.41 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -58.1 -44.89 87.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.779 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.5 pt-20 -70.56 -24.42 62.79 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.058 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.1 -41.96 66.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 102' ' ' VAL . 10.6 mp -63.01 -42.17 99.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.005 176.823 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 46' ' ' GLU . 69.3 mt -107.66 126.73 64.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.1 mmt -121.63 145.65 43.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.745 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.3 148.14 54.65 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.838 2.359 . . . . 0.0 112.645 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.473 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 25.4 t70 -117.15 98.41 6.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.44 89.1 5.73 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 33.9 m -110.21 139.88 21.86 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.941 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 3.1 Cg_exo -75.08 84.88 1.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.896 1.731 . . . . 0.0 110.98 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 50.2 m -81.53 -51.12 8.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.186 0.517 . . . . 0.0 110.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.12 43.74 89.29 Favored Glycine 0 N--CA 1.431 -1.666 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.758 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.26 -34.73 75.64 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.121 0.46 . . . . 0.0 110.371 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -79.06 -11.73 60.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.244 0.545 . . . . 0.0 110.563 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.443 -0.784 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.209 -178.335 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.209 0.528 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 63.7 m-85 -142.26 139.81 32.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.036 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -116.45 133.48 62.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.038 0.447 . . . . 0.0 110.808 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -88.01 125.94 34.81 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.857 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.33 143.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.99 -169.37 45.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.119 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.76 133.73 56.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 0.0 111.597 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 mt -125.89 160.33 30.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.02 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.35 146.05 49.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.01 -21.22 65.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.429 . . . . 0.0 110.724 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.75 -13.65 58.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.76 129.58 34.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.1 p -109.27 179.37 4.18 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.895 0.379 . . . . 0.0 110.681 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.91 -21.07 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 110.049 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.26 -34.22 85.0 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.552 ' O ' ' HB ' ' A' ' 29' ' ' THR . 27.5 m-20 -72.12 -36.76 69.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.69 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.74 -34.64 78.65 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.385 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 53.4 m -59.24 -46.82 87.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.101 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 26' ' ' ASP . 58.3 t -67.52 -50.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.943 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -70.86 -9.34 57.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -22.08 66.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.845 0.355 . . . . 0.0 110.124 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.99 -19.5 64.94 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.213 0.53 . . . . 0.0 110.654 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 39.1 m-85 -83.01 -20.16 35.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.82 17.13 80.16 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.203 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.87 104.57 3.9 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.378 0.608 . . . . 0.0 111.207 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.07 116.3 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.747 2.298 . . . . 0.0 111.961 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.45 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -124.83 -166.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.45 ' H ' HG11 ' A' ' 38' ' ' VAL . 5.9 m-20 -62.55 120.34 10.93 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.01 111.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.292 0.568 . . . . 0.0 109.938 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.432 HG12 ' CZ ' ' A' ' 99' ' ' TYR . 4.3 mp -108.46 104.48 17.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.57 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.29 120.58 26.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 m -75.14 99.34 3.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.139 0.495 . . . . 0.0 110.964 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH2' ' H ' ' B' ' 211' ' ' ASP . 56.5 mtt180 -103.91 170.16 8.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.762 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.7 p-10 -108.78 149.35 29.18 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' HD13 ' B' ' 208' ' ' ILE . 4.6 pt-20 -81.46 -9.95 59.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.27 -61.99 1.82 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.944 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -105.49 -28.02 11.06 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.871 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 94.32 24.8 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.833 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 10.8 pt-20 -101.57 169.68 8.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -68.5 132.13 46.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.48 2.69 21.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.869 0.366 . . . . 0.0 111.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.78 9.66 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.043 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -169.51 163.15 10.32 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.05 0.452 . . . . 0.0 111.349 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.52 161.44 42.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.433 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -133.04 130.84 39.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.44 ' CD2' ' HD2' ' A' ' 59' ' ' TYR . 8.3 tt -121.15 139.07 53.85 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.912 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 13.5 tmtt? -125.69 121.07 32.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.441 0.639 . . . . 0.0 111.474 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.662 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 7.6 p90 -131.8 151.25 51.8 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.587 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.02 104.97 15.66 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.953 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 176.4 137.95 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.134 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -78.36 -40.97 34.75 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.417 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -69.47 -41.04 76.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 111.254 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -58.08 -26.67 62.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.999 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.662 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 53.0 p -62.83 -42.96 99.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.602 0.715 . . . . 0.0 110.401 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.1 mt -75.18 -41.05 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.031 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.87 -52.73 64.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.851 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.545 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -57.8 -43.92 85.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.863 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.43 -57.72 10.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.163 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.29 -24.61 67.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -82.54 -54.0 5.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.8 0.333 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HG ' ' HH ' ' A' ' 34' ' ' TYR . 79.0 mt -93.62 -16.1 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.68 109.75 2.13 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -0.36 61.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.523 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -69.13 136.87 52.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.38 122.97 33.73 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.95 118.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.702 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.27 8.52 79.73 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.342 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.89 10.23 46.87 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -129.43 145.38 51.43 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.027 -0.586 . . . . 0.0 110.771 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.19 32.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.872 0.368 . . . . 0.0 111.203 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.44 120.43 22.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.1 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -92.98 113.31 25.55 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.2 mm -118.59 118.89 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.653 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -135.81 149.76 49.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.878 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -76.23 134.76 39.75 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.2 t -160.13 160.58 33.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -91.16 153.09 20.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 44.9 t80 -147.13 119.4 8.34 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.089 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -112.26 99.27 45.98 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.879 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.61 149.52 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -85.13 149.09 25.77 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.04 -8.8 40.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.044 0.45 . . . . 0.0 110.571 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -68.62 -19.06 64.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.221 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.5 mt -118.49 24.43 10.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.58 0.229 . . . . 0.0 111.566 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.1 pt20 -69.97 -25.61 63.71 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.195 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -67.28 -24.42 65.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -69.38 -36.69 77.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CZ ' HG12 ' A' ' 41' ' ' ILE . 53.2 m-85 -69.12 -41.53 77.27 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.077 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 41.8 mm-40 -58.96 -50.64 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' SD ' ' B' ' 209' ' ' MET . . . -57.89 -51.21 70.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.734 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 13.1 p -64.1 -37.87 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.02 -49.31 76.54 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.433 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 54.9 mt-10 -64.67 -38.32 90.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.44 -50.17 72.52 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.927 0.394 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 85.5 mt -65.99 -41.99 90.39 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.164 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.383 179.349 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 122.022 0.915 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 46' ' ' GLU . 66.4 mt -128.74 137.63 56.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.068 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.475 ' SD ' ' HB1' ' A' ' 101' ' ' ALA . 21.3 mmt -110.09 145.23 31.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 14.6 Cg_exo -70.04 129.05 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.012 2.475 . . . . 0.0 112.295 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.444 ' H ' ' NH2' ' A' ' 44' ' ' ARG . 31.2 m-20 -96.01 82.48 3.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.505 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.17 89.39 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.516 . . . . 0.0 110.912 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 3.2 m -112.37 129.48 24.3 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.52 70.32 7.34 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.857 1.704 . . . . 0.0 111.293 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.4 m -65.49 -50.21 66.14 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.62 43.62 96.19 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.691 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.57 -50.65 71.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.38 -31.61 72.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -178.291 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.191 0.52 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 75.5 m-85 -133.48 146.01 50.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.077 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.95 137.15 52.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.342 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 74.8 t80 -85.28 128.89 34.86 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.624 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.18 132.26 61.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.86 -168.59 44.59 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.215 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -49.77 119.99 3.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.517 0.675 . . . . 0.0 112.669 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.29 179.1 4.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -81.81 151.04 27.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.693 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -73.99 -17.13 61.03 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.056 0.455 . . . . 0.0 111.231 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.23 -14.57 40.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.344 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.26 109.32 17.7 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.838 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 27' ' ' ILE . 54.1 p -88.77 176.39 7.09 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.236 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.3 -25.09 67.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.287 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.96 -44.73 54.72 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -63.83 -33.48 75.78 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.755 0.312 . . . . 0.0 110.938 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 23' ' ' THR . 64.5 mt -58.17 -53.09 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.275 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.33 -21.15 62.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.983 0.42 . . . . 0.0 110.673 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.5 m -63.99 -42.89 97.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.533 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.52 -48.46 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.095 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -70.96 -6.97 42.77 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 p -50.87 -44.38 59.64 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.247 0.546 . . . . 0.0 111.631 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -76.32 -6.88 53.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.624 0.726 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.98 26.38 8.62 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.525 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.68 70.09 0.35 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 118.829 -1.653 . . . . 0.0 112.756 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' O ' HG21 ' A' ' 38' ' ' VAL . 12.4 m -44.0 147.52 0.9 Allowed Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.26 1.024 . . . . 0.0 112.634 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -11.34 98.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.7 4.934 . . . . 0.0 117.029 -173.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -128.82 -164.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 26.9 m-20 -70.41 109.54 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.725 -175.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.66 143.35 21.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.2 106.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.11 121.83 37.15 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.2 t -78.42 110.32 13.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.045 0.45 . . . . 0.0 110.51 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -110.45 154.67 23.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.87 139.24 48.75 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.74 -9.56 58.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -109.75 -60.44 1.78 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.3 t -89.62 -11.22 43.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.16 66.82 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.912 -0.661 . . . . 0.0 114.229 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -78.35 156.79 29.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.024 0.412 . . . . 0.0 110.244 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.5 p -65.2 128.85 37.51 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.18 -14.73 63.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.804 0.335 . . . . 0.0 111.608 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.69 18.52 8.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.17 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -161.81 159.42 26.98 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 120.922 0.391 . . . . 0.0 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.43 170.61 19.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.804 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -136.34 139.2 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.7 tp -126.2 130.63 51.34 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.619 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.1 tttt -116.15 103.58 10.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.585 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 37.4 p90 -118.66 153.45 34.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 tt0 -101.02 105.8 17.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.814 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 13.4 t70 175.48 108.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.058 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -73.59 -8.75 57.21 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.72 -49.23 6.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 0.0 109.911 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -63.84 -26.89 68.82 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.396 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.682 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 17.2 p -59.12 -41.32 87.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 110.337 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 mm -69.01 -49.18 65.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.637 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.73 -55.56 28.92 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.252 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.7 74.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 68.0 t -60.48 -48.09 89.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.29 -33.88 42.92 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.192 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.24 -44.95 35.16 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.35 -15.09 58.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 53.2 t30 -68.45 108.72 3.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.79 -8.91 59.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.776 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.96 128.51 35.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.37 134.84 33.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.33 109.88 3.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.583 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.79 22.13 75.3 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.554 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.71 -3.9 81.61 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.473 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.07 123.65 49.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 111.048 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.96 107.68 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.76 143.73 53.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.37 111.7 21.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 8.4 mm -114.74 138.72 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -146.4 146.9 30.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.157 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -72.16 124.8 25.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -147.4 160.8 42.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.01 0.434 . . . . 0.0 110.928 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.6 117.49 34.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 57.2 t80 -102.74 127.6 49.82 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.891 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -100.18 102.08 16.81 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 50.9 Cg_exo -55.85 126.6 22.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.243 2.629 . . . . 0.0 113.706 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -77.13 128.65 34.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -77.28 -12.56 59.96 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.574 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 m -64.42 -23.07 67.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.404 0.621 . . . . 0.0 109.819 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.41 26.29 5.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.459 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -54.16 -46.42 72.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.873 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -71.67 -27.06 62.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 110.722 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -68.15 -48.78 64.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -59.52 -44.42 93.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 35.6 tt0 -60.96 -52.62 64.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.528 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.16 75.48 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 53.7 t -59.0 -49.21 84.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -64.04 -44.09 93.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 36.6 mt-10 -62.36 -43.16 99.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 110.509 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.29 -43.46 83.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.551 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -69.93 -43.06 72.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.064 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.959 -179.817 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.863 0.363 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.66 130.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.01 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.8 mmt -124.29 149.12 60.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.142 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.92 170.47 16.63 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -147.28 114.65 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -108.37 88.18 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.621 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -111.38 119.59 44.88 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.94 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 110.83 1.23 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.448 2.099 . . . . 0.0 112.536 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 19.8 m -101.64 -50.82 3.61 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.83 41.25 50.18 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.786 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.14 -30.04 69.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.322 0.561 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.99 -26.86 68.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.171 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 0.0 110.987 -177.332 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 21.6 m-85 -147.7 148.07 30.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.07 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.17 136.52 60.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.981 0.419 . . . . 0.0 110.542 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -86.39 131.54 34.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.585 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -113.7 138.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -171.27 47.57 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.422 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.2 t-20 -58.9 104.8 0.26 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.286 0.565 . . . . 0.0 111.735 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -95.41 -172.46 2.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 40.7 t30 -76.37 130.05 37.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -66.14 1.33 1.55 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.43 -10.58 29.53 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.182 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 19' ' ' ASN . 6.5 mp -76.06 140.12 41.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.029 0.442 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.498 HG22 ' HB2' ' B' ' 213' ' ' SER . 44.0 p -110.44 -178.12 3.41 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.785 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.71 -36.25 82.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.52 95.31 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.492 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 29' ' ' THR . 13.8 m-20 -63.32 -47.83 80.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 110.377 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.68 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.717 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.12 -38.18 90.16 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.318 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.8 m -56.12 -45.22 79.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.716 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.25 -46.39 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.102 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.05 -20.12 33.22 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 t -63.73 -24.72 67.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.648 0.261 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.29 -7.13 28.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.76 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HH ' ' CD2' ' A' ' 72' ' ' LEU . 29.0 m-85 -88.35 -4.09 58.73 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.985 0.421 . . . . 0.0 110.895 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.27 -20.99 27.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.048 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.72 111.03 9.54 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 117.42 0.61 . . . . 0.0 111.582 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.68 110.44 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.789 2.326 . . . . 0.0 111.082 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG11 ' H ' ' A' ' 39' ' ' ASP . 1.9 t -111.03 -167.23 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.498 ' H ' HG11 ' A' ' 38' ' ' VAL . 31.2 m-20 -73.36 147.04 44.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.56 140.73 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.391 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.94 99.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.67 0.271 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 1.3 tt -84.85 122.99 29.95 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 m -67.4 122.25 17.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.461 ' HD2' ' OH ' ' A' ' 98' ' ' TYR . 81.1 mtt85 -121.34 161.27 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.07 147.07 26.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.042 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' B' ' 208' ' ' ILE . 1.9 mp0 -72.68 -25.12 61.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -93.08 -59.68 1.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -81.87 -24.48 35.74 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.462 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.82 77.9 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.026 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.4 166.61 21.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.819 0.343 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.7 p -70.15 142.29 52.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.58 3.23 48.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.148 0.499 . . . . 0.0 110.305 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.76 -31.93 8.17 Favored Glycine 0 C--O 1.219 -0.828 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.73 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -109.61 162.36 14.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.164 0.482 . . . . 0.0 111.174 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.81 171.48 16.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.234 0.54 . . . . 0.0 111.587 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -134.39 133.83 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.11 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.9 tp -114.37 144.98 42.4 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.972 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 39.2 tttm -125.51 123.35 38.96 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.244 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.71 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 23.4 p90 -148.15 145.86 28.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -100.95 105.46 16.7 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.805 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 65' ' ' THR . 39.1 t70 175.71 134.15 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.809 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.84 -53.97 22.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.803 0.335 . . . . 0.0 111.179 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -59.31 -39.91 84.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.999 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -61.1 -27.98 68.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.71 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.7 p -69.6 -36.29 76.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.583 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.96 -47.61 54.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.305 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.73 -54.85 40.18 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.76 77.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 86.8 t -60.86 -48.46 88.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.194 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.19 -41.21 81.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -71.85 -53.74 12.29 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 3.0 mm? -80.08 -25.57 39.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 33.9 t-20 -62.37 109.57 1.39 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.071 0.462 . . . . 0.0 111.143 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.65 -4.79 50.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.129 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.52 131.91 43.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 110.382 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 mt -127.2 105.18 13.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.986 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.65 71.77 Favored Glycine 0 C--N 1.312 -0.784 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.734 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.57 -19.57 43.54 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -89.26 143.93 26.47 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.571 0.224 . . . . 0.0 110.444 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.97 128.29 47.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 55.1 mt -68.77 110.6 4.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.688 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.87 111.66 23.58 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.53 141.82 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.479 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -149.78 148.91 29.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.584 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.18 121.16 23.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -133.71 160.11 38.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.649 0.261 . . . . 0.0 110.881 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -106.63 118.41 36.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.55 160.88 43.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.69 155.32 35.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.241 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 99' ' ' TYR . 32.2 Cg_exo -58.74 132.52 48.4 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.84 2.36 . . . . 0.0 113.434 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.28 142.32 34.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.093 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -71.45 -17.05 62.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.881 0.372 . . . . 0.0 111.219 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -74.99 -26.06 59.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.23 0.538 . . . . 0.0 110.371 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.93 28.56 8.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.211 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -53.81 -37.48 63.59 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.952 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.69 -23.93 65.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.424 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.461 ' OH ' ' HD2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.9 -51.73 20.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 91' ' ' PRO . 53.1 m-85 -63.27 -41.2 99.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.58 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 44.9 mt-10 -64.24 -50.16 69.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.229 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.92 68.37 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.98 -45.29 80.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.779 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.41 -25.26 68.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.51 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 43.8 mt-10 -59.67 -40.88 89.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.15 -25.81 58.66 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.439 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.01 -42.6 60.12 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.44 178.87 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.419 HD13 ' HG3' ' A' ' 46' ' ' GLU . 21.7 mt -137.94 139.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.582 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 2.5 mmt -135.58 133.62 20.39 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.621 0.248 . . . . 0.0 111.494 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.582 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 42.2 Cg_endo -69.91 142.95 48.62 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.313 2.009 . . . . 0.0 110.563 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -104.22 133.41 49.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.074 0.464 . . . . 0.0 111.355 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.25 86.82 2.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.138 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.498 ' HB2' HG22 ' A' ' 23' ' ' THR . 34.2 m -113.74 119.46 41.25 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 175.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 82.59 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.88 1.72 . . . . 0.0 111.178 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.8 m -72.24 -50.53 26.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.349 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.1 32.42 56.33 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.26 -35.19 73.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.378 . . . . 0.0 111.656 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.4 ' H ' HD21 ' B' ' 218' ' ' LEU . 0.8 OUTLIER -70.11 -30.2 67.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 178.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 0.0 110.008 -179.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.886 0 CA-C-O 121.192 0.52 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 87' ' ' THR . 89.7 m-85 -134.1 151.73 51.52 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 17.8 pt -121.88 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.952 0.406 . . . . 0.0 110.62 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.6 t80 -75.11 129.63 37.88 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.668 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -115.64 144.53 23.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.58 -169.07 44.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.761 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -54.92 117.29 3.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.545 0.738 . . . . 0.0 110.878 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.39 162.88 12.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.896 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.12 149.68 47.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -71.91 -8.92 57.22 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.382 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -97.71 -3.37 39.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.577 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.59 112.9 22.77 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.839 0.352 . . . . 0.0 110.395 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 27' ' ' ILE . 30.2 p -98.88 173.33 6.91 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' CD ' HH12 ' A' ' 44' ' ' ARG . 2.0 mp0 -60.22 -27.47 67.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.71 -40.92 85.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 29' ' ' THR . 18.4 m-20 -67.93 -37.32 81.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 23' ' ' THR . 66.8 mt -60.76 -49.0 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.1 -32.5 74.09 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 27.1 m -58.77 -46.09 88.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.432 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.38 -40.52 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.89 -14.32 56.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.7 m -63.23 -19.53 64.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.54 -28.91 69.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.38 0.61 . . . . 0.0 109.893 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HH ' ' HG ' ' A' ' 72' ' ' LEU . 49.9 m-85 -78.28 -14.22 59.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 14.77 69.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.056 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.04 89.55 33.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.3 98.68 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.624 2.216 . . . . 0.0 110.245 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.51 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -126.23 -166.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.349 -176.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' H ' HG11 ' A' ' 38' ' ' VAL . 22.4 m-20 -60.43 135.17 57.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -128.44 130.48 69.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.85 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.21 102.52 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.735 0.302 . . . . 0.0 111.327 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.449 HD12 ' NH2' ' A' ' 44' ' ' ARG . 1.7 tt -91.9 124.45 36.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.6 t -74.57 121.8 22.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.078 0.466 . . . . 0.0 111.886 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 5.3 mpt_? -120.1 165.43 14.75 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.69 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -89.59 160.86 16.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.945 0.402 . . . . 0.0 110.05 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -80.97 -9.5 59.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.25 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -93.06 -69.78 0.73 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 t -97.72 -40.33 8.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.94 32.73 2.77 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.796 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 32.6 mm-40 -91.79 153.05 19.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.788 0.327 . . . . 0.0 110.309 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -70.53 130.99 43.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.02 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -75.96 -0.38 21.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.72 16.04 37.86 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.88 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -162.62 156.17 20.38 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.005 0.431 . . . . 0.0 111.172 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.99 171.08 14.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 66.1 m-85 -139.53 140.47 37.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 12.8 tp -120.53 139.25 53.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -125.39 115.41 20.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.0 110.505 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.716 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.8 p90 -134.23 158.21 44.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 50.9 mt-10 -100.26 105.54 17.11 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.587 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' O ' HG21 ' A' ' 65' ' ' THR . 11.4 t70 175.43 125.63 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.086 0.866 . . . . 0.0 108.935 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -73.04 -54.63 8.06 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.089 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -64.5 -31.41 72.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.4 m -70.06 -19.79 63.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.716 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 65.4 p -67.35 -45.53 76.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.934 0.874 . . . . 0.0 109.002 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.8 mt -70.12 -41.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.28 -55.54 23.92 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.119 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -48.26 65.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 86' ' ' HIS . 90.6 t -63.59 -54.45 32.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.292 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.83 -31.71 73.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' HG ' ' HH ' ' A' ' 34' ' ' TYR . 93.0 mt -93.28 -13.98 27.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.06 109.18 2.9 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.403 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.25 52.67 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.09 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -73.91 138.92 44.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 121.6 32.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 111.908 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.97 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.83 35.69 91.67 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.77 -14.73 55.49 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.144 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -104.22 146.69 28.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.003 0.401 . . . . 0.0 110.527 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.32 129.46 41.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.872 0.368 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.57 108.2 7.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 9.3 mtmp? -91.35 104.57 17.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 14.9 mm -106.58 141.03 22.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.611 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -150.68 153.14 35.04 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.746 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.45 ' CD2' HG23 ' A' ' 69' ' ' VAL . 43.8 m-70 -78.8 119.56 22.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.8 t -160.36 161.27 33.09 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -112.32 143.93 42.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -119.4 119.87 35.21 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.845 0.355 . . . . 0.0 110.583 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.65 104.14 54.68 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.13 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' ' HH ' ' A' ' 99' ' ' TYR . 58.8 Cg_endo -86.03 -178.56 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.768 2.312 . . . . 0.0 111.859 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.38 151.7 23.87 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -66.81 -9.45 37.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -75.26 -19.4 59.74 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.24 18.29 22.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 13.9 pt20 -63.0 -25.39 68.37 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.907 0.384 . . . . 0.0 110.095 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.554 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 12.7 mptt -52.95 -39.05 62.61 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.336 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.432 ' O ' HG21 ' A' ' 102' ' ' VAL . 3.6 t80 -63.08 -52.02 64.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.425 ' HH ' ' HG3' ' A' ' 91' ' ' PRO . 53.3 m-85 -64.25 -36.34 83.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.893 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 52.5 mt-10 -65.37 -54.05 34.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.597 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.99 69.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.734 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 106' ' ' LEU . 92.7 t -63.43 -57.62 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.87 -41.83 98.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.838 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.63 -36.83 79.6 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.08 -33.63 65.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 102' ' ' VAL . 6.6 mp -63.78 -48.82 75.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.84 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 121.354 0.597 . . . . 0.0 110.574 178.015 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.914 0.387 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.15 102.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.554 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 92.0 mmm -107.73 139.84 20.99 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.976 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.46 155.71 66.15 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.689 2.259 . . . . 0.0 111.856 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.39 124.54 34.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -109.81 87.98 2.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.597 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.424 ' HB3' HG23 ' A' ' 23' ' ' THR . 33.2 t -112.36 117.73 46.83 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 15.8 Cg_exo -69.35 91.33 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.129 1.886 . . . . 0.0 111.794 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 4.2 m -76.66 -41.98 43.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.33 56.33 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.087 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.47 -36.73 85.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.343 . . . . 0.0 111.391 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.404 ' H ' HD22 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -79.26 -22.83 44.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.85 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 120.755 0.312 . . . . 0.0 110.762 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 50.2 m-85 -127.55 139.59 52.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.293 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.02 123.45 62.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.153 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 52.4 t80 -86.53 127.45 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 42.8 mt -109.79 141.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.96 -169.67 46.1 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.514 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -39.62 111.89 0.22 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.436 1.094 . . . . 0.0 113.87 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.52 -178.49 3.61 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.479 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.98 149.54 24.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.19 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 9.0 mpt_? -76.42 -20.14 57.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.487 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 -10.0 59.12 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.429 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.93 112.15 22.23 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.628 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 p -102.49 -178.85 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.81 0.338 . . . . 0.0 111.047 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.97 -22.41 60.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.371 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.42 53.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.101 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -69.93 -40.55 75.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.723 0.297 . . . . 0.0 110.842 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.91 -43.8 85.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.26 -36.94 82.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 48.6 m -59.69 -36.8 77.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.04 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.76 -38.69 58.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -77.03 -28.16 54.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 p -66.73 -12.72 59.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 111.093 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.06 -21.86 65.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.188 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -2.55 58.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.084 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.61 3.62 90.57 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.204 -0.522 . . . . 0.0 114.152 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.66 106.42 2.53 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 117.305 0.553 . . . . 0.0 112.146 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.28 114.32 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.855 2.37 . . . . 0.0 111.785 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.3 t -111.89 -165.6 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' H ' HG12 ' A' ' 38' ' ' VAL . 18.3 m-20 -61.56 112.19 2.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.36 130.17 65.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.056 0.455 . . . . 0.0 110.618 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.37 130.37 74.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.329 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 tp -116.65 139.52 50.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.446 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 37.2 p -73.21 103.89 4.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 7.4 tpp180 -106.89 131.85 53.52 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.78 137.46 57.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' HG2' HD11 ' B' ' 208' ' ' ILE . 33.0 mt-10 -80.19 -9.5 59.72 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -111.29 -58.0 2.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.816 0.341 . . . . 0.0 111.598 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 p -81.49 -40.75 22.76 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.524 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 95.05 17.64 36.87 Favored Glycine 0 N--CA 1.407 -3.299 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.659 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.95 170.37 11.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 20' ' ' ARG . 5.1 p -86.82 130.46 34.46 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.446 ' OE1' ' HB2' ' A' ' 43' ' ' SER . 87.7 mt-30 -70.9 -20.69 62.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.028 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.28 -2.88 29.66 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.791 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.47 143.04 39.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.459 0.63 . . . . 0.0 110.06 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -130.92 142.52 50.37 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.424 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 119.59 22.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.03 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.5 tp -111.12 136.18 50.54 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 12.6 tmtt? -121.86 121.24 36.72 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.095 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 16.2 p90 -140.49 156.6 46.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.121 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 mp0 -100.75 105.65 17.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.902 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 12.0 t70 175.33 141.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.943 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -80.54 -51.4 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.238 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.0 -38.72 92.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.321 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 12.3 t -60.73 -28.37 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.969 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.67 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.4 p -63.73 -46.72 84.1 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 121.477 0.656 . . . . 0.0 110.027 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.69 -39.11 68.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.127 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.78 -60.41 3.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.173 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.75 83.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.437 HG21 ' CD2' ' A' ' 86' ' ' HIS . 65.9 t -60.18 -55.08 26.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.71 -9.59 59.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -87.69 -53.91 4.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.38 -19.73 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 63.3 t30 -60.78 109.29 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.11 0.481 . . . . 0.0 111.33 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.44 33.79 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.919 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -72.87 132.91 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -93.28 123.16 36.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mt -126.57 112.7 30.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.88 23.84 69.58 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.322 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 -16.39 61.16 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.662 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -96.01 139.74 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 133.87 34.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 85.5 mt -74.72 102.77 4.75 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.05 109.14 21.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 7.1 mm -101.74 131.94 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.14 142.21 47.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.613 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.437 ' CD2' HG21 ' A' ' 69' ' ' VAL . 22.9 m-70 -72.42 112.86 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -133.25 161.26 34.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.044 0.449 . . . . 0.0 111.036 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -114.23 99.74 7.84 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.459 0.647 . . . . 0.0 109.848 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' HB3' ' CD2' ' A' ' 12' ' ' TYR . 87.2 t80 -95.3 139.77 31.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.033 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -110.95 116.86 51.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.272 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.05 129.01 32.59 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.695 2.263 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.19 128.99 42.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.179 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -68.75 -21.12 64.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.32 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -76.1 -6.08 49.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.161 0.505 . . . . 0.0 110.365 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.4 mt -122.72 22.22 9.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -62.32 -26.18 68.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.222 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' HE1' ' B' ' 209' ' ' MET . 35.5 mmtp -59.02 -38.86 80.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.385 0.612 . . . . 0.0 109.972 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.71 -44.24 64.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.144 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.82 -43.02 97.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.693 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -69.04 -46.62 67.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.13 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.7 t -61.53 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.062 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.79 -41.8 78.36 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.087 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -65.02 -36.79 85.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.085 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.16 -39.95 68.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.685 0.278 . . . . 0.0 110.423 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -57.66 -53.8 54.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.451 -177.885 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.5 t70 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.448 HD11 ' HG2' ' A' ' 46' ' ' GLU . 38.2 mt -131.76 140.66 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 -177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.427 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 8.2 mmt -121.55 144.2 39.76 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.721 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 13.5 Cg_exo -71.15 170.74 17.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.912 2.408 . . . . 0.0 111.984 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -150.25 109.64 3.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.057 0.456 . . . . 0.0 111.457 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.55 89.3 6.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.951 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.6 t -110.28 142.95 27.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.62 92.31 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.81 1.673 . . . . 0.0 111.482 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.572 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 46.3 m -77.82 -48.07 17.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.704 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.96 27.2 73.38 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.69 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 7.8 mp -72.06 -20.64 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.297 0.549 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -93.2 -7.88 43.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.153 0.501 . . . . 0.0 109.902 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.149 -178.19 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 96.1 m-85 -141.56 148.7 39.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.956 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 pt -115.92 140.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.48 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.42 ' HB2' ' CG2' ' A' ' 87' ' ' THR . 86.1 t80 -92.87 131.95 37.45 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.48 132.23 59.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.53 -167.53 43.67 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.824 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -39.74 126.28 1.93 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.517 1.127 . . . . 0.0 112.662 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.56 161.63 24.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.043 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.61 153.91 41.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.591 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -67.76 -37.59 82.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.012 0.434 . . . . 0.0 110.259 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -80.03 1.37 27.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.53 109.57 20.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 27' ' ' ILE . 81.3 p -93.35 176.16 6.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.71 -20.59 66.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.251 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.95 67.24 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' B' ' 215' ' ' SER . 0.7 OUTLIER -66.74 -35.47 80.19 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.591 0.234 . . . . 0.0 110.904 178.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 23' ' ' THR . 64.6 mt -58.32 -46.2 89.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.98 -38.13 82.35 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 m -54.7 -46.84 74.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.397 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.19 -47.22 94.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.281 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -74.31 -9.64 58.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -71.01 -15.32 62.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.781 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -62.98 -33.98 76.55 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.285 0.564 . . . . 0.0 109.948 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 8.3 m-85 -98.4 -13.78 20.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.962 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 78.25 60.91 2.59 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.362 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -111.97 91.65 16.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 14.0 Cg_endo -98.49 31.84 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.503 2.802 . . . . 0.0 110.971 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -94.26 -165.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.581 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.478 ' H ' HG12 ' A' ' 38' ' ' VAL . 64.3 m-20 -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.95 135.97 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.099 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.47 115.5 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.931 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.37 149.13 24.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 51' ' ' SER . 16.8 p -73.02 107.33 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.091 0.472 . . . . 0.0 110.899 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -114.53 129.6 56.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.775 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.406 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 17.9 t70 -71.76 139.79 49.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.5 -12.73 60.03 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.8 -57.89 1.97 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.44 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -89.29 -20.1 24.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 74.03 20.31 79.71 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.486 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -96.37 170.3 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.861 0.331 . . . . 0.0 111.402 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' SER . 15.1 m -83.29 138.07 33.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.01 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.59 -16.25 35.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.27 23.06 7.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.448 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -156.94 154.35 29.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.18 0.49 . . . . 0.0 109.852 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.44 17.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.237 0.542 . . . . 0.0 112.434 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -134.07 131.94 39.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.526 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 tp -121.66 138.61 54.27 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.804 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 57.6 tttt -120.31 113.97 21.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.676 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 33.1 p90 -139.95 148.65 42.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 9.5 tp10 -100.67 105.73 17.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 54.0 t0 174.62 122.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.328 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HA ' ' HG1' ' A' ' 65' ' ' THR . 19.8 tt0 -80.34 -12.33 59.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -86.99 -49.48 7.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.091 0.472 . . . . 0.0 110.071 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 t -67.5 -22.65 65.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.062 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.676 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 1.2 p -61.79 -59.1 5.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.872 0.367 . . . . 0.0 111.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.75 -38.06 81.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.963 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.7 -53.89 53.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.267 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.08 84.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 65' ' ' THR . 88.3 t -63.41 -60.41 2.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.479 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -63.65 -34.27 77.47 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -69.05 -49.5 56.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.708 0.289 . . . . 0.0 111.021 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 85.9 mt -84.68 -27.68 26.9 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -59.79 108.23 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.03 -5.66 59.54 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.868 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.8 t80 -74.31 130.24 39.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.14 124.32 28.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.568 . . . . 0.0 112.481 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -129.88 105.46 12.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.705 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.97 72.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.602 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.61 59.12 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -111.45 130.31 55.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.583 -0.309 . . . . 0.0 110.524 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -82.28 129.88 34.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.565 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.52 127.63 32.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.335 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 45.4 tptt -110.68 116.46 31.35 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mm -110.13 140.15 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.21 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.13 171.25 16.19 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -101.32 128.95 47.24 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.5 t -153.92 161.8 41.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -114.78 110.41 19.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.931 0.396 . . . . 0.0 111.347 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.0 120.17 30.81 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.321 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -98.79 139.48 21.1 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.131 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.08 138.13 60.54 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.801 2.334 . . . . 0.0 111.887 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -110.31 144.64 38.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.897 0.379 . . . . 0.0 111.694 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -55.3 -31.17 61.42 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.134 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -64.63 -22.1 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.76 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.22 21.32 17.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.108 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -56.9 -38.98 73.57 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.13 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -55.61 -43.17 75.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.853 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.44 ' O ' HG21 ' A' ' 102' ' ' VAL . 49.1 t80 -67.72 -45.82 73.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.506 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.06 -44.39 95.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.138 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.21 -40.88 97.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.76 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.54 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.311 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 98' ' ' TYR . 72.5 t -64.61 -38.04 81.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.081 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -60.05 -39.19 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.672 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -61.68 -49.79 75.07 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.773 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.58 -40.67 79.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.71 -42.47 91.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 0.0 109.83 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.082 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 67.0 mt -123.41 131.09 73.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.9 mmt -114.31 136.0 22.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.86 169.0 15.6 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.934 2.423 . . . . 0.0 111.95 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -142.78 102.56 4.06 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.702 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -96.99 87.39 4.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.896 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.2 m -111.5 119.53 44.85 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.823 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.21 105.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.823 2.348 . . . . 0.0 112.167 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 3.6 m -96.28 -50.04 4.96 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.559 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.05 33.82 84.8 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.94 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 11.0 mp -66.94 -33.07 74.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 110.43 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -76.89 -14.24 59.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.794 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.197 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.956 0 CA-C-O 121.025 0.441 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.602 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.5 m-85 -158.85 136.99 10.59 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.268 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.65 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.158 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -87.08 122.54 31.04 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 26.5 mm -95.29 135.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -168.97 45.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.966 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -40.0 107.83 0.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.152 0.981 . . . . 0.0 113.547 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.55 152.87 23.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.978 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.428 HD21 HD11 ' B' ' 217' ' ' LEU . 48.9 t30 -67.28 138.52 56.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -63.1 -19.78 64.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 0.0 111.473 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 57.6 mm-40 -80.59 -4.1 52.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.147 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.8 mt -83.28 139.23 33.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.914 0.387 . . . . 0.0 110.556 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -110.22 168.62 9.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.655 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HG2' ' HH ' ' A' ' 98' ' ' TYR . 1.4 mp0 -60.84 -27.53 68.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.44 97.73 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.708 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.63 -47.67 83.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 110.781 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.85 -46.63 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.92 -35.96 82.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.031 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.3 m -56.35 -49.29 74.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' CG2' HD23 ' B' ' 218' ' ' LEU . 95.1 t -65.18 -46.51 90.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.724 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -75.15 -22.97 57.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 m -64.6 -24.58 67.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.818 0.342 . . . . 0.0 110.478 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.08 -20.32 66.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -89.75 -2.31 58.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.603 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.44 34.69 44.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.626 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.0 89.81 37.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 111.778 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -89.06 78.27 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.636 2.224 . . . . 0.0 111.116 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -115.86 -166.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.905 -177.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' CG ' ' HZ3' ' A' ' 58' ' ' LYS . 4.6 p-10 -85.41 144.88 27.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -171.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.02 133.29 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.428 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.2 mp -123.68 107.91 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 43' ' ' SER . 5.0 tt -92.27 134.05 35.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.465 ' N ' HD23 ' A' ' 42' ' ' LEU . 19.5 m -67.92 95.52 0.54 Allowed 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -114.2 145.67 41.39 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.485 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 38.1 m-20 -61.52 150.63 35.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.215 0.531 . . . . 0.0 112.062 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -77.13 -41.88 40.09 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.421 -176.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.65 -59.39 2.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -85.79 -15.86 40.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 66.09 31.52 79.58 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.778 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -92.82 155.21 17.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.611 0.206 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -67.04 111.06 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.93 -20.89 60.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.047 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.71 11.12 20.02 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 120.311 -0.947 . . . . 0.0 115.052 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.25 165.51 24.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.878 0.839 . . . . 0.0 109.082 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.499 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.86 121.65 27.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.731 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.77 142.69 46.19 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.117 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -131.72 117.06 18.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.352 0.596 . . . . 0.0 111.701 179.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.713 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.0 p90 -129.7 156.01 44.96 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.34 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -102.15 106.15 16.96 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.731 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.2 t70 176.94 139.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.891 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -80.76 -46.56 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -75.41 -29.59 59.82 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 m -68.59 -23.02 64.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.713 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 67.2 p -61.6 -46.87 87.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.557 0.694 . . . . 0.0 109.645 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.59 -33.38 48.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.966 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.423 ' C ' HD21 ' A' ' 67' ' ' LEU . 7.3 tt -61.78 -52.54 63.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.14 89.44 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 79.9 t -63.3 -44.51 99.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.029 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.2 -48.66 56.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.907 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.51 -49.83 65.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.308 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.2 mt -86.57 -2.12 58.22 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 48.1 t-20 -67.73 108.96 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.93 6.69 61.78 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.421 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -72.16 121.82 19.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -83.65 117.51 23.23 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.03 113.51 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.244 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.64 76.62 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.94 -2.56 88.19 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.969 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.92 145.58 36.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.09 135.9 33.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 80.8 mt -76.06 133.68 40.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.795 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.39 113.09 15.76 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm -103.59 134.5 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.02 157.6 40.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.13 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -92.49 133.14 36.21 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -159.57 157.41 29.81 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -107.07 143.08 35.73 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -149.98 138.56 20.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.998 0.428 . . . . 0.0 111.316 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -105.72 138.56 19.65 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HA ' ' HH ' ' A' ' 99' ' ' TYR . 34.9 Cg_endo -64.9 136.41 48.68 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 122.649 2.233 . . . . 0.0 113.33 -177.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -77.29 137.87 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 33.9 ttp85 -68.81 -26.0 64.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.995 0.426 . . . . 0.0 110.826 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -77.56 -30.01 52.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.086 0.47 . . . . 0.0 110.596 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.56 18.74 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 29.6 pt20 -65.26 -27.1 68.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.279 0.562 . . . . 0.0 110.132 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HB3' ' HZ1' ' A' ' 97' ' ' LYS . 9.6 mtpm? -70.87 -21.15 62.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.746 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.51 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.9 t80 -64.16 -46.42 84.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.442 ' HH ' ' HA ' ' A' ' 91' ' ' PRO . 32.3 m-85 -63.65 -38.05 89.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.752 177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.89 -48.09 80.51 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.958 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.6 74.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.356 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.524 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.8 t -70.64 -41.48 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.831 0.348 . . . . 0.0 110.119 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -55.54 -48.43 74.73 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.986 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.28 -23.74 67.41 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.766 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -24.66 37.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.012 0.435 . . . . 0.0 110.35 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 69.5 mt -80.93 -44.22 18.57 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--O 1.236 0.38 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.819 177.711 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 61.3 mt -103.39 123.04 56.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.502 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' MET . . . . . 0.501 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 15.2 mmt -101.99 128.61 28.24 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.875 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.51 146.14 88.79 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -120.39 116.97 26.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.522 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -100.33 86.25 3.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.35 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.8 m -113.57 119.1 42.29 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.307 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.44 103.74 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.214 1.943 . . . . 0.0 111.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' B' ' 217' ' ' LEU . 89.9 p -81.35 -32.51 32.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.88 9.25 86.67 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.521 ' HB2' ' OG ' ' B' ' 215' ' ' SER . 0.3 OUTLIER -56.86 -51.58 68.47 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.728 0.811 . . . . 0.0 111.307 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.407 HD23 ' CG2' ' A' ' 30' ' ' VAL . 3.9 pp -84.19 -17.25 40.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.578 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.634 -176.825 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.589 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.84 0.352 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -160.63 136.27 8.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.229 1.012 . . . . 0.0 109.142 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 pt -120.01 137.14 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 121.028 0.442 . . . . 0.0 110.848 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -89.4 131.5 35.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.537 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.4 mt -113.84 144.84 20.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.21 -169.16 45.5 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.285 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.36 112.37 3.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.788 0.328 . . . . 0.0 110.695 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 74.0 mt -93.95 177.17 6.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 0.0 111.732 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -69.13 138.11 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.018 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.75 -20.33 61.08 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.18 2.63 53.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.67 109.61 19.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -97.41 177.7 5.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.109 0.481 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.44 -27.53 69.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.34 -42.98 89.45 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.428 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 30' ' ' VAL . 10.4 m-20 -63.61 -47.24 82.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.23 -47.04 88.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.778 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.23 -41.8 98.74 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 m -60.33 -48.89 79.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.404 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 26' ' ' ASP . 74.9 t -54.7 -47.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.436 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.72 -22.63 37.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -64.76 -26.73 68.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.403 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.66 -16.05 63.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.467 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.87 -4.49 59.18 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.1 0.476 . . . . 0.0 110.249 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.37 17.04 78.74 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.377 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.88 90.18 51.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.716 0.293 . . . . 0.0 110.24 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.89 105.51 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.019 2.479 . . . . 0.0 112.094 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.2 t -132.48 -166.57 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.522 ' H ' HG11 ' A' ' 38' ' ' VAL . 20.9 t70 -70.84 140.21 51.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.07 136.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.35 100.84 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.618 0.246 . . . . 0.0 111.629 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -85.94 112.98 21.69 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.8 t -65.83 118.59 9.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.4 0.619 . . . . 0.0 111.837 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -133.95 155.79 49.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.604 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.403 ' OD2' HG22 ' A' ' 48' ' ' THR . 32.3 t70 -73.11 135.41 44.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.873 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.94 -18.72 63.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -96.36 -61.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.672 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.403 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.0 t -84.36 -33.25 23.87 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.65 60.99 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.827 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.21 155.34 40.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.099 0.449 . . . . 0.0 110.367 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 m -68.15 138.69 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.89 -8.89 59.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.099 0.476 . . . . 0.0 111.074 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.43 30.41 7.73 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.329 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -170.61 170.8 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.68 170.82 19.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.72 155.96 49.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.175 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.77 140.26 34.75 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.655 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 49.9 tttp -123.13 115.34 21.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.909 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 8.2 p90 -132.91 143.2 49.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -102.89 107.57 18.45 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.521 -0.871 . . . . 0.0 113.194 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t70 178.61 143.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.883 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -79.98 -35.01 38.14 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -83.06 -35.52 25.65 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.093 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.8 t -57.6 -29.9 64.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.413 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.605 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 75.4 p -59.43 -52.76 64.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.478 0.656 . . . . 0.0 109.423 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.5 -46.07 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.953 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 tp -50.06 -58.58 5.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.936 0.773 . . . . 0.0 111.562 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.628 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 65' ' ' THR . 97.3 t -66.99 -57.85 8.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.527 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.22 -18.04 64.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.561 -0.456 . . . . 0.0 112.15 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -90.5 -55.8 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.989 0.423 . . . . 0.0 111.308 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 92.1 mt -91.34 -17.38 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.79 109.05 2.74 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.436 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.13 2.62 64.12 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.105 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 61.0 t80 -76.87 143.39 39.69 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 1.8 tppp? -94.61 114.23 26.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.901 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.6 117.65 42.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.26 35.18 76.45 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.324 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.67 22.26 75.19 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.758 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 24.9 mtp180 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 122.635 -0.332 . . . . 0.0 110.694 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -98.76 135.79 39.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.933 0.397 . . . . 0.0 111.46 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 41.2 mt -85.54 122.27 29.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.617 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.0 107.45 19.4 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -108.25 124.36 64.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.966 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -136.26 149.99 48.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -77.64 124.39 27.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 t -149.39 162.01 40.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.613 0.244 . . . . 0.0 110.966 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -114.96 108.86 17.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.22 139.8 50.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.297 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -107.47 132.27 21.1 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.74 133.73 46.67 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.969 2.446 . . . . 0.0 112.583 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -76.78 131.98 38.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -70.65 -20.92 62.67 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 p -74.58 -14.46 60.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.786 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.414 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 94.9 mt -113.72 25.12 11.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.855 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -56.79 -35.03 68.24 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -55.76 -46.07 77.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.128 0.49 . . . . 0.0 110.638 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.39 -53.78 50.01 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.066 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.414 ' HD1' ' O ' ' A' ' 95' ' ' LEU . 77.2 m-85 -59.09 -44.69 91.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -68.52 -32.88 73.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.458 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.22 -46.71 73.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.18 -39.79 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.16 0.505 . . . . 0.0 109.946 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -57.02 -54.23 49.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.673 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.24 -28.19 67.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.8 -51.95 59.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.0 110.854 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 -27.01 56.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 177.748 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.971 0.415 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 63.9 mt -134.85 100.1 2.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.354 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 80.0 mmm -103.87 136.11 19.25 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.4 156.08 62.46 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.921 2.414 . . . . 0.0 113.24 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.85 117.56 7.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -87.47 89.63 8.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.19 0.519 . . . . 0.0 111.142 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 1.0 OUTLIER -91.49 143.24 27.82 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.009 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 28.4 Cg_endo -96.15 84.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 18.7 t -71.97 -47.04 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.22 63.58 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.828 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.31 -33.21 72.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.42 -35.09 79.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.266 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.346 0.593 . . . . 0.0 110.703 -177.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.272 0.558 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 8.8 m-85 -125.38 154.49 41.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.397 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.58 139.09 52.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.737 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -99.08 123.37 43.33 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.31 141.65 18.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.32 -168.82 45.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.64 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 3.7 t-20 -48.47 110.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.51 0.724 . . . . 0.0 112.743 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.94 177.62 5.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.24 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.66 142.82 33.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -57.19 -26.39 60.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.585 0.354 . . . . 0.0 111.64 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.99 -10.69 59.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.957 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.436 HD12 HD12 ' B' ' 217' ' ' LEU . 6.3 mp -87.28 110.07 19.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.071 0.463 . . . . 0.0 111.018 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.5 p -94.08 172.67 8.08 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.633 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -63.9 -22.59 66.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.289 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.98 -41.03 95.5 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.973 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 29' ' ' THR . 28.8 t70 -75.36 -36.84 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.985 0.421 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.23 -41.04 85.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.633 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.34 -38.94 92.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.303 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 17.4 m -58.02 -45.05 87.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.457 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 26' ' ' ASP . 88.9 t -56.83 -50.14 76.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.29 -16.81 58.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.6 m -72.46 -13.75 61.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.49 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -83.63 -11.03 57.81 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.83 72.94 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.909 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.15 89.63 48.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.58 95.82 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.86 2.373 . . . . 0.0 110.513 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG13 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -118.86 -166.7 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.229 -177.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.458 ' H ' HG13 ' A' ' 38' ' ' VAL . 25.0 m-20 -68.13 114.7 6.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.961 0.41 . . . . 0.0 111.997 -172.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.68 127.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.704 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.09 113.19 39.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.488 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 54' ' ' PHE . 59.9 tp -87.26 133.61 33.65 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 38.6 m -68.73 102.84 1.6 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -123.55 154.57 39.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.968 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 47' ' ' ASN . 5.6 p-10 -84.77 152.09 23.93 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.323 0.582 . . . . 0.0 111.354 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.13 -9.88 59.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.413 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.433 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 16.4 m120 -83.06 -67.33 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.574 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 t -104.42 -30.55 10.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.56 46.62 4.26 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.62 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.63 164.5 11.71 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.778 0.289 . . . . 0.0 110.693 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -79.55 106.18 11.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.856 0.36 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.3 -33.68 75.79 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.16 31.91 2.95 Favored Glycine 0 C--O 1.218 -0.892 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.997 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.2 m-85 -135.37 157.32 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.98 29.99 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.997 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -121.07 119.11 31.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.51 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 27.8 tp -115.54 139.77 49.77 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.092 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 1.7 tmtp? -124.14 112.68 17.38 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.183 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.768 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -129.71 150.73 50.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.72 105.34 16.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.203 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 176.2 143.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.425 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -80.76 -48.98 11.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 64' ' ' SER . 2.6 ptp180 -67.16 -33.71 76.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 63' ' ' ARG . 46.9 m -63.65 -27.45 69.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.086 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.768 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 68.9 p -63.29 -48.43 78.13 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.693 0.759 . . . . 0.0 110.08 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.68 -38.64 45.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.29 -52.6 64.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.12 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -43.09 76.85 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.362 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 65' ' ' THR . 90.9 t -61.87 -59.82 3.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.297 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.38 -22.16 66.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.28 -45.67 15.89 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.76 0.314 . . . . 0.0 111.146 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -97.83 -20.41 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.84 110.13 1.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.77 -0.88 56.6 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.495 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -77.58 123.79 27.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -88.99 117.51 28.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.172 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' B' ' 218' ' ' LEU . 57.2 mt -121.57 115.77 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.064 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.22 35.28 69.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.716 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.31 13.55 78.51 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.097 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -128.8 130.7 47.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.912 0.356 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.88 133.02 33.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 89.5 mt -79.11 128.04 32.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.596 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -123.93 118.18 26.47 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -107.92 126.43 64.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -123.25 142.87 50.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.975 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -84.79 106.75 16.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.769 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 136.52 21.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.852 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -80.67 156.84 26.14 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.39 137.86 32.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.604 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -94.5 120.57 64.89 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.731 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -62.66 110.57 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.531 2.154 . . . . 0.0 111.481 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.55 140.19 44.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -70.09 -31.05 68.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.416 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 p -79.87 -11.42 59.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 48.9 tp -105.16 8.22 34.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -62.09 -20.1 63.66 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -59.15 -41.62 88.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.631 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 3.5 t80 -69.37 -45.62 68.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -58.08 -50.09 74.67 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.568 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -61.65 -46.34 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.333 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.9 86.42 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.427 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.6 t -74.25 -39.83 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.221 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.76 -45.02 94.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.62 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.83 -29.94 71.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 111.054 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.97 -37.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 70.8 mt -68.82 -39.62 79.94 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.221 -0.405 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.792 179.504 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 68.6 mt -128.51 110.09 20.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.071 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.7 mmt -84.19 118.63 71.72 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.916 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.48 164.98 10.15 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.112 2.542 . . . . 0.0 112.608 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -122.25 94.86 4.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.752 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -84.22 88.62 7.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.321 0.581 . . . . 0.0 110.118 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 23.8 m -109.84 157.08 38.69 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.733 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.39 59.98 2.56 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.911 2.407 . . . . 0.0 112.183 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' SER . . . . . 0.596 ' O ' HD13 ' B' ' 217' ' ' LEU . 73.6 m -78.68 33.24 0.21 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.241 0.616 . . . . 0.0 111.456 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.94 58.84 0.37 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.56 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.596 HD13 ' O ' ' B' ' 215' ' ' SER . 5.0 mp -64.85 -27.86 69.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 77' ' ' ILE . 4.0 pp -100.73 -7.63 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.753 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -178.812 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.909 0.385 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -154.23 136.63 14.98 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.209 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 pt -108.42 137.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.899 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 89.4 t80 -94.6 134.76 36.82 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.059 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.56 138.53 45.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.39 -167.62 43.44 Favored Glycine 0 C--N 1.32 -0.312 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.344 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' A' ' 80' ' ' ARG . 6.3 p30 -48.19 139.42 8.44 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.302 0.572 . . . . 0.0 112.0 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.46 -176.99 3.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.071 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.36 147.67 22.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HD3' ' OE1' ' A' ' 50' ' ' GLU . 75.8 mtt180 -70.89 -15.75 62.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.91 1.61 56.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.407 . . . . 0.0 110.116 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.418 HD21 HD13 ' B' ' 217' ' ' LEU . 1.8 tm? -97.77 118.48 34.43 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.6 p -109.95 176.61 5.0 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 111.983 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.16 -31.77 67.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.913 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.69 98.86 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.049 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.96 -45.02 64.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.4 mt -55.72 -46.46 79.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.724 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -41.32 96.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.836 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -56.82 -46.55 81.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.649 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.56 -49.44 80.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.466 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.37 -15.91 58.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -68.41 -15.68 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.07 -33.66 73.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.357 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.26 -0.27 56.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.731 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.22 56.78 23.32 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.559 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 38' ' ' VAL . 8.0 p -151.23 89.7 4.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-O 121.694 0.759 . . . . 0.0 111.381 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.39 100.08 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 112.156 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.65 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.8 t -131.56 -165.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.555 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.8 t70 -66.95 131.51 46.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.83 131.47 42.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.551 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.41 108.98 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 tp -94.5 126.93 40.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -77.83 95.43 4.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.435 0.636 . . . . 0.0 111.039 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -104.73 141.56 36.25 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.577 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -51.97 144.64 11.45 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.173 0.589 . . . . 0.0 111.92 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -72.75 -26.82 61.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.072 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -74.69 -66.2 0.77 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -115.24 -24.7 8.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.409 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 108.85 28.14 4.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.623 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE1' ' HD3' ' A' ' 20' ' ' ARG . 18.0 mm-40 -69.6 139.15 53.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.018 0.409 . . . . 0.0 110.519 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 m -56.93 116.65 3.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -74.01 -14.49 61.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.694 0.283 . . . . 0.0 111.673 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 31.41 6.21 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.496 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.53 154.72 4.71 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.647 0.26 . . . . 0.0 110.69 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.55 165.51 34.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -133.83 138.25 45.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.865 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.81 137.17 48.02 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.471 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.65 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.8 ttmt -123.88 121.61 35.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.684 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.4 p90 -136.41 160.98 37.09 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -101.13 104.2 15.29 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 173.99 140.23 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.279 1.432 . . . . 0.0 108.146 172.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -80.21 -46.11 16.86 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -71.22 -35.52 71.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.695 0.283 . . . . 0.0 111.24 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 t -59.02 -26.84 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.49 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.684 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 38.0 p -63.45 -38.52 91.45 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.463 0.649 . . . . 0.0 109.427 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.4 mt -77.3 -33.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.66 -55.44 32.09 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.93 87.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.461 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 65' ' ' THR . 74.7 t -59.54 -54.29 36.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 120.849 0.357 . . . . 0.0 111.308 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -70.2 -31.95 69.64 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.01 -41.23 14.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 84' ' ' ILE . 3.0 mm? -89.21 -22.92 22.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 39.2 t30 -56.83 112.83 1.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.828 0.347 . . . . 0.0 111.526 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.89 -7.88 55.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.215 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -66.84 130.27 42.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.994 0.397 . . . . 0.0 110.074 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -86.64 119.32 26.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.21 118.17 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.573 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.62 36.17 92.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.947 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.98 51.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.935 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 17' ' ' ASN . 9.5 mmt180 -105.54 156.02 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.633 -0.334 . . . . 0.0 110.726 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.56 128.6 52.58 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 78.6 mt -63.48 106.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.29 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -89.11 105.66 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 72' ' ' LEU . 17.1 mm -114.7 137.93 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.77 -179.3 7.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 65' ' ' THR . 24.9 m170 -90.46 149.51 22.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -159.89 161.26 34.31 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -108.07 119.95 40.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -131.89 141.33 49.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.05 0.452 . . . . 0.0 111.372 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.523 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 3.4 mmp_? -117.23 114.48 38.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.5 135.12 54.48 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.915 2.41 . . . . 0.0 111.955 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.448 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 45.8 mmtm -93.52 128.81 39.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.589 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -71.76 -15.76 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.089 0.471 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -72.83 -25.23 61.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.382 0.611 . . . . 0.0 109.677 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.8 mt -102.78 27.98 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -55.4 -33.45 63.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.207 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -59.12 -49.73 76.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.425 ' O ' HG21 ' A' ' 102' ' ' VAL . 12.2 t80 -59.88 -45.91 90.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.582 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.448 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 22.9 m-85 -64.0 -46.91 82.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -62.58 -37.52 86.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.598 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.44 85.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 110.477 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 73.7 t -71.87 -40.24 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.196 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -56.8 -48.36 78.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.193 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.71 -27.03 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 111.03 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' HG2' ' CD1' ' B' ' 212' ' ' PHE . 7.6 tp10 -68.15 -42.24 80.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 84.4 mt -69.24 -34.43 74.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.537 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.001 179.97 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 44.6 mt -123.6 135.27 63.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.987 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.58 135.69 23.77 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.852 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.17 152.43 45.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.731 2.287 . . . . 0.0 112.729 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -125.88 103.77 7.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . 0.467 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 49.8 m-85 -90.21 86.47 6.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.304 0.574 . . . . 0.0 110.09 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 16.8 p -111.85 134.98 21.22 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.576 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 7.6 Cg_exo -73.27 92.5 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.969 1.779 . . . . 0.0 111.089 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 5.1 m -77.9 -39.94 41.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.51 25.03 61.69 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.427 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.418 HD13 HD21 ' A' ' 22' ' ' LEU . 17.9 mt -60.79 -32.11 71.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.175 0.488 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.62 -38.58 58.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -177.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 120.776 0.322 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 58' ' ' LYS . 36.3 m-85 -149.79 132.49 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.97 0.908 . . . . 0.0 108.715 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.86 128.63 69.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.347 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -91.19 130.98 37.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.286 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 52.0 mt -112.45 143.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.88 -177.15 50.15 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.39 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.6 t-20 -54.64 105.9 0.18 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.897 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.71 -173.07 3.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.519 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -79.2 144.37 34.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -70.41 -22.7 62.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.054 0.454 . . . . 0.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.98 2.47 30.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.45 130.77 38.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 p -109.17 170.49 8.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.294 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.2 -28.75 68.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.146 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.16 99.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.537 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -66.47 -48.13 70.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.12 -45.62 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.073 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.45 -36.93 85.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.062 0.458 . . . . 0.0 110.065 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -60.67 -44.35 96.58 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.81 -47.33 93.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.764 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -75.81 -9.71 58.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.734 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.4 t -70.72 -17.16 62.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -73.51 -21.91 60.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -99.14 -20.45 16.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 83.87 50.47 4.39 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.547 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.52 94.64 28.56 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.597 0.237 . . . . 0.0 111.263 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 26.2 Cg_endo -98.65 30.02 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.416 2.744 . . . . 0.0 111.445 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -92.0 -166.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -63.58 139.68 58.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -135.8 120.1 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.566 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.86 136.76 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.013 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 54' ' ' PHE . 60.0 tp -128.03 134.15 49.19 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.9 p -65.32 99.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 22.4 tpp180 -113.63 124.28 51.95 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.553 ' OD2' HG23 ' A' ' 48' ' ' THR . 23.5 t70 -71.55 136.79 47.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 110.79 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -72.13 -26.67 62.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.15 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 26.0 m-80 -81.59 -65.59 0.99 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.157 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.553 HG23 ' OD2' ' A' ' 45' ' ' ASP . 10.1 t -87.47 -21.22 25.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.619 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 80.83 19.51 67.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.756 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.14 163.43 12.28 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.556 0.217 . . . . 0.0 111.108 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -78.4 141.42 38.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -89.04 -6.84 56.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.74 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 100.59 -7.1 57.68 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.277 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' HD11 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -107.95 148.22 29.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 118.027 0.913 . . . . 0.0 110.574 -177.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.22 150.5 50.11 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.794 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.75 119.38 17.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 tp -106.62 140.76 38.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.551 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 12' ' ' TYR . 7.8 tmtm? -129.42 108.84 10.59 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.755 0.788 . . . . 0.0 112.032 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 4.7 p90 -119.7 156.24 30.87 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.01 105.81 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.562 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 178.22 145.66 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.161 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -81.01 -45.6 16.33 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.09 -32.96 50.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -55.64 -30.53 61.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.384 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.711 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.1 p -61.39 -52.36 64.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.501 0.667 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.1 mt -63.53 -36.97 78.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.667 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 tt -62.08 -58.68 6.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.221 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.88 86.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.048 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 65.6 t -61.14 -46.57 96.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -78.23 -40.12 38.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -66.94 -50.43 62.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.484 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.64 -4.86 57.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 25.9 t-20 -63.54 109.41 1.64 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.496 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 -2.83 65.33 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.163 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.9 127.15 30.88 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -88.14 115.0 25.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.262 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.6 mt -120.63 109.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.64 25.49 75.63 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 -16.01 59.55 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.461 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -97.11 132.7 42.64 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.837 0.351 . . . . 0.0 111.208 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.83 135.68 35.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.239 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.72 133.22 45.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.423 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 12.7 mptt -107.52 116.78 32.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -117.31 138.6 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.53 166.73 30.25 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -88.56 140.14 29.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 15.2 t -153.72 161.55 42.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.661 0.267 . . . . 0.0 110.855 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -116.36 104.69 11.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -115.92 150.04 37.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -125.42 135.57 27.09 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.114 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.87 122.4 10.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.923 2.416 . . . . 0.0 112.214 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -69.21 135.24 50.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.697 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -60.88 3.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -74.14 -22.3 59.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.03 0.443 . . . . 0.0 112.087 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.87 6.06 45.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.333 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.92 -22.36 62.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.553 0.216 . . . . 0.0 111.419 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -58.99 -39.55 82.14 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.652 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.96 -35.96 79.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -66.66 -50.07 64.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.1 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 44.9 mt-10 -65.32 -42.95 92.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.04 -47.49 80.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.547 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.8 p -71.89 -33.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.571 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -65.81 -39.21 90.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 18.7 mm-40 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.894 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.86 -48.18 77.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 102' ' ' VAL . 11.0 mp -63.12 -45.17 93.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.134 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.082 179.243 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.042 0.449 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 44' ' ' ARG . 62.5 mt -138.46 123.41 22.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.4 mmt -100.84 149.97 36.63 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.172 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.88 163.29 37.38 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.678 2.252 . . . . 0.0 111.714 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -130.17 126.32 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.275 0.559 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -111.2 90.7 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.494 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 72.3 m -110.42 147.58 36.65 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.99 52.54 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.708 2.272 . . . . 0.0 111.257 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.1 m -54.29 -50.15 67.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.938 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.73 47.7 59.93 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.882 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.76 -15.22 59.27 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.405 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -80.56 -15.82 55.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.909 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.227 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.27 120.78 37.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.403 ' HB2' ' OD1' ' A' ' 5' ' ' ASN . 83.0 mtp -102.43 -6.82 22.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.113 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.73 40.22 6.37 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 3' ' ' MET . 2.1 m-20 -64.12 -23.53 67.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.721 0.408 . . . . 0.0 111.498 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.07 -12.23 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.469 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -99.44 109.84 22.38 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.591 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.84 86.09 1.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.623 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 11' ' ' ALA . 2.9 p-10 -86.01 -22.6 27.21 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 89' ' ' TYR . 5.7 p30 -76.71 21.11 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.765 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . -87.2 142.54 27.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.873 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.626 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 4.6 p90 -157.97 -179.59 8.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.219 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -102.65 144.27 13.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 40.4 t80 -101.97 124.96 48.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.525 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 3.8 mp -102.38 139.25 23.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.06 -169.78 46.29 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.124 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.4 ' HB2' ' NH2' ' A' ' 80' ' ' ARG . 11.6 m120 -45.51 112.23 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.63 0.772 . . . . 0.0 112.553 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.4 mt -104.42 168.9 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.201 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.17 140.31 58.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -64.55 -17.24 63.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.896 0.379 . . . . 0.0 110.561 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HB2' HD13 ' B' ' 217' ' ' LEU . 63.9 mm-40 -82.68 -11.6 58.23 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.93 128.27 34.55 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.8 p -110.43 176.56 5.0 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.489 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.42 -30.33 64.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.634 0.373 . . . . 0.0 111.137 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.64 94.96 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.644 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' CG ' ' HG ' ' B' ' 215' ' ' SER . 19.3 m-20 -67.83 -42.39 81.52 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.088 0.471 . . . . 0.0 109.866 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.08 -47.84 88.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.787 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.46 -32.57 74.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 109.874 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -63.71 -41.27 98.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.0 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.65 -46.81 93.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.031 0.443 . . . . 0.0 110.456 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.497 ' CG ' HD22 ' A' ' 57' ' ' LEU . 60.4 m-85 -73.81 -13.07 60.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.08 -16.48 63.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.395 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.46 -39.56 84.06 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.916 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -85.29 -16.02 41.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.669 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 27.44 73.47 Favored Glycine 0 N--CA 1.454 -0.155 0 CA-C-N 115.877 -0.602 . . . . 0.0 113.327 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.08 97.36 42.15 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.13 101.74 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.079 2.519 . . . . 0.0 112.564 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -137.13 -166.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.466 ' H ' HG11 ' A' ' 38' ' ' VAL . 17.4 m-20 -60.2 140.9 56.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.9 128.95 32.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.52 118.62 52.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.784 0.326 . . . . 0.0 111.065 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -109.11 128.69 55.21 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 23.9 m -70.03 108.24 3.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.972 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -126.71 143.3 51.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.693 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.7 138.47 35.05 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.763 0.665 . . . . 0.0 111.229 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.54 -13.93 62.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.25 -55.72 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.059 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 t -101.55 -5.34 25.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.02 18.71 76.6 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.892 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -56.28 134.18 53.17 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.916 0.358 . . . . 0.0 111.283 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.0 m -66.2 107.98 2.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -71.33 -19.17 62.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.661 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.88 -0.12 51.95 Favored Glycine 0 C--O 1.221 -0.67 0 C-N-CA 120.747 -0.74 . . . . 0.0 114.452 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 4.0 m-85 -108.99 129.83 55.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.551 0.675 . . . . 0.0 109.592 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.453 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -125.83 149.73 48.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.025 0.441 . . . . 0.0 111.365 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.488 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 20.3 m-85 -137.9 148.8 45.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.281 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.626 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.2 tp -140.66 115.23 9.47 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.531 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 9' ' ' ASP . 1.5 tmtp? -100.25 114.11 27.3 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.265 0.555 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 42.7 p90 -132.06 143.73 50.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.165 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -101.06 106.81 18.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.24 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 65' ' ' THR . 21.0 t70 175.27 109.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.599 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -64.07 -47.18 81.15 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.339 0.59 . . . . 0.0 110.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 m -67.37 -25.42 65.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.534 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.2 p -62.77 -61.2 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.12 -34.98 62.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.59 -61.01 2.83 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.131 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.84 91.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 73.7 t -58.95 -51.59 70.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 120.586 0.231 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.58 -36.77 68.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.828 0.347 . . . . 0.0 111.334 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.56 -43.83 72.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.88 -18.17 31.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 32.9 t-20 -65.06 109.49 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.069 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.9 -2.44 52.04 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -81.13 132.08 35.34 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -88.86 132.26 34.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.146 0.498 . . . . 0.0 112.214 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.1 mm -129.22 101.76 6.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.79 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.43 23.59 77.87 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.458 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 -15.78 60.5 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.043 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 17' ' ' ASN . 30.3 mmm180 -94.86 110.2 22.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.616 0.246 . . . . 0.0 111.596 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 83' ' ' LYS . . . -68.41 127.69 33.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.23 117.88 16.54 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.635 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 81' ' ' ALA . 10.8 mptt -100.84 110.75 22.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 20.5 mm -103.16 121.65 54.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.727 0.298 . . . . 0.0 111.423 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -116.53 166.6 11.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.858 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -96.35 136.43 36.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.3 t -161.24 160.8 30.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.758 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.53 138.99 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.911 0.386 . . . . 0.0 110.175 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.516 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 15.6 t80 -149.88 135.24 18.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -96.28 112.32 59.42 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.249 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.54 115.35 2.99 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -73.91 144.84 45.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.916 0.388 . . . . 0.0 110.376 178.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -72.94 -13.42 61.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.371 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -68.52 -17.08 64.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.112 0.482 . . . . 0.0 110.063 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 tp -123.01 24.83 8.8 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -58.7 -32.49 69.22 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.172 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.42 -32.63 71.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.531 0.205 . . . . 0.0 111.513 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.55 -55.69 16.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -64.49 -34.5 78.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.73 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 34.0 tt0 -65.6 -41.52 92.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.136 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.61 -30.24 70.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 110.019 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.23 -48.48 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -70.84 -12.74 61.72 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 25.5 mm-40 -61.26 -35.13 76.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -83.23 -26.16 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.496 ' O ' HG12 ' A' ' 110' ' ' ILE . 25.3 mt -85.58 -14.99 44.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.696 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.36 -29.31 63.91 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.29 -26.46 64.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.58 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.48 -37.55 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.394 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 106' ' ' LEU . 47.4 mm -62.69 -22.95 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.43 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.06 -33.62 29.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.833 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.6 t -75.79 102.45 5.47 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.439 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -95.68 153.94 17.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.487 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -66.21 153.31 42.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.048 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 67.62 103.23 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.71 105.5 11.06 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.928 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 45.37 -154.32 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.16 0.984 . . . . 0.0 112.789 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.6 mptt . . . . . 0 C--O 1.244 0.807 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.262 -179.247 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 36.8 p -59.75 -37.62 79.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -104.61 11.51 34.11 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.367 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 16.3 t -110.29 -1.22 17.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.169 0.509 . . . . 0.0 110.172 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -104.2 4.5 34.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.91 151.83 21.54 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.37 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.0 101.58 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 121.023 0.44 . . . . 0.0 110.048 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -147.55 119.0 7.89 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.434 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 24.4 mt -134.55 117.22 23.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.482 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 3.1 mmt -114.54 117.95 42.02 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.35 133.65 37.05 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.191 2.594 . . . . 0.0 112.512 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -123.27 108.24 12.56 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.699 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -88.96 88.86 7.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 61.7 m -112.55 155.17 44.22 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.753 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -100.87 112.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.747 2.298 . . . . 0.0 112.044 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.402 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 95.3 p -78.89 -43.41 24.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 109.822 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.18 72.86 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.211 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 21' ' ' GLU . 42.4 mt -58.29 -36.39 73.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.13 -9.59 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.081 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -68.37 -33.63 74.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.29 0.567 . . . . 0.0 110.558 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.04 0.68 17.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.69 12.23 3.17 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.279 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.257 -179.441 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.48 24.06 10.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.945 0.402 . . . . 0.0 111.167 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.86 -24.46 67.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.6 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.05 72.51 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.818 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -92.42 -6.69 49.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.384 0.592 . . . . 0.0 111.152 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.92 -53.87 3.15 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.83 162.08 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -82.39 93.02 7.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.261 0.553 . . . . 0.0 109.813 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.19 -22.31 42.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.664 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -87.16 16.65 4.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.123 0.487 . . . . 0.0 110.186 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 99.5 4.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.742 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.525 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 33.4 m-85 -134.74 166.69 22.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 pt -141.92 138.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -85.47 116.81 24.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.477 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.48 130.92 35.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.42 -168.27 44.6 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.25 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 12.4 t30 -39.69 101.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.944 0.898 . . . . 0.0 112.964 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 77.3 mt -97.94 -173.8 2.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.08 139.58 35.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -64.89 -17.39 64.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.654 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.69 -6.38 58.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 0.0 110.517 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.2 tp -90.59 110.7 21.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.1 p -98.27 172.95 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -57.99 -32.18 67.64 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.986 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.16 98.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 29' ' ' THR . 6.2 t70 -74.83 -38.83 61.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.565 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 72.0 mt -58.32 -45.05 89.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.413 0.625 . . . . 0.0 109.581 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.06 -26.63 65.06 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.339 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.3 m -57.97 -54.06 51.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.03 -31.19 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 67.8 m-85 -79.26 -20.61 47.7 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.171 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.2 t -70.89 -17.69 62.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 109.892 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.13 -22.13 65.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.701 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.59 2.55 52.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.0 81.38 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.779 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -127.03 98.72 29.86 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 117.254 0.527 . . . . 0.0 111.687 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.14 120.08 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.936 2.424 . . . . 0.0 110.68 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -124.44 -167.4 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.788 -177.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.77 136.18 39.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 111.802 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.33 134.86 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 41' ' ' ILE . 4.1 mp -124.84 108.61 20.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.0 tp -88.13 139.4 30.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -83.68 109.55 17.55 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.506 ' NE ' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -121.79 145.5 47.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.294 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.11 131.48 50.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.088 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' B' ' 208' ' ' ILE . 29.3 mt-10 -75.08 -15.8 60.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.61 -61.39 1.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.1 t -108.06 -22.15 12.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.39 21.58 12.84 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.712 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -71.87 161.37 31.05 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 120.684 0.278 . . . . 0.0 111.162 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 t -81.22 130.97 35.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -80.07 -9.11 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 97.41 13.82 43.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.708 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -158.33 165.48 34.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.169 0.485 . . . . 0.0 110.732 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.73 14.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.983 0.42 . . . . 0.0 111.627 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.81 124.91 27.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.14 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 11.0 tp -110.32 136.52 49.38 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.55 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -114.62 120.38 39.96 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -140.99 -166.82 2.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.809 -176.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.69 179.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 65' ' ' THR . 14.9 m-20 -61.42 -174.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.868 -1.06 . . . . 0.0 113.421 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -49.8 -39.79 39.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.601 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -51.29 -52.79 41.97 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 m -70.81 -30.84 67.4 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.383 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.642 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 32.8 p -61.1 -47.48 86.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 110.757 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.76 -37.53 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.867 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.85 -57.76 10.58 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.147 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.69 82.22 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 65' ' ' THR . 60.4 t -56.47 -52.43 52.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.226 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.47 -37.57 88.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -77.27 -49.22 15.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.47 -29.97 57.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -66.59 110.27 3.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 0.0 109.967 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.76 -19.99 25.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.093 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -74.99 139.02 42.65 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 37.0 ttpt -109.86 135.74 50.27 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.924 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.22 119.29 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.429 ' H ' ' HB2' ' B' ' 221' ' ' GLU . . . 62.64 30.38 76.55 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.626 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.75 1.44 68.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.494 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.558 ' C ' ' HG3' ' A' ' 76' ' ' LYS . 81.6 mtt180 -129.06 119.55 24.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.347 0.574 . . . . 0.0 111.494 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -68.96 137.27 53.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.637 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.93 125.79 30.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.067 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -108.11 105.34 15.04 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -99.21 109.81 25.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.034 0.445 . . . . 0.0 111.11 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -104.61 112.74 25.94 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.1 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.4 124.17 22.01 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.856 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -159.37 136.66 9.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -74.52 155.99 37.36 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.525 ' HB3' ' CG ' ' A' ' 12' ' ' TYR . 82.9 t80 -150.75 149.89 30.33 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -108.49 121.14 44.32 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.06 129.89 37.75 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.072 2.514 . . . . 0.0 112.442 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.42 128.69 39.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -80.22 -10.18 59.75 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.8 m -76.88 -22.74 53.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.205 0.526 . . . . 0.0 109.886 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 tp -110.9 26.67 10.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.79 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -57.64 -31.32 66.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.956 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -58.66 -38.13 77.5 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.584 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -64.64 -43.89 92.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.6 -47.71 80.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.977 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -59.06 -43.68 91.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.25 86.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.28 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.89 -45.7 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -60.37 -50.39 73.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.499 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.53 -38.64 91.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.69 -51.55 68.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.513 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.33 -30.02 69.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.713 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.39 -34.34 77.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.104 0.478 . . . . 0.0 110.313 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -67.88 -38.16 82.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.531 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.22 -26.87 67.58 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.07 -35.41 58.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.255 0.55 . . . . 0.0 110.14 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.18 -42.22 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.034 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.4 t -68.31 109.56 3.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -73.22 89.67 1.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.637 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -61.59 -35.25 77.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.831 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.96 -15.9 60.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.257 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.66 -68.33 0.18 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.453 0.701 . . . . 0.0 111.172 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.53 -179.04 7.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.219 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.807 178.74 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 31.3 m -101.68 39.64 1.42 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.747 0.308 . . . . 0.0 110.449 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -67.68 -18.48 64.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.474 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.6 p -80.62 -17.99 49.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.329 0.585 . . . . 0.0 110.25 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -99.25 -57.05 2.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.559 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -91.27 124.52 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.05 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 57.4 mt -71.4 102.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.486 0.66 . . . . 0.0 110.622 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.92 102.23 5.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.006 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -129.56 129.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.605 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 14.7 mmt -110.18 149.7 40.48 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.445 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.76 146.79 91.27 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.946 2.43 . . . . 0.0 111.557 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -120.14 88.88 3.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.461 0.648 . . . . 0.0 111.348 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.87 96.68 4.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.912 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.6 m -110.22 145.19 31.64 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.91 62.05 3.9 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.472 2.115 . . . . 0.0 111.216 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.571 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 34.4 m -59.12 -51.82 68.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.91 37.98 93.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.108 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.571 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 8.5 mp -68.06 -26.62 65.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.23 0.515 . . . . 0.0 111.245 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.98 -22.28 64.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 109.901 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -83.65 -33.81 25.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.516 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.22 0.65 35.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.175 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.429 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 11.3 tp10 -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.303 -1.45 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.511 179.18 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.71 80.12 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.286 0.565 . . . . 0.0 111.006 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 mmt -113.07 30.79 6.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.852 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.13 47.92 21.91 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.016 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.36 -24.5 65.12 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.866 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.33 -27.57 62.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.636 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.61 -5.82 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.669 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -100.1 -24.71 14.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.64 -4.72 50.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -80.34 -8.03 59.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.707 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.1 -167.97 2.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.374 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 87' ' ' THR . 0.2 OUTLIER -55.88 155.83 5.74 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -109.94 152.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.722 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.43 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 39.2 t80 -99.92 137.8 37.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.779 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 51.6 mt -123.63 143.6 36.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.74 -168.76 45.2 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.79 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 9.2 t30 -55.22 117.86 3.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.3 0.572 . . . . 0.0 112.434 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.57 -168.4 1.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . 56.6 t30 -79.11 154.4 29.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.353 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -70.69 -31.83 68.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.77 -0.5 55.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.413 HD13 ' H ' ' A' ' 19' ' ' ASN . 16.8 mt -81.64 109.51 16.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.945 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -98.52 178.74 4.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.915 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -60.06 -25.17 65.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.36 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.35 -51.48 31.99 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 29' ' ' THR . 2.9 m-20 -64.0 -39.64 94.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.784 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.22 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.5 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.23 -35.47 80.91 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 36.9 m -59.01 -48.94 79.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.656 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG21 HD11 ' B' ' 218' ' ' LEU . 68.9 t -56.38 -51.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.542 ' CG ' HD23 ' A' ' 57' ' ' LEU . 95.7 m-85 -78.26 -17.75 56.25 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -20.0 64.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.07 -24.05 63.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.425 ' HH ' ' HG ' ' A' ' 72' ' ' LEU . 41.8 m-85 -81.45 -20.34 40.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.128 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.78 9.68 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.721 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.0 m -127.41 89.23 51.91 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 121.21 0.529 . . . . 0.0 111.95 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 84.32 1.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.88 2.387 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.8 t -124.78 -166.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' H ' HG11 ' A' ' 38' ' ' VAL . 7.0 m-20 -72.58 131.81 42.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.39 133.41 68.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.482 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.5 mp -130.43 124.96 58.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.603 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 43' ' ' SER . 2.0 tt -107.79 134.85 50.15 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.415 ' N ' HD22 ' A' ' 42' ' ' LEU . 51.3 p -61.21 114.77 3.34 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 51.4 mtp180 -134.72 137.52 43.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.755 0.312 . . . . 0.0 110.224 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.586 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 16.5 m-20 -68.62 156.02 38.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.032 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.92 -35.58 28.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.434 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -71.43 -70.51 0.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.796 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -85.7 -19.9 30.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 73.9 18.59 79.65 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.311 178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 44.0 mt-10 -93.02 164.55 13.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.739 0.304 . . . . 0.0 111.309 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -72.12 129.07 37.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -80.16 -13.59 59.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.583 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.42 -10.28 30.81 Favored Glycine 0 C--O 1.215 -1.058 0 C-N-CA 120.6 -0.81 . . . . 0.0 114.305 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.16 148.49 28.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.865 0.833 . . . . 0.0 109.853 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB1' ' HB ' ' A' ' 15' ' ' ILE . . . -124.77 153.15 42.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.991 0.424 . . . . 0.0 110.836 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.43 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 55.1 m-85 -138.54 136.4 36.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD23 ' CG ' ' A' ' 31' ' ' PHE . 16.5 tp -135.21 122.79 22.09 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.735 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.589 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 55.5 tttp -102.13 117.25 34.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.754 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 50.8 p90 -145.09 145.27 31.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.6 107.58 18.88 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.426 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.675 ' O ' HG22 ' A' ' 65' ' ' THR . 28.0 t70 177.22 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.536 0.522 . . . . 0.0 110.783 174.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -51.17 -39.39 56.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -65.25 -54.86 22.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.794 0.33 . . . . 0.0 111.565 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.44 ' HG ' ' HB3' ' A' ' 61' ' ' ASP . 31.9 p -67.24 -19.93 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.754 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.3 p -61.63 -49.13 77.79 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.757 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -65.23 -38.73 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.788 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.4 tp -58.77 -56.89 16.35 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.181 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.07 83.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.489 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' THR . 71.4 t -63.56 -53.06 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.909 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.93 -40.08 63.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.84 -37.81 87.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -95.62 -10.66 28.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 47.8 t-20 -64.84 109.73 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.0 110.578 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.25 3.65 65.06 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.514 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.06 132.78 39.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.0 mmtp -91.88 125.35 36.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.095 0.474 . . . . 0.0 112.221 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mt -134.61 115.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.051 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.44 72.41 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.627 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -3.71 86.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.42 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 mmt180 -102.37 150.13 23.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.94 126.31 51.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 45.4 mt -73.68 128.94 36.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.754 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 75.3 mmtt -122.4 115.14 21.75 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 3.4 mm -114.22 148.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.519 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.09 145.97 23.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.029 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.401 ' HE2' ' CB ' ' A' ' 65' ' ' THR . 27.6 m80 -74.4 136.75 42.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.539 HG21 ' CE1' ' A' ' 12' ' ' TYR . 10.2 t -159.24 159.85 34.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.819 0.343 . . . . 0.0 111.128 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -124.27 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.461 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 33.6 t80 -136.74 142.8 43.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.65 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -98.14 107.59 42.07 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.446 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.81 119.73 6.47 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.081 2.52 . . . . 0.0 112.839 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.15 150.65 31.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.456 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -70.66 -19.86 62.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.923 0.392 . . . . 0.0 110.73 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.1 m -75.94 -11.16 59.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.373 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp -114.96 18.65 16.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.215 0.531 . . . . 0.0 109.813 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -58.56 -42.12 87.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.942 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -61.78 -29.11 69.92 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.673 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 3.7 t80 -67.94 -52.54 34.97 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.728 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.29 -46.45 73.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.27 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.57 91.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.701 0.286 . . . . 0.0 111.241 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.1 t -64.5 -50.39 76.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.39 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -63.28 -40.61 97.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.884 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 43.6 mm-40 -66.31 -39.64 89.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.49 -35.13 78.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 90.7 mt -63.09 -48.54 78.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -64.59 -31.72 73.06 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.174 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 91.1 mtt180 -62.99 -33.6 75.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.18 -39.59 33.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.688 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 106' ' ' LEU . 44.1 mm -70.14 -32.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.406 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.9 t 74.52 -60.17 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.761 0.824 . . . . 0.0 110.875 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.0 t -162.67 -60.76 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.514 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 tttp 66.78 111.95 0.04 OUTLIER 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.887 0.742 . . . . 0.0 111.453 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -86.14 94.71 9.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -155.39 -156.61 0.67 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.23 20.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.322 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 66.67 16.14 10.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.969 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm . . . . . 0 C--O 1.244 0.782 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.547 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 39.2 m -104.83 3.26 30.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.43 -31.45 72.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.178 0.514 . . . . 0.0 111.232 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 23.1 m -82.17 -11.84 58.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.994 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.87 -62.81 1.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -90.32 121.96 32.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.041 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.45 134.13 28.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.846 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -122.59 98.9 6.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.271 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.99 99.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.145 0.498 . . . . 0.0 109.781 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' B' ' 209' ' ' MET . 17.7 mmt -99.64 125.74 39.64 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.558 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.37 135.36 39.34 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.632 2.221 . . . . 0.0 112.369 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -109.31 104.37 13.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.35 87.39 6.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.2 m -112.42 117.97 46.3 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.629 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.31 100.85 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.05 1.833 . . . . 0.0 112.184 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -75.27 -44.18 47.24 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.2 27.98 38.43 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.294 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.51 -42.01 98.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.564 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.45 HD11 HG21 ' A' ' 30' ' ' VAL . 2.5 pt? -76.99 -11.58 59.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -92.88 -52.42 4.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.481 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.05 -56.02 4.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.809 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 62.52 86.82 0.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.73 0.644 . . . . 0.0 111.183 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.296 179.664 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.174 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.23 96.58 4.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.52 -29.82 70.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.989 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.07 -17.89 76.02 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.355 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.72 -37.36 9.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.225 0.536 . . . . 0.0 110.031 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.56 -44.07 36.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.806 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.02 71.66 1.28 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.102 0.477 . . . . 0.0 111.699 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.98 -10.79 56.68 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.77 8.5 9.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.992 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -89.81 -17.26 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.265 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.69 98.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 17.2 m-85 -138.48 147.94 43.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.101 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -124.5 137.56 56.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.725 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.2 t80 -91.66 129.97 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.275 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.5 142.39 16.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.97 -169.89 46.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.576 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -63.83 105.66 0.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.9 mt -97.73 -173.02 2.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -72.7 143.09 48.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -59.09 -31.83 69.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -84.91 9.73 13.61 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.617 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tt -96.59 121.03 37.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.107 0.48 . . . . 0.0 109.849 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -100.16 174.72 6.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.96 -22.7 65.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.148 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.03 -38.84 94.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.451 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.537 ' O ' ' HB ' ' A' ' 29' ' ' THR . 9.6 t70 -72.89 -38.57 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.36 -46.2 97.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.303 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.6 -34.74 78.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.0 m -56.96 -46.39 82.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.415 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.33 -46.92 91.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -72.52 -19.29 61.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -66.47 -21.34 66.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.459 0.171 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -68.07 -18.4 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.994 0.426 . . . . 0.0 110.587 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.69 3.77 40.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 71.44 44.35 51.25 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.74 89.93 20.52 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 120.821 0.343 . . . . 0.0 111.256 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 97.3 Cg_endo -103.22 47.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.742 2.961 . . . . 0.0 110.949 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.5 t -104.56 -166.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' H ' HG11 ' A' ' 38' ' ' VAL . 10.0 m-20 -67.07 120.02 12.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -116.78 115.33 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.957 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.8 106.66 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.053 0.454 . . . . 0.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.99 141.17 28.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 78.7 p -73.81 100.23 3.4 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.345 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt-85 -106.38 146.41 30.5 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' OD2' HG23 ' A' ' 48' ' ' THR . 18.7 t70 -58.89 137.53 57.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.94 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -72.04 -9.73 58.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.271 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -102.6 -65.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.4 HG23 ' OD2' ' A' ' 45' ' ' ASP . 12.1 t -93.91 -25.67 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.55 35.78 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.688 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.41 154.84 24.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.249 0.524 . . . . 0.0 110.355 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 m -66.34 133.65 50.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.049 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 74.8 mt-30 -89.17 -14.1 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.55 -29.33 8.31 Favored Glycine 0 C--O 1.219 -0.825 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.389 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -108.83 173.44 6.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.011 0.905 . . . . 0.0 111.039 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.44 167.84 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.484 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -131.69 123.36 27.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.945 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 tp -111.45 138.16 48.32 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.712 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 35.0 tttm -122.24 123.09 40.64 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.443 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.73 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.6 p90 -143.7 148.56 35.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.278 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.6 106.08 17.1 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.727 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' HG21 ' A' ' 65' ' ' THR . 14.7 t70 177.07 126.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.218 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -70.65 -48.12 56.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -63.49 -40.02 95.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -60.94 -32.85 72.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.831 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.73 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.1 p -59.28 -45.73 90.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.347 0.594 . . . . 0.0 110.938 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.78 -38.92 45.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.543 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.17 -56.1 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.604 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.92 78.8 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 88.6 t -65.97 -53.14 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.05 -29.11 66.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -81.25 -48.96 11.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.17 -18.38 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 38.1 t-20 -61.86 112.35 2.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.922 0.391 . . . . 0.0 110.047 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . 105.76 -11.33 45.77 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.755 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -67.13 133.13 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -81.37 115.74 20.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.931 0.395 . . . . 0.0 111.697 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -132.37 112.43 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.82 29.67 67.01 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.749 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.5 16.35 80.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.347 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.5 148.72 51.71 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 122.788 -0.242 . . . . 0.0 110.48 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB2' ' HA2' ' A' ' 74' ' ' GLY . . . -84.87 128.59 34.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.457 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 77.8 mt -62.72 108.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -89.22 99.73 12.66 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.589 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 9.8 mm -105.83 138.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -151.41 148.28 27.91 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.194 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -72.06 118.63 15.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.616 0.246 . . . . 0.0 110.428 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -132.15 160.24 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -106.62 136.91 45.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -149.97 136.61 19.2 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 4.3 mpt_? -108.92 127.19 27.77 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.91 104.32 0.17 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.71 2.273 . . . . 0.0 111.901 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.67 134.34 33.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 15.1 ptm180 -60.02 -22.73 62.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -65.31 -19.34 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.118 0.485 . . . . 0.0 110.454 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.9 16.95 6.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 13.7 pt20 -64.94 -20.26 66.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.583 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.08 -41.44 78.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.765 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.474 ' O ' HG12 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -62.96 -45.3 93.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.594 -178.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.14 -41.56 92.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.076 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 35.7 tt0 -74.25 -43.15 58.13 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.478 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.1 84.85 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.266 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.557 ' O ' HD12 ' A' ' 106' ' ' LEU . 10.4 m -70.15 -34.6 59.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.858 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.24 -44.11 97.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 5.1 mm-40 -61.27 -41.11 96.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.114 0.483 . . . . 0.0 109.926 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.8 tp10 -70.7 -32.41 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.132 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 102' ' ' VAL . 5.8 mp -84.16 -44.72 13.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.664 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -70.88 -23.98 62.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.912 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 9.5 ptm180 -63.25 -23.64 67.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.932 0.396 . . . . 0.0 110.574 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -78.52 -39.66 37.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.792 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.77 -45.04 98.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.703 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.5 -17.86 14.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.771 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 t 68.78 80.3 0.2 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.35 78.48 1.16 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.705 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -87.75 -59.46 2.24 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 59.94 16.36 5.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.87 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.97 -77.73 0.56 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 60.25 98.76 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 O-C-N 123.656 0.598 . . . . 0.0 112.331 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.207 178.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.276 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 16.2 m -93.83 -62.81 1.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -76.12 -17.11 59.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.7 t -68.1 -5.02 15.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.44 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -78.93 -23.55 44.58 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 110.441 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -88.72 166.25 14.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.523 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.2 122.13 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.956 0.407 . . . . 0.0 110.324 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.26 106.55 10.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.046 0.451 . . . . 0.0 111.051 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 53.4 mt -121.7 107.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.714 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.2 mmt -110.37 124.61 32.83 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-O 121.074 0.464 . . . . 0.0 111.907 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 58.9 Cg_endo -72.09 166.29 30.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.105 2.537 . . . . 0.0 112.289 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.74 102.99 4.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.666 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -81.05 85.87 6.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.258 0.551 . . . . 0.0 111.728 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 70.0 m -113.72 119.35 41.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.308 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 98.55 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.151 1.901 . . . . 0.0 111.034 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.45 ' OG ' ' HG ' ' B' ' 217' ' ' LEU . 11.3 t -63.86 -40.88 97.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 79.8 20.36 68.43 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.45 ' HG ' ' OG ' ' B' ' 215' ' ' SER . 57.4 mt -65.29 -40.32 93.67 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -61.55 -27.1 68.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.899 0.381 . . . . 0.0 110.72 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.22 -50.28 8.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.765 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 40.4 mt -74.87 -59.49 2.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.556 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -117.04 90.94 3.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.533 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.645 178.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.19 83.86 0.12 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 112.259 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -97.59 -60.07 1.65 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.57 177.52 42.85 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.732 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -79.56 -41.33 27.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.832 0.348 . . . . 0.0 110.658 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.1 -5.42 14.77 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.19 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 69.93 -55.38 0.6 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.902 0.881 . . . . 0.0 112.015 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp 61.5 17.32 8.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.777 0.831 . . . . 0.0 111.726 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -101.68 -7.46 22.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.372 0.606 . . . . 0.0 109.774 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.465 ' OD1' ' HB2' ' A' ' 88' ' ' PHE . 7.0 p30 -120.89 5.25 10.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.336 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.52 130.95 35.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.1 p90 -159.31 -178.89 7.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.845 0.355 . . . . 0.0 110.835 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -112.91 144.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.471 . . . . 0.0 111.309 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 83.9 t80 -97.13 131.0 44.32 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 mp -109.7 136.37 45.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.36 -169.4 45.89 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.262 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.24 114.67 0.99 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.369 0.604 . . . . 0.0 112.595 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.17 -170.87 1.94 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.217 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -82.98 151.32 25.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.975 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -66.91 -20.05 65.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.709 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.51 10.59 40.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.812 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.7 mt -96.27 127.21 42.07 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.9 p -110.3 -179.13 3.69 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 38.1 mt-10 -64.62 -25.26 67.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.983 0.42 . . . . 0.0 110.916 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.96 -42.05 70.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.451 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' O ' ' HB ' ' A' ' 29' ' ' THR . 14.3 m-20 -66.08 -42.64 89.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 109.942 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.14 -45.81 95.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.194 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.6 -35.49 81.16 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.049 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 28.1 m -57.49 -47.03 83.01 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.684 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.04 -48.89 86.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -75.53 -17.17 60.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 t -64.74 -32.42 74.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 0.0 110.235 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.05 -22.2 63.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 110.287 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.4 ' HH ' ' CD2' ' A' ' 72' ' ' LEU . 70.9 m-85 -89.42 0.76 56.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.227 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.78 38.85 97.18 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.62 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.06 88.52 52.53 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.228 0.537 . . . . 0.0 112.266 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -93.57 70.26 0.41 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.133 2.556 . . . . 0.0 110.244 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -117.76 -166.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.043 -177.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.46 ' H ' HG11 ' A' ' 38' ' ' VAL . 5.6 m-20 -64.27 120.46 12.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.672 0.272 . . . . 0.0 111.431 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.02 138.2 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.7 130.37 49.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 54' ' ' PHE . 49.3 tp -109.95 133.12 53.52 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 26.9 m -67.8 106.62 2.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -117.84 151.95 36.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 12.9 t70 -66.85 135.89 54.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.648 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -81.95 -11.44 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -84.45 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.76 0.314 . . . . 0.0 111.292 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -104.41 -20.4 13.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.024 0.44 . . . . 0.0 111.117 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 91.86 32.3 8.63 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.96 165.22 13.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.996 0.398 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -67.5 128.05 35.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.695 0.283 . . . . 0.0 110.601 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.87 -17.62 27.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.84 -4.41 29.03 Favored Glycine 0 C--O 1.221 -0.69 0 C-N-CA 120.075 -1.059 . . . . 0.0 115.207 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.54 ' O ' HD11 ' A' ' 42' ' ' LEU . 5.0 m-85 -114.46 146.84 40.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.049 0.924 . . . . 0.0 109.533 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -133.35 148.37 51.86 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 32.8 m-85 -129.29 138.78 51.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 25.0 tp -138.18 118.68 13.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.177 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -105.43 106.1 16.45 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.711 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.701 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 26.9 p90 -124.79 145.93 49.49 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -103.35 106.21 16.67 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.768 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 65' ' ' THR . 33.4 t70 176.46 108.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.557 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.17 -36.39 72.98 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -66.99 -49.11 66.38 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.427 ' HG ' ' HB3' ' A' ' 61' ' ' ASP . 19.6 p -69.97 -20.72 63.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.701 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 72.4 p -58.36 -46.78 85.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.1 mt -74.26 -36.15 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.044 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.6 tt -61.97 -54.79 36.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.126 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.66 90.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.867 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 65' ' ' THR . 79.4 t -60.92 -52.16 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.03 -38.38 79.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -69.89 -50.02 46.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.931 0.396 . . . . 0.0 111.267 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 94.7 mt -78.13 -12.98 60.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.083 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.91 109.86 1.38 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.35 . . . . 0.0 110.497 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.47 76.85 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.382 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -78.82 129.66 34.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 3.2 tppp? -82.05 116.01 21.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.166 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.4 mm -125.02 101.68 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.468 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.4 42.39 93.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.289 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 20.64 79.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.7 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 51.5 mmm-85 -129.68 144.19 51.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.1 118.7 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.726 0.298 . . . . 0.0 110.242 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 94.7 mt -64.89 140.14 58.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.2 0.524 . . . . 0.0 111.502 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.14 116.51 21.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 5.6 mm -111.7 138.15 41.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.0 145.56 37.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.668 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.36 127.86 32.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 14' ' ' TYR . 1.8 t -147.65 160.37 42.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.575 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.465 ' HB2' ' OD1' ' A' ' 10' ' ' ASN . 6.2 p90 -126.94 135.45 50.92 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -150.48 124.09 9.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.311 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -81.64 128.87 67.76 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.13 142.37 96.65 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.09 2.527 . . . . 0.0 112.602 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -95.47 137.72 34.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.389 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -18.12 58.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.032 0.444 . . . . 0.0 109.833 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -66.81 -27.6 67.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.425 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.34 31.79 5.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.285 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.78 -32.51 67.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.28 -21.13 63.91 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.442 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -70.25 -51.51 30.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -64.15 -30.73 71.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.96 -46.49 71.24 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.28 74.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.359 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.582 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 34.4 m -60.19 -35.0 59.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -58.65 -57.62 12.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.51 -34.91 79.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.508 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -65.5 -51.46 59.89 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.513 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 89.4 mt -61.17 -40.51 94.16 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.872 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.57 -55.49 34.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -71.9 -20.15 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.038 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.24 -30.06 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 106' ' ' LEU . 81.0 mt -65.63 -46.97 87.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.195 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t 70.63 -45.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -78.42 -2.37 38.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.213 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -75.91 -39.46 56.25 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.602 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.02 -176.95 0.11 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.076 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -38.97 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 62.77 29.4 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.83 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 59.77 -158.41 0.32 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tptt . . . . . 0 N--CA 1.438 -1.058 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.654 177.67 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.142 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 35.6 t 73.06 155.09 0.16 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.434 0.635 . . . . 0.0 111.868 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -70.01 -26.59 64.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.808 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 20.3 m -70.84 -8.98 56.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.819 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.18 -31.38 65.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.092 0.472 . . . . 0.0 110.236 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -85.07 170.42 12.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.17 103.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.57 99.28 5.11 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.811 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 7.4 mm -93.1 107.04 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.026 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 93.9 mmm -121.72 125.12 26.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.458 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 77.0 Cg_exo -52.66 132.97 48.33 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.227 2.618 . . . . 0.0 113.576 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -126.13 103.69 7.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.863 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -88.63 96.02 10.48 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.391 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 36.1 t -110.56 139.12 21.27 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.932 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.83 79.1 0.41 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.079 1.853 . . . . 0.0 111.908 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -67.74 -39.14 84.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.67 36.0 62.19 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.456 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 62.7 mt -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.715 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -95.52 -5.88 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.42 -45.9 6.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.521 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 9.4 mp -88.6 -8.98 53.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.492 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -135.18 129.83 34.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.352 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.38 1.05 . . . . 0.0 111.277 177.681 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.283 0 N-CA-C 112.341 -0.304 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.14 -179.7 4.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.649 0.261 . . . . 0.0 110.758 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.3 ttp -69.38 -21.08 63.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.1 0.476 . . . . 0.0 110.268 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.66 -8.8 41.87 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.402 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.63 -39.56 73.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.32 -48.66 15.16 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.845 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.91 89.73 3.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -75.39 106.5 6.96 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.156 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -100.46 -13.87 18.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.135 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.94 19.76 6.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.096 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.36 96.97 4.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.53 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 87' ' ' THR . 99.0 m-85 -154.4 141.2 19.1 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.178 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.463 HG22 ' HH ' ' A' ' 59' ' ' TYR . 25.1 pt -116.4 142.13 31.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.407 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -93.16 122.53 35.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 71.7 mt -107.45 138.49 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.85 -169.54 46.0 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.277 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -50.24 119.28 3.54 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 112.489 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.5 mt -98.87 169.46 9.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.173 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.445 HD21 HD11 ' B' ' 217' ' ' LEU . 56.7 t30 -70.28 149.22 47.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -64.71 -24.93 67.73 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.044 0.449 . . . . 0.0 110.726 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.85 5.33 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.823 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 tt -96.7 127.24 42.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -110.73 179.75 3.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.266 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.4 -23.17 66.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.055 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.13 -41.61 96.94 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' B' ' 215' ' ' SER . 6.1 m-20 -65.1 -39.86 93.74 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.24 -49.67 80.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.68 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.87 -35.6 81.09 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.436 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -57.35 -45.43 84.37 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.07 -46.46 45.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.74 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -76.1 -19.61 58.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -19.86 66.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.092 0.473 . . . . 0.0 110.574 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.26 -0.69 15.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.738 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -96.88 -1.21 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.968 0.413 . . . . 0.0 110.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.45 -21.25 24.24 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.819 -0.705 . . . . 0.0 114.563 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.08 129.51 3.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 117.93 0.865 . . . . 0.0 112.29 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.5 112.56 1.07 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.585 2.19 . . . . 0.0 111.458 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 2.2 t -103.06 -167.54 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.468 ' H ' HG11 ' A' ' 38' ' ' VAL . 28.4 t70 -68.2 144.47 54.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.02 133.23 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 111.391 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.31 134.89 61.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.828 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.9 tp -132.22 139.6 48.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.715 0.293 . . . . 0.0 111.053 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.6 p -77.06 125.24 28.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.97 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -121.82 142.75 49.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.176 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.28 138.52 43.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.181 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.37 -17.12 52.87 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.41 -67.87 0.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.879 0.371 . . . . 0.0 111.171 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' HG3' ' A' ' 50' ' ' GLU . 9.9 t -115.36 -31.45 5.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.978 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.82 43.65 0.79 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.194 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.44 ' HG3' HG22 ' A' ' 48' ' ' THR . 43.1 mt-10 -94.53 168.47 10.84 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -74.99 134.63 41.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -84.05 -9.47 58.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.142 0.496 . . . . 0.0 110.591 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.23 3.45 51.0 Favored Glycine 0 C--O 1.222 -0.635 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.772 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.94 130.0 54.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.494 0.647 . . . . 0.0 110.192 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -131.07 141.2 50.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -128.19 127.98 43.91 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.7 tp -116.91 142.4 46.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.665 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 42.3 tttp -122.66 125.74 46.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.889 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.707 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -146.76 147.47 30.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 105.33 16.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.407 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' O ' HG21 ' A' ' 65' ' ' THR . 30.4 t70 176.04 137.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.416 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -75.91 -45.52 34.89 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.788 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -62.75 -43.07 99.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 m -58.98 -27.58 65.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.848 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.707 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.1 p -63.98 -40.17 95.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.597 0.713 . . . . 0.0 109.942 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.9 mt -76.64 -39.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.12 -58.32 8.95 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.535 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.63 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.592 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 76.7 t -65.4 -59.98 3.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.599 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 -36.66 78.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.97 -51.04 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.71 -8.99 45.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 20.0 t-20 -62.74 109.69 1.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.131 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.59 2.07 76.65 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.682 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -72.51 137.49 46.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -85.64 110.1 19.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.777 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' B' ' 218' ' ' LEU . 29.0 mm -119.13 108.4 23.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.296 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.97 13.77 80.68 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.693 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.76 -10.42 58.95 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.75 130.95 35.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD13 HG13 ' A' ' 77' ' ' ILE . 60.4 mt -84.74 128.3 34.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -104.91 111.43 24.19 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 13.8 mm -105.21 129.33 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -135.92 -179.77 5.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -111.84 129.36 56.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.1 t -155.14 160.96 41.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.123 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -110.52 121.67 45.88 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.86 148.73 41.02 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -113.15 116.01 47.28 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.466 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.13 110.24 0.98 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 112.038 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -94.79 147.24 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.79 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -78.13 -0.66 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.604 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 m -63.5 -22.95 67.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 0.0 110.018 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -122.54 34.36 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.634 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.542 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 29.1 pt20 -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.271 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 29.8 mmtp -58.11 -44.53 87.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.018 0.437 . . . . 0.0 110.737 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 102' ' ' VAL . 11.8 t80 -62.98 -46.66 86.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.514 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -48.19 82.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.565 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 49.2 mt-10 -57.81 -49.45 76.58 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.081 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -38.23 81.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 98' ' ' TYR . 68.4 t -63.1 -51.98 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.886 0.374 . . . . 0.0 110.139 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -54.78 -48.67 72.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.91 -30.16 66.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.958 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.65 -47.38 69.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.705 0.288 . . . . 0.0 110.299 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.86 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -63.31 -38.31 90.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -69.0 -24.64 64.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.686 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.4 -44.98 27.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.341 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.79 -55.86 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.9 t 69.5 -65.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.371 0.669 . . . . 0.0 110.436 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.9 p -178.7 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.893 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 62.47 97.39 0.03 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.628 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 62.9 t30 75.98 164.5 0.26 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.59 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.75 83.96 2.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.19 0.519 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.58 -52.06 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.867 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.12 0.91 7.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.218 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.323 -178.783 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.5 m 68.36 102.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.975 0.51 . . . . 0.0 111.581 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.71 -30.07 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 17.7 m -77.75 1.83 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.724 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -89.1 -14.59 35.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.361 0.6 . . . . 0.0 109.602 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -88.92 110.64 21.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.722 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 64.0 mt -85.81 133.34 29.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.326 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . 0.534 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 17.5 t70 -135.86 110.99 8.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.64 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 58.0 mt -136.78 140.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.576 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.441 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 2.9 mmt -107.73 143.85 28.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -73.1 175.61 10.26 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.728 2.286 . . . . 0.0 111.921 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.03 93.0 2.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 0.0 111.064 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -90.48 86.19 6.36 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.962 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 11.0 p -113.08 141.79 26.25 Favored Pre-proline 0 N--CA 1.435 -1.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.579 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 13.6 Cg_exo -70.25 86.84 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.906 1.737 . . . . 0.0 111.476 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.432 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 13.8 t -78.03 -51.25 10.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.492 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 72.54 36.71 58.66 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.63 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 19' ' ' ASN . 57.1 mt -60.35 -39.91 88.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.12 0.486 . . . . 0.0 111.058 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.04 -18.13 63.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.56 -34.74 16.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.961 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 91.2 mt -70.93 -43.06 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.732 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' B' ' 220' ' ' LEU . 72.9 mm-40 71.81 132.22 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.758 0.661 . . . . 0.0 111.321 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 C--N 1.31 -1.127 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.491 179.578 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.6 153.39 22.42 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.708 0.289 . . . . 0.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.74 -53.08 16.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.155 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.19 30.8 0.43 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.223 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -63.1 -58.81 6.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -99.63 10.52 41.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.779 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 59.37 -156.36 0.34 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.255 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -127.73 157.44 40.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.907 0.384 . . . . 0.0 111.072 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.89 -38.82 61.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.738 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 88' ' ' PHE . 30.3 p-10 -75.47 -8.47 56.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.696 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -74.98 109.4 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.685 ' CE1' ' HB2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -157.07 178.76 9.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.226 0.328 . . . . 0.0 110.313 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -118.97 145.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 0.0 111.738 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -94.57 133.77 37.85 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.274 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 62.6 mt -111.59 135.05 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 83' ' ' LYS . . . -87.45 -167.32 43.48 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.933 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 26.2 t-20 -39.69 112.48 0.26 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.372 1.069 . . . . 0.0 113.583 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -107.54 171.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.119 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -87.96 142.52 27.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -60.51 -23.96 64.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.905 0.384 . . . . 0.0 111.396 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -88.07 -7.6 56.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.75 111.02 22.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.491 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 p -91.87 173.9 7.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' B' ' 212' ' ' PHE . 7.5 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.725 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' B' ' 212' ' ' PHE . . . -70.51 -43.1 62.3 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.63 -41.03 98.3 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.97 -53.04 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.761 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.28 -33.17 74.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.69 0.281 . . . . 0.0 110.603 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 m -59.89 -45.59 92.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.543 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.43 -41.36 92.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.639 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.407 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 70.5 m-85 -74.79 -22.65 58.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -72.78 -17.62 61.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.324 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.56 -33.52 76.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 121.219 0.533 . . . . 0.0 109.774 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -91.73 -15.42 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.801 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.29 44.99 6.02 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.546 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -137.51 88.28 16.87 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 121.528 0.68 . . . . 0.0 111.596 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -98.44 99.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.502 2.802 . . . . 0.0 111.723 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -130.7 -165.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.8 m-20 -64.42 116.09 5.76 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.2 129.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.57 106.24 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 57.0 tp -87.21 131.31 34.24 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -74.97 102.44 4.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 19.1 mtp85 -115.7 149.43 38.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.464 ' OD2' HG21 ' A' ' 48' ' ' THR . 25.5 t70 -67.72 135.16 52.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.794 0.33 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.99 -28.25 66.18 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.46 -56.23 2.67 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.464 HG21 ' OD2' ' A' ' 45' ' ' ASP . 10.3 t -84.82 -23.1 29.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 44' ' ' ARG . . . 82.02 -6.54 66.51 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.698 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -71.34 155.34 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.688 -0.301 . . . . 0.0 111.274 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -68.63 138.18 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.3 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -85.25 -5.23 59.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.987 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 106.93 7.63 33.08 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.383 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -152.07 167.97 26.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.785 0.793 . . . . 0.0 110.924 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.44 176.28 11.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.27 0.557 . . . . 0.0 111.998 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.466 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 50.8 m-85 -136.62 153.02 51.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.932 . . . . 0.0 108.972 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 HD22 ' CZ ' ' A' ' 31' ' ' PHE . 12.4 tp -142.04 125.87 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.1 tmtm? -116.15 113.21 22.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.687 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 15.6 p90 -125.18 158.83 33.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.867 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 40.2 mt-10 -103.09 105.54 15.87 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.962 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.455 ' O ' HG21 ' A' ' 65' ' ' THR . 14.6 t70 175.7 133.46 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.79 -37.3 30.47 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.654 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -71.32 -40.61 70.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.72 0.295 . . . . 0.0 110.513 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 26.1 t -58.09 -27.83 64.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.687 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.4 p -60.82 -52.52 64.74 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.518 0.675 . . . . 0.0 109.775 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.87 -36.35 63.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.086 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.05 -61.18 2.83 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.367 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.07 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.481 HG22 ' CD2' ' A' ' 86' ' ' HIS . 54.2 t -64.36 -47.47 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.4 -33.37 60.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.107 0.479 . . . . 0.0 111.154 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.69 -53.19 7.84 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -91.43 -23.61 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 t30 -67.76 109.31 3.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.65 -5.05 32.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.673 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -75.05 126.35 30.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -83.72 122.76 29.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.386 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.9 mt -136.5 120.29 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.299 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.77 35.83 87.77 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.408 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.47 3.91 86.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.742 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -133.09 154.5 50.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.546 0.673 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.12 134.82 43.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.727 0.299 . . . . 0.0 111.224 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 75.9 mt -73.22 125.72 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.593 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 56.2 mtpt -108.11 122.42 46.85 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -120.46 129.65 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.621 0.248 . . . . 0.0 110.483 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -138.99 146.22 40.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.127 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.481 ' CD2' HG22 ' A' ' 69' ' ' VAL . 14.7 m-70 -79.57 130.48 35.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.676 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.624 HG22 ' CE1' ' A' ' 12' ' ' TYR . 3.5 t -156.27 162.52 40.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.825 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 10' ' ' ASN . 36.5 p90 -109.68 143.12 39.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.685 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 47.5 t80 -128.65 136.64 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.893 0.378 . . . . 0.0 111.178 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -108.07 96.03 16.83 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.74 146.71 84.49 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.98 2.453 . . . . 0.0 113.506 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.67 136.71 46.96 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.937 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.66 -6.96 44.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.868 0.366 . . . . 0.0 111.41 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -74.74 -27.68 60.45 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 17.26 16.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.987 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -59.04 -28.61 66.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.637 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.39 -40.09 85.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.097 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -72.86 -46.77 51.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.65 -51.82 68.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 36.4 mm-40 -62.27 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.493 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.84 -49.38 77.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.945 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -47.38 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.592 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -56.02 -54.41 45.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.539 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.3 pt-20 -69.89 -26.63 64.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.23 -58.16 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.501 ' O ' HD11 ' A' ' 110' ' ' ILE . 4.1 pp -66.47 -28.33 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.423 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.446 ' N ' HD12 ' A' ' 106' ' ' LEU . 19.0 t70 -59.87 -36.28 76.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.68 -36.11 65.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.733 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.61 -39.46 84.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.125 0.488 . . . . 0.0 110.178 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.501 HD11 ' O ' ' A' ' 106' ' ' LEU . 1.6 mp -63.93 -36.04 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.49 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t 73.72 -60.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 m -85.07 80.49 9.24 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -67.45 -23.25 65.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.866 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -79.6 74.63 6.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.967 0.413 . . . . 0.0 111.326 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -88.99 -33.43 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.2 105.94 1.17 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.403 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.36 112.32 5.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.397 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.8 pttt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.093 -179.816 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 112.081 -0.407 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 36.7 t -161.83 149.65 14.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.938 0.399 . . . . 0.0 110.709 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -7.68 59.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.153 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 62.1 m -92.71 1.98 56.98 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -72.29 -56.95 4.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.189 0.519 . . . . 0.0 110.23 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -90.93 118.66 30.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.367 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 39.6 mm -125.0 98.41 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 CA-C-O 121.437 0.637 . . . . 0.0 110.103 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.03 144.27 30.91 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.943 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 46.6 mt -134.22 144.39 35.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.6 mmt -127.19 139.93 36.48 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.854 0.359 . . . . 0.0 111.713 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.61 151.23 41.33 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.435 2.09 . . . . 0.0 111.203 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -158.02 76.22 0.78 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 24' ' ' GLU . 36.8 p90 -110.88 115.72 30.01 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.7 p -110.28 117.96 50.3 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.263 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.84 114.49 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.75 2.3 . . . . 0.0 113.001 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.414 ' HB2' HD12 ' B' ' 217' ' ' LEU . 37.7 m -78.89 -40.48 32.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.69 38.35 8.18 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.386 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.3 mp -63.69 -40.18 96.17 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.15 -20.31 66.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.16 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -80.94 -35.16 32.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.351 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.39 -70.52 0.6 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.971 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 53.56 23.71 3.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.047 0.539 . . . . 0.0 112.268 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.042 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 112.168 -0.373 . . . . 0.0 112.168 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.72 151.33 27.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.637 0.256 . . . . 0.0 110.867 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -13.89 18.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.305 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.5 117.14 5.36 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.494 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.84 -24.63 38.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.076 0.465 . . . . 0.0 110.426 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.99 -44.52 94.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.57 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.4 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 10.0 m-85 -85.13 88.89 7.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -73.39 108.21 6.12 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.363 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.409 ' O ' ' HE1' ' A' ' 12' ' ' TYR . 18.8 t70 -90.74 -19.34 23.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.647 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -93.19 -6.67 47.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.832 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.21 97.59 7.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.257 0.551 . . . . 0.0 111.75 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 74.2 m-85 -147.59 156.0 42.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.126 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.21 133.39 69.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.656 0.265 . . . . 0.0 110.498 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -85.49 126.06 33.53 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -105.9 137.02 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.71 -169.5 45.96 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.557 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -53.67 112.39 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.654 0.782 . . . . 0.0 112.239 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 HD23 ' A' ' 22' ' ' LEU . 67.6 mt -102.74 -173.42 2.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.405 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 16.4 m120 -79.31 148.19 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.08 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -65.43 -35.69 81.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.85 7.82 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.803 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 18' ' ' LEU . 26.8 tp -81.67 109.96 16.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -85.17 166.07 16.89 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.615 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 32.1 mt-10 -65.66 -22.4 66.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.53 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -45.76 78.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.581 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -64.26 -40.48 96.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 110.471 178.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.66 -46.39 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.582 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.42 -30.63 70.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.103 0.478 . . . . 0.0 109.733 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 30.8 m -62.57 -41.14 98.75 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG21 HD13 ' B' ' 218' ' ' LEU . 81.4 t -67.5 -46.86 82.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.26 -21.99 55.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -70.77 -14.31 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.784 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.45 -8.73 55.75 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.391 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.627 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 79.8 m-85 -92.15 -10.9 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.63 10.45 86.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -129.15 89.83 47.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.683 0.278 . . . . 0.0 110.737 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -88.01 114.66 0.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.963 2.442 . . . . 0.0 111.964 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.6 t -132.31 -167.42 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.485 ' H ' HG12 ' A' ' 38' ' ' VAL . 6.4 m-20 -62.0 144.23 55.43 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.24 140.28 46.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.864 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -137.32 110.33 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.668 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.52 136.42 42.38 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -79.36 112.38 16.53 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -123.29 149.62 44.58 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.72 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.63 142.45 42.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.557 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.52 -29.3 41.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.819 0.342 . . . . 0.0 111.424 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.74 -58.01 3.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 50' ' ' GLU . 3.7 t -91.79 -40.28 11.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.13 43.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.558 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 48' ' ' THR . 42.7 mt-10 -67.49 160.33 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.968 0.507 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.2 m -75.69 141.37 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.03 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -82.81 -12.96 57.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.03 -30.58 7.9 Favored Glycine 0 C--O 1.216 -0.997 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.969 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -109.36 161.81 14.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.775 0.788 . . . . 0.0 111.575 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.54 26.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -134.09 135.27 43.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.735 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.8 tp -119.15 143.43 47.21 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 31.6 tttm -124.37 118.54 26.95 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.207 0.527 . . . . 0.0 111.788 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.772 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 12.3 p90 -138.82 144.04 39.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 7' ' ' TYR . 37.0 mt-10 -102.45 104.4 14.85 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.675 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HG ' ' A' ' 64' ' ' SER . 25.1 t70 175.46 141.88 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.433 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -80.83 -37.48 29.96 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.02 -43.19 71.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' A' ' 61' ' ' ASP . 8.6 p -63.86 -22.72 67.05 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.772 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.1 p -62.23 -50.71 70.66 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.337 0.589 . . . . 0.0 109.762 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mt -64.78 -37.05 79.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.072 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.83 -58.65 7.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.426 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.66 89.23 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 65' ' ' THR . 72.2 t -57.32 -58.98 3.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.44 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.3 -31.38 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -67.23 -46.73 72.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.316 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 72.5 mt -93.78 -20.49 20.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.12 109.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.52 7.97 58.79 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.061 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.06 138.46 31.5 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -86.32 127.58 34.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.407 HG13 HD11 ' A' ' 82' ' ' LEU . 23.7 mm -131.91 110.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.88 20.84 77.96 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.753 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.31 -12.57 65.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.359 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -107.47 150.88 26.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.269 0.534 . . . . 0.0 110.926 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.51 33.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 111.067 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 78.5 mt -80.14 130.62 35.37 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -114.81 108.86 17.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.31 141.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.656 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.26 155.27 38.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.662 0.268 . . . . 0.0 110.95 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -71.68 128.25 35.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.625 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.4 t -153.72 161.26 42.27 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -108.94 159.26 16.95 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -149.48 138.92 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.355 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -112.78 113.73 49.92 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.8 140.34 79.58 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.722 2.282 . . . . 0.0 111.823 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -94.15 128.39 40.53 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -71.8 -15.26 62.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.068 0.461 . . . . 0.0 110.478 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -66.8 -29.63 69.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.6 30.87 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.628 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -53.38 -33.39 53.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.328 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -71.06 -27.09 63.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -68.37 -49.85 57.26 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -64.64 -32.17 73.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.221 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -53.31 48.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.421 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.431 ' HB3' ' SD ' ' B' ' 209' ' ' MET . . . -63.03 -38.39 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.914 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 9.0 p -70.92 -27.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.451 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 tptt -76.68 -42.53 41.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.958 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.76 -26.39 67.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.87 -31.04 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.999 0.428 . . . . 0.0 110.206 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 12.7 tp -63.39 -64.7 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.12 -34.5 72.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.769 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -63.89 -45.2 90.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.516 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.028 0.442 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 106' ' ' LEU . 49.7 mt -69.64 -9.69 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.113 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 111' ' ' VAL . 22.2 t 73.04 4.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.953 0.882 . . . . 0.0 110.002 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.2 t -86.7 88.6 7.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.219 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -151.18 24.42 0.73 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 109.815 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.92 -35.25 78.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.732 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -103.01 -32.06 9.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.947 0.403 . . . . 0.0 110.524 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.2 88.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.516 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -111.95 158.48 19.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 pttp . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.488 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.978 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 37.7 m -115.04 20.9 14.7 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.16 0.505 . . . . 0.0 110.215 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.63 -8.42 56.76 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 31.7 m -79.77 6.13 11.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.715 0.293 . . . . 0.0 111.31 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -72.83 -35.75 67.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.067 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -92.42 116.07 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.174 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.37 132.39 38.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.541 0.686 . . . . 0.0 110.814 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -109.48 120.76 43.48 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.372 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 62.4 mt -108.26 131.09 59.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.797 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 101' ' ' ALA . 20.5 mmt -107.22 134.74 19.79 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.4 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 29.6 Cg_endo -62.05 129.59 27.78 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.205 2.603 . . . . 0.0 111.829 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -103.26 102.4 12.36 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.699 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.28 83.38 3.57 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.548 0.689 . . . . 0.0 109.674 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.0 t -113.64 119.41 41.54 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.446 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.31 96.61 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.707 1.605 . . . . 0.0 111.227 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.444 ' HB2' HD11 ' B' ' 217' ' ' LEU . 17.2 m -81.39 -43.79 18.48 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 81.28 38.82 13.84 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.905 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' B' ' 215' ' ' SER . 5.6 mp -62.72 -37.76 87.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.584 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 30' ' ' VAL . 2.6 pt? -80.34 -22.7 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.517 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -50.7 49.37 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.848 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.22 -14.95 61.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.6 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -81.39 -29.22 34.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.245 0.837 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.997 179.322 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.55 102.56 13.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.878 0.37 . . . . 0.0 110.19 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.53 -21.91 15.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.489 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.12 95.07 0.56 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.017 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -74.97 -7.1 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.84 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -110.17 -2.01 17.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.855 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 55.49 38.05 29.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.363 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -78.35 52.28 1.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.84 0.829 . . . . 0.0 110.505 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.53 10.36 25.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.466 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -81.8 29.95 0.38 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.732 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.08 98.43 9.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.11 0.481 . . . . 0.0 110.75 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -139.2 137.73 36.26 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.338 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.139 0.495 . . . . 0.0 111.667 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 50.5 t80 -88.42 132.0 34.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.991 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 63.4 mt -106.9 132.69 53.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.44 -168.22 44.55 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.696 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 66.5 t30 -52.12 108.76 0.31 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -175.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.96 -165.6 1.33 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.647 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -101.15 149.03 24.39 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -72.0 -26.53 62.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.72 -19.05 62.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.765 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.1 tp -84.04 109.04 17.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.418 ' O ' HG12 ' A' ' 27' ' ' ILE . 80.4 p -91.12 178.12 6.08 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 120.927 0.394 . . . . 0.0 110.704 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.34 -9.81 58.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.466 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.77 -45.8 56.52 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.33 -39.22 85.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 23' ' ' THR . 46.7 mm -51.11 -51.62 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.636 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -67.7 -36.85 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.8 m -61.95 -42.24 98.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.652 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.04 -45.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -79.34 -21.97 45.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -75.8 -12.57 60.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.954 -0.466 . . . . 0.0 111.069 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.41 -24.53 56.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.878 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -75.2 -1.65 24.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.71 -21.3 45.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.355 -0.45 . . . . 0.0 114.096 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.99 107.2 15.1 Favored Pre-proline 0 C--N 1.313 -0.988 0 O-C-N 122.462 -0.434 . . . . 0.0 110.906 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.8 100.9 1.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.534 2.156 . . . . 0.0 110.718 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -101.05 -166.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.306 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.485 ' H ' HG13 ' A' ' 38' ' ' VAL . 34.9 t70 -63.16 129.0 38.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.929 0.395 . . . . 0.0 111.478 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.8 134.87 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.766 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 mt -131.52 106.42 11.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -93.03 127.4 38.54 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.6 t -75.74 91.58 2.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.16 0.505 . . . . 0.0 110.952 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.473 ' NH1' ' HB3' ' B' ' 211' ' ' ASP . 4.4 tpt180 -91.44 136.14 33.33 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p30 -80.75 147.16 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.093 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HB3' HD11 ' B' ' 208' ' ' ILE . 1.5 pm0 -81.59 -9.59 59.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.042 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -75.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 111.473 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -112.68 -18.93 12.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.216 0.532 . . . . 0.0 110.153 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 90.82 32.05 9.5 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.937 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -103.93 171.29 7.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.806 0.336 . . . . 0.0 111.626 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -73.3 130.85 41.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.59 -8.65 58.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.014 0.435 . . . . 0.0 110.894 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 105.95 -3.55 38.58 Favored Glycine 0 C--O 1.206 -1.63 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.673 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -137.22 163.09 31.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 117.962 0.881 . . . . 0.0 111.292 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.03 175.28 12.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.34 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 84.4 m-85 -138.87 147.99 43.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 tp -137.39 144.11 42.27 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.568 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 31.5 tttt -132.39 123.27 26.42 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.659 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 6.2 p90 -134.06 150.91 51.21 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -101.18 103.59 14.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.654 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 174.29 122.87 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.097 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -69.24 -33.36 73.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.04 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -68.04 -41.38 82.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 0.0 111.531 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.3 m -61.9 -26.32 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.659 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.7 p -61.57 -50.78 71.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.568 0.699 . . . . 0.0 109.955 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.6 mt -70.98 -34.77 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.182 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.36 -58.21 8.52 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.831 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.12 75.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.538 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 95.7 t -69.01 -30.14 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.154 0.502 . . . . 0.0 111.594 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.41 -31.9 18.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.275 0.56 . . . . 0.0 111.355 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.22 -45.23 9.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.006 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.04 -30.78 13.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.538 ' HB3' ' O ' ' A' ' 69' ' ' VAL . 8.8 t30 -67.42 109.89 3.37 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.816 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.78 31.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.185 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -72.71 132.22 43.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.21 116.85 21.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.305 0.574 . . . . 0.0 112.334 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.61 109.6 22.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.02 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.89 30.82 77.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.765 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 -13.61 65.43 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.238 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.72 148.7 35.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.925 0.363 . . . . 0.0 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.99 143.46 26.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.691 0.282 . . . . 0.0 111.307 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 87.7 mt -76.74 124.41 27.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.238 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 40.0 ttmt -104.64 117.06 33.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mm -114.96 117.22 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -127.32 146.13 50.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.738 0.304 . . . . 0.0 111.324 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -80.04 125.36 29.69 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -154.96 160.65 41.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -100.55 99.63 10.25 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -115.86 132.76 56.55 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.432 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -113.98 132.87 22.47 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.962 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.16 163.24 34.93 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 60.6 mttp -98.72 129.34 45.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.31 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.36 -11.82 60.13 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.872 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -75.08 -32.73 61.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.18 0.514 . . . . 0.0 110.236 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -89.53 33.46 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -51.4 -36.13 42.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.085 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -60.41 -49.36 77.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 111.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.82 -51.47 69.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.326 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.516 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 59.3 m-85 -61.58 -36.3 80.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.287 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 37.7 tt0 -66.5 -51.88 52.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.24 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.7 69.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.194 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HD12 ' A' ' 106' ' ' LEU . 74.4 t -69.52 -50.41 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -58.1 -44.89 87.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.779 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.5 pt-20 -70.56 -24.42 62.79 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.058 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.1 -41.96 66.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 102' ' ' VAL . 10.6 mp -63.01 -42.17 99.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' O ' HG22 ' A' ' 111' ' ' VAL . 16.7 t70 -58.1 -45.58 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.005 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -59.08 -38.05 78.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.403 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.19 -29.27 70.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.055 0.455 . . . . 0.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.9 mm -80.77 -45.97 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.317 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 57.5 t -62.86 -34.98 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 p -73.05 -3.14 24.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -86.81 92.82 9.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.23 5.61 4.3 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.348 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.647 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.2 t-20 58.96 31.65 21.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.571 0.701 . . . . 0.0 110.084 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.38 -176.16 4.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.808 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.1 -170.0 1.63 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.792 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.9 mttm . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.187 176.454 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 45.4 m -108.97 133.02 53.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.748 0.308 . . . . 0.0 110.438 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.24 -16.38 63.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.584 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 22.7 t -68.2 -13.63 62.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.042 0.449 . . . . 0.0 110.403 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -69.73 -33.91 73.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.9 156.58 17.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.5 99.15 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -132.77 101.95 5.47 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 46' ' ' GLU . 69.3 mt -107.66 126.73 64.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.1 mmt -121.63 145.65 43.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.745 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.3 148.14 54.65 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.838 2.359 . . . . 0.0 112.645 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.473 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 25.4 t70 -117.15 98.41 6.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.44 89.1 5.73 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 33.9 m -110.21 139.88 21.86 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.941 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 3.1 Cg_exo -75.08 84.88 1.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.896 1.731 . . . . 0.0 110.98 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 50.2 m -81.53 -51.12 8.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.186 0.517 . . . . 0.0 110.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.12 43.74 89.29 Favored Glycine 0 N--CA 1.431 -1.666 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.758 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.9 mp -61.26 -34.73 75.64 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.121 0.46 . . . . 0.0 110.371 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -79.06 -11.73 60.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.244 0.545 . . . . 0.0 110.563 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.28 -55.38 2.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.209 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 40.4 mt -77.79 -27.57 50.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.43 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 58.15 28.15 16.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.363 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.644 -178.864 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.221 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.1 105.29 10.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.446 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ttt -118.53 -1.33 11.21 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.905 0.859 . . . . 0.0 108.982 177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.22 -4.65 79.46 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.753 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 6' ' ' GLU . 5.9 p-10 -59.49 -37.2 77.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 0.0 110.538 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HG3' ' ND2' ' A' ' 5' ' ' ASN . 77.0 mt-10 -111.55 7.16 20.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.709 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 59.17 23.36 11.64 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.068 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.9 -27.93 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.452 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -97.93 7.37 46.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.396 0.617 . . . . 0.0 109.944 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.21 -16.18 12.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.85 97.89 4.7 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.209 0.528 . . . . 0.0 111.379 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 63.7 m-85 -142.26 139.81 32.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.036 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -116.45 133.48 62.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.038 0.447 . . . . 0.0 110.808 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -88.01 125.94 34.81 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.857 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.33 143.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.99 -169.37 45.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.119 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.76 133.73 56.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 0.0 111.597 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 mt -125.89 160.33 30.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.02 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.35 146.05 49.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.01 -21.22 65.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.429 . . . . 0.0 110.724 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.75 -13.65 58.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.76 129.58 34.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.1 p -109.27 179.37 4.18 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.895 0.379 . . . . 0.0 110.681 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.91 -21.07 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 110.049 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.26 -34.22 85.0 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.552 ' O ' ' HB ' ' A' ' 29' ' ' THR . 27.5 m-20 -72.12 -36.76 69.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.69 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.74 -34.64 78.65 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.385 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 53.4 m -59.24 -46.82 87.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.101 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 26' ' ' ASP . 58.3 t -67.52 -50.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.943 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -70.86 -9.34 57.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -22.08 66.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.845 0.355 . . . . 0.0 110.124 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.99 -19.5 64.94 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.213 0.53 . . . . 0.0 110.654 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.545 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 39.1 m-85 -83.01 -20.16 35.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.82 17.13 80.16 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.203 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.87 104.57 3.9 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.378 0.608 . . . . 0.0 111.207 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.07 116.3 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.747 2.298 . . . . 0.0 111.961 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.45 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -124.83 -166.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' H ' HG11 ' A' ' 38' ' ' VAL . 5.9 m-20 -62.55 120.34 10.93 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.01 111.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.292 0.568 . . . . 0.0 109.938 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.432 HG12 ' CZ ' ' A' ' 99' ' ' TYR . 4.3 mp -108.46 104.48 17.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.57 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.29 120.58 26.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 m -75.14 99.34 3.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.139 0.495 . . . . 0.0 110.964 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH2' ' H ' ' B' ' 211' ' ' ASP . 56.5 mtt180 -103.91 170.16 8.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.762 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.7 p-10 -108.78 149.35 29.18 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' HD13 ' B' ' 208' ' ' ILE . 4.6 pt-20 -81.46 -9.95 59.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.27 -61.99 1.82 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.944 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -105.49 -28.02 11.06 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.871 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 94.32 24.8 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.833 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 10.8 pt-20 -101.57 169.68 8.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -68.5 132.13 46.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.48 2.69 21.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.869 0.366 . . . . 0.0 111.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.78 9.66 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.043 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -169.51 163.15 10.32 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.05 0.452 . . . . 0.0 111.349 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.52 161.44 42.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.433 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -133.04 130.84 39.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.44 ' CD2' ' HD2' ' A' ' 59' ' ' TYR . 8.3 tt -121.15 139.07 53.85 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.912 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 13.5 tmtt? -125.69 121.07 32.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.441 0.639 . . . . 0.0 111.474 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.662 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 7.6 p90 -131.8 151.25 51.8 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.587 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.02 104.97 15.66 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.953 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 176.4 137.95 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.134 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -78.36 -40.97 34.75 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.417 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -69.47 -41.04 76.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 111.254 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -58.08 -26.67 62.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.999 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.662 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 53.0 p -62.83 -42.96 99.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.602 0.715 . . . . 0.0 110.401 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.1 mt -75.18 -41.05 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.031 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.87 -52.73 64.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.851 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.545 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -57.8 -43.92 85.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.863 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.43 -57.72 10.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.163 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.29 -24.61 67.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -82.54 -54.0 5.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.8 0.333 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HG ' ' HH ' ' A' ' 34' ' ' TYR . 79.0 mt -93.62 -16.1 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.68 109.75 2.13 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -0.36 61.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.523 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -69.13 136.87 52.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.38 122.97 33.73 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.95 118.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.702 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.27 8.52 79.73 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.342 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.89 10.23 46.87 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -129.43 145.38 51.43 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.027 -0.586 . . . . 0.0 110.771 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.19 32.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.872 0.368 . . . . 0.0 111.203 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.44 120.43 22.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.1 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -92.98 113.31 25.55 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.2 mm -118.59 118.89 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.653 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -135.81 149.76 49.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.878 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -76.23 134.76 39.75 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.2 t -160.13 160.58 33.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -91.16 153.09 20.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 44.9 t80 -147.13 119.4 8.34 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.089 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -112.26 99.27 45.98 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.879 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.61 149.52 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -85.13 149.09 25.77 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.04 -8.8 40.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.044 0.45 . . . . 0.0 110.571 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -68.62 -19.06 64.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.221 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.5 mt -118.49 24.43 10.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.58 0.229 . . . . 0.0 111.566 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.1 pt20 -69.97 -25.61 63.71 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.195 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -67.28 -24.42 65.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -69.38 -36.69 77.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CZ ' HG12 ' A' ' 41' ' ' ILE . 53.2 m-85 -69.12 -41.53 77.27 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.077 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 41.8 mm-40 -58.96 -50.64 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' SD ' ' B' ' 209' ' ' MET . . . -57.89 -51.21 70.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.734 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 13.1 p -64.1 -37.87 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.02 -49.31 76.54 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.433 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 54.9 mt-10 -64.67 -38.32 90.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.44 -50.17 72.52 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.927 0.394 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.522 ' O ' HG13 ' A' ' 110' ' ' ILE . 85.5 mt -65.99 -41.99 90.39 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.164 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.39 -42.41 77.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.8 ttm105 -68.94 -39.21 79.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.443 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.93 -39.88 87.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 106' ' ' LEU . 75.7 mt -68.66 -29.96 45.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.255 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 70.7 t 75.32 -61.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.593 0.757 . . . . 0.0 111.837 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.3 m -140.58 90.89 2.38 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.5 95.98 10.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.439 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -97.94 129.41 44.85 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.969 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.0 -43.89 94.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.044 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 64.16 98.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.884 0.74 . . . . 0.0 111.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -62.55 136.1 57.73 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.506 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.789 179.753 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' B' ' 204' ' ' GLN . . . . . . . . 0 N--CA 1.476 1.339 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 12.6 p -59.05 -37.88 78.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.38 -22.71 62.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.616 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 39.1 t -86.35 -19.32 29.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' B' ' 200' ' ' GLY . 18.8 mt-30 -69.29 -39.03 78.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.275 0.559 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -91.11 123.83 34.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.138 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 62.6 mt -80.71 122.51 36.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.453 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -117.77 98.74 6.51 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.022 0.915 . . . . 0.0 111.003 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 46' ' ' GLU . 66.4 mt -128.74 137.63 56.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.068 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.475 ' SD ' ' HB1' ' A' ' 101' ' ' ALA . 21.3 mmt -110.09 145.23 31.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 14.6 Cg_exo -70.04 129.05 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.012 2.475 . . . . 0.0 112.295 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.444 ' H ' ' NH2' ' A' ' 44' ' ' ARG . 31.2 m-20 -96.01 82.48 3.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.505 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.17 89.39 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.516 . . . . 0.0 110.912 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 3.2 m -112.37 129.48 24.3 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.52 70.32 7.34 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.857 1.704 . . . . 0.0 111.293 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.4 m -65.49 -50.21 66.14 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.62 43.62 96.19 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.691 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' B' ' 221' ' ' GLU . 18.5 mt -56.57 -50.65 71.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.38 -31.61 72.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.388 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.17 -37.74 88.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.82 -16.56 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' B' ' 217' ' ' LEU . 43.9 mt-10 -89.16 -23.36 22.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.502 . . . . 0.0 111.32 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.301 -1.536 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.025 -178.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.17 -46.99 84.56 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.99 -24.47 66.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.25 -22.49 78.54 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.97 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -55.42 -52.14 64.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.855 0.328 . . . . 0.0 111.186 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.08 11.94 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 64.62 29.41 13.04 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.014 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -63.87 -30.84 71.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.274 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -84.06 0.52 47.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.611 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -114.73 7.34 15.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.486 0.66 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.54 98.73 6.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.596 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 75.5 m-85 -133.48 146.01 50.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.077 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.95 137.15 52.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.342 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 74.8 t80 -85.28 128.89 34.86 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.624 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.18 132.26 61.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.86 -168.59 44.59 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.215 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -49.77 119.99 3.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.517 0.675 . . . . 0.0 112.669 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.29 179.1 4.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -81.81 151.04 27.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.693 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -73.99 -17.13 61.03 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.056 0.455 . . . . 0.0 111.231 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.23 -14.57 40.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.344 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.26 109.32 17.7 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.838 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.462 ' O ' HG13 ' A' ' 27' ' ' ILE . 54.1 p -88.77 176.39 7.09 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.236 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.3 -25.09 67.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.287 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.96 -44.73 54.72 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -63.83 -33.48 75.78 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.755 0.312 . . . . 0.0 110.938 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 23' ' ' THR . 64.5 mt -58.17 -53.09 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.275 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.33 -21.15 62.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.983 0.42 . . . . 0.0 110.673 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.5 m -63.99 -42.89 97.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.533 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.52 -48.46 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.095 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -70.96 -6.97 42.77 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 p -50.87 -44.38 59.64 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.247 0.546 . . . . 0.0 111.631 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -76.32 -6.88 53.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.624 0.726 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.98 26.38 8.62 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.525 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.68 70.09 0.35 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 118.829 -1.653 . . . . 0.0 112.756 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' O ' HG21 ' A' ' 38' ' ' VAL . 12.4 m -44.0 147.52 0.9 Allowed Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.26 1.024 . . . . 0.0 112.634 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -11.34 98.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.7 4.934 . . . . 0.0 117.029 -173.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -128.82 -164.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 26.9 m-20 -70.41 109.54 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.725 -175.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.66 143.35 21.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.2 106.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -95.11 121.83 37.15 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.2 t -78.42 110.32 13.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.045 0.45 . . . . 0.0 110.51 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -110.45 154.67 23.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.87 139.24 48.75 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.74 -9.56 58.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -109.75 -60.44 1.78 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.3 t -89.62 -11.22 43.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.16 66.82 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.912 -0.661 . . . . 0.0 114.229 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -78.35 156.79 29.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.024 0.412 . . . . 0.0 110.244 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.5 p -65.2 128.85 37.51 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.18 -14.73 63.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.804 0.335 . . . . 0.0 111.608 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.69 18.52 8.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.17 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -161.81 159.42 26.98 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 120.922 0.391 . . . . 0.0 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.43 170.61 19.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.804 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -136.34 139.2 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.7 tp -126.2 130.63 51.34 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.619 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.1 tttt -116.15 103.58 10.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.585 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.682 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 37.4 p90 -118.66 153.45 34.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 tt0 -101.02 105.8 17.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.814 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 13.4 t70 175.48 108.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.058 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -73.59 -8.75 57.21 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -91.72 -49.23 6.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 0.0 109.911 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -63.84 -26.89 68.82 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.396 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.682 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 17.2 p -59.12 -41.32 87.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 110.337 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 mm -69.01 -49.18 65.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.637 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.73 -55.56 28.92 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.252 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.7 74.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 68.0 t -60.48 -48.09 89.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.29 -33.88 42.92 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.192 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.24 -44.95 35.16 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.35 -15.09 58.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 53.2 t30 -68.45 108.72 3.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.79 -8.91 59.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.776 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.96 128.51 35.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.37 134.84 33.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.33 109.88 3.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.583 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.79 22.13 75.3 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.554 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.71 -3.9 81.61 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.473 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.07 123.65 49.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 111.048 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.96 107.68 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.76 143.73 53.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.37 111.7 21.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 8.4 mm -114.74 138.72 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -146.4 146.9 30.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.157 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -72.16 124.8 25.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -147.4 160.8 42.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.01 0.434 . . . . 0.0 110.928 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.6 117.49 34.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 57.2 t80 -102.74 127.6 49.82 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.891 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -100.18 102.08 16.81 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 50.9 Cg_exo -55.85 126.6 22.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.243 2.629 . . . . 0.0 113.706 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -77.13 128.65 34.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -77.28 -12.56 59.96 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.574 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 m -64.42 -23.07 67.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.404 0.621 . . . . 0.0 109.819 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.41 26.29 5.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.459 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -54.16 -46.42 72.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.873 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -71.67 -27.06 62.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 110.722 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -68.15 -48.78 64.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -59.52 -44.42 93.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 35.6 tt0 -60.96 -52.62 64.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.528 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.16 75.48 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 53.7 t -59.0 -49.21 84.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -64.04 -44.09 93.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 36.6 mt-10 -62.36 -43.16 99.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 110.509 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.29 -43.46 83.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.551 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -69.93 -43.06 72.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.064 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.3 -29.53 70.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.959 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.4 mmt85 -83.5 -16.67 44.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 110.846 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.39 -41.08 20.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.687 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.84 -70.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.232 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.2 t 65.93 -74.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 111.762 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m 65.35 -67.79 0.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.746 0.818 . . . . 0.0 110.756 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -113.93 113.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.56 -58.51 2.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.53 81.04 0.16 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.96 100.68 10.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.75 -2.58 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.696 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.049 -179.121 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.427 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.8 t -70.14 -15.0 62.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -66.01 -20.32 66.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 50.6 m -91.75 -3.88 55.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.092 0.473 . . . . 0.0 110.462 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -96.22 30.25 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.257 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -68.84 157.53 36.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.092 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.15 127.67 44.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.55 110.09 13.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.863 0.363 . . . . 0.0 110.763 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 48.2 mt -124.66 130.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.01 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.8 mmt -124.29 149.12 60.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.142 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.92 170.47 16.63 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -147.28 114.65 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -108.37 88.18 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.621 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 19.3 m -111.38 119.59 44.88 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.94 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 110.83 1.23 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.448 2.099 . . . . 0.0 112.536 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 19.8 m -101.64 -50.82 3.61 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.83 41.25 50.18 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.786 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.14 -30.04 69.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.322 0.561 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.99 -26.86 68.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.171 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -78.87 -17.87 54.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 0.0 110.987 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.53 -4.19 55.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 58.72 85.47 0.09 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.628 0.58 . . . . 0.0 110.48 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.31 -1.109 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.179 -178.681 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.48 148.13 41.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.755 0.312 . . . . 0.0 110.349 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.6 mmm -89.74 -18.45 26.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.007 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.95 -26.59 15.03 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.731 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -70.01 -10.7 59.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.27 -32.31 64.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -82.3 74.62 9.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 110.113 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -89.52 0.06 57.16 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.731 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.85 9.06 28.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.144 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -84.77 -0.02 52.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.45 97.71 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 21.6 m-85 -147.7 148.07 30.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.07 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.17 136.52 60.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.981 0.419 . . . . 0.0 110.542 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -86.39 131.54 34.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.585 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -113.7 138.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -171.27 47.57 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.422 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.2 t-20 -58.9 104.8 0.26 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.286 0.565 . . . . 0.0 111.735 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -95.41 -172.46 2.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 40.7 t30 -76.37 130.05 37.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -66.14 1.33 1.55 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.43 -10.58 29.53 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.182 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 19' ' ' ASN . 6.5 mp -76.06 140.12 41.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.029 0.442 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.498 HG22 ' HB2' ' B' ' 213' ' ' SER . 44.0 p -110.44 -178.12 3.41 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.785 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.71 -36.25 82.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.52 95.31 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.492 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 29' ' ' THR . 13.8 m-20 -63.32 -47.83 80.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 110.377 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.68 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.717 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.12 -38.18 90.16 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.318 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.8 m -56.12 -45.22 79.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.716 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.25 -46.39 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.102 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.05 -20.12 33.22 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 t -63.73 -24.72 67.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.648 0.261 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.29 -7.13 28.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.76 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HH ' ' CD2' ' A' ' 72' ' ' LEU . 29.0 m-85 -88.35 -4.09 58.73 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.985 0.421 . . . . 0.0 110.895 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.27 -20.99 27.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.048 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.72 111.03 9.54 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 117.42 0.61 . . . . 0.0 111.582 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.68 110.44 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.789 2.326 . . . . 0.0 111.082 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG11 ' H ' ' A' ' 39' ' ' ASP . 1.9 t -111.03 -167.23 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.498 ' H ' HG11 ' A' ' 38' ' ' VAL . 31.2 m-20 -73.36 147.04 44.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.56 140.73 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.391 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.94 99.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.67 0.271 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 1.3 tt -84.85 122.99 29.95 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 m -67.4 122.25 17.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.461 ' HD2' ' OH ' ' A' ' 98' ' ' TYR . 81.1 mtt85 -121.34 161.27 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.07 147.07 26.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.042 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' B' ' 208' ' ' ILE . 1.9 mp0 -72.68 -25.12 61.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -93.08 -59.68 1.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -81.87 -24.48 35.74 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.462 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.82 77.9 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.026 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.4 166.61 21.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.819 0.343 . . . . 0.0 110.909 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.7 p -70.15 142.29 52.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.58 3.23 48.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.148 0.499 . . . . 0.0 110.305 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.76 -31.93 8.17 Favored Glycine 0 C--O 1.219 -0.828 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.73 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -109.61 162.36 14.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.164 0.482 . . . . 0.0 111.174 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.81 171.48 16.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.234 0.54 . . . . 0.0 111.587 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -134.39 133.83 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.11 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.9 tp -114.37 144.98 42.4 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.972 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.49 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 39.2 tttm -125.51 123.35 38.96 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.244 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.71 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 23.4 p90 -148.15 145.86 28.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -100.95 105.46 16.7 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.805 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 65' ' ' THR . 39.1 t70 175.71 134.15 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.809 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.84 -53.97 22.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.803 0.335 . . . . 0.0 111.179 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -59.31 -39.91 84.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.999 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -61.1 -27.98 68.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.71 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.7 p -69.6 -36.29 76.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.583 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.96 -47.61 54.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.305 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.73 -54.85 40.18 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.76 77.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 86.8 t -60.86 -48.46 88.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.194 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.19 -41.21 81.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -71.85 -53.74 12.29 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 3.0 mm? -80.08 -25.57 39.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 33.9 t-20 -62.37 109.57 1.39 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.071 0.462 . . . . 0.0 111.143 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.65 -4.79 50.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.129 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.52 131.91 43.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 110.382 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 mt -127.2 105.18 13.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.986 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 69.33 29.65 71.77 Favored Glycine 0 C--N 1.312 -0.784 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.734 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.57 -19.57 43.54 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -89.26 143.93 26.47 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.571 0.224 . . . . 0.0 110.444 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.97 128.29 47.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 55.1 mt -68.77 110.6 4.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.688 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.87 111.66 23.58 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.4 mm -113.53 141.82 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.479 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -149.78 148.91 29.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.584 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.18 121.16 23.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -133.71 160.11 38.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.649 0.261 . . . . 0.0 110.881 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -106.63 118.41 36.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.55 160.88 43.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.69 155.32 35.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.241 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 99' ' ' TYR . 32.2 Cg_exo -58.74 132.52 48.4 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.84 2.36 . . . . 0.0 113.434 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.28 142.32 34.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.093 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -71.45 -17.05 62.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.881 0.372 . . . . 0.0 111.219 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -74.99 -26.06 59.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.23 0.538 . . . . 0.0 110.371 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.93 28.56 8.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.211 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -53.81 -37.48 63.59 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.952 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.69 -23.93 65.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.424 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.461 ' OH ' ' HD2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.9 -51.73 20.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 91' ' ' PRO . 53.1 m-85 -63.27 -41.2 99.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.58 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 44.9 mt-10 -64.24 -50.16 69.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.229 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.92 68.37 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.98 -45.29 80.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.779 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.41 -25.26 68.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.51 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 43.8 mt-10 -59.67 -40.88 89.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.15 -25.81 58.66 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.439 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.01 -42.6 60.12 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.17 -25.23 65.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.44 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 108' ' ' ARG . 8.9 tpt180 -61.79 -33.5 74.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.44 -33.95 58.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.12 0.486 . . . . 0.0 110.014 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.439 HG23 ' C ' ' A' ' 113' ' ' LYS . 1.7 mp -62.11 -52.86 55.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t 67.74 -63.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.544 0.738 . . . . 0.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.8 t -154.24 6.5 0.3 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.087 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.439 ' C ' HG23 ' A' ' 110' ' ' ILE . 56.7 tttm -116.56 88.65 2.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -103.14 -160.06 0.76 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.563 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -51.79 -74.71 0.03 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.799 0.44 . . . . 0.0 111.068 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.73 116.93 0.07 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.42 149.63 11.86 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.988 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.793 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.426 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 29.3 m -75.68 155.34 35.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 0.0 111.198 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -100.03 10.42 41.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.131 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 27.8 m -57.02 -27.12 61.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.314 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.807 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -90.16 112.03 23.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.992 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 74.9 mt -113.2 126.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.003 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.94 134.97 51.37 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.419 HD13 ' HG3' ' A' ' 46' ' ' GLU . 21.7 mt -137.94 139.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.582 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 2.5 mmt -135.58 133.62 20.39 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.621 0.248 . . . . 0.0 111.494 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.582 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 42.2 Cg_endo -69.91 142.95 48.62 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.313 2.009 . . . . 0.0 110.563 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -104.22 133.41 49.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.074 0.464 . . . . 0.0 111.355 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.25 86.82 2.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.138 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.498 ' HB2' HG22 ' A' ' 23' ' ' THR . 34.2 m -113.74 119.46 41.25 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 175.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 82.59 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.88 1.72 . . . . 0.0 111.178 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.8 m -72.24 -50.53 26.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.349 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.1 32.42 56.33 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 25.5 mt -59.26 -35.19 73.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.378 . . . . 0.0 111.656 -177.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.4 ' H ' HD21 ' B' ' 218' ' ' LEU . 0.8 OUTLIER -70.11 -30.2 67.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 178.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.53 -29.06 63.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 0.0 110.008 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 61.9 mt -72.16 -20.85 61.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.931 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 28.1 mm-40 -93.81 -151.79 0.32 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.104 179.673 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.39 115.77 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.3 ttm -76.46 -14.41 60.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.985 0.422 . . . . 0.0 110.71 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.24 51.52 1.58 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.482 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -66.6 -37.72 85.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.226 0.536 . . . . 0.0 109.858 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.21 -48.0 81.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.187 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.66 -0.65 57.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.66 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.9 mttp 58.37 50.61 9.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.769 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.98 -17.27 63.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.973 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -83.22 2.96 33.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.73 99.26 4.33 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 87' ' ' THR . 89.7 m-85 -134.1 151.73 51.52 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 17.8 pt -121.88 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.952 0.406 . . . . 0.0 110.62 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.6 t80 -75.11 129.63 37.88 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.668 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -115.64 144.53 23.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.58 -169.07 44.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.761 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -54.92 117.29 3.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.545 0.738 . . . . 0.0 110.878 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.39 162.88 12.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.896 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.12 149.68 47.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -71.91 -8.92 57.22 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.382 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -97.71 -3.37 39.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.577 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.59 112.9 22.77 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.839 0.352 . . . . 0.0 110.395 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.459 ' O ' HG13 ' A' ' 27' ' ' ILE . 30.2 p -98.88 173.33 6.91 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' CD ' HH12 ' A' ' 44' ' ' ARG . 2.0 mp0 -60.22 -27.47 67.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.71 -40.92 85.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' A' ' 29' ' ' THR . 18.4 m-20 -67.93 -37.32 81.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 23' ' ' THR . 66.8 mt -60.76 -49.0 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.1 -32.5 74.09 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 27.1 m -58.77 -46.09 88.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.432 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.38 -40.52 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.89 -14.32 56.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.7 m -63.23 -19.53 64.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.54 -28.91 69.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.38 0.61 . . . . 0.0 109.893 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HH ' ' HG ' ' A' ' 72' ' ' LEU . 49.9 m-85 -78.28 -14.22 59.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 14.77 69.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.056 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.04 89.55 33.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.3 98.68 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.624 2.216 . . . . 0.0 110.245 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.51 HG11 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -126.23 -166.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.349 -176.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' H ' HG11 ' A' ' 38' ' ' VAL . 22.4 m-20 -60.43 135.17 57.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -128.44 130.48 69.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.85 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.21 102.52 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.735 0.302 . . . . 0.0 111.327 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.449 HD12 ' NH2' ' A' ' 44' ' ' ARG . 1.7 tt -91.9 124.45 36.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.6 t -74.57 121.8 22.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.078 0.466 . . . . 0.0 111.886 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 5.3 mpt_? -120.1 165.43 14.75 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.69 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -89.59 160.86 16.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.945 0.402 . . . . 0.0 110.05 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -80.97 -9.5 59.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.25 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -93.06 -69.78 0.73 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 t -97.72 -40.33 8.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.94 32.73 2.77 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.796 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 32.6 mm-40 -91.79 153.05 19.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.788 0.327 . . . . 0.0 110.309 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -70.53 130.99 43.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.02 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -75.96 -0.38 21.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.72 16.04 37.86 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.88 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -162.62 156.17 20.38 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.005 0.431 . . . . 0.0 111.172 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.99 171.08 14.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 66.1 m-85 -139.53 140.47 37.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 12.8 tp -120.53 139.25 53.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -125.39 115.41 20.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.0 110.505 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.716 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.8 p90 -134.23 158.21 44.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 50.9 mt-10 -100.26 105.54 17.11 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.587 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' O ' HG21 ' A' ' 65' ' ' THR . 11.4 t70 175.43 125.63 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.086 0.866 . . . . 0.0 108.935 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -73.04 -54.63 8.06 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.089 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -64.5 -31.41 72.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.4 m -70.06 -19.79 63.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.716 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 65.4 p -67.35 -45.53 76.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.934 0.874 . . . . 0.0 109.002 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.8 mt -70.12 -41.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.28 -55.54 23.92 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.119 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -48.26 65.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 86' ' ' HIS . 90.6 t -63.59 -54.45 32.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.292 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.83 -31.71 73.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' HG ' ' HH ' ' A' ' 34' ' ' TYR . 93.0 mt -93.28 -13.98 27.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.06 109.18 2.9 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.403 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.25 52.67 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.09 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -73.91 138.92 44.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 121.6 32.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 111.908 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.9 mm -127.97 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.83 35.69 91.67 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.77 -14.73 55.49 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.144 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -104.22 146.69 28.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.003 0.401 . . . . 0.0 110.527 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.32 129.46 41.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.872 0.368 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.57 108.2 7.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 9.3 mtmp? -91.35 104.57 17.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 14.9 mm -106.58 141.03 22.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.611 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -150.68 153.14 35.04 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.746 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.45 ' CD2' HG23 ' A' ' 69' ' ' VAL . 43.8 m-70 -78.8 119.56 22.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.8 t -160.36 161.27 33.09 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -112.32 143.93 42.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -119.4 119.87 35.21 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.845 0.355 . . . . 0.0 110.583 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.65 104.14 54.68 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.13 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' ' HH ' ' A' ' 99' ' ' TYR . 58.8 Cg_endo -86.03 -178.56 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.768 2.312 . . . . 0.0 111.859 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.38 151.7 23.87 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -66.81 -9.45 37.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -75.26 -19.4 59.74 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.24 18.29 22.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 13.9 pt20 -63.0 -25.39 68.37 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.907 0.384 . . . . 0.0 110.095 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.554 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 12.7 mptt -52.95 -39.05 62.61 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.336 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.432 ' O ' HG21 ' A' ' 102' ' ' VAL . 3.6 t80 -63.08 -52.02 64.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.425 ' HH ' ' HG3' ' A' ' 91' ' ' PRO . 53.3 m-85 -64.25 -36.34 83.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.893 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 52.5 mt-10 -65.37 -54.05 34.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.597 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.99 69.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.734 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 106' ' ' LEU . 92.7 t -63.43 -57.62 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.87 -41.83 98.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.838 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.63 -36.83 79.6 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.08 -33.63 65.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 102' ' ' VAL . 6.6 mp -63.78 -48.82 75.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.84 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.78 -33.34 70.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.354 0.597 . . . . 0.0 110.574 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.449 ' HG2' ' HA ' ' A' ' 114' ' ' ASN . 7.7 mtp180 -70.9 -26.26 63.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.989 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.8 -37.9 23.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.4 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 106' ' ' LEU . 70.3 mt -56.99 -48.73 81.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.912 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.36 -31.27 23.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.235 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.6 m 71.23 123.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.634 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 70.03 48.51 0.53 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.715 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.449 ' HA ' ' HG2' ' A' ' 108' ' ' ARG . 90.6 m-20 70.48 171.08 0.31 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.061 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.94 -86.6 0.1 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.29 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 172.15 -65.57 0.01 OUTLIER 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.567 0.747 . . . . 0.0 109.522 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -173.74 143.11 0.96 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.225 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.677 -0.677 . . . . 0.0 110.486 -177.572 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.4 m -88.91 -23.74 22.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.589 0.233 . . . . 0.0 111.15 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' B' ' 205' ' ' TYR . 61.7 mttp -73.71 -6.87 49.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.14 0.495 . . . . 0.0 111.04 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.7 m -72.02 -18.07 61.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.471 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -130.66 -56.52 1.06 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.977 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' B' ' 202' ' ' LYS . 98.6 m-85 -90.9 127.84 36.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.162 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 43.7 mm -77.41 102.16 3.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -108.15 100.53 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.15 102.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.554 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 92.0 mmm -107.73 139.84 20.99 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.976 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.46 155.71 66.15 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.689 2.259 . . . . 0.0 111.856 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.39 124.54 34.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -109.81 87.98 2.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.597 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.424 ' HB3' HG23 ' A' ' 23' ' ' THR . 33.2 t -112.36 117.73 46.83 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 15.8 Cg_exo -69.35 91.33 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.129 1.886 . . . . 0.0 111.794 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 4.2 m -76.66 -41.98 43.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.33 56.33 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.087 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.47 -36.73 85.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.343 . . . . 0.0 111.391 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.404 ' H ' HD22 ' B' ' 218' ' ' LEU . 0.9 OUTLIER -79.26 -22.83 44.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.85 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.67 10.75 39.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.755 0.312 . . . . 0.0 110.762 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -50.76 64.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.969 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.59 91.04 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.101 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.309 -1.153 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.761 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.232 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.97 -49.95 18.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.844 0.354 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.9 mtp -102.55 -37.79 7.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.49 112.24 3.81 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.301 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -78.01 -44.75 25.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.134 0.492 . . . . 0.0 110.366 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.44 -33.28 75.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -84.35 98.53 10.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.118 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -112.97 81.29 1.47 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.442 0.639 . . . . 0.0 110.823 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' O ' ' HE1' ' A' ' 12' ' ' TYR . 8.8 p-10 -88.23 -3.62 58.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.318 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -104.1 0.32 29.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.555 0.693 . . . . 0.0 109.552 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.97 99.81 12.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.144 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 50.2 m-85 -127.55 139.59 52.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.293 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.02 123.45 62.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.153 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 52.4 t80 -86.53 127.45 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 42.8 mt -109.79 141.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.96 -169.67 46.1 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.514 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -39.62 111.89 0.22 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.436 1.094 . . . . 0.0 113.87 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.52 -178.49 3.61 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.479 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.98 149.54 24.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.19 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 9.0 mpt_? -76.42 -20.14 57.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.487 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 -10.0 59.12 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.429 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.93 112.15 22.23 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.628 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 p -102.49 -178.85 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.81 0.338 . . . . 0.0 111.047 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.97 -22.41 60.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.371 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.42 53.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.101 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -69.93 -40.55 75.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.723 0.297 . . . . 0.0 110.842 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.91 -43.8 85.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.26 -36.94 82.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 48.6 m -59.69 -36.8 77.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.04 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.76 -38.69 58.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -77.03 -28.16 54.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 p -66.73 -12.72 59.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 111.093 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.06 -21.86 65.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.188 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -2.55 58.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.084 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.61 3.62 90.57 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.204 -0.522 . . . . 0.0 114.152 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.66 106.42 2.53 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 117.305 0.553 . . . . 0.0 112.146 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.28 114.32 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.855 2.37 . . . . 0.0 111.785 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.3 t -111.89 -165.6 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' H ' HG12 ' A' ' 38' ' ' VAL . 18.3 m-20 -61.56 112.19 2.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.36 130.17 65.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.056 0.455 . . . . 0.0 110.618 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.37 130.37 74.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.329 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 tp -116.65 139.52 50.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.446 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 37.2 p -73.21 103.89 4.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 7.4 tpp180 -106.89 131.85 53.52 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.78 137.46 57.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' HG2' HD11 ' B' ' 208' ' ' ILE . 33.0 mt-10 -80.19 -9.5 59.72 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -111.29 -58.0 2.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.816 0.341 . . . . 0.0 111.598 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 p -81.49 -40.75 22.76 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 95.05 17.64 36.87 Favored Glycine 0 N--CA 1.407 -3.299 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.659 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.95 170.37 11.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 20' ' ' ARG . 5.1 p -86.82 130.46 34.46 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.446 ' OE1' ' HB2' ' A' ' 43' ' ' SER . 87.7 mt-30 -70.9 -20.69 62.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.028 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.28 -2.88 29.66 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.791 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.47 143.04 39.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.459 0.63 . . . . 0.0 110.06 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -130.92 142.52 50.37 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.424 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 119.59 22.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.03 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.5 tp -111.12 136.18 50.54 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 12.6 tmtt? -121.86 121.24 36.72 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.095 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 16.2 p90 -140.49 156.6 46.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.121 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 mp0 -100.75 105.65 17.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.902 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 12.0 t70 175.33 141.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.943 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -80.54 -51.4 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.238 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.0 -38.72 92.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.321 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 12.3 t -60.73 -28.37 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.969 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.67 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.4 p -63.73 -46.72 84.1 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 121.477 0.656 . . . . 0.0 110.027 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.69 -39.11 68.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.127 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.78 -60.41 3.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.173 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.75 83.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.437 HG21 ' CD2' ' A' ' 86' ' ' HIS . 65.9 t -60.18 -55.08 26.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.71 -9.59 59.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -87.69 -53.91 4.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.38 -19.73 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 63.3 t30 -60.78 109.29 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.11 0.481 . . . . 0.0 111.33 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.44 33.79 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.919 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -72.87 132.91 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -93.28 123.16 36.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mt -126.57 112.7 30.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.88 23.84 69.58 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.322 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 -16.39 61.16 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.662 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -96.01 139.74 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 133.87 34.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 85.5 mt -74.72 102.77 4.75 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.05 109.14 21.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 7.1 mm -101.74 131.94 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.14 142.21 47.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.613 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.437 ' CD2' HG21 ' A' ' 69' ' ' VAL . 22.9 m-70 -72.42 112.86 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -133.25 161.26 34.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.044 0.449 . . . . 0.0 111.036 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -114.23 99.74 7.84 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.459 0.647 . . . . 0.0 109.848 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' HB3' ' CD2' ' A' ' 12' ' ' TYR . 87.2 t80 -95.3 139.77 31.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.033 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -110.95 116.86 51.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.272 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.05 129.01 32.59 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.695 2.263 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.19 128.99 42.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.179 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -68.75 -21.12 64.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.32 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -76.1 -6.08 49.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.161 0.505 . . . . 0.0 110.365 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.4 mt -122.72 22.22 9.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -62.32 -26.18 68.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.222 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' HE1' ' B' ' 209' ' ' MET . 35.5 mmtp -59.02 -38.86 80.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.385 0.612 . . . . 0.0 109.972 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.71 -44.24 64.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.144 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.82 -43.02 97.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.693 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -69.04 -46.62 67.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.13 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.7 t -61.53 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.062 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.79 -41.8 78.36 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.087 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -65.02 -36.79 85.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.085 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.16 -39.95 68.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.685 0.278 . . . . 0.0 110.423 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -57.66 -53.8 54.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.02 -37.23 76.46 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.451 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -73.54 -36.76 65.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.737 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.12 -36.7 77.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 110.815 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 106' ' ' LEU . 76.1 mt -66.33 -44.22 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.3 t 71.75 -61.66 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.471 0.708 . . . . 0.0 111.758 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 m -90.96 101.55 14.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -71.55 -52.73 16.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.277 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -172.26 152.58 2.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.79 -11.78 58.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.358 . . . . 0.0 110.736 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.59 135.78 40.52 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 171.83 8.27 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.666 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 mttp . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.267 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.259 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 37.4 m -81.08 -1.88 45.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.359 . . . . 0.0 111.561 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -91.46 13.43 17.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.816 0.341 . . . . 0.0 111.69 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 44.9 p -82.03 21.58 0.87 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.079 0.466 . . . . 0.0 110.759 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -70.82 -2.66 15.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.335 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.52 114.99 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.47 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.7 mt -95.6 121.92 46.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -136.7 129.63 30.88 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.551 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.448 HD11 ' HG2' ' A' ' 46' ' ' GLU . 38.2 mt -131.76 140.66 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 -177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.427 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 8.2 mmt -121.55 144.2 39.76 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.721 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 13.5 Cg_exo -71.15 170.74 17.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.912 2.408 . . . . 0.0 111.984 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -150.25 109.64 3.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.057 0.456 . . . . 0.0 111.457 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.55 89.3 6.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.951 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.6 t -110.28 142.95 27.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.62 92.31 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.81 1.673 . . . . 0.0 111.482 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.572 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 46.3 m -77.82 -48.07 17.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.704 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.96 27.2 73.38 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.69 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 7.8 mp -72.06 -20.64 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.297 0.549 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -93.2 -7.88 43.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.153 0.501 . . . . 0.0 109.902 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.67 -43.85 6.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.149 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.27 -10.14 59.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.059 0.457 . . . . 0.0 111.19 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -86.69 101.33 13.18 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.456 -179.11 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.5 -1.8 54.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.9 mmt -65.58 -42.41 91.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.883 0.373 . . . . 0.0 110.576 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.71 47.49 3.95 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.888 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -71.99 -63.87 1.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.983 0.42 . . . . 0.0 110.408 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.16 -14.54 13.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.098 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.7 p90 40.3 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.133 0.973 . . . . 0.0 113.513 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -113.5 108.1 16.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.224 0.535 . . . . 0.0 111.709 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.08 -14.76 61.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.542 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.53 16.87 2.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.778 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.73 98.48 7.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.047 0.451 . . . . 0.0 111.337 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 96.1 m-85 -141.56 148.7 39.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.956 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 pt -115.92 140.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.48 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.42 ' HB2' ' CG2' ' A' ' 87' ' ' THR . 86.1 t80 -92.87 131.95 37.45 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.48 132.23 59.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.53 -167.53 43.67 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.824 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -39.74 126.28 1.93 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.517 1.127 . . . . 0.0 112.662 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.56 161.63 24.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.043 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.61 153.91 41.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.591 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -67.76 -37.59 82.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.012 0.434 . . . . 0.0 110.259 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -80.03 1.37 27.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.53 109.57 20.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 27' ' ' ILE . 81.3 p -93.35 176.16 6.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.71 -20.59 66.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.251 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.95 67.24 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' B' ' 215' ' ' SER . 0.7 OUTLIER -66.74 -35.47 80.19 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.591 0.234 . . . . 0.0 110.904 178.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 23' ' ' THR . 64.6 mt -58.32 -46.2 89.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.98 -38.13 82.35 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 m -54.7 -46.84 74.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.397 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.19 -47.22 94.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.281 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -74.31 -9.64 58.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -71.01 -15.32 62.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.781 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -62.98 -33.98 76.55 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.285 0.564 . . . . 0.0 109.948 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 8.3 m-85 -98.4 -13.78 20.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.962 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 78.25 60.91 2.59 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.362 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -111.97 91.65 16.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 14.0 Cg_endo -98.49 31.84 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.503 2.802 . . . . 0.0 110.971 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -94.26 -165.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.581 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.478 ' H ' HG12 ' A' ' 38' ' ' VAL . 64.3 m-20 -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.95 135.97 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.099 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.47 115.5 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.931 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.37 149.13 24.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 51' ' ' SER . 16.8 p -73.02 107.33 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.091 0.472 . . . . 0.0 110.899 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -114.53 129.6 56.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.775 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.406 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 17.9 t70 -71.76 139.79 49.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.5 -12.73 60.03 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.8 -57.89 1.97 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.44 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.5 t -89.29 -20.1 24.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 74.03 20.31 79.71 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.486 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -96.37 170.3 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.861 0.331 . . . . 0.0 111.402 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' SER . 15.1 m -83.29 138.07 33.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.01 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.59 -16.25 35.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.27 23.06 7.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.448 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -156.94 154.35 29.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.18 0.49 . . . . 0.0 109.852 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.44 17.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.237 0.542 . . . . 0.0 112.434 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -134.07 131.94 39.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.526 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 tp -121.66 138.61 54.27 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.804 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 57.6 tttt -120.31 113.97 21.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.676 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 33.1 p90 -139.95 148.65 42.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 9.5 tp10 -100.67 105.73 17.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 54.0 t0 174.62 122.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.328 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HA ' ' HG1' ' A' ' 65' ' ' THR . 19.8 tt0 -80.34 -12.33 59.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -86.99 -49.48 7.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.091 0.472 . . . . 0.0 110.071 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 t -67.5 -22.65 65.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.062 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.676 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 1.2 p -61.79 -59.1 5.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.872 0.367 . . . . 0.0 111.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.75 -38.06 81.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.963 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.7 -53.89 53.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.267 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.08 84.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 65' ' ' THR . 88.3 t -63.41 -60.41 2.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.479 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -63.65 -34.27 77.47 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -69.05 -49.5 56.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.708 0.289 . . . . 0.0 111.021 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 85.9 mt -84.68 -27.68 26.9 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -59.79 108.23 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.03 -5.66 59.54 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.868 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.8 t80 -74.31 130.24 39.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.14 124.32 28.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.568 . . . . 0.0 112.481 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -129.88 105.46 12.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.705 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.97 72.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.602 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.61 59.12 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -111.45 130.31 55.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.583 -0.309 . . . . 0.0 110.524 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -82.28 129.88 34.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.565 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.52 127.63 32.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.335 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 45.4 tptt -110.68 116.46 31.35 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mm -110.13 140.15 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.21 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.13 171.25 16.19 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -101.32 128.95 47.24 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.5 t -153.92 161.8 41.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -114.78 110.41 19.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.931 0.396 . . . . 0.0 111.347 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.0 120.17 30.81 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.321 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -98.79 139.48 21.1 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.131 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.08 138.13 60.54 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.801 2.334 . . . . 0.0 111.887 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -110.31 144.64 38.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.897 0.379 . . . . 0.0 111.694 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -55.3 -31.17 61.42 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.134 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -64.63 -22.1 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.76 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.22 21.32 17.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.108 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -56.9 -38.98 73.57 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.13 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -55.61 -43.17 75.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.853 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.44 ' O ' HG21 ' A' ' 102' ' ' VAL . 49.1 t80 -67.72 -45.82 73.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.506 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.06 -44.39 95.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.138 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.21 -40.88 97.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.76 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.54 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.311 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 98' ' ' TYR . 72.5 t -64.61 -38.04 81.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.081 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -60.05 -39.19 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.672 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 75.2 mm-40 -61.68 -49.79 75.07 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.773 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.58 -40.67 79.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 110' ' ' ILE . 88.9 mt -65.71 -42.47 91.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 0.0 109.83 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 112' ' ' SER . 27.3 t70 -65.77 -47.92 73.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.082 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 19.1 mmt180 -63.45 -36.94 85.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.335 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.39 -38.49 84.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.975 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.59 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 70.7 mt -68.49 -50.07 59.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.668 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.59 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 8.9 p 162.05 -13.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.785 0.678 . . . . 0.0 109.833 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.522 ' HA ' ' OD2' ' A' ' 107' ' ' ASP . 10.7 t 83.5 100.35 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.133 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 113' ' ' LYS . 9.0 mtmp? -73.82 96.37 2.56 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.712 -175.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -85.32 -12.51 52.13 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.41 89.5 0.69 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.891 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.64 129.65 40.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.713 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.1 104.0 16.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.721 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm . . . . . 0 C--O 1.245 0.842 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.021 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 179.46 4.7 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -80.87 -13.19 59.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.771 0.32 . . . . 0.0 110.471 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.6 p -70.58 -10.38 59.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.692 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -66.43 -32.52 73.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.365 0.602 . . . . 0.0 109.379 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -91.47 112.54 24.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.57 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -89.74 106.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.17 0.51 . . . . 0.0 111.28 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -116.4 99.35 7.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.671 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 67.0 mt -123.41 131.09 73.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 16.9 mmt -114.31 136.0 22.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.86 169.0 15.6 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.934 2.423 . . . . 0.0 111.95 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -142.78 102.56 4.06 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.702 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -96.99 87.39 4.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.896 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.2 m -111.5 119.53 44.85 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.823 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.21 105.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.823 2.348 . . . . 0.0 112.167 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 3.6 m -96.28 -50.04 4.96 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.559 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.05 33.82 84.8 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.94 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 11.0 mp -66.94 -33.07 74.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 110.43 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' B' ' 222' ' ' SER . 2.6 pt? -76.89 -14.24 59.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.794 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.09 -45.44 5.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.197 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.37 -53.19 8.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.861 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -82.89 -47.93 11.29 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' B' ' 218' ' ' LEU . 19.5 m . . . . . 0 C--N 1.294 -1.821 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.867 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.67 -73.53 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.358 0.663 . . . . 0.0 112.465 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.9 ttm -55.1 -53.86 50.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.884 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.16 9.84 76.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.739 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -110.07 -57.29 2.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.906 0.384 . . . . 0.0 110.649 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.3 -46.96 59.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.35 0.595 . . . . 0.0 110.228 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -100.42 35.28 2.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.479 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -61.09 -8.35 3.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.529 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.3 -2.92 14.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.945 0.402 . . . . 0.0 110.854 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.465 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 2.1 p-10 -83.92 -13.43 53.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.408 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.47 96.15 10.49 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.025 0.441 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.602 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.5 m-85 -158.85 136.99 10.59 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.268 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.65 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.158 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -87.08 122.54 31.04 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 26.5 mm -95.29 135.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -168.97 45.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.966 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -40.0 107.83 0.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.152 0.981 . . . . 0.0 113.547 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.55 152.87 23.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.978 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.428 HD21 HD11 ' B' ' 217' ' ' LEU . 48.9 t30 -67.28 138.52 56.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -63.1 -19.78 64.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 0.0 111.473 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 57.6 mm-40 -80.59 -4.1 52.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.147 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.8 mt -83.28 139.23 33.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.914 0.387 . . . . 0.0 110.556 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -110.22 168.62 9.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.655 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HG2' ' HH ' ' A' ' 98' ' ' TYR . 1.4 mp0 -60.84 -27.53 68.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.44 97.73 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.708 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.63 -47.67 83.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 110.781 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.85 -46.63 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.92 -35.96 82.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.031 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.3 m -56.35 -49.29 74.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.407 ' CG2' HD23 ' B' ' 218' ' ' LEU . 95.1 t -65.18 -46.51 90.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.724 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -75.15 -22.97 57.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 m -64.6 -24.58 67.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.818 0.342 . . . . 0.0 110.478 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.08 -20.32 66.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -89.75 -2.31 58.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.603 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.44 34.69 44.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.626 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.0 89.81 37.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 111.778 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -89.06 78.27 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.636 2.224 . . . . 0.0 111.116 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -115.86 -166.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.905 -177.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' CG ' ' HZ3' ' A' ' 58' ' ' LYS . 4.6 p-10 -85.41 144.88 27.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -171.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.02 133.29 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.428 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.2 mp -123.68 107.91 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 43' ' ' SER . 5.0 tt -92.27 134.05 35.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.465 ' N ' HD23 ' A' ' 42' ' ' LEU . 19.5 m -67.92 95.52 0.54 Allowed 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -114.2 145.67 41.39 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.485 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 38.1 m-20 -61.52 150.63 35.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.215 0.531 . . . . 0.0 112.062 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -77.13 -41.88 40.09 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.421 -176.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.65 -59.39 2.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -85.79 -15.86 40.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 66.09 31.52 79.58 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.778 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -92.82 155.21 17.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.611 0.206 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -67.04 111.06 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.93 -20.89 60.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.047 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.71 11.12 20.02 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 120.311 -0.947 . . . . 0.0 115.052 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.25 165.51 24.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.878 0.839 . . . . 0.0 109.082 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 15' ' ' ILE . . . -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.499 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.86 121.65 27.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.731 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.77 142.69 46.19 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.117 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.602 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -131.72 117.06 18.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.352 0.596 . . . . 0.0 111.701 179.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.713 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.0 p90 -129.7 156.01 44.96 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.34 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -102.15 106.15 16.96 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.731 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.2 t70 176.94 139.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.891 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -80.76 -46.56 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -75.41 -29.59 59.82 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 m -68.59 -23.02 64.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.713 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 67.2 p -61.6 -46.87 87.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.557 0.694 . . . . 0.0 109.645 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.59 -33.38 48.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.966 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.423 ' C ' HD21 ' A' ' 67' ' ' LEU . 7.3 tt -61.78 -52.54 63.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.14 89.44 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 79.9 t -63.3 -44.51 99.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.029 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.2 -48.66 56.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.907 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.51 -49.83 65.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.308 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.2 mt -86.57 -2.12 58.22 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 48.1 t-20 -67.73 108.96 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.93 6.69 61.78 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.421 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -72.16 121.82 19.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -83.65 117.51 23.23 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.03 113.51 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.244 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.64 76.62 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.94 -2.56 88.19 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.969 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.92 145.58 36.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.09 135.9 33.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 80.8 mt -76.06 133.68 40.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.795 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.39 113.09 15.76 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm -103.59 134.5 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.02 157.6 40.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.13 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -92.49 133.14 36.21 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -159.57 157.41 29.81 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.465 ' CB ' ' HA ' ' A' ' 10' ' ' ASN . 49.6 p90 -107.07 143.08 35.73 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -149.98 138.56 20.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.998 0.428 . . . . 0.0 111.316 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -105.72 138.56 19.65 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HA ' ' HH ' ' A' ' 99' ' ' TYR . 34.9 Cg_endo -64.9 136.41 48.68 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 122.649 2.233 . . . . 0.0 113.33 -177.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -77.29 137.87 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 33.9 ttp85 -68.81 -26.0 64.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.995 0.426 . . . . 0.0 110.826 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -77.56 -30.01 52.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.086 0.47 . . . . 0.0 110.596 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.56 18.74 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 29.6 pt20 -65.26 -27.1 68.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.279 0.562 . . . . 0.0 110.132 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HB3' ' HZ1' ' A' ' 97' ' ' LYS . 9.6 mtpm? -70.87 -21.15 62.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.746 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.51 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.9 t80 -64.16 -46.42 84.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.442 ' HH ' ' HA ' ' A' ' 91' ' ' PRO . 32.3 m-85 -63.65 -38.05 89.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.752 177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.89 -48.09 80.51 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.958 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.6 74.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.356 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.524 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.8 t -70.64 -41.48 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.831 0.348 . . . . 0.0 110.119 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -55.54 -48.43 74.73 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.986 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.28 -23.74 67.41 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.766 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -24.66 37.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.012 0.435 . . . . 0.0 110.35 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 69.5 mt -80.93 -44.22 18.57 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.57 -9.71 51.17 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.819 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -62.46 -29.07 70.25 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.019 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.81 -36.31 80.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.597 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -70.47 -45.65 73.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.271 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.0 t 71.93 -70.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.6 t -173.96 -169.74 0.5 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.617 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -132.1 -47.91 0.93 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -151.54 117.78 5.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -134.54 -48.27 0.76 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.39 -173.79 4.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.661 0.267 . . . . 0.0 111.631 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.36 -85.69 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.677 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.315 -0.85 . . . . 0.0 109.777 179.4 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.7 m -125.73 -9.24 6.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.733 0.302 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' B' ' 202' ' ' LYS . 10.4 mtmp? -78.66 -23.62 45.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.4 p -83.5 3.16 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.198 0.523 . . . . 0.0 110.934 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.82 -24.28 35.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.519 0.676 . . . . 0.0 109.438 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -90.6 172.68 8.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.855 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 44.1 mm -59.37 102.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.208 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -136.52 99.86 4.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.648 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 61.3 mt -103.39 123.04 56.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.502 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' MET . . . . . 0.501 ' HA ' ' HE1' ' B' ' 209' ' ' MET . 15.2 mmt -101.99 128.61 28.24 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.875 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.51 146.14 88.79 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -120.39 116.97 26.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.522 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -100.33 86.25 3.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.35 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.8 m -113.57 119.1 42.29 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.307 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.44 103.74 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.214 1.943 . . . . 0.0 111.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.521 ' OG ' ' HB2' ' B' ' 217' ' ' LEU . 89.9 p -81.35 -32.51 32.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.88 9.25 86.67 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.521 ' HB2' ' OG ' ' B' ' 215' ' ' SER . 0.3 OUTLIER -56.86 -51.58 68.47 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.728 0.811 . . . . 0.0 111.307 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.407 HD23 ' CG2' ' A' ' 30' ' ' VAL . 3.9 pp -84.19 -17.25 40.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.578 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.634 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.74 -12.76 58.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.045 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.98 12.89 11.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.614 -0.707 . . . . 0.0 110.211 179.154 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.85 100.78 4.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.736 0.303 . . . . 0.0 110.755 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.5 -39.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.28 125.27 0.77 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -64.48 -27.18 68.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.46 -13.51 58.94 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -123.36 13.96 9.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.189 0.519 . . . . 0.0 109.786 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -114.78 -41.44 3.38 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.9 -39.73 49.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.19 0.11 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.753 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.589 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -71.93 96.54 1.71 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -160.63 136.27 8.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.229 1.012 . . . . 0.0 109.142 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 pt -120.01 137.14 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 121.028 0.442 . . . . 0.0 110.848 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -89.4 131.5 35.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.537 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.4 mt -113.84 144.84 20.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.21 -169.16 45.5 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.285 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.36 112.37 3.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.788 0.328 . . . . 0.0 110.695 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 74.0 mt -93.95 177.17 6.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 0.0 111.732 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -69.13 138.11 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.018 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.75 -20.33 61.08 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.18 2.63 53.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.67 109.61 19.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -97.41 177.7 5.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.109 0.481 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.44 -27.53 69.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.34 -42.98 89.45 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.428 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 30' ' ' VAL . 10.4 m-20 -63.61 -47.24 82.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.23 -47.04 88.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.778 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.23 -41.8 98.74 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 m -60.33 -48.89 79.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.404 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 26' ' ' ASP . 74.9 t -54.7 -47.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.436 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.72 -22.63 37.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -64.76 -26.73 68.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.403 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.66 -16.05 63.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.467 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.87 -4.49 59.18 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.1 0.476 . . . . 0.0 110.249 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.37 17.04 78.74 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.377 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.88 90.18 51.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.716 0.293 . . . . 0.0 110.24 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.89 105.51 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.019 2.479 . . . . 0.0 112.094 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.2 t -132.48 -166.57 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.522 ' H ' HG11 ' A' ' 38' ' ' VAL . 20.9 t70 -70.84 140.21 51.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.07 136.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.35 100.84 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.618 0.246 . . . . 0.0 111.629 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -85.94 112.98 21.69 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.8 t -65.83 118.59 9.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.4 0.619 . . . . 0.0 111.837 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -133.95 155.79 49.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.604 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.403 ' OD2' HG22 ' A' ' 48' ' ' THR . 32.3 t70 -73.11 135.41 44.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.873 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.94 -18.72 63.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -96.36 -61.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.672 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.403 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.0 t -84.36 -33.25 23.87 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.65 60.99 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.827 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.21 155.34 40.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.099 0.449 . . . . 0.0 110.367 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 m -68.15 138.69 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.89 -8.89 59.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.099 0.476 . . . . 0.0 111.074 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.43 30.41 7.73 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.329 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -170.61 170.8 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.68 170.82 19.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.72 155.96 49.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.175 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.77 140.26 34.75 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.655 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 49.9 tttp -123.13 115.34 21.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.909 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 8.2 p90 -132.91 143.2 49.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -102.89 107.57 18.45 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.521 -0.871 . . . . 0.0 113.194 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 t70 178.61 143.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.883 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -79.98 -35.01 38.14 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -83.06 -35.52 25.65 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.093 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.8 t -57.6 -29.9 64.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.413 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.605 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 75.4 p -59.43 -52.76 64.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.478 0.656 . . . . 0.0 109.423 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.5 -46.07 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.953 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 tp -50.06 -58.58 5.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.936 0.773 . . . . 0.0 111.562 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.628 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 65' ' ' THR . 97.3 t -66.99 -57.85 8.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.527 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.22 -18.04 64.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.561 -0.456 . . . . 0.0 112.15 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -90.5 -55.8 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.989 0.423 . . . . 0.0 111.308 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 92.1 mt -91.34 -17.38 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.79 109.05 2.74 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.436 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.13 2.62 64.12 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.105 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 61.0 t80 -76.87 143.39 39.69 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 1.8 tppp? -94.61 114.23 26.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.901 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.6 117.65 42.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.26 35.18 76.45 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.324 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.67 22.26 75.19 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.758 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 24.9 mtp180 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 122.635 -0.332 . . . . 0.0 110.694 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -98.76 135.79 39.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.933 0.397 . . . . 0.0 111.46 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 41.2 mt -85.54 122.27 29.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.617 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.0 107.45 19.4 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -108.25 124.36 64.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.966 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -136.26 149.99 48.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -77.64 124.39 27.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 t -149.39 162.01 40.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.613 0.244 . . . . 0.0 110.966 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -114.96 108.86 17.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.22 139.8 50.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.297 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -107.47 132.27 21.1 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.74 133.73 46.67 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.969 2.446 . . . . 0.0 112.583 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -76.78 131.98 38.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -70.65 -20.92 62.67 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 p -74.58 -14.46 60.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.786 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.414 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 94.9 mt -113.72 25.12 11.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.855 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -56.79 -35.03 68.24 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -55.76 -46.07 77.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.128 0.49 . . . . 0.0 110.638 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.39 -53.78 50.01 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.066 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.414 ' HD1' ' O ' ' A' ' 95' ' ' LEU . 77.2 m-85 -59.09 -44.69 91.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -68.52 -32.88 73.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.458 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.22 -46.71 73.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.18 -39.79 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.16 0.505 . . . . 0.0 109.946 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -57.02 -54.23 49.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.673 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.24 -28.19 67.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.8 -51.95 59.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.0 110.854 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 -27.01 56.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.1 t70 -58.01 -27.25 63.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -59.52 -27.06 65.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.41 -36.8 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.161 0.505 . . . . 0.0 109.897 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 114' ' ' ASN . 58.2 mt -73.63 -36.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.952 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.6 t -59.47 -30.28 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.427 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.6 t -78.47 88.25 4.44 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 62.51 94.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.205 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 63.9 t30 -123.98 63.1 1.07 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.189 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 70.09 -48.86 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.71 114.71 4.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.953 0.406 . . . . 0.0 111.834 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.71 155.48 50.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 tttp . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.22 179.384 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 22.2 t 73.1 159.2 0.22 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.996 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -117.9 0.11 11.83 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.655 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 25.8 p -68.34 -20.4 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.625 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -61.49 -29.72 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.973 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.77 118.03 18.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.976 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.8 mt -108.76 112.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -140.64 104.37 4.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.791 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 63.9 mt -134.85 100.1 2.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.354 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 80.0 mmm -103.87 136.11 19.25 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.4 156.08 62.46 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.921 2.414 . . . . 0.0 113.24 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.85 117.56 7.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -87.47 89.63 8.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.19 0.519 . . . . 0.0 111.142 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 1.0 OUTLIER -91.49 143.24 27.82 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.009 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 28.4 Cg_endo -96.15 84.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 18.7 t -71.97 -47.04 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 84.97 17.22 63.58 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.828 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.31 -33.21 72.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.42 -35.09 79.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.266 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.07 -27.91 57.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.346 0.593 . . . . 0.0 110.703 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 73.2 mt -76.5 -3.38 37.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.18 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -94.17 9.29 38.46 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.75 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.722 179.3 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.424 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.73 83.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.153 0.581 . . . . 0.0 111.632 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.33 -52.6 61.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.474 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.25 -10.53 6.1 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.523 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -64.11 -18.39 64.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.75 4.32 19.89 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 52.47 35.56 17.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.076 0.55 . . . . 0.0 112.164 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -62.71 -26.68 68.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.578 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.99 -22.01 64.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.601 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -97.99 6.19 47.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.485 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.77 99.4 2.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 8.8 m-85 -125.38 154.49 41.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.397 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.58 139.09 52.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.737 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -99.08 123.37 43.33 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.31 141.65 18.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.32 -168.82 45.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.64 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 3.7 t-20 -48.47 110.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.51 0.724 . . . . 0.0 112.743 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.94 177.62 5.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.24 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.66 142.82 33.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -57.19 -26.39 60.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.585 0.354 . . . . 0.0 111.64 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.99 -10.69 59.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.957 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD12 HD12 ' B' ' 217' ' ' LEU . 6.3 mp -87.28 110.07 19.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.071 0.463 . . . . 0.0 111.018 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.5 p -94.08 172.67 8.08 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.633 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -63.9 -22.59 66.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.289 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.98 -41.03 95.5 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.973 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 29' ' ' THR . 28.8 t70 -75.36 -36.84 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.985 0.421 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.23 -41.04 85.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.633 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.34 -38.94 92.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.303 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 17.4 m -58.02 -45.05 87.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.457 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 26' ' ' ASP . 88.9 t -56.83 -50.14 76.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.29 -16.81 58.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.6 m -72.46 -13.75 61.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.49 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -83.63 -11.03 57.81 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.83 72.94 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.909 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.15 89.63 48.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.58 95.82 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.86 2.373 . . . . 0.0 110.513 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG13 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -118.86 -166.7 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.229 -177.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.458 ' H ' HG13 ' A' ' 38' ' ' VAL . 25.0 m-20 -68.13 114.7 6.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.961 0.41 . . . . 0.0 111.997 -172.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.68 127.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.704 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.09 113.19 39.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.488 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 54' ' ' PHE . 59.9 tp -87.26 133.61 33.65 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 38.6 m -68.73 102.84 1.6 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -123.55 154.57 39.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.968 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 47' ' ' ASN . 5.6 p-10 -84.77 152.09 23.93 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.323 0.582 . . . . 0.0 111.354 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG2' HD13 ' B' ' 206' ' ' ILE . 1.3 mp0 -81.13 -9.88 59.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.413 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 16.4 m120 -83.06 -67.33 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.574 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 t -104.42 -30.55 10.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.56 46.62 4.26 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.62 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.63 164.5 11.71 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.778 0.289 . . . . 0.0 110.693 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -79.55 106.18 11.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.856 0.36 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.3 -33.68 75.79 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.16 31.91 2.95 Favored Glycine 0 C--O 1.218 -0.892 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.997 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.2 m-85 -135.37 157.32 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.98 29.99 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.997 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -121.07 119.11 31.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.51 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 27.8 tp -115.54 139.77 49.77 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.092 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 1.7 tmtp? -124.14 112.68 17.38 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.183 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.768 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -129.71 150.73 50.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.72 105.34 16.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.203 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 176.2 143.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.425 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -80.76 -48.98 11.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 64' ' ' SER . 2.6 ptp180 -67.16 -33.71 76.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 63' ' ' ARG . 46.9 m -63.65 -27.45 69.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.086 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.768 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 68.9 p -63.29 -48.43 78.13 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.693 0.759 . . . . 0.0 110.08 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.68 -38.64 45.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.29 -52.6 64.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.12 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -43.09 76.85 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.362 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 65' ' ' THR . 90.9 t -61.87 -59.82 3.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.297 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.38 -22.16 66.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.28 -45.67 15.89 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.76 0.314 . . . . 0.0 111.146 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -97.83 -20.41 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.84 110.13 1.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.77 -0.88 56.6 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.495 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -77.58 123.79 27.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -88.99 117.51 28.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.172 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' B' ' 218' ' ' LEU . 57.2 mt -121.57 115.77 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.064 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.22 35.28 69.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.716 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.31 13.55 78.51 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.097 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -128.8 130.7 47.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.912 0.356 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.88 133.02 33.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 89.5 mt -79.11 128.04 32.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.596 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -123.93 118.18 26.47 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -107.92 126.43 64.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -123.25 142.87 50.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.975 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -84.79 106.75 16.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.769 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 136.52 21.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.852 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -80.67 156.84 26.14 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.39 137.86 32.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.604 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -94.5 120.57 64.89 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.731 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -62.66 110.57 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.531 2.154 . . . . 0.0 111.481 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.55 140.19 44.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -70.09 -31.05 68.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.416 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 p -79.87 -11.42 59.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 48.9 tp -105.16 8.22 34.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -62.09 -20.1 63.66 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -59.15 -41.62 88.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.631 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 3.5 t80 -69.37 -45.62 68.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -58.08 -50.09 74.67 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.568 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -61.65 -46.34 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.333 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.9 86.42 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.427 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.6 t -74.25 -39.83 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.221 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.76 -45.02 94.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.62 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.83 -29.94 71.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 111.054 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.97 -37.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 70.8 mt -68.82 -39.62 79.94 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.4 -21.34 66.66 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.792 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -65.14 -17.81 64.78 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.504 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.59 -32.54 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.424 0.63 . . . . 0.0 109.719 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.42 -25.9 5.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.914 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.6 t 73.25 -60.7 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.861 0.864 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 p -153.32 -67.2 0.15 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.365 0.602 . . . . 0.0 109.544 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -136.87 17.03 3.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.29 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 63.7 t30 69.12 96.01 0.07 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -74.15 85.16 1.85 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.657 0.742 . . . . 0.0 112.837 -173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.92 12.84 28.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.251 174.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.22 156.16 39.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.22 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.314 179.45 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.227 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -95.37 -28.96 14.7 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.14 -13.41 58.06 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 64.7 m -80.43 -11.33 59.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.686 0.279 . . . . 0.0 111.334 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.6 -3.05 50.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.251 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -86.0 138.4 32.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.947 0.403 . . . . 0.0 110.317 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.451 HD13 ' HG2' ' A' ' 46' ' ' GLU . 22.4 mm -90.56 98.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.238 0.542 . . . . 0.0 111.191 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -109.69 98.94 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.534 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 68.6 mt -128.51 110.09 20.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.071 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.7 mmt -84.19 118.63 71.72 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.916 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.48 164.98 10.15 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.112 2.542 . . . . 0.0 112.608 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -122.25 94.86 4.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.752 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -84.22 88.62 7.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.321 0.581 . . . . 0.0 110.118 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 23.8 m -109.84 157.08 38.69 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.733 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.39 59.98 2.56 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.911 2.407 . . . . 0.0 112.183 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' SER . . . . . 0.596 ' O ' HD13 ' B' ' 217' ' ' LEU . 73.6 m -78.68 33.24 0.21 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.241 0.616 . . . . 0.0 111.456 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.94 58.84 0.37 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.56 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.596 HD13 ' O ' ' B' ' 215' ' ' SER . 5.0 mp -64.85 -27.86 69.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.427 ' CD2' HD11 ' A' ' 77' ' ' ILE . 4.0 pp -100.73 -7.63 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.753 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.18 -53.0 3.25 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.24 0.82 38.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' B' ' 217' ' ' LEU . 26.7 mm-40 61.24 28.48 18.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.16 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.448 -177.831 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.268 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.61 -21.36 59.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.495 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.0 mmm -78.53 -6.97 56.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.25 63.41 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.272 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -65.5 -29.38 70.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.11 6.37 48.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -122.29 10.8 9.98 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.632 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -76.01 -11.5 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.955 0.407 . . . . 0.0 110.924 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.34 -7.83 58.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.59 6.66 44.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.088 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 97.88 4.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.729 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -154.23 136.63 14.98 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.209 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 pt -108.42 137.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.899 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 89.4 t80 -94.6 134.76 36.82 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.059 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.56 138.53 45.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.39 -167.62 43.44 Favored Glycine 0 C--N 1.32 -0.312 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.344 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' A' ' 80' ' ' ARG . 6.3 p30 -48.19 139.42 8.44 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.302 0.572 . . . . 0.0 112.0 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.46 -176.99 3.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.071 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.36 147.67 22.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HD3' ' OE1' ' A' ' 50' ' ' GLU . 75.8 mtt180 -70.89 -15.75 62.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.91 1.61 56.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.407 . . . . 0.0 110.116 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.418 HD21 HD13 ' B' ' 217' ' ' LEU . 1.8 tm? -97.77 118.48 34.43 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.6 p -109.95 176.61 5.0 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 111.983 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.16 -31.77 67.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.913 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.69 98.86 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.049 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.96 -45.02 64.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.4 mt -55.72 -46.46 79.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.724 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -41.32 96.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.836 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -56.82 -46.55 81.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.649 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.56 -49.44 80.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.466 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.37 -15.91 58.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -68.41 -15.68 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.07 -33.66 73.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.357 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.26 -0.27 56.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.731 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.22 56.78 23.32 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.559 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 38' ' ' VAL . 8.0 p -151.23 89.7 4.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-O 121.694 0.759 . . . . 0.0 111.381 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.39 100.08 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 112.156 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.65 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.8 t -131.56 -165.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.555 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.8 t70 -66.95 131.51 46.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.83 131.47 42.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.551 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.41 108.98 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 tp -94.5 126.93 40.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -77.83 95.43 4.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.435 0.636 . . . . 0.0 111.039 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -104.73 141.56 36.25 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.577 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -51.97 144.64 11.45 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.173 0.589 . . . . 0.0 111.92 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -72.75 -26.82 61.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.072 -175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -74.69 -66.2 0.77 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -115.24 -24.7 8.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.409 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 108.85 28.14 4.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.623 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' OE1' ' HD3' ' A' ' 20' ' ' ARG . 18.0 mm-40 -69.6 139.15 53.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.018 0.409 . . . . 0.0 110.519 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 m -56.93 116.65 3.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -74.01 -14.49 61.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.694 0.283 . . . . 0.0 111.673 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 31.41 6.21 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.496 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.53 154.72 4.71 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.647 0.26 . . . . 0.0 110.69 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.55 165.51 34.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -133.83 138.25 45.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.865 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.81 137.17 48.02 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.471 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.65 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.8 ttmt -123.88 121.61 35.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.684 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.4 p90 -136.41 160.98 37.09 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -101.13 104.2 15.29 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 173.99 140.23 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.279 1.432 . . . . 0.0 108.146 172.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -80.21 -46.11 16.86 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -71.22 -35.52 71.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.695 0.283 . . . . 0.0 111.24 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 t -59.02 -26.84 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.49 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.684 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 38.0 p -63.45 -38.52 91.45 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.463 0.649 . . . . 0.0 109.427 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.4 mt -77.3 -33.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.66 -55.44 32.09 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.93 87.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.461 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 65' ' ' THR . 74.7 t -59.54 -54.29 36.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 120.849 0.357 . . . . 0.0 111.308 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -70.2 -31.95 69.64 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.01 -41.23 14.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 84' ' ' ILE . 3.0 mm? -89.21 -22.92 22.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 39.2 t30 -56.83 112.83 1.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.828 0.347 . . . . 0.0 111.526 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.89 -7.88 55.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.215 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -66.84 130.27 42.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.994 0.397 . . . . 0.0 110.074 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -86.64 119.32 26.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.21 118.17 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.573 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.62 36.17 92.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.947 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.98 51.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.935 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 17' ' ' ASN . 9.5 mmt180 -105.54 156.02 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.633 -0.334 . . . . 0.0 110.726 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.56 128.6 52.58 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 78.6 mt -63.48 106.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.29 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -89.11 105.66 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 72' ' ' LEU . 17.1 mm -114.7 137.93 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.77 -179.3 7.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 65' ' ' THR . 24.9 m170 -90.46 149.51 22.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -159.89 161.26 34.31 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -108.07 119.95 40.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -131.89 141.33 49.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.05 0.452 . . . . 0.0 111.372 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.523 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 3.4 mmp_? -117.23 114.48 38.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.5 135.12 54.48 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.915 2.41 . . . . 0.0 111.955 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.448 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 45.8 mmtm -93.52 128.81 39.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.589 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -71.76 -15.76 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.089 0.471 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -72.83 -25.23 61.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.382 0.611 . . . . 0.0 109.677 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.8 mt -102.78 27.98 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -55.4 -33.45 63.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.207 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -59.12 -49.73 76.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.425 ' O ' HG21 ' A' ' 102' ' ' VAL . 12.2 t80 -59.88 -45.91 90.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.582 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.448 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 22.9 m-85 -64.0 -46.91 82.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -62.58 -37.52 86.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.598 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.44 85.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 110.477 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 73.7 t -71.87 -40.24 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.196 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -56.8 -48.36 78.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.193 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.71 -27.03 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 111.03 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 7.6 tp10 -68.15 -42.24 80.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 84.4 mt -69.24 -34.43 74.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.537 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.43 -44.48 89.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 6.1 ppt_? -76.69 -9.89 58.99 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.816 0.341 . . . . 0.0 111.211 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -88.05 -35.99 17.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 106' ' ' LEU . 72.2 mt -66.84 -35.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.161 176.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.07 109.19 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.232 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.1 t -81.21 -173.65 4.45 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.959 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.418 ' HE2' ' OD1' ' A' ' 115' ' ' ASN . 54.2 mtpt -77.76 137.19 38.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.072 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -85.31 15.23 4.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' OD1' ' HE2' ' A' ' 113' ' ' LYS . 16.8 m120 -60.28 -34.01 73.14 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.78 -0.93 28.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.387 . . . . 0.0 111.042 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.4 -51.01 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.136 0.493 . . . . 0.0 110.432 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.832 -178.864 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 20.1 m 60.22 29.1 18.72 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.946 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.58 -20.14 64.5 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.037 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.5 m -111.5 13.83 21.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.796 0.332 . . . . 0.0 110.967 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -91.29 0.29 57.55 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.555 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -74.11 169.23 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.739 0.304 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.96 112.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -112.09 112.99 25.01 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.085 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 44.6 mt -123.6 135.27 63.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.987 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.58 135.69 23.77 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.852 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.17 152.43 45.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.731 2.287 . . . . 0.0 112.729 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -125.88 103.77 7.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . 0.467 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 49.8 m-85 -90.21 86.47 6.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.304 0.574 . . . . 0.0 110.09 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 16.8 p -111.85 134.98 21.22 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.576 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 7.6 Cg_exo -73.27 92.5 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.969 1.779 . . . . 0.0 111.089 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 5.1 m -77.9 -39.94 41.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.51 25.03 61.69 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.427 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.418 HD13 HD21 ' A' ' 22' ' ' LEU . 17.9 mt -60.79 -32.11 71.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.175 0.488 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.62 -38.58 58.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.74 -44.67 66.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.9 -8.38 59.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.755 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 58.44 60.45 2.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.215 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.253 1.237 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.426 -179.938 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.98 -24.66 52.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.697 0.284 . . . . 0.0 111.203 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 26.2 mmt -77.14 -48.88 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.53 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.32 157.17 32.16 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -73.42 -40.65 64.08 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.927 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -110.37 10.47 23.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.351 . . . . 0.0 111.345 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 3' ' ' MET . 17.8 m-85 66.95 136.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -103.27 -15.96 15.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.71 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -85.97 3.18 43.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.041 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -94.01 -0.13 55.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.272 0.558 . . . . 0.0 110.323 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -81.22 98.58 8.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.685 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 58' ' ' LYS . 36.3 m-85 -149.79 132.49 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.97 0.908 . . . . 0.0 108.715 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.86 128.63 69.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.347 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -91.19 130.98 37.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.286 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 52.0 mt -112.45 143.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.88 -177.15 50.15 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.39 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.6 t-20 -54.64 105.9 0.18 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.897 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.71 -173.07 3.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.519 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -79.2 144.37 34.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -70.41 -22.7 62.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.054 0.454 . . . . 0.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.98 2.47 30.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.45 130.77 38.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 p -109.17 170.49 8.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.294 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.2 -28.75 68.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.146 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.16 99.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.537 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -66.47 -48.13 70.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.12 -45.62 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.073 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.45 -36.93 85.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.062 0.458 . . . . 0.0 110.065 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -60.67 -44.35 96.58 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.81 -47.33 93.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.764 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -75.81 -9.71 58.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.734 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.4 t -70.72 -17.16 62.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -73.51 -21.91 60.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -99.14 -20.45 16.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 83.87 50.47 4.39 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.547 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.52 94.64 28.56 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.597 0.237 . . . . 0.0 111.263 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 26.2 Cg_endo -98.65 30.02 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.416 2.744 . . . . 0.0 111.445 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -92.0 -166.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -63.58 139.68 58.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -135.8 120.1 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.566 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.86 136.76 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.013 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 54' ' ' PHE . 60.0 tp -128.03 134.15 49.19 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.9 p -65.32 99.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 22.4 tpp180 -113.63 124.28 51.95 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.553 ' OD2' HG23 ' A' ' 48' ' ' THR . 23.5 t70 -71.55 136.79 47.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 110.79 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -72.13 -26.67 62.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.15 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 26.0 m-80 -81.59 -65.59 0.99 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.157 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.553 HG23 ' OD2' ' A' ' 45' ' ' ASP . 10.1 t -87.47 -21.22 25.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.619 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 80.83 19.51 67.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.756 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -101.14 163.43 12.28 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.556 0.217 . . . . 0.0 111.108 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -78.4 141.42 38.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -89.04 -6.84 56.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.74 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 100.59 -7.1 57.68 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.277 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' HD11 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -107.95 148.22 29.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 118.027 0.913 . . . . 0.0 110.574 -177.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.22 150.5 50.11 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.794 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.75 119.38 17.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 tp -106.62 140.76 38.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.551 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 12' ' ' TYR . 7.8 tmtm? -129.42 108.84 10.59 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.755 0.788 . . . . 0.0 112.032 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 4.7 p90 -119.7 156.24 30.87 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.01 105.81 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.562 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 178.22 145.66 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.161 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -81.01 -45.6 16.33 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.09 -32.96 50.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -55.64 -30.53 61.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.384 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.711 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.1 p -61.39 -52.36 64.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.501 0.667 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.1 mt -63.53 -36.97 78.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.667 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 tt -62.08 -58.68 6.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.221 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.88 86.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.048 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 65.6 t -61.14 -46.57 96.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -78.23 -40.12 38.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -66.94 -50.43 62.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.484 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.64 -4.86 57.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 25.9 t-20 -63.54 109.41 1.64 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.496 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 -2.83 65.33 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.163 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.9 127.15 30.88 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -88.14 115.0 25.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.262 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.6 mt -120.63 109.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.64 25.49 75.63 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 -16.01 59.55 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.461 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -97.11 132.7 42.64 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.837 0.351 . . . . 0.0 111.208 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.83 135.68 35.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.239 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.72 133.22 45.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.423 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 12.7 mptt -107.52 116.78 32.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -117.31 138.6 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.53 166.73 30.25 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -88.56 140.14 29.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 15.2 t -153.72 161.55 42.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.661 0.267 . . . . 0.0 110.855 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -116.36 104.69 11.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -115.92 150.04 37.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -125.42 135.57 27.09 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.114 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.87 122.4 10.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.923 2.416 . . . . 0.0 112.214 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -69.21 135.24 50.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.697 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -60.88 3.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -74.14 -22.3 59.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.03 0.443 . . . . 0.0 112.087 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.87 6.06 45.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.333 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.92 -22.36 62.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.553 0.216 . . . . 0.0 111.419 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -58.99 -39.55 82.14 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.652 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.96 -35.96 79.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -66.66 -50.07 64.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.1 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 44.9 mt-10 -65.32 -42.95 92.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.04 -47.49 80.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.547 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.8 p -71.89 -33.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.571 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -65.81 -39.21 90.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 18.7 mm-40 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.894 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.86 -48.18 77.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.53 ' O ' HG13 ' A' ' 110' ' ' ILE . 11.0 mp -63.12 -45.17 93.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.134 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.51 -41.64 73.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.082 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -70.14 -41.69 73.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.96 -37.93 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.378 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 106' ' ' LEU . 85.3 mt -56.7 -40.81 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.114 0.483 . . . . 0.0 110.194 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.9 t -73.91 -55.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.65 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.5 m 69.94 169.18 0.3 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.62 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -95.12 158.82 15.3 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.018 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -84.62 94.74 8.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -117.25 100.07 7.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.454 0.645 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.72 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.57 11.35 37.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.335 0.588 . . . . 0.0 109.864 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 117.809 -1.091 . . . . 0.0 108.579 -179.894 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -107.25 35.03 3.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.985 0.422 . . . . 0.0 110.586 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.0 -20.51 65.95 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 32.0 t -110.81 3.0 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.815 0.34 . . . . 0.0 110.5 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -130.74 23.37 5.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.555 0.693 . . . . 0.0 110.134 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -79.29 135.42 36.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.583 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.2 mt -110.32 112.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.346 0.593 . . . . 0.0 110.131 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.09 98.82 3.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.23 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 44' ' ' ARG . 62.5 mt -138.46 123.41 22.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.4 mmt -100.84 149.97 36.63 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.172 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.88 163.29 37.38 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.678 2.252 . . . . 0.0 111.714 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -130.17 126.32 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.275 0.559 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -111.2 90.7 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.494 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 72.3 m -110.42 147.58 36.65 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.99 52.54 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.708 2.272 . . . . 0.0 111.257 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.1 m -54.29 -50.15 67.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.938 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.73 47.7 59.93 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.882 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.76 -15.22 59.27 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.405 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -80.56 -15.82 55.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.909 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -9.41 59.06 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.227 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.62 -22.27 63.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.03 80.54 6.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.474 0.654 . . . . 0.0 109.793 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.314 -0.977 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.283 -179.178 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 4.6 p90 -157.97 -179.59 8.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.219 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -102.65 144.27 13.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 40.4 t80 -101.97 124.96 48.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.525 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 mp -102.38 139.25 23.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.06 -169.78 46.29 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.124 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HB2' ' NH2' ' A' ' 80' ' ' ARG . 11.6 m120 -45.51 112.23 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.63 0.772 . . . . 0.0 112.553 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.4 mt -104.42 168.9 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.201 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.17 140.31 58.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -64.55 -17.24 63.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.896 0.379 . . . . 0.0 110.561 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' B' ' 217' ' ' LEU . 63.9 mm-40 -82.68 -11.6 58.23 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.93 128.27 34.55 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.8 p -110.43 176.56 5.0 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.489 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.8 mp0 -57.42 -30.33 64.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.634 0.373 . . . . 0.0 111.137 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.64 94.96 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.644 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -67.83 -42.39 81.52 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.088 0.471 . . . . 0.0 109.866 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.08 -47.84 88.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.787 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.46 -32.57 74.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 109.874 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -63.71 -41.27 98.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.0 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.65 -46.81 93.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.031 0.443 . . . . 0.0 110.456 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CG ' HD22 ' A' ' 57' ' ' LEU . 60.4 m-85 -73.81 -13.07 60.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.08 -16.48 63.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.395 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.46 -39.56 84.06 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.916 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -85.29 -16.02 41.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.669 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 27.44 73.47 Favored Glycine 0 N--CA 1.454 -0.155 0 CA-C-N 115.877 -0.602 . . . . 0.0 113.327 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.08 97.36 42.15 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.13 101.74 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.079 2.519 . . . . 0.0 112.564 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -137.13 -166.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.4 m-20 -60.2 140.9 56.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.2 p -138.9 128.95 32.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.52 118.62 52.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.784 0.326 . . . . 0.0 111.065 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -109.11 128.69 55.21 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 23.9 m -70.03 108.24 3.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.972 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -126.71 143.3 51.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.693 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 16.2 t70 -53.7 138.47 35.05 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.763 0.665 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' B' ' 208' ' ' ILE . 2.4 mp0 -69.54 -13.93 62.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -110.25 -55.72 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.059 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.517 HG23 ' HG2' ' A' ' 50' ' ' GLU . 3.6 t -101.55 -5.34 25.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.02 18.71 76.6 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.892 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.5 mm-40 -56.28 134.18 53.17 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.916 0.358 . . . . 0.0 111.283 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.0 m -66.2 107.98 2.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -71.33 -19.17 62.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.661 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.88 -0.12 51.95 Favored Glycine 0 C--O 1.221 -0.67 0 C-N-CA 120.747 -0.74 . . . . 0.0 114.452 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 4.0 m-85 -108.99 129.83 55.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.551 0.675 . . . . 0.0 109.592 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -125.83 149.73 48.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.025 0.441 . . . . 0.0 111.365 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 20.3 m-85 -137.9 148.8 45.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.281 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.2 tp -140.66 115.23 9.47 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.531 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 12' ' ' TYR . 1.5 tmtp? -100.25 114.11 27.3 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.265 0.555 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 42.7 p90 -132.06 143.73 50.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.165 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -101.06 106.81 18.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.24 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 65' ' ' THR . 21.0 t70 175.27 109.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.599 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -64.07 -47.18 81.15 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.339 0.59 . . . . 0.0 110.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 m -67.37 -25.42 65.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.534 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.2 p -62.77 -61.2 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.12 -34.98 62.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.59 -61.01 2.83 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.131 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.84 91.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 73.7 t -58.95 -51.59 70.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 120.586 0.231 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.58 -36.77 68.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.828 0.347 . . . . 0.0 111.334 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.56 -43.83 72.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.88 -18.17 31.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 32.9 t-20 -65.06 109.49 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.069 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.9 -2.44 52.04 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -81.13 132.08 35.34 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -88.86 132.26 34.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.146 0.498 . . . . 0.0 112.214 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.1 mm -129.22 101.76 6.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.79 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.43 23.59 77.87 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.458 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 -15.78 60.5 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.043 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.412 ' NH2' ' HB2' ' A' ' 17' ' ' ASN . 30.3 mmm180 -94.86 110.2 22.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.616 0.246 . . . . 0.0 111.596 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 83' ' ' LYS . . . -68.41 127.69 33.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.23 117.88 16.54 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.635 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 81' ' ' ALA . 10.8 mptt -100.84 110.75 22.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 20.5 mm -103.16 121.65 54.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.727 0.298 . . . . 0.0 111.423 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -116.53 166.6 11.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.858 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -96.35 136.43 36.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.3 t -161.24 160.8 30.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.758 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.53 138.99 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.911 0.386 . . . . 0.0 110.175 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 15.6 t80 -149.88 135.24 18.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -96.28 112.32 59.42 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.249 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.54 115.35 2.99 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.564 ' HD3' ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -73.91 144.84 45.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.916 0.388 . . . . 0.0 110.376 178.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -72.94 -13.42 61.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.371 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -68.52 -17.08 64.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.112 0.482 . . . . 0.0 110.063 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 tp -123.01 24.83 8.8 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -58.7 -32.49 69.22 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.172 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.42 -32.63 71.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.531 0.205 . . . . 0.0 111.513 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.55 -55.69 16.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -64.49 -34.5 78.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.73 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 34.0 tt0 -65.6 -41.52 92.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.136 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.61 -30.24 70.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 110.019 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG11 ' H ' ' A' ' 40' ' ' VAL . 86.2 t -68.23 -48.48 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -70.84 -12.74 61.72 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 25.5 mm-40 -61.26 -35.13 76.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -83.23 -26.16 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.58 -14.99 44.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.696 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -178.102 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 121.325 0.583 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 46' ' ' GLU . 24.4 mt -134.55 117.22 23.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.482 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.1 mmt -114.54 117.95 42.02 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.411 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.2 Cg_exo -50.35 133.65 37.05 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.191 2.594 . . . . 0.0 112.512 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -123.27 108.24 12.56 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.699 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -88.96 88.86 7.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 61.7 m -112.55 155.17 44.22 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.753 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -100.87 112.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.747 2.298 . . . . 0.0 112.044 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.3 p -78.89 -43.41 24.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 109.822 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.18 72.86 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.211 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 21' ' ' GLU . 42.4 mt -58.29 -36.39 73.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.13 -9.59 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.081 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.29 0.567 . . . . 0.0 110.558 -177.894 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.973 0 CA-C-O 121.123 0.487 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 33.4 m-85 -134.74 166.69 22.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 pt -141.92 138.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -85.47 116.81 24.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.477 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.48 130.92 35.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . -86.42 -168.27 44.6 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.25 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 12.4 t30 -39.69 101.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.944 0.898 . . . . 0.0 112.964 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 16' ' ' GLY . 77.3 mt -97.94 -173.8 2.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.345 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.08 139.58 35.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 20' ' ' ARG . 5.7 ptp180 -64.89 -17.39 64.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.654 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.69 -6.38 58.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 0.0 110.517 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.2 tp -90.59 110.7 21.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.1 p -98.27 172.95 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -57.99 -32.18 67.64 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.986 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.16 98.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' O ' ' HB ' ' A' ' 29' ' ' THR . 6.2 t70 -74.83 -38.83 61.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 72.0 mt -58.32 -45.05 89.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.413 0.625 . . . . 0.0 109.581 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 106' ' ' LEU . 83.2 mt -69.06 -26.63 65.06 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.339 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.3 m -57.97 -54.06 51.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.03 -31.19 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 67.8 m-85 -79.26 -20.61 47.7 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.171 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.2 t -70.89 -17.69 62.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 109.892 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.13 -22.13 65.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.701 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.59 2.55 52.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.0 81.38 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.779 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.41 HG12 HG22 ' A' ' 38' ' ' VAL . 32.1 t -127.03 98.72 29.86 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 117.254 0.527 . . . . 0.0 111.687 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.14 120.08 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.936 2.424 . . . . 0.0 110.68 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -124.44 -167.4 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.788 -177.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.77 136.18 39.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 111.802 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.33 134.86 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 41' ' ' ILE . 4.1 mp -124.84 108.61 20.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.0 tp -88.13 139.4 30.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -83.68 109.55 17.55 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.564 ' NE ' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -121.79 145.5 47.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.294 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.11 131.48 50.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.088 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 29.3 mt-10 -75.08 -15.8 60.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.61 -61.39 1.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.1 t -108.06 -22.15 12.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.39 21.58 12.84 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.712 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -71.87 161.37 31.05 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 120.684 0.278 . . . . 0.0 111.162 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 t -81.22 130.97 35.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -80.07 -9.11 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 97.41 13.82 43.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.708 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -158.33 165.48 34.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.169 0.485 . . . . 0.0 110.732 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.73 14.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.983 0.42 . . . . 0.0 111.627 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.81 124.91 27.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.14 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 11.0 tp -110.32 136.52 49.38 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.55 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -114.62 120.38 39.96 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.634 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -140.99 -166.82 2.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.809 -176.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.69 179.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 14.9 m-20 -61.42 -174.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.868 -1.06 . . . . 0.0 113.421 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -49.8 -39.79 39.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.601 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -51.29 -52.79 41.97 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 m -70.81 -30.84 67.4 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.383 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.634 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 32.8 p -61.1 -47.48 86.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 110.757 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.76 -37.53 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.867 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.85 -57.76 10.58 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.147 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.69 82.22 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' THR . 60.4 t -56.47 -52.43 52.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.226 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.47 -37.57 88.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -77.27 -49.22 15.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.47 -29.97 57.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -66.59 110.27 3.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 0.0 109.967 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.76 -19.99 25.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.093 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -74.99 139.02 42.65 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 37.0 ttpt -109.86 135.74 50.27 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.924 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.22 119.29 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.64 30.38 76.55 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.626 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.75 1.44 68.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.494 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.572 ' C ' ' HG3' ' A' ' 76' ' ' LYS . 81.6 mtt180 -129.06 119.55 24.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.347 0.574 . . . . 0.0 111.494 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -68.96 137.27 53.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.637 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.93 125.79 30.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.067 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -108.11 105.34 15.04 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -99.21 109.81 25.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.034 0.445 . . . . 0.0 111.11 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -104.61 112.74 25.94 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.1 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.4 124.17 22.01 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.856 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -159.37 136.66 9.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -74.52 155.99 37.36 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HB3' ' CG ' ' A' ' 12' ' ' TYR . 82.9 t80 -150.75 149.89 30.33 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -108.49 121.14 44.32 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.06 129.89 37.75 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.072 2.514 . . . . 0.0 112.442 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.42 128.69 39.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -80.22 -10.18 59.75 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.8 m -76.88 -22.74 53.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.205 0.526 . . . . 0.0 109.886 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 tp -110.9 26.67 10.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.79 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -57.64 -31.32 66.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.956 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -58.66 -38.13 77.5 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.584 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -64.64 -43.89 92.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.6 -47.71 80.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.977 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -59.06 -43.68 91.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.25 86.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.28 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.89 -45.7 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -60.37 -50.39 73.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.499 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.53 -38.64 91.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.69 -51.55 68.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.513 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 28' ' ' LEU . 80.0 mt -67.33 -30.02 69.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.713 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.104 0.478 . . . . 0.0 110.313 179.827 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.038 0.447 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -129.56 129.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.605 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 14.7 mmt -110.18 149.7 40.48 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.445 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.76 146.79 91.27 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.946 2.43 . . . . 0.0 111.557 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -120.14 88.88 3.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.461 0.648 . . . . 0.0 111.348 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.87 96.68 4.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.912 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.6 m -110.22 145.19 31.64 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.91 62.05 3.9 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.472 2.115 . . . . 0.0 111.216 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 34.4 m -59.12 -51.82 68.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.91 37.98 93.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.108 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.594 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 8.5 mp -68.06 -26.62 65.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.23 0.515 . . . . 0.0 111.245 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.98 -22.28 64.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 109.901 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.516 176.831 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.577 ' CE1' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -55.88 155.83 5.74 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -109.94 152.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.722 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -99.92 137.8 37.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.779 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 51.6 mt -123.63 143.6 36.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.74 -168.76 45.2 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.79 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 9.2 t30 -55.22 117.86 3.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.3 0.572 . . . . 0.0 112.434 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.57 -168.4 1.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.491 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . 56.6 t30 -79.11 154.4 29.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.353 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -70.69 -31.83 68.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.77 -0.5 55.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.8 mt -81.64 109.51 16.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.945 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -98.52 178.74 4.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.915 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 3.3 mp0 -60.06 -25.17 65.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.36 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.35 -51.48 31.99 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 29' ' ' THR . 2.9 m-20 -64.0 -39.64 94.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.784 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.22 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.5 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.23 -35.47 80.91 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 36.9 m -59.01 -48.94 79.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.656 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 HD13 ' B' ' 218' ' ' LEU . 68.9 t -56.38 -51.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.544 ' CG ' HD22 ' A' ' 57' ' ' LEU . 95.7 m-85 -78.26 -17.75 56.25 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -20.0 64.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.07 -24.05 63.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.45 -20.34 40.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.128 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.78 9.68 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.721 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.0 m -127.41 89.23 51.91 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 121.21 0.529 . . . . 0.0 111.95 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 84.32 1.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.88 2.387 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -124.78 -166.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.608 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.0 m-20 -72.58 131.81 42.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.3 p -121.39 133.41 68.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.5 mp -130.43 124.96 58.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.603 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 43' ' ' SER . 2.0 tt -107.79 134.85 50.15 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 42' ' ' LEU . 51.3 p -61.21 114.77 3.34 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 51.4 mtp180 -134.72 137.52 43.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.755 0.312 . . . . 0.0 110.224 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 16.5 m-20 -68.62 156.02 38.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.032 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.92 -35.58 28.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.434 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -71.43 -70.51 0.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.796 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -85.7 -19.9 30.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 73.9 18.59 79.65 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.311 178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 48' ' ' THR . 44.0 mt-10 -93.02 164.55 13.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.739 0.304 . . . . 0.0 111.309 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -72.12 129.07 37.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -80.16 -13.59 59.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.583 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.42 -10.28 30.81 Favored Glycine 0 C--O 1.215 -1.058 0 C-N-CA 120.6 -0.81 . . . . 0.0 114.305 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.16 148.49 28.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.865 0.833 . . . . 0.0 109.853 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -124.77 153.15 42.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.991 0.424 . . . . 0.0 110.836 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.437 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 55.1 m-85 -138.54 136.4 36.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 31' ' ' PHE . 16.5 tp -135.21 122.79 22.09 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.735 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.6 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 55.5 tttp -102.13 117.25 34.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.757 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 50.8 p90 -145.09 145.27 31.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 2.6 mp0 -101.6 107.58 18.88 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.426 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 65' ' ' THR . 28.0 t70 177.22 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.536 0.522 . . . . 0.0 110.783 174.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -51.17 -39.39 56.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -65.25 -54.86 22.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.794 0.33 . . . . 0.0 111.565 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 31.9 p -67.24 -19.93 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.757 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.3 p -61.63 -49.13 77.79 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.757 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -65.23 -38.73 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.788 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 27.4 tp -58.77 -56.89 16.35 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.181 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.07 83.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.489 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 65' ' ' THR . 71.4 t -63.56 -53.06 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.909 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.93 -40.08 63.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.84 -37.81 87.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -95.62 -10.66 28.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 47.8 t-20 -64.84 109.73 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.0 110.578 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.25 3.65 65.06 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.514 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.06 132.78 39.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.0 mmtp -91.88 125.35 36.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.095 0.474 . . . . 0.0 112.221 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mt -134.61 115.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.051 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.44 72.41 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.627 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -3.71 86.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.42 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 mmt180 -102.37 150.13 23.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.94 126.31 51.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 45.4 mt -73.68 128.94 36.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.754 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 75.3 mmtt -122.4 115.14 21.75 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 3.4 mm -114.22 148.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.519 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.09 145.97 23.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.029 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -74.4 136.75 42.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 12' ' ' TYR . 10.2 t -159.24 159.85 34.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.819 0.343 . . . . 0.0 111.128 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -124.27 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 33.6 t80 -136.74 142.8 43.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.65 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -98.14 107.59 42.07 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.446 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.81 119.73 6.47 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.081 2.52 . . . . 0.0 112.839 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.15 150.65 31.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.456 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -70.66 -19.86 62.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.923 0.392 . . . . 0.0 110.73 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.1 m -75.94 -11.16 59.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.373 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp -114.96 18.65 16.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.215 0.531 . . . . 0.0 109.813 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -58.56 -42.12 87.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.942 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB3' ' HE3' ' B' ' 209' ' ' MET . 92.8 mttt -61.78 -29.11 69.92 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.673 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 3.7 t80 -67.94 -52.54 34.97 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.728 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.29 -46.45 73.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.27 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.57 91.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.701 0.286 . . . . 0.0 111.241 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.1 t -64.5 -50.39 76.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.39 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -63.28 -40.61 97.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.884 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.31 -39.64 89.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.49 -35.13 78.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 90.7 mt -63.09 -48.54 78.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 CA--C 1.517 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.174 179.608 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 N--CA 1.443 -0.823 0 CA-C-O 120.877 0.37 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.99 99.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.145 0.498 . . . . 0.0 109.781 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 17.7 mmt -99.64 125.74 39.64 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.558 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 38.0 Cg_endo -66.37 135.36 39.34 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.632 2.221 . . . . 0.0 112.369 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -109.31 104.37 13.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.35 87.39 6.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.2 m -112.42 117.97 46.3 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.629 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.31 100.85 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.05 1.833 . . . . 0.0 112.184 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -75.27 -44.18 47.24 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.2 27.98 38.43 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.294 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 19' ' ' ASN . 93.4 mt -61.51 -42.01 98.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.564 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 30' ' ' VAL . 2.5 pt? -76.99 -11.58 59.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.481 -177.76 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.975 0.417 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 17.2 m-85 -138.48 147.94 43.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.101 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -124.5 137.56 56.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.725 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.2 t80 -91.66 129.97 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.275 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.5 142.39 16.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.97 -169.89 46.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.576 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -63.83 105.66 0.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.9 mt -97.73 -173.02 2.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -72.7 143.09 48.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -59.09 -31.83 69.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -84.91 9.73 13.61 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.617 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tt -96.59 121.03 37.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.107 0.48 . . . . 0.0 109.849 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -100.16 174.72 6.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.8 OUTLIER -67.96 -22.7 65.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.148 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.03 -38.84 94.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.451 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.547 ' O ' ' HB ' ' A' ' 29' ' ' THR . 9.6 t70 -72.89 -38.57 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.36 -46.2 97.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.303 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.6 -34.74 78.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.0 m -56.96 -46.39 82.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.415 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.492 HG22 HD13 ' B' ' 218' ' ' LEU . 84.1 t -64.33 -46.92 91.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -72.52 -19.29 61.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -66.47 -21.34 66.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.459 0.171 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -68.07 -18.4 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.994 0.426 . . . . 0.0 110.587 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.69 3.77 40.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 71.44 44.35 51.25 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.74 89.93 20.52 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 120.821 0.343 . . . . 0.0 111.256 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 97.3 Cg_endo -103.22 47.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.742 2.961 . . . . 0.0 110.949 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.5 t -104.56 -166.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.622 ' H ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -67.07 120.02 12.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -116.78 115.33 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.957 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.8 106.66 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.053 0.454 . . . . 0.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.99 141.17 28.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 78.7 p -73.81 100.23 3.4 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.345 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 44' ' ' ARG . 72.3 mtt-85 -106.38 146.41 30.5 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 48' ' ' THR . 18.7 t70 -58.89 137.53 57.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.94 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.0 mt-10 -72.04 -9.73 58.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.271 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.6 -65.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.407 HG22 ' OD2' ' A' ' 45' ' ' ASP . 12.1 t -93.91 -25.67 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.55 35.78 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.688 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.41 154.84 24.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.249 0.524 . . . . 0.0 110.355 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 m -66.34 133.65 50.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.049 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 74.8 mt-30 -89.17 -14.1 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.55 -29.33 8.31 Favored Glycine 0 C--O 1.219 -0.825 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.389 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -108.83 173.44 6.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.011 0.905 . . . . 0.0 111.039 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.44 167.84 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.484 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -131.69 123.36 27.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.945 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 tp -111.45 138.16 48.32 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.712 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 35.0 tttm -122.24 123.09 40.64 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.443 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.743 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.6 p90 -143.7 148.56 35.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.278 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.6 106.08 17.1 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.727 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 65' ' ' THR . 14.7 t70 177.07 126.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.218 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -70.65 -48.12 56.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -63.49 -40.02 95.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -60.94 -32.85 72.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.831 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.743 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.1 p -59.28 -45.73 90.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.347 0.594 . . . . 0.0 110.938 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.78 -38.92 45.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.543 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.17 -56.1 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.604 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.92 78.8 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 88.6 t -65.97 -53.14 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.05 -29.11 66.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -81.25 -48.96 11.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.17 -18.38 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 38.1 t-20 -61.86 112.35 2.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.922 0.391 . . . . 0.0 110.047 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.45 ' HA2' ' HB1' ' A' ' 81' ' ' ALA . . . 105.76 -11.33 45.77 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.755 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -67.13 133.13 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -81.37 115.74 20.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.931 0.395 . . . . 0.0 111.697 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -132.37 112.43 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.82 29.67 67.01 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.749 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.5 16.35 80.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.347 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.5 148.72 51.71 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 122.788 -0.242 . . . . 0.0 110.48 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 74' ' ' GLY . . . -84.87 128.59 34.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.457 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 77.8 mt -62.72 108.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -89.22 99.73 12.66 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.589 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 69' ' ' VAL . 9.8 mm -105.83 138.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -151.41 148.28 27.91 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.194 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -72.06 118.63 15.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.616 0.246 . . . . 0.0 110.428 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -132.15 160.24 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -106.62 136.91 45.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -149.97 136.61 19.2 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 4.3 mpt_? -108.92 127.19 27.77 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.91 104.32 0.17 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.71 2.273 . . . . 0.0 111.901 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.67 134.34 33.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 15.1 ptm180 -60.02 -22.73 62.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -65.31 -19.34 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.118 0.485 . . . . 0.0 110.454 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.9 16.95 6.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 13.7 pt20 -64.94 -20.26 66.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.583 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.08 -41.44 78.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.765 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -62.96 -45.3 93.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.594 -178.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.14 -41.56 92.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.076 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 35.7 tt0 -74.25 -43.15 58.13 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.478 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.1 84.85 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.266 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.563 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.4 m -70.15 -34.6 59.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.858 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.24 -44.11 97.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 5.1 mm-40 -61.27 -41.11 96.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.114 0.483 . . . . 0.0 109.926 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -70.7 -32.41 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.132 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 102' ' ' VAL . 5.8 mp -84.16 -44.72 13.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.664 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.912 -176.874 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 121.046 0.451 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 53.4 mt -121.7 107.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.714 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.2 mmt -110.37 124.61 32.83 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-O 121.074 0.464 . . . . 0.0 111.907 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 58.9 Cg_endo -72.09 166.29 30.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.105 2.537 . . . . 0.0 112.289 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.74 102.99 4.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.666 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -81.05 85.87 6.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.258 0.551 . . . . 0.0 111.728 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 70.0 m -113.72 119.35 41.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.308 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 98.55 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.151 1.901 . . . . 0.0 111.034 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' B' ' 217' ' ' LEU . 11.3 t -63.86 -40.88 97.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.8 20.36 68.43 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.447 ' HG ' ' OG ' ' B' ' 215' ' ' SER . 57.4 mt -65.29 -40.32 93.67 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 30' ' ' VAL . 2.7 pt? -61.55 -27.1 68.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.899 0.381 . . . . 0.0 110.72 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.765 179.8 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.535 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.1 p90 -159.31 -178.89 7.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.845 0.355 . . . . 0.0 110.835 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -112.91 144.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.471 . . . . 0.0 111.309 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' HB2' HG21 ' A' ' 87' ' ' THR . 83.9 t80 -97.13 131.0 44.32 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 mp -109.7 136.37 45.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.36 -169.4 45.89 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.262 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.24 114.67 0.99 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.369 0.604 . . . . 0.0 112.595 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HB3' HD12 ' A' ' 22' ' ' LEU . 93.4 mt -100.17 -170.87 1.94 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.217 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.442 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.3 m-20 -82.98 151.32 25.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.975 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -66.91 -20.05 65.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.709 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.51 10.59 40.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.812 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 19' ' ' ASN . 25.7 mt -96.27 127.21 42.07 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.9 p -110.3 -179.13 3.69 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 38.1 mt-10 -64.62 -25.26 67.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.983 0.42 . . . . 0.0 110.916 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.96 -42.05 70.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.451 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 29' ' ' THR . 14.3 m-20 -66.08 -42.64 89.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 109.942 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.14 -45.81 95.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.194 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.6 -35.49 81.16 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.049 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 28.1 m -57.49 -47.03 83.01 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.684 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.04 -48.89 86.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -75.53 -17.17 60.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 t -64.74 -32.42 74.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 0.0 110.235 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.05 -22.2 63.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 110.287 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -89.42 0.76 56.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.227 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.78 38.85 97.18 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.62 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.06 88.52 52.53 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.228 0.537 . . . . 0.0 112.266 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -93.57 70.26 0.41 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.133 2.556 . . . . 0.0 110.244 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -117.76 -166.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.043 -177.018 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -64.27 120.46 12.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.672 0.272 . . . . 0.0 111.431 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.02 138.2 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.7 130.37 49.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 54' ' ' PHE . 49.3 tp -109.95 133.12 53.52 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 26.9 m -67.8 106.62 2.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -117.84 151.95 36.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.481 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 12.9 t70 -66.85 135.89 54.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.648 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.7 mt-10 -81.95 -11.44 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -84.45 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.76 0.314 . . . . 0.0 111.292 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -104.41 -20.4 13.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.024 0.44 . . . . 0.0 111.117 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 91.86 32.3 8.63 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.96 165.22 13.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.996 0.398 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -67.5 128.05 35.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.695 0.283 . . . . 0.0 110.601 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.87 -17.62 27.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.84 -4.41 29.03 Favored Glycine 0 C--O 1.221 -0.69 0 C-N-CA 120.075 -1.059 . . . . 0.0 115.207 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.0 m-85 -114.46 146.84 40.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.049 0.924 . . . . 0.0 109.533 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -133.35 148.37 51.86 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 32.8 m-85 -129.29 138.78 51.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 25.0 tp -138.18 118.68 13.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.177 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -105.43 106.1 16.45 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.711 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 26.9 p90 -124.79 145.93 49.49 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -103.35 106.21 16.67 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.768 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 65' ' ' THR . 33.4 t70 176.46 108.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.557 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.17 -36.39 72.98 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.6 tpt85 -66.99 -49.11 66.38 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p -69.97 -20.72 63.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.711 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 72.4 p -58.36 -46.78 85.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.1 mt -74.26 -36.15 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.044 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 67' ' ' LEU . 6.6 tt -61.97 -54.79 36.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.126 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.66 90.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.867 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 79.4 t -60.92 -52.16 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.03 -38.38 79.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -69.89 -50.02 46.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.931 0.396 . . . . 0.0 111.267 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 94.7 mt -78.13 -12.98 60.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.083 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.91 109.86 1.38 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.35 . . . . 0.0 110.497 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.47 76.85 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.382 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -78.82 129.66 34.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 3.2 tppp? -82.05 116.01 21.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.166 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.4 mm -125.02 101.68 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.468 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.4 42.39 93.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.289 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 20.64 79.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.7 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 51.5 mmm-85 -129.68 144.19 51.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.1 118.7 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.726 0.298 . . . . 0.0 110.242 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 94.7 mt -64.89 140.14 58.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.2 0.524 . . . . 0.0 111.502 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.14 116.51 21.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 5.6 mm -111.7 138.15 41.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.0 145.56 37.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.668 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.36 127.86 32.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 14' ' ' TYR . 1.8 t -147.65 160.37 42.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.575 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -126.94 135.45 50.92 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -150.48 124.09 9.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.311 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -81.64 128.87 67.76 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.13 142.37 96.65 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.09 2.527 . . . . 0.0 112.602 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -95.47 137.72 34.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.389 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -18.12 58.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.032 0.444 . . . . 0.0 109.833 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -66.81 -27.6 67.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.425 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.34 31.79 5.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.285 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.78 -32.51 67.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.28 -21.13 63.91 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.442 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -70.25 -51.51 30.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -64.15 -30.73 71.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.96 -46.49 71.24 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -60.74 -50.28 74.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.359 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 34.4 m -60.19 -35.0 59.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -58.65 -57.62 12.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.51 -34.91 79.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.508 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 10.7 mm-40 -65.5 -51.46 59.89 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.513 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 89.4 mt -61.17 -40.51 94.16 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.872 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -178.933 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 N--CA 1.444 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mm -93.1 107.04 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.026 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 93.9 mmm -121.72 125.12 26.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.499 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 77.0 Cg_exo -52.66 132.97 48.33 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.227 2.618 . . . . 0.0 113.576 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -126.13 103.69 7.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.863 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -88.63 96.02 10.48 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.391 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 36.1 t -110.56 139.12 21.27 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.932 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.83 79.1 0.41 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.079 1.853 . . . . 0.0 111.908 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -67.74 -39.14 84.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.67 36.0 62.19 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.456 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.417 HD12 ' HG ' ' A' ' 22' ' ' LEU . 62.7 mt -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.715 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.563 HD23 ' H ' ' B' ' 218' ' ' LEU . 1.5 pt? -95.52 -5.88 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.521 -176.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 120.999 0.428 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 87' ' ' THR . 99.0 m-85 -154.4 141.2 19.1 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.178 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 pt -116.4 142.13 31.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.407 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -93.16 122.53 35.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 71.7 mt -107.45 138.49 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.85 -169.54 46.0 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.277 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 2.6 m-20 -50.24 119.28 3.54 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 112.489 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 22' ' ' LEU . 57.5 mt -98.87 169.46 9.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.173 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.525 HD22 HD13 ' B' ' 217' ' ' LEU . 56.7 t30 -70.28 149.22 47.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -64.71 -24.93 67.73 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.044 0.449 . . . . 0.0 110.726 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.85 5.33 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.823 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.405 HD22 HD13 ' A' ' 18' ' ' LEU . 3.7 tt -96.7 127.24 42.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -110.73 179.75 3.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.266 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.4 -23.17 66.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.055 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.13 -41.61 96.94 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' B' ' 215' ' ' SER . 6.1 m-20 -65.1 -39.86 93.74 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.24 -49.67 80.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.68 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.87 -35.6 81.09 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.436 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -57.35 -45.43 84.37 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.07 -46.46 45.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.74 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -76.1 -19.61 58.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -19.86 66.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.092 0.473 . . . . 0.0 110.574 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.26 -0.69 15.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.738 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -96.88 -1.21 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.968 0.413 . . . . 0.0 110.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.45 -21.25 24.24 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.819 -0.705 . . . . 0.0 114.563 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.08 129.51 3.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 117.93 0.865 . . . . 0.0 112.29 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.5 112.56 1.07 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.585 2.19 . . . . 0.0 111.458 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.755 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.2 t -103.06 -167.54 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.755 ' H ' HG12 ' A' ' 38' ' ' VAL . 28.4 t70 -68.2 144.47 54.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.02 133.23 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 111.391 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.31 134.89 61.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.828 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.9 tp -132.22 139.6 48.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.715 0.293 . . . . 0.0 111.053 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.6 p -77.06 125.24 28.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.97 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -121.82 142.75 49.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.176 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -74.28 138.52 43.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.181 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.37 -17.12 52.87 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.41 -67.87 0.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.879 0.371 . . . . 0.0 111.171 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 50' ' ' GLU . 9.9 t -115.36 -31.45 5.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.978 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.82 43.65 0.79 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.194 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 48' ' ' THR . 43.1 mt-10 -94.53 168.47 10.84 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -74.99 134.63 41.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -84.05 -9.47 58.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.142 0.496 . . . . 0.0 110.591 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.23 3.45 51.0 Favored Glycine 0 C--O 1.222 -0.635 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.772 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.94 130.0 54.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.494 0.647 . . . . 0.0 110.192 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -131.07 141.2 50.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -128.19 127.98 43.91 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.7 tp -116.91 142.4 46.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.665 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 42.3 tttp -122.66 125.74 46.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.889 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.715 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -146.76 147.47 30.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 105.33 16.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.407 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 30.4 t70 176.04 137.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.416 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -75.91 -45.52 34.89 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.788 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -62.75 -43.07 99.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 33.7 m -58.98 -27.58 65.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.848 -177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.715 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.1 p -63.98 -40.17 95.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.597 0.713 . . . . 0.0 109.942 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.9 mt -76.64 -39.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 43.2 tp -58.12 -58.32 8.95 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.535 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.63 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.592 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 76.7 t -65.4 -59.98 3.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.599 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 -36.66 78.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.97 -51.04 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.71 -8.99 45.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 20.0 t-20 -62.74 109.69 1.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.131 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.59 2.07 76.65 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.682 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -72.51 137.49 46.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -85.64 110.1 19.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.777 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 82' ' ' LEU . 29.0 mm -119.13 108.4 23.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.296 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.97 13.77 80.68 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.693 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.76 -10.42 58.95 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.75 130.95 35.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 77' ' ' ILE . 60.4 mt -84.74 128.3 34.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -104.91 111.43 24.19 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 13.8 mm -105.21 129.33 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -135.92 -179.77 5.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -111.84 129.36 56.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.1 t -155.14 160.96 41.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.123 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -110.52 121.67 45.88 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.86 148.73 41.02 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -113.15 116.01 47.28 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.466 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.13 110.24 0.98 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 112.038 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -94.79 147.24 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.79 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -78.13 -0.66 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.604 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 m -63.5 -22.95 67.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 0.0 110.018 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -122.54 34.36 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.634 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 29.1 pt20 -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.271 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 29.8 mmtp -58.11 -44.53 87.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.018 0.437 . . . . 0.0 110.737 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.8 t80 -62.98 -46.66 86.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.514 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -48.19 82.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.565 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 49.2 mt-10 -57.81 -49.45 76.58 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.081 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -38.23 81.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 68.4 t -63.1 -51.98 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.886 0.374 . . . . 0.0 110.139 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -54.78 -48.67 72.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.91 -30.16 66.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.958 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.65 -47.38 69.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.705 0.288 . . . . 0.0 110.299 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.86 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 178.716 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 207' ' ' ASP . . . . . 0.543 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 17.5 t70 . . . . . 0 C--O 1.237 0.404 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 58.0 mt -136.78 140.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.576 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.9 mmt -107.73 143.85 28.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -73.1 175.61 10.26 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.728 2.286 . . . . 0.0 111.921 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.03 93.0 2.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 0.0 111.064 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -90.48 86.19 6.36 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.962 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 11.0 p -113.08 141.79 26.25 Favored Pre-proline 0 N--CA 1.435 -1.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.579 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 13.6 Cg_exo -70.25 86.84 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.906 1.737 . . . . 0.0 111.476 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 13.8 t -78.03 -51.25 10.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.54 36.71 58.66 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.63 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.525 HD13 HD22 ' A' ' 19' ' ' ASN . 57.1 mt -60.35 -39.91 88.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.12 0.486 . . . . 0.0 111.058 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.497 ' HB3' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.04 -18.13 63.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 178.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.961 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . . . . . . 0 C--O 1.241 0.621 0 CA-C-O 120.255 0.074 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.701 ' CE1' ' HB2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -157.07 178.76 9.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.226 0.328 . . . . 0.0 110.313 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -118.97 145.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 0.0 111.738 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -94.57 133.77 37.85 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.274 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 62.6 mt -111.59 135.05 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 83' ' ' LYS . . . -87.45 -167.32 43.48 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.933 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 26.2 t-20 -39.69 112.48 0.26 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.372 1.069 . . . . 0.0 113.583 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -107.54 171.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.119 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -87.96 142.52 27.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -60.51 -23.96 64.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.905 0.384 . . . . 0.0 111.396 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB2' HD21 ' B' ' 217' ' ' LEU . 34.2 mm-40 -88.07 -7.6 56.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.75 111.02 22.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.491 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 27' ' ' ILE . 41.0 p -91.87 173.9 7.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HB2' ' CD2' ' B' ' 212' ' ' PHE . 7.5 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.725 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' B' ' 212' ' ' PHE . . . -70.51 -43.1 62.3 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.7 m-20 -63.63 -41.03 98.3 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 24' ' ' GLU . 62.9 mt -58.97 -53.04 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.761 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.28 -33.17 74.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.69 0.281 . . . . 0.0 110.603 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 m -59.89 -45.59 92.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.543 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 26' ' ' ASP . 93.2 t -63.43 -41.36 92.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.639 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 70.5 m-85 -74.79 -22.65 58.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -72.78 -17.62 61.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.324 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.56 -33.52 76.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 121.219 0.533 . . . . 0.0 109.774 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -91.73 -15.42 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.801 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.29 44.99 6.02 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.546 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -137.51 88.28 16.87 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 121.528 0.68 . . . . 0.0 111.596 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -98.44 99.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.502 2.802 . . . . 0.0 111.723 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -130.7 -165.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.537 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.8 m-20 -64.42 116.09 5.76 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.2 129.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.57 106.24 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 57.0 tp -87.21 131.31 34.24 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -74.97 102.44 4.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 19.1 mtp85 -115.7 149.43 38.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 48' ' ' THR . 25.5 t70 -67.72 135.16 52.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.794 0.33 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.99 -28.25 66.18 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -96.46 -56.23 2.67 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.474 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.3 t -84.82 -23.1 29.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 44' ' ' ARG . . . 82.02 -6.54 66.51 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.698 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 48' ' ' THR . 41.9 mm-40 -71.34 155.34 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.688 -0.301 . . . . 0.0 111.274 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -68.63 138.18 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.3 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -85.25 -5.23 59.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.987 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 106.93 7.63 33.08 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.383 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -152.07 167.97 26.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.785 0.793 . . . . 0.0 110.924 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -150.44 176.28 11.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.27 0.557 . . . . 0.0 111.998 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 50.8 m-85 -136.62 153.02 51.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.932 . . . . 0.0 108.972 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 31' ' ' PHE . 12.4 tp -142.04 125.87 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.1 tmtm? -116.15 113.21 22.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 15.6 p90 -125.18 158.83 33.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.867 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 40.2 mt-10 -103.09 105.54 15.87 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.962 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 14.6 t70 175.7 133.46 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.79 -37.3 30.47 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.654 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -71.32 -40.61 70.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.72 0.295 . . . . 0.0 110.513 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 26.1 t -58.09 -27.83 64.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.695 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.4 p -60.82 -52.52 64.74 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.518 0.675 . . . . 0.0 109.775 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.87 -36.35 63.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.086 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.05 -61.18 2.83 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.367 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.07 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 65' ' ' THR . 54.2 t -64.36 -47.47 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.4 -33.37 60.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.107 0.479 . . . . 0.0 111.154 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.69 -53.19 7.84 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.1 mt -91.43 -23.61 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 t30 -67.76 109.31 3.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.65 -5.05 32.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.673 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -75.05 126.35 30.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -83.72 122.76 29.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.386 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 HD11 ' A' ' 82' ' ' LEU . 41.9 mt -136.5 120.29 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.299 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.77 35.83 87.77 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.408 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.47 3.91 86.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.742 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -133.09 154.5 50.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.546 0.673 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.12 134.82 43.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.727 0.299 . . . . 0.0 111.224 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD11 HD12 ' A' ' 77' ' ' ILE . 75.9 mt -73.22 125.72 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.593 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 56.2 mtpt -108.11 122.42 46.85 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' VAL . 13.5 mm -120.46 129.65 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.621 0.248 . . . . 0.0 110.483 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -138.99 146.22 40.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.127 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.57 130.48 35.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.676 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.658 HG23 ' CE1' ' A' ' 12' ' ' TYR . 3.5 t -156.27 162.52 40.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.825 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -109.68 143.12 39.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.701 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 47.5 t80 -128.65 136.64 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.893 0.378 . . . . 0.0 111.178 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -108.07 96.03 16.83 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.74 146.71 84.49 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.98 2.453 . . . . 0.0 113.506 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.67 136.71 46.96 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.937 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.66 -6.96 44.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.868 0.366 . . . . 0.0 111.41 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -74.74 -27.68 60.45 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 17.26 16.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.987 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -59.04 -28.61 66.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.637 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.39 -40.09 85.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.097 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -72.86 -46.77 51.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.65 -51.82 68.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 36.4 mm-40 -62.27 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.493 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.84 -49.38 77.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.945 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -47.38 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.592 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -56.02 -54.41 45.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.539 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.3 pt-20 -69.89 -26.63 64.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.23 -58.16 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 107' ' ' ASP . 4.1 pp -66.47 -28.33 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.423 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 106' ' ' LEU . 19.0 t70 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.426 -1.636 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 44' ' ' ARG . 46.6 mt -134.22 144.39 35.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.6 mmt -127.19 139.93 36.48 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.854 0.359 . . . . 0.0 111.713 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.61 151.23 41.33 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.435 2.09 . . . . 0.0 111.203 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -158.02 76.22 0.78 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 24' ' ' GLU . 36.8 p90 -110.88 115.72 30.01 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.7 p -110.28 117.96 50.3 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.263 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.84 114.49 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.75 2.3 . . . . 0.0 113.001 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.495 ' HB2' HD12 ' B' ' 217' ' ' LEU . 37.7 m -78.89 -40.48 32.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.69 38.35 8.18 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.386 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.3 mp -63.69 -40.18 96.17 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.428 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.7 pt? -65.15 -20.31 66.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.16 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.351 179.163 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.257 0.551 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 74.2 m-85 -147.59 156.0 42.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.126 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.21 133.39 69.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.656 0.265 . . . . 0.0 110.498 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -85.49 126.06 33.53 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -105.9 137.02 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.71 -169.5 45.96 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.557 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -53.67 112.39 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.654 0.782 . . . . 0.0 112.239 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 HD23 ' A' ' 22' ' ' LEU . 67.6 mt -102.74 -173.42 2.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.405 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 16.4 m120 -79.31 148.19 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.08 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -65.43 -35.69 81.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.85 7.82 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.803 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 18' ' ' LEU . 26.8 tp -81.67 109.96 16.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -85.17 166.07 16.89 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.615 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 32.1 mt-10 -65.66 -22.4 66.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.53 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -45.76 78.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.581 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -64.26 -40.48 96.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 110.471 178.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.66 -46.39 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.582 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.42 -30.63 70.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.103 0.478 . . . . 0.0 109.733 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 30.8 m -62.57 -41.14 98.75 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 HD13 ' B' ' 218' ' ' LEU . 81.4 t -67.5 -46.86 82.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.26 -21.99 55.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -70.77 -14.31 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.784 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.45 -8.73 55.75 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.391 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.631 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 79.8 m-85 -92.15 -10.9 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.63 10.45 86.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -129.15 89.83 47.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.683 0.278 . . . . 0.0 110.737 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -88.01 114.66 0.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.963 2.442 . . . . 0.0 111.964 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.805 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.6 t -132.31 -167.42 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.805 ' H ' HG12 ' A' ' 38' ' ' VAL . 6.4 m-20 -62.0 144.23 55.43 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.24 140.28 46.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.864 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -137.32 110.33 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.668 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.52 136.42 42.38 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 92.1 p -79.36 112.38 16.53 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.166 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -123.29 149.62 44.58 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.72 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.63 142.45 42.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.557 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.52 -29.3 41.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.819 0.342 . . . . 0.0 111.424 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.74 -58.01 3.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 50' ' ' GLU . 3.7 t -91.79 -40.28 11.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.13 43.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.558 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' H ' HG23 ' A' ' 48' ' ' THR . 42.7 mt-10 -67.49 160.33 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.968 0.507 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.2 m -75.69 141.37 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.03 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 76.8 mt-30 -82.81 -12.96 57.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.03 -30.58 7.9 Favored Glycine 0 C--O 1.216 -0.997 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.969 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -109.36 161.81 14.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.775 0.788 . . . . 0.0 111.575 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.54 26.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -134.09 135.27 43.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.735 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.8 tp -119.15 143.43 47.21 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.624 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 31.6 tttm -124.37 118.54 26.95 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.207 0.527 . . . . 0.0 111.788 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.779 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 12.3 p90 -138.82 144.04 39.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.45 104.4 14.85 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.675 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 65' ' ' THR . 25.1 t70 175.46 141.88 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.433 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -80.83 -37.48 29.96 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.02 -43.19 71.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 8.6 p -63.86 -22.72 67.05 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.779 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.1 p -62.23 -50.71 70.66 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.337 0.589 . . . . 0.0 109.762 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mt -64.78 -37.05 79.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.072 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.83 -58.65 7.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.426 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.66 89.23 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 65' ' ' THR . 72.2 t -57.32 -58.98 3.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.44 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.3 -31.38 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -67.23 -46.73 72.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.316 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.631 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 72.5 mt -93.78 -20.49 20.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.12 109.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.52 7.97 58.79 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.061 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.06 138.46 31.5 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -86.32 127.58 34.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG13 HD11 ' A' ' 82' ' ' LEU . 23.7 mm -131.91 110.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.88 20.84 77.96 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.753 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.31 -12.57 65.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.359 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -107.47 150.88 26.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.269 0.534 . . . . 0.0 110.926 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.51 33.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 111.067 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 78.5 mt -80.14 130.62 35.37 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -114.81 108.86 17.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.31 141.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.656 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.26 155.27 38.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.662 0.268 . . . . 0.0 110.95 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -71.68 128.25 35.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.625 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.4 t -153.72 161.26 42.27 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -108.94 159.26 16.95 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -149.48 138.92 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.355 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -112.78 113.73 49.92 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.8 140.34 79.58 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.722 2.282 . . . . 0.0 111.823 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -94.15 128.39 40.53 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -71.8 -15.26 62.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.068 0.461 . . . . 0.0 110.478 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -66.8 -29.63 69.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.6 30.87 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.628 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -53.38 -33.39 53.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.328 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -71.06 -27.09 63.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -68.37 -49.85 57.26 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.431 ' HA ' HG12 ' A' ' 102' ' ' VAL . 64.7 m-85 -64.64 -32.17 73.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.221 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -53.31 48.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.421 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -63.03 -38.39 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.914 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 9.0 p -70.92 -27.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.451 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 tptt -76.68 -42.53 41.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.958 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.76 -26.39 67.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.87 -31.04 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.999 0.428 . . . . 0.0 110.206 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 12.7 tp -63.39 -64.7 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.467 0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.769 -178.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 62.4 mt -108.26 131.09 59.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.797 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.421 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 20.5 mmt -107.22 134.74 19.79 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.431 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 29.6 Cg_endo -62.05 129.59 27.78 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.205 2.603 . . . . 0.0 111.829 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -103.26 102.4 12.36 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.699 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.28 83.38 3.57 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.548 0.689 . . . . 0.0 109.674 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.0 t -113.64 119.41 41.54 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.446 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.31 96.61 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.707 1.605 . . . . 0.0 111.227 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.51 ' HB2' HD12 ' B' ' 217' ' ' LEU . 17.2 m -81.39 -43.79 18.48 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 81.28 38.82 13.84 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.905 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.6 mp -62.72 -37.76 87.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.584 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.537 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.34 -22.7 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.517 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.224 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.848 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -139.2 137.73 36.26 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.338 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.139 0.495 . . . . 0.0 111.667 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 50.5 t80 -88.42 132.0 34.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.991 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 63.4 mt -106.9 132.69 53.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 83' ' ' LYS . . . -86.44 -168.22 44.55 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.696 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 66.5 t30 -52.12 108.76 0.31 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -175.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.96 -165.6 1.33 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.647 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -101.15 149.03 24.39 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -72.0 -26.53 62.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.72 -19.05 62.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.765 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.475 HD12 HD13 ' B' ' 217' ' ' LEU . 27.1 tp -84.04 109.04 17.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' ILE . 80.4 p -91.12 178.12 6.08 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 120.927 0.394 . . . . 0.0 110.704 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.34 -9.81 58.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.466 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.77 -45.8 56.52 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.33 -39.22 85.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 23' ' ' THR . 46.7 mm -51.11 -51.62 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.636 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -67.7 -36.85 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.8 m -61.95 -42.24 98.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.652 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.47 HG22 HD13 ' B' ' 218' ' ' LEU . 75.4 t -76.04 -45.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -79.34 -21.97 45.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -75.8 -12.57 60.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.954 -0.466 . . . . 0.0 111.069 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.41 -24.53 56.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.878 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -75.2 -1.65 24.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.71 -21.3 45.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.355 -0.45 . . . . 0.0 114.096 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.99 107.2 15.1 Favored Pre-proline 0 C--N 1.313 -0.988 0 O-C-N 122.462 -0.434 . . . . 0.0 110.906 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.8 100.9 1.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.534 2.156 . . . . 0.0 110.718 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -101.05 -166.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.306 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.559 ' H ' HG12 ' A' ' 38' ' ' VAL . 34.9 t70 -63.16 129.0 38.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.929 0.395 . . . . 0.0 111.478 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.8 134.87 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.766 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 mt -131.52 106.42 11.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -93.03 127.4 38.54 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.6 t -75.74 91.58 2.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.16 0.505 . . . . 0.0 110.952 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' B' ' 211' ' ' ASP . 4.4 tpt180 -91.44 136.14 33.33 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p30 -80.75 147.16 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.093 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.534 ' HB3' HD11 ' B' ' 208' ' ' ILE . 1.5 pm0 -81.59 -9.59 59.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.042 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -75.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 111.473 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -112.68 -18.93 12.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.216 0.532 . . . . 0.0 110.153 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 90.82 32.05 9.5 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.937 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -103.93 171.29 7.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.806 0.336 . . . . 0.0 111.626 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -73.3 130.85 41.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.59 -8.65 58.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.014 0.435 . . . . 0.0 110.894 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 105.95 -3.55 38.58 Favored Glycine 0 C--O 1.206 -1.63 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.673 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -137.22 163.09 31.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 117.962 0.881 . . . . 0.0 111.292 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.03 175.28 12.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.34 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 84.4 m-85 -138.87 147.99 43.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 tp -137.39 144.11 42.27 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.569 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 31.5 tttt -132.39 123.27 26.42 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 6.2 p90 -134.06 150.91 51.21 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -101.18 103.59 14.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.654 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 174.29 122.87 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.097 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -69.24 -33.36 73.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.04 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -68.04 -41.38 82.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 0.0 111.531 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.3 m -61.9 -26.32 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.669 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.7 p -61.57 -50.78 71.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.568 0.699 . . . . 0.0 109.955 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.6 mt -70.98 -34.77 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.182 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.36 -58.21 8.52 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.831 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.12 75.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 95.7 t -69.01 -30.14 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.154 0.502 . . . . 0.0 111.594 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.41 -31.9 18.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.275 0.56 . . . . 0.0 111.355 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.22 -45.23 9.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.006 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 89.5 mt -96.04 -30.78 13.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 69' ' ' VAL . 8.8 t30 -67.42 109.89 3.37 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.816 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.78 31.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.185 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -72.71 132.22 43.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.21 116.85 21.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.305 0.574 . . . . 0.0 112.334 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.61 109.6 22.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.02 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.89 30.82 77.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.765 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 -13.61 65.43 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.238 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.72 148.7 35.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.925 0.363 . . . . 0.0 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.99 143.46 26.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.691 0.282 . . . . 0.0 111.307 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 87.7 mt -76.74 124.41 27.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.238 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 40.0 ttmt -104.64 117.06 33.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mm -114.96 117.22 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -127.32 146.13 50.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.738 0.304 . . . . 0.0 111.324 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -80.04 125.36 29.69 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 14' ' ' TYR . 13.3 t -154.96 160.65 41.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -100.55 99.63 10.25 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -115.86 132.76 56.55 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.432 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -113.98 132.87 22.47 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.962 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.16 163.24 34.93 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.513 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 60.6 mttp -98.72 129.34 45.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.31 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.36 -11.82 60.13 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.872 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -75.08 -32.73 61.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.18 0.514 . . . . 0.0 110.236 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -89.53 33.46 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -51.4 -36.13 42.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.085 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -60.41 -49.36 77.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 111.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.82 -51.47 69.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.326 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 59.3 m-85 -61.58 -36.3 80.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.287 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 37.7 tt0 -66.5 -51.88 52.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.24 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.7 69.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.194 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.427 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.4 t -69.52 -50.41 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 103' ' ' LYS . 35.8 ttmt -58.1 -44.89 87.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.779 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.5 pt-20 -70.56 -24.42 62.79 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.058 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.1 -41.96 66.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 102' ' ' VAL . 10.6 mp -63.01 -42.17 99.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.005 176.823 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 46' ' ' GLU . 69.3 mt -107.66 126.73 64.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.1 mmt -121.63 145.65 43.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.745 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.3 148.14 54.65 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.838 2.359 . . . . 0.0 112.645 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.49 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 25.4 t70 -117.15 98.41 6.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.44 89.1 5.73 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 33.9 m -110.21 139.88 21.86 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.941 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 3.1 Cg_exo -75.08 84.88 1.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.896 1.731 . . . . 0.0 110.98 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 50.2 m -81.53 -51.12 8.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.186 0.517 . . . . 0.0 110.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.12 43.74 89.29 Favored Glycine 0 N--CA 1.431 -1.666 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.758 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 22' ' ' LEU . 6.9 mp -61.26 -34.73 75.64 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.121 0.46 . . . . 0.0 110.371 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.476 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -79.06 -11.73 60.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.244 0.545 . . . . 0.0 110.563 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.443 -0.784 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.209 -178.335 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.209 0.528 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 63.7 m-85 -142.26 139.81 32.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.036 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -116.45 133.48 62.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.038 0.447 . . . . 0.0 110.808 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HG21 ' A' ' 87' ' ' THR . 76.4 t80 -88.01 125.94 34.81 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.857 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.33 143.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.99 -169.37 45.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.119 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.76 133.73 56.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 0.0 111.597 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 mt -125.89 160.33 30.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.02 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.35 146.05 49.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.01 -21.22 65.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.429 . . . . 0.0 110.724 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.75 -13.65 58.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.76 129.58 34.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.434 HG21 ' HB2' ' B' ' 213' ' ' SER . 32.1 p -109.27 179.37 4.18 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.895 0.379 . . . . 0.0 110.681 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.1 pm0 -72.91 -21.07 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 110.049 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.26 -34.22 85.0 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.557 ' O ' ' HB ' ' A' ' 29' ' ' THR . 27.5 m-20 -72.12 -36.76 69.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.69 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.74 -34.64 78.65 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.385 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 53.4 m -59.24 -46.82 87.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.101 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' ASP . 58.3 t -67.52 -50.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.943 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -70.86 -9.34 57.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -22.08 66.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.845 0.355 . . . . 0.0 110.124 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.99 -19.5 64.94 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.213 0.53 . . . . 0.0 110.654 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 39.1 m-85 -83.01 -20.16 35.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.82 17.13 80.16 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.203 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.87 104.57 3.9 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.378 0.608 . . . . 0.0 111.207 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.07 116.3 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.747 2.298 . . . . 0.0 111.961 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -124.83 -166.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.9 m-20 -62.55 120.34 10.93 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.01 111.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.292 0.568 . . . . 0.0 109.938 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 ' CZ ' ' A' ' 99' ' ' TYR . 4.3 mp -108.46 104.48 17.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.57 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.29 120.58 26.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 m -75.14 99.34 3.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.139 0.495 . . . . 0.0 110.964 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.508 ' NH2' ' H ' ' B' ' 211' ' ' ASP . 56.5 mtt180 -103.91 170.16 8.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.762 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.7 p-10 -108.78 149.35 29.18 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.588 ' HA ' HD11 ' B' ' 208' ' ' ILE . 4.6 pt-20 -81.46 -9.95 59.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -78.27 -61.99 1.82 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.944 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -105.49 -28.02 11.06 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.871 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 94.32 24.8 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.833 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.57 169.68 8.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.636 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -68.5 132.13 46.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.48 2.69 21.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.869 0.366 . . . . 0.0 111.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.78 9.66 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.043 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -169.51 163.15 10.32 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.05 0.452 . . . . 0.0 111.349 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.52 161.44 42.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.433 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -133.04 130.84 39.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 8.3 tt -121.15 139.07 53.85 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.912 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 13.5 tmtt? -125.69 121.07 32.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.441 0.639 . . . . 0.0 111.474 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 7.6 p90 -131.8 151.25 51.8 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.587 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.02 104.97 15.66 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.953 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 176.4 137.95 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.134 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -78.36 -40.97 34.75 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.417 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -69.47 -41.04 76.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 111.254 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -58.08 -26.67 62.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.999 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.67 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 53.0 p -62.83 -42.96 99.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.602 0.715 . . . . 0.0 110.401 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.1 mt -75.18 -41.05 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.031 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.87 -52.73 64.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.851 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -57.8 -43.92 85.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.863 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.43 -57.72 10.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.163 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.29 -24.61 67.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -82.54 -54.0 5.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.8 0.333 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.62 -16.1 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.68 109.75 2.13 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -0.36 61.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.523 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -69.13 136.87 52.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.38 122.97 33.73 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.95 118.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.702 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.27 8.52 79.73 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.342 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.89 10.23 46.87 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -129.43 145.38 51.43 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.027 -0.586 . . . . 0.0 110.771 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.19 32.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.872 0.368 . . . . 0.0 111.203 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.44 120.43 22.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.1 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -92.98 113.31 25.55 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.2 mm -118.59 118.89 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.653 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -135.81 149.76 49.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.878 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -76.23 134.76 39.75 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.2 t -160.13 160.58 33.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -91.16 153.09 20.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 44.9 t80 -147.13 119.4 8.34 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.089 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 90' ' ' ARG . 49.0 mtt180 -112.26 99.27 45.98 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.879 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.61 149.52 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -85.13 149.09 25.77 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.04 -8.8 40.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.044 0.45 . . . . 0.0 110.571 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -68.62 -19.06 64.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.221 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.5 mt -118.49 24.43 10.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.58 0.229 . . . . 0.0 111.566 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.1 pt20 -69.97 -25.61 63.71 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.195 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -67.28 -24.42 65.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -69.38 -36.69 77.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CZ ' HG12 ' A' ' 41' ' ' ILE . 53.2 m-85 -69.12 -41.53 77.27 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.077 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 41.8 mm-40 -58.96 -50.64 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.489 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -57.89 -51.21 70.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.734 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 13.1 p -64.1 -37.87 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.02 -49.31 76.54 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.433 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 54.9 mt-10 -64.67 -38.32 90.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.44 -50.17 72.52 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.927 0.394 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 85.5 mt -65.99 -41.99 90.39 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.164 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.383 179.349 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 122.022 0.915 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 46' ' ' GLU . 66.4 mt -128.74 137.63 56.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.068 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 21.3 mmt -110.09 145.23 31.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 14.6 Cg_exo -70.04 129.05 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.012 2.475 . . . . 0.0 112.295 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.508 ' H ' ' NH2' ' A' ' 44' ' ' ARG . 31.2 m-20 -96.01 82.48 3.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.505 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.17 89.39 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.516 . . . . 0.0 110.912 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 23' ' ' THR . 3.2 m -112.37 129.48 24.3 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.906 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.52 70.32 7.34 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.857 1.704 . . . . 0.0 111.293 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.4 m -65.49 -50.21 66.14 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.62 43.62 96.19 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.691 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.57 -50.65 71.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -65.38 -31.61 72.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.388 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -178.291 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.191 0.52 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 75.5 m-85 -133.48 146.01 50.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.077 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.95 137.15 52.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.342 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 74.8 t80 -85.28 128.89 34.86 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.624 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.18 132.26 61.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.86 -168.59 44.59 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.215 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -49.77 119.99 3.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.517 0.675 . . . . 0.0 112.669 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.29 179.1 4.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 m120 -81.81 151.04 27.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.693 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -73.99 -17.13 61.03 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.056 0.455 . . . . 0.0 111.231 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.23 -14.57 40.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.344 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 19' ' ' ASN . 73.3 mt -84.26 109.32 17.7 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.838 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 27' ' ' ILE . 54.1 p -88.77 176.39 7.09 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.236 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.3 -25.09 67.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.287 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.96 -44.73 54.72 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -63.83 -33.48 75.78 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.755 0.312 . . . . 0.0 110.938 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 23' ' ' THR . 64.5 mt -58.17 -53.09 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.275 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.33 -21.15 62.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.983 0.42 . . . . 0.0 110.673 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.5 m -63.99 -42.89 97.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.533 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.631 HG22 HD13 ' B' ' 218' ' ' LEU . 86.1 t -75.52 -48.46 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.095 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -70.96 -6.97 42.77 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 p -50.87 -44.38 59.64 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.247 0.546 . . . . 0.0 111.631 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -76.32 -6.88 53.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.624 0.726 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.98 26.38 8.62 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.525 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.68 70.09 0.35 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 118.829 -1.653 . . . . 0.0 112.756 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.4 m -44.0 147.52 0.9 Allowed Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.26 1.024 . . . . 0.0 112.634 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -11.34 98.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.7 4.934 . . . . 0.0 117.029 -173.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -128.82 -164.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 26.9 m-20 -70.41 109.54 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.725 -175.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.66 143.35 21.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.2 106.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 55' ' ' ALA . 2.6 tm? -95.11 121.83 37.15 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.2 t -78.42 110.32 13.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.045 0.45 . . . . 0.0 110.51 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -110.45 154.67 23.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.87 139.24 48.75 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HA ' HD11 ' B' ' 208' ' ' ILE . 39.0 mt-10 -74.74 -9.56 58.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -109.75 -60.44 1.78 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.3 t -89.62 -11.22 43.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.16 66.82 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.912 -0.661 . . . . 0.0 114.229 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 48' ' ' THR . 46.3 mm-40 -78.35 156.79 29.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.024 0.412 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.5 p -65.2 128.85 37.51 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.18 -14.73 63.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.804 0.335 . . . . 0.0 111.608 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.69 18.52 8.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.17 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -161.81 159.42 26.98 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 120.922 0.391 . . . . 0.0 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -151.43 170.61 19.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.804 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -136.34 139.2 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.7 tp -126.2 130.63 51.34 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.619 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.1 tttt -116.15 103.58 10.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.585 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 37.4 p90 -118.66 153.45 34.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 tt0 -101.02 105.8 17.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.814 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 13.4 t70 175.48 108.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.058 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -73.59 -8.75 57.21 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 26.6 mtm180 -91.72 -49.23 6.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 0.0 109.911 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -63.84 -26.89 68.82 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.396 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 17.2 p -59.12 -41.32 87.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 110.337 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 mm -69.01 -49.18 65.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.637 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.73 -55.56 28.92 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.252 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.7 74.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 68.0 t -60.48 -48.09 89.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.29 -33.88 42.92 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.192 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.24 -44.95 35.16 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.35 -15.09 58.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 53.2 t30 -68.45 108.72 3.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.79 -8.91 59.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.776 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.96 128.51 35.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.37 134.84 33.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.33 109.88 3.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.583 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.79 22.13 75.3 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.554 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.71 -3.9 81.61 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.473 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.07 123.65 49.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 111.048 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.96 107.68 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.76 143.73 53.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.37 111.7 21.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 8.4 mm -114.74 138.72 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -146.4 146.9 30.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.157 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -72.16 124.8 25.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -147.4 160.8 42.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.01 0.434 . . . . 0.0 110.928 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.6 117.49 34.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 57.2 t80 -102.74 127.6 49.82 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.891 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -100.18 102.08 16.81 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 50.9 Cg_exo -55.85 126.6 22.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.243 2.629 . . . . 0.0 113.706 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -77.13 128.65 34.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -77.28 -12.56 59.96 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.574 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 m -64.42 -23.07 67.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.404 0.621 . . . . 0.0 109.819 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.41 26.29 5.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.459 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -54.16 -46.42 72.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.873 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -71.67 -27.06 62.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 110.722 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -68.15 -48.78 64.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -59.52 -44.42 93.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 35.6 tt0 -60.96 -52.62 64.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.528 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.16 75.48 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 53.7 t -59.0 -49.21 84.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -64.04 -44.09 93.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 36.6 mt-10 -62.36 -43.16 99.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 110.509 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.29 -43.46 83.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.551 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -69.93 -43.06 72.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.064 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.959 -179.817 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.863 0.363 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 46' ' ' GLU . 48.2 mt -124.66 130.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.01 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.408 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 11.8 mmt -124.29 149.12 60.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.142 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 5.6 Cg_exo -79.92 170.47 16.63 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -147.28 114.65 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -108.37 88.18 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.621 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 19.3 m -111.38 119.59 44.88 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.94 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 24.8 Cg_exo -63.0 110.83 1.23 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.448 2.099 . . . . 0.0 112.536 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 19.8 m -101.64 -50.82 3.61 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.83 41.25 50.18 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.786 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.14 -30.04 69.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.322 0.561 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -64.99 -26.86 68.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.171 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 0.0 110.987 -177.332 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 21.6 m-85 -147.7 148.07 30.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.07 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.17 136.52 60.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.981 0.419 . . . . 0.0 110.542 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -86.39 131.54 34.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.585 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -113.7 138.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -171.27 47.57 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.422 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.2 t-20 -58.9 104.8 0.26 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.286 0.565 . . . . 0.0 111.735 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -95.41 -172.46 2.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 40.7 t30 -76.37 130.05 37.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -66.14 1.33 1.55 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.43 -10.58 29.53 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.182 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 19' ' ' ASN . 6.5 mp -76.06 140.12 41.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.029 0.442 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.517 HG21 ' HB2' ' B' ' 213' ' ' SER . 44.0 p -110.44 -178.12 3.41 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.785 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' B' ' 210' ' ' PRO . 3.0 mm-40 -62.71 -36.25 82.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.52 95.31 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.492 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 29' ' ' THR . 13.8 m-20 -63.32 -47.83 80.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 110.377 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.68 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.717 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.12 -38.18 90.16 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.318 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.8 m -56.12 -45.22 79.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.716 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.434 HG22 HD13 ' B' ' 218' ' ' LEU . 99.0 t -64.25 -46.39 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.102 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.05 -20.12 33.22 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 t -63.73 -24.72 67.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.648 0.261 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.29 -7.13 28.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.76 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -88.35 -4.09 58.73 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.985 0.421 . . . . 0.0 110.895 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.27 -20.99 27.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.048 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.72 111.03 9.54 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 117.42 0.61 . . . . 0.0 111.582 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.68 110.44 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.789 2.326 . . . . 0.0 111.082 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.9 t -111.03 -167.23 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.716 ' H ' HG12 ' A' ' 38' ' ' VAL . 31.2 m-20 -73.36 147.04 44.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' H ' HG11 ' A' ' 102' ' ' VAL . 14.3 p -135.56 140.73 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.391 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.94 99.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.67 0.271 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 1.3 tt -84.85 122.99 29.95 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 m -67.4 122.25 17.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HD2' ' OH ' ' A' ' 98' ' ' TYR . 81.1 mtt85 -121.34 161.27 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.07 147.07 26.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.042 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HG3' HD11 ' B' ' 208' ' ' ILE . 1.9 mp0 -72.68 -25.12 61.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -93.08 -59.68 1.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 50' ' ' GLU . 5.2 t -81.87 -24.48 35.74 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.462 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.82 77.9 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.026 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 48' ' ' THR . 47.7 mt-10 -80.4 166.61 21.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.819 0.343 . . . . 0.0 110.909 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.7 p -70.15 142.29 52.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.58 3.23 48.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.148 0.499 . . . . 0.0 110.305 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.76 -31.93 8.17 Favored Glycine 0 C--O 1.219 -0.828 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.73 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -109.61 162.36 14.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.164 0.482 . . . . 0.0 111.174 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.81 171.48 16.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.234 0.54 . . . . 0.0 111.587 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -134.39 133.83 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.11 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.9 tp -114.37 144.98 42.4 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.972 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 39.2 tttm -125.51 123.35 38.96 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.244 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.718 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 23.4 p90 -148.15 145.86 28.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -100.95 105.46 16.7 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.805 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' THR . 39.1 t70 175.71 134.15 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.809 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.84 -53.97 22.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.803 0.335 . . . . 0.0 111.179 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -59.31 -39.91 84.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.999 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -61.1 -27.98 68.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.718 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.7 p -69.6 -36.29 76.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.583 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.96 -47.61 54.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.305 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.73 -54.85 40.18 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.76 77.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 86.8 t -60.86 -48.46 88.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.194 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.19 -41.21 81.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -71.85 -53.74 12.29 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 3.0 mm? -80.08 -25.57 39.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 33.9 t-20 -62.37 109.57 1.39 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.071 0.462 . . . . 0.0 111.143 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.65 -4.79 50.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.129 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.52 131.91 43.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 110.382 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 mt -127.2 105.18 13.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.986 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.65 71.77 Favored Glycine 0 C--N 1.312 -0.784 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.734 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.57 -19.57 43.54 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -89.26 143.93 26.47 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.571 0.224 . . . . 0.0 110.444 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.97 128.29 47.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 55.1 mt -68.77 110.6 4.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.688 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.87 111.66 23.58 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 69' ' ' VAL . 11.4 mm -113.53 141.82 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.479 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -149.78 148.91 29.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.584 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.18 121.16 23.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -133.71 160.11 38.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.649 0.261 . . . . 0.0 110.881 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -106.63 118.41 36.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.55 160.88 43.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.69 155.32 35.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.241 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 99' ' ' TYR . 32.2 Cg_exo -58.74 132.52 48.4 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.84 2.36 . . . . 0.0 113.434 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.28 142.32 34.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.093 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -71.45 -17.05 62.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.881 0.372 . . . . 0.0 111.219 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -74.99 -26.06 59.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.23 0.538 . . . . 0.0 110.371 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.93 28.56 8.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.211 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -53.81 -37.48 63.59 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.952 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.69 -23.93 65.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.424 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.467 ' OH ' ' HD2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.9 -51.73 20.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 91' ' ' PRO . 53.1 m-85 -63.27 -41.2 99.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.58 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.65 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 44.9 mt-10 -64.24 -50.16 69.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.229 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.92 68.37 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.475 HG11 ' H ' ' A' ' 40' ' ' VAL . 91.1 t -68.98 -45.29 80.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.779 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.9 ttmm -63.41 -25.26 68.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.51 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 43.8 mt-10 -59.67 -40.88 89.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.15 -25.81 58.66 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.439 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 103' ' ' LYS . 39.0 mt -74.01 -42.6 60.12 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.44 178.87 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.483 HD11 ' HG3' ' A' ' 46' ' ' GLU . 21.7 mt -137.94 139.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.593 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 2.5 mmt -135.58 133.62 20.39 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.621 0.248 . . . . 0.0 111.494 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.593 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 42.2 Cg_endo -69.91 142.95 48.62 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.313 2.009 . . . . 0.0 110.563 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -104.22 133.41 49.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.074 0.464 . . . . 0.0 111.355 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.25 86.82 2.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.138 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.517 ' HB2' HG21 ' A' ' 23' ' ' THR . 34.2 m -113.74 119.46 41.25 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 175.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 82.59 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.88 1.72 . . . . 0.0 111.178 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.8 m -72.24 -50.53 26.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.349 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.1 32.42 56.33 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.26 -35.19 73.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.378 . . . . 0.0 111.656 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.526 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.8 OUTLIER -70.11 -30.2 67.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 178.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 0.0 110.008 -179.889 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.886 0 CA-C-O 121.192 0.52 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 87' ' ' THR . 89.7 m-85 -134.1 151.73 51.52 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 17.8 pt -121.88 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.952 0.406 . . . . 0.0 110.62 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.6 t80 -75.11 129.63 37.88 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.668 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -115.64 144.53 23.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.58 -169.07 44.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.761 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -54.92 117.29 3.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.545 0.738 . . . . 0.0 110.878 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.39 162.88 12.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.896 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.457 ' H ' HD12 ' A' ' 22' ' ' LEU . 8.6 m120 -64.12 149.68 47.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -71.91 -8.92 57.22 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.382 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 217' ' ' LEU . 46.7 mm-40 -97.71 -3.37 39.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.577 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 19' ' ' ASN . 17.6 mt -87.59 112.9 22.77 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.839 0.352 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.487 HG21 ' HB3' ' B' ' 213' ' ' SER . 30.2 p -98.88 173.33 6.91 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' CD ' HH12 ' A' ' 44' ' ' ARG . 2.0 mp0 -60.22 -27.47 67.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.71 -40.92 85.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 29' ' ' THR . 18.4 m-20 -67.93 -37.32 81.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' THR . 66.8 mt -60.76 -49.0 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.1 -32.5 74.09 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 27.1 m -58.77 -46.09 88.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.432 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG22 HD13 ' B' ' 218' ' ' LEU . 84.5 t -64.38 -40.52 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.89 -14.32 56.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.7 m -63.23 -19.53 64.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.54 -28.91 69.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.38 0.61 . . . . 0.0 109.893 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.28 -14.22 59.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 14.77 69.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.056 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.04 89.55 33.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.3 98.68 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.624 2.216 . . . . 0.0 110.245 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -126.23 -166.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.349 -176.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 22.4 m-20 -60.43 135.17 57.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' H ' HG11 ' A' ' 102' ' ' VAL . 6.3 p -128.44 130.48 69.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.85 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.21 102.52 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.735 0.302 . . . . 0.0 111.327 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.465 HD13 ' NH2' ' A' ' 44' ' ' ARG . 1.7 tt -91.9 124.45 36.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.6 t -74.57 121.8 22.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.078 0.466 . . . . 0.0 111.886 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.465 ' NH2' HD13 ' A' ' 42' ' ' LEU . 5.3 mpt_? -120.1 165.43 14.75 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.69 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -89.59 160.86 16.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.945 0.402 . . . . 0.0 110.05 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -80.97 -9.5 59.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.25 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -93.06 -69.78 0.73 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 t -97.72 -40.33 8.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.94 32.73 2.77 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.796 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 32.6 mm-40 -91.79 153.05 19.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.788 0.327 . . . . 0.0 110.309 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -70.53 130.99 43.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.02 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -75.96 -0.38 21.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.72 16.04 37.86 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.88 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -162.62 156.17 20.38 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.005 0.431 . . . . 0.0 111.172 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.99 171.08 14.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 66.1 m-85 -139.53 140.47 37.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 12.8 tp -120.53 139.25 53.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -125.39 115.41 20.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.0 110.505 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.722 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.8 p90 -134.23 158.21 44.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 50.9 mt-10 -100.26 105.54 17.11 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.587 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 65' ' ' THR . 11.4 t70 175.43 125.63 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.086 0.866 . . . . 0.0 108.935 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -73.04 -54.63 8.06 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.089 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -64.5 -31.41 72.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . 38.4 m -70.06 -19.79 63.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.722 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 65.4 p -67.35 -45.53 76.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.934 0.874 . . . . 0.0 109.002 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.8 mt -70.12 -41.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.28 -55.54 23.92 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.119 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -48.26 65.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 84' ' ' ILE . 90.6 t -63.59 -54.45 32.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.292 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.83 -31.71 73.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.28 -13.98 27.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.06 109.18 2.9 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.403 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.25 52.67 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.09 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -73.91 138.92 44.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 121.6 32.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 111.908 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 HD11 ' A' ' 82' ' ' LEU . 20.9 mm -127.97 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.83 35.69 91.67 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.77 -14.73 55.49 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.144 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -104.22 146.69 28.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.003 0.401 . . . . 0.0 110.527 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.32 129.46 41.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.872 0.368 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 HG13 ' A' ' 77' ' ' ILE . 77.3 mt -74.57 108.2 7.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.35 104.57 17.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 14.9 mm -106.58 141.03 22.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.611 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -150.68 153.14 35.04 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.746 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.8 119.56 22.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.8 t -160.36 161.27 33.09 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -112.32 143.93 42.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -119.4 119.87 35.21 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.845 0.355 . . . . 0.0 110.583 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.65 104.14 54.68 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.13 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.03 -178.56 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.768 2.312 . . . . 0.0 111.859 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.38 151.7 23.87 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 93' ' ' ARG . 51.5 mtm180 -66.81 -9.45 37.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -75.26 -19.4 59.74 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.24 18.29 22.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 13.9 pt20 -63.0 -25.39 68.37 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.907 0.384 . . . . 0.0 110.095 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.558 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 12.7 mptt -52.95 -39.05 62.61 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.336 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.434 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.6 t80 -63.08 -52.02 64.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -64.25 -36.34 83.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.893 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 52.5 mt-10 -65.37 -54.05 34.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.597 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.99 69.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.734 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.497 ' O ' HD13 ' A' ' 106' ' ' LEU . 92.7 t -63.43 -57.62 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.87 -41.83 98.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.838 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.63 -36.83 79.6 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.08 -33.63 65.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 102' ' ' VAL . 6.6 mp -63.78 -48.82 75.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.84 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 121.354 0.597 . . . . 0.0 110.574 178.015 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.914 0.387 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.15 102.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.558 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 92.0 mmm -107.73 139.84 20.99 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.976 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.46 155.71 66.15 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.689 2.259 . . . . 0.0 111.856 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.39 124.54 34.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -109.81 87.98 2.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.597 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.487 ' HB3' HG21 ' A' ' 23' ' ' THR . 33.2 t -112.36 117.73 46.83 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 15.8 Cg_exo -69.35 91.33 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.129 1.886 . . . . 0.0 111.794 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 4.2 m -76.66 -41.98 43.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.33 56.33 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.087 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 21' ' ' GLU . 65.8 mt -64.47 -36.73 85.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.343 . . . . 0.0 111.391 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.535 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -79.26 -22.83 44.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.85 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 120.755 0.312 . . . . 0.0 110.762 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.551 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 50.2 m-85 -127.55 139.59 52.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.293 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.02 123.45 62.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.153 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 52.4 t80 -86.53 127.45 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 42.8 mt -109.79 141.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.96 -169.67 46.1 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.514 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -39.62 111.89 0.22 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.436 1.094 . . . . 0.0 113.87 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.52 -178.49 3.61 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.479 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.98 149.54 24.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.19 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.625 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 9.0 mpt_? -76.42 -20.14 57.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.487 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 -10.0 59.12 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.429 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.93 112.15 22.23 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.628 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 p -102.49 -178.85 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.81 0.338 . . . . 0.0 111.047 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.97 -22.41 60.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.371 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.42 53.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.101 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -69.93 -40.55 75.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.723 0.297 . . . . 0.0 110.842 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.91 -43.8 85.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.26 -36.94 82.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 48.6 m -59.69 -36.8 77.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.04 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.76 -38.69 58.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -77.03 -28.16 54.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 p -66.73 -12.72 59.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 111.093 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.06 -21.86 65.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.188 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -2.55 58.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.084 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.61 3.62 90.57 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.204 -0.522 . . . . 0.0 114.152 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -153.66 106.42 2.53 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 117.305 0.553 . . . . 0.0 112.146 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 2.6 Cg_endo -83.28 114.32 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.855 2.37 . . . . 0.0 111.785 176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.3 t -111.89 -165.6 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 18.3 m-20 -61.56 112.19 2.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.36 130.17 65.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.056 0.455 . . . . 0.0 110.618 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 mp -122.37 130.37 74.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.329 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 tp -116.65 139.52 50.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.458 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 37.2 p -73.21 103.89 4.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 7.4 tpp180 -106.89 131.85 53.52 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.78 137.46 57.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' B' ' 208' ' ' ILE . 33.0 mt-10 -80.19 -9.5 59.72 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -111.29 -58.0 2.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.816 0.341 . . . . 0.0 111.598 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 p -81.49 -40.75 22.76 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 95.05 17.64 36.87 Favored Glycine 0 N--CA 1.407 -3.299 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.659 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.95 170.37 11.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 20' ' ' ARG . 5.1 p -86.82 130.46 34.46 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 43' ' ' SER . 87.7 mt-30 -70.9 -20.69 62.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.028 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.28 -2.88 29.66 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.791 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.47 143.04 39.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.459 0.63 . . . . 0.0 110.06 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -130.92 142.52 50.37 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.424 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 119.59 22.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.03 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.5 tp -111.12 136.18 50.54 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 12.6 tmtt? -121.86 121.24 36.72 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.095 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.676 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 16.2 p90 -140.49 156.6 46.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.121 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 mp0 -100.75 105.65 17.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.902 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 12.0 t70 175.33 141.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.943 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -80.54 -51.4 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.238 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.0 -38.72 92.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.321 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 12.3 t -60.73 -28.37 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.969 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.676 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.4 p -63.73 -46.72 84.1 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 121.477 0.656 . . . . 0.0 110.027 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.69 -39.11 68.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.127 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.78 -60.41 3.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.173 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.75 83.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 86' ' ' HIS . 65.9 t -60.18 -55.08 26.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.71 -9.59 59.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -87.69 -53.91 4.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.38 -19.73 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 63.3 t30 -60.78 109.29 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.11 0.481 . . . . 0.0 111.33 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.44 33.79 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.919 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -72.87 132.91 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -93.28 123.16 36.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mt -126.57 112.7 30.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.88 23.84 69.58 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.322 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 -16.39 61.16 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.662 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -96.01 139.74 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 133.87 34.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 85.5 mt -74.72 102.77 4.75 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.05 109.14 21.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 7.1 mm -101.74 131.94 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.14 142.21 47.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.613 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.446 ' CD2' HG21 ' A' ' 69' ' ' VAL . 22.9 m-70 -72.42 112.86 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 14' ' ' TYR . 11.6 t -133.25 161.26 34.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.044 0.449 . . . . 0.0 111.036 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -114.23 99.74 7.84 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.459 0.647 . . . . 0.0 109.848 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.517 ' HB3' ' CD2' ' A' ' 12' ' ' TYR . 87.2 t80 -95.3 139.77 31.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.033 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -110.95 116.86 51.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.272 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.05 129.01 32.59 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.695 2.263 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.19 128.99 42.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.179 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -68.75 -21.12 64.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.32 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -76.1 -6.08 49.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.161 0.505 . . . . 0.0 110.365 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.4 mt -122.72 22.22 9.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -62.32 -26.18 68.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.222 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.02 -38.86 80.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.385 0.612 . . . . 0.0 109.972 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.71 -44.24 64.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.144 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.82 -43.02 97.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.693 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -69.04 -46.62 67.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.13 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.628 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.7 t -61.53 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.062 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.79 -41.8 78.36 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.087 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -65.02 -36.79 85.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.085 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.16 -39.95 68.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.685 0.278 . . . . 0.0 110.423 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -57.66 -53.8 54.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.451 -177.885 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.5 t70 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 46' ' ' GLU . 38.2 mt -131.76 140.66 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 -177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 8.2 mmt -121.55 144.2 39.76 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.721 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 13.5 Cg_exo -71.15 170.74 17.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.912 2.408 . . . . 0.0 111.984 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -150.25 109.64 3.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.057 0.456 . . . . 0.0 111.457 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.55 89.3 6.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.951 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.6 t -110.28 142.95 27.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.62 92.31 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.81 1.673 . . . . 0.0 111.482 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.597 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 46.3 m -77.82 -48.07 17.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.704 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.96 27.2 73.38 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.69 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 7.8 mp -72.06 -20.64 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.297 0.549 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -93.2 -7.88 43.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.153 0.501 . . . . 0.0 109.902 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.149 -178.19 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 96.1 m-85 -141.56 148.7 39.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.956 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 pt -115.92 140.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.48 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HB2' ' CG2' ' A' ' 87' ' ' THR . 86.1 t80 -92.87 131.95 37.45 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.48 132.23 59.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.53 -167.53 43.67 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.824 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -39.74 126.28 1.93 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.517 1.127 . . . . 0.0 112.662 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.56 161.63 24.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.043 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.61 153.91 41.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.591 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -67.76 -37.59 82.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.012 0.434 . . . . 0.0 110.259 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -80.03 1.37 27.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.53 109.57 20.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 27' ' ' ILE . 81.3 p -93.35 176.16 6.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.71 -20.59 66.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.251 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.95 67.24 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' B' ' 215' ' ' SER . 0.7 OUTLIER -66.74 -35.47 80.19 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.591 0.234 . . . . 0.0 110.904 178.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 23' ' ' THR . 64.6 mt -58.32 -46.2 89.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.98 -38.13 82.35 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 55.5 m -54.7 -46.84 74.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.397 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 HD13 ' B' ' 218' ' ' LEU . 55.0 t -62.19 -47.22 94.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.281 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -74.31 -9.64 58.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -71.01 -15.32 62.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.781 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -62.98 -33.98 76.55 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.285 0.564 . . . . 0.0 109.948 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.419 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 8.3 m-85 -98.4 -13.78 20.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.962 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 78.25 60.91 2.59 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.362 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 57' ' ' LEU . 61.3 t -111.97 91.65 16.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 14.0 Cg_endo -98.49 31.84 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.503 2.802 . . . . 0.0 110.971 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -94.26 -165.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.581 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 38' ' ' VAL . 64.3 m-20 -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.95 135.97 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.099 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.47 115.5 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.931 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.37 149.13 24.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' SER . 16.8 p -73.02 107.33 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.091 0.472 . . . . 0.0 110.899 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -114.53 129.6 56.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.775 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 17.9 t70 -71.76 139.79 49.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.5 -12.73 60.03 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -102.8 -57.89 1.97 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.44 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.5 t -89.29 -20.1 24.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 74.03 20.31 79.71 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.486 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 48' ' ' THR . 48.9 mt-10 -96.37 170.3 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.861 0.331 . . . . 0.0 111.402 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' SER . 15.1 m -83.29 138.07 33.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.01 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.59 -16.25 35.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.27 23.06 7.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.448 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -156.94 154.35 29.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.18 0.49 . . . . 0.0 109.852 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.44 17.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.237 0.542 . . . . 0.0 112.434 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -134.07 131.94 39.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.526 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 36' ' ' VAL . 16.7 tp -121.66 138.61 54.27 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.804 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 57.6 tttt -120.31 113.97 21.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 33.1 p90 -139.95 148.65 42.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 9.5 tp10 -100.67 105.73 17.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 54.0 t0 174.62 122.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.328 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.34 -12.33 59.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -86.99 -49.48 7.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.091 0.472 . . . . 0.0 110.071 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 t -67.5 -22.65 65.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.062 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.679 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 1.2 p -61.79 -59.1 5.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.872 0.367 . . . . 0.0 111.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.75 -38.06 81.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.963 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 41.3 tp -57.7 -53.89 53.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.267 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.08 84.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 88.3 t -63.41 -60.41 2.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.479 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -63.65 -34.27 77.47 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -69.05 -49.5 56.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.708 0.289 . . . . 0.0 111.021 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 85.9 mt -84.68 -27.68 26.9 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -59.79 108.23 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.03 -5.66 59.54 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.868 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.8 t80 -74.31 130.24 39.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.14 124.32 28.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.568 . . . . 0.0 112.481 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -129.88 105.46 12.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.705 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.97 72.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.602 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.61 59.12 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -111.45 130.31 55.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.583 -0.309 . . . . 0.0 110.524 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -82.28 129.88 34.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.565 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.52 127.63 32.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.335 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 45.4 tptt -110.68 116.46 31.35 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mm -110.13 140.15 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.21 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.13 171.25 16.19 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -101.32 128.95 47.24 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.5 t -153.92 161.8 41.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -114.78 110.41 19.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.931 0.396 . . . . 0.0 111.347 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.0 120.17 30.81 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.321 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -98.79 139.48 21.1 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.131 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.08 138.13 60.54 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.801 2.334 . . . . 0.0 111.887 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -110.31 144.64 38.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.897 0.379 . . . . 0.0 111.694 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -55.3 -31.17 61.42 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.134 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -64.63 -22.1 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.76 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.22 21.32 17.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.108 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -56.9 -38.98 73.57 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.13 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -55.61 -43.17 75.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.853 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 102' ' ' VAL . 49.1 t80 -67.72 -45.82 73.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.506 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.06 -44.39 95.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.138 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.21 -40.88 97.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.76 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -67.96 -41.54 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.311 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 98' ' ' TYR . 72.5 t -64.61 -38.04 81.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.081 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -60.05 -39.19 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.672 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -61.68 -49.79 75.07 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.773 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.58 -40.67 79.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.71 -42.47 91.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 0.0 109.83 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.082 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 67.0 mt -123.41 131.09 73.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 16.9 mmt -114.31 136.0 22.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.86 169.0 15.6 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.934 2.423 . . . . 0.0 111.95 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -142.78 102.56 4.06 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.702 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -96.99 87.39 4.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.896 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.2 m -111.5 119.53 44.85 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.823 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.21 105.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.823 2.348 . . . . 0.0 112.167 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.504 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 3.6 m -96.28 -50.04 4.96 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.559 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.05 33.82 84.8 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.94 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 11.0 mp -66.94 -33.07 74.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 110.43 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -76.89 -14.24 59.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.794 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.197 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.956 0 CA-C-O 121.025 0.441 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.5 m-85 -158.85 136.99 10.59 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.268 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.65 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.158 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -87.08 122.54 31.04 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 26.5 mm -95.29 135.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -168.97 45.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.966 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -40.0 107.83 0.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.152 0.981 . . . . 0.0 113.547 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.55 152.87 23.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.978 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.28 138.52 56.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -63.1 -19.78 64.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 0.0 111.473 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -80.59 -4.1 52.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.147 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.8 mt -83.28 139.23 33.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.914 0.387 . . . . 0.0 110.556 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -110.22 168.62 9.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.655 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.84 -27.53 68.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.44 97.73 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.708 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.63 -47.67 83.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 110.781 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.85 -46.63 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.92 -35.96 82.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.031 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.3 m -56.35 -49.29 74.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' CG2' HD22 ' B' ' 218' ' ' LEU . 95.1 t -65.18 -46.51 90.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.724 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -75.15 -22.97 57.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 m -64.6 -24.58 67.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.818 0.342 . . . . 0.0 110.478 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.08 -20.32 66.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -89.75 -2.31 58.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.603 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.44 34.69 44.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.626 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.0 89.81 37.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 111.778 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -89.06 78.27 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.636 2.224 . . . . 0.0 111.116 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -115.86 -166.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.905 -177.492 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' H ' HG12 ' A' ' 38' ' ' VAL . 4.6 p-10 -85.41 144.88 27.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -171.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.02 133.29 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.2 mp -123.68 107.91 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 43' ' ' SER . 5.0 tt -92.27 134.05 35.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 42' ' ' LEU . 19.5 m -67.92 95.52 0.54 Allowed 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -114.2 145.67 41.39 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.483 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 38.1 m-20 -61.52 150.63 35.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.215 0.531 . . . . 0.0 112.062 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -77.13 -41.88 40.09 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.421 -176.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.65 -59.39 2.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -85.79 -15.86 40.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 66.09 31.52 79.58 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.778 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -92.82 155.21 17.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.611 0.206 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -67.04 111.06 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.93 -20.89 60.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.047 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.71 11.12 20.02 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 120.311 -0.947 . . . . 0.0 115.052 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.25 165.51 24.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.878 0.839 . . . . 0.0 109.082 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.499 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.86 121.65 27.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.731 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.77 142.69 46.19 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.117 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -131.72 117.06 18.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.352 0.596 . . . . 0.0 111.701 179.136 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.72 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.0 p90 -129.7 156.01 44.96 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.34 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -102.15 106.15 16.96 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.731 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.2 t70 176.94 139.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.891 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -80.76 -46.56 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -75.41 -29.59 59.82 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 m -68.59 -23.02 64.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.72 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 67.2 p -61.6 -46.87 87.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.557 0.694 . . . . 0.0 109.645 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.59 -33.38 48.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.966 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 67' ' ' LEU . 7.3 tt -61.78 -52.54 63.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.14 89.44 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 79.9 t -63.3 -44.51 99.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.029 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.2 -48.66 56.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.907 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.51 -49.83 65.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.308 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.2 mt -86.57 -2.12 58.22 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.648 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 48.1 t-20 -67.73 108.96 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.93 6.69 61.78 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.421 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -72.16 121.82 19.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -83.65 117.51 23.23 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.03 113.51 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.244 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.64 76.62 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.94 -2.56 88.19 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.969 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.92 145.58 36.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.09 135.9 33.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 80.8 mt -76.06 133.68 40.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.795 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.39 113.09 15.76 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm -103.59 134.5 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.02 157.6 40.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.13 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -92.49 133.14 36.21 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -159.57 157.41 29.81 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -107.07 143.08 35.73 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -149.98 138.56 20.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.998 0.428 . . . . 0.0 111.316 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -105.72 138.56 19.65 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.9 136.41 48.68 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 122.649 2.233 . . . . 0.0 113.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -77.29 137.87 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -68.81 -26.0 64.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.995 0.426 . . . . 0.0 110.826 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -77.56 -30.01 52.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.086 0.47 . . . . 0.0 110.596 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.56 18.74 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -65.26 -27.1 68.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.279 0.562 . . . . 0.0 110.132 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.87 -21.15 62.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.746 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.9 t80 -64.16 -46.42 84.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -63.65 -38.05 89.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.752 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.89 -48.09 80.51 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.958 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.6 74.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.356 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.8 t -70.64 -41.48 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.831 0.348 . . . . 0.0 110.119 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -55.54 -48.43 74.73 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.986 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.28 -23.74 67.41 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.766 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -24.66 37.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.012 0.435 . . . . 0.0 110.35 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 69.5 mt -80.93 -44.22 18.57 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--O 1.236 0.38 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.819 177.711 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 61.3 mt -103.39 123.04 56.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.502 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.2 mmt -101.99 128.61 28.24 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.875 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.51 146.14 88.79 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -120.39 116.97 26.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.522 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -100.33 86.25 3.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.35 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.8 m -113.57 119.1 42.29 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.307 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.44 103.74 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.214 1.943 . . . . 0.0 111.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' B' ' 217' ' ' LEU . 89.9 p -81.35 -32.51 32.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.88 9.25 86.67 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.527 ' HB2' ' OG ' ' B' ' 215' ' ' SER . 0.3 OUTLIER -56.86 -51.58 68.47 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.728 0.811 . . . . 0.0 111.307 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 30' ' ' VAL . 3.9 pp -84.19 -17.25 40.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.578 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.634 -176.825 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.84 0.352 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -160.63 136.27 8.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.229 1.012 . . . . 0.0 109.142 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 pt -120.01 137.14 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 121.028 0.442 . . . . 0.0 110.848 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -89.4 131.5 35.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.537 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.4 mt -113.84 144.84 20.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.21 -169.16 45.5 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.285 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -65.36 112.37 3.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.788 0.328 . . . . 0.0 110.695 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 74.0 mt -93.95 177.17 6.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 0.0 111.732 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.427 ' H ' HD12 ' A' ' 22' ' ' LEU . 43.9 t-20 -69.13 138.11 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.018 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.75 -20.33 61.08 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.18 2.63 53.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.7 mt -86.67 109.61 19.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -97.41 177.7 5.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.109 0.481 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.44 -27.53 69.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.34 -42.98 89.45 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.428 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.4 m-20 -63.61 -47.24 82.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.23 -47.04 88.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.778 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.23 -41.8 98.74 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 m -60.33 -48.89 79.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.404 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' ASP . 74.9 t -54.7 -47.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.436 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.72 -22.63 37.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -64.76 -26.73 68.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.403 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.66 -16.05 63.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.467 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.87 -4.49 59.18 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.1 0.476 . . . . 0.0 110.249 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.37 17.04 78.74 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.377 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.88 90.18 51.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.716 0.293 . . . . 0.0 110.24 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.89 105.51 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.019 2.479 . . . . 0.0 112.094 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.2 t -132.48 -166.57 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.564 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.9 t70 -70.84 140.21 51.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.07 136.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.35 100.84 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.618 0.246 . . . . 0.0 111.629 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -85.94 112.98 21.69 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.8 t -65.83 118.59 9.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.4 0.619 . . . . 0.0 111.837 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -133.95 155.79 49.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.604 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 48' ' ' THR . 32.3 t70 -73.11 135.41 44.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.873 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' B' ' 208' ' ' ILE . 38.1 mt-10 -69.94 -18.72 63.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -96.36 -61.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.672 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.0 t -84.36 -33.25 23.87 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.65 60.99 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.827 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' H ' HG23 ' A' ' 48' ' ' THR . 12.9 pt-20 -71.21 155.34 40.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.099 0.449 . . . . 0.0 110.367 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 m -68.15 138.69 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.89 -8.89 59.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.099 0.476 . . . . 0.0 111.074 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.43 30.41 7.73 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.329 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -170.61 170.8 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.68 170.82 19.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.72 155.96 49.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.175 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.77 140.26 34.75 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.66 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 49.9 tttp -123.13 115.34 21.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.909 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 8.2 p90 -132.91 143.2 49.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -102.89 107.57 18.45 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.521 -0.871 . . . . 0.0 113.194 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 65' ' ' THR . 29.2 t70 178.61 143.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.883 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.98 -35.01 38.14 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -83.06 -35.52 25.65 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.093 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.8 t -57.6 -29.9 64.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.413 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.605 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 75.4 p -59.43 -52.76 64.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.478 0.656 . . . . 0.0 109.423 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.5 -46.07 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.953 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 tp -50.06 -58.58 5.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.936 0.773 . . . . 0.0 111.562 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.628 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 97.3 t -66.99 -57.85 8.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.527 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.22 -18.04 64.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.561 -0.456 . . . . 0.0 112.15 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -90.5 -55.8 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.989 0.423 . . . . 0.0 111.308 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 92.1 mt -91.34 -17.38 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.79 109.05 2.74 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.436 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.13 2.62 64.12 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.105 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 61.0 t80 -76.87 143.39 39.69 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 1.8 tppp? -94.61 114.23 26.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.901 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 82' ' ' LEU . 16.4 mt -129.6 117.65 42.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.26 35.18 76.45 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.324 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.67 22.26 75.19 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.758 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 24.9 mtp180 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 122.635 -0.332 . . . . 0.0 110.694 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -98.76 135.79 39.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.933 0.397 . . . . 0.0 111.46 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.527 HD11 HD12 ' A' ' 77' ' ' ILE . 41.2 mt -85.54 122.27 29.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.617 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.0 107.45 19.4 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -108.25 124.36 64.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.966 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -136.26 149.99 48.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -77.64 124.39 27.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 t -149.39 162.01 40.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.613 0.244 . . . . 0.0 110.966 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -114.96 108.86 17.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.22 139.8 50.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.297 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -107.47 132.27 21.1 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.74 133.73 46.67 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.969 2.446 . . . . 0.0 112.583 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -76.78 131.98 38.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -70.65 -20.92 62.67 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 p -74.58 -14.46 60.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.786 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.416 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 94.9 mt -113.72 25.12 11.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.855 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -56.79 -35.03 68.24 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 63.3 mmtt -55.76 -46.07 77.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.128 0.49 . . . . 0.0 110.638 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.39 -53.78 50.01 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.066 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 95' ' ' LEU . 77.2 m-85 -59.09 -44.69 91.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -68.52 -32.88 73.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.458 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -67.22 -46.71 73.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.18 -39.79 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.16 0.505 . . . . 0.0 109.946 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -57.02 -54.23 49.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.673 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.24 -28.19 67.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 24.1 mm-40 -64.8 -51.95 59.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.0 110.854 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 -27.01 56.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 177.748 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.971 0.415 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 46' ' ' GLU . 63.9 mt -134.85 100.1 2.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.354 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 80.0 mmm -103.87 136.11 19.25 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.4 156.08 62.46 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.921 2.414 . . . . 0.0 113.24 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.85 117.56 7.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -87.47 89.63 8.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.19 0.519 . . . . 0.0 111.142 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 1.0 OUTLIER -91.49 143.24 27.82 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.009 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 214' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 28.4 Cg_endo -96.15 84.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 18.7 t -71.97 -47.04 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.22 63.58 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.828 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.409 HD12 ' HG ' ' A' ' 22' ' ' LEU . 91.4 mt -60.31 -33.21 72.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.502 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -66.42 -35.09 79.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.266 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.346 0.593 . . . . 0.0 110.703 -177.782 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.272 0.558 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 8.8 m-85 -125.38 154.49 41.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.397 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.58 139.09 52.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.737 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -99.08 123.37 43.33 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.31 141.65 18.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.32 -168.82 45.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.64 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 t30 -48.47 110.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.51 0.724 . . . . 0.0 112.743 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.94 177.62 5.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.24 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' HD13 ' A' ' 22' ' ' LEU . 37.5 t-20 -80.66 142.82 33.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -57.19 -26.39 60.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.585 0.354 . . . . 0.0 111.64 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.99 -10.69 59.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.957 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HD13 ' B' ' 217' ' ' LEU . 6.3 mp -87.28 110.07 19.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.071 0.463 . . . . 0.0 111.018 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.5 p -94.08 172.67 8.08 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.633 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -63.9 -22.59 66.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.289 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.98 -41.03 95.5 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.973 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 29' ' ' THR . 28.8 t70 -75.36 -36.84 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.985 0.421 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.23 -41.04 85.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.633 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.34 -38.94 92.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.303 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 17.4 m -58.02 -45.05 87.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.457 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 26' ' ' ASP . 88.9 t -56.83 -50.14 76.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.29 -16.81 58.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.6 m -72.46 -13.75 61.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.49 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -83.63 -11.03 57.81 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.83 72.94 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.909 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.15 89.63 48.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.58 95.82 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.86 2.373 . . . . 0.0 110.513 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -118.86 -166.7 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.229 -177.548 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.496 ' H ' HG12 ' A' ' 38' ' ' VAL . 25.0 m-20 -68.13 114.7 6.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.961 0.41 . . . . 0.0 111.997 -172.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.68 127.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.704 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.09 113.19 39.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.488 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' PHE . 59.9 tp -87.26 133.61 33.65 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.497 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 38.6 m -68.73 102.84 1.6 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -123.55 154.57 39.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.968 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 47' ' ' ASN . 5.6 p-10 -84.77 152.09 23.93 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.323 0.582 . . . . 0.0 111.354 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.13 -9.88 59.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.413 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.433 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 16.4 m120 -83.06 -67.33 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.574 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 t -104.42 -30.55 10.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.56 46.62 4.26 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.62 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.63 164.5 11.71 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.778 0.289 . . . . 0.0 110.693 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -79.55 106.18 11.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.856 0.36 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.3 -33.68 75.79 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.16 31.91 2.95 Favored Glycine 0 C--O 1.218 -0.892 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.997 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.498 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.2 m-85 -135.37 157.32 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.98 29.99 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.997 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -121.07 119.11 31.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.51 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 27.8 tp -115.54 139.77 49.77 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.092 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 1.7 tmtp? -124.14 112.68 17.38 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.183 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.774 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -129.71 150.73 50.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.72 105.34 16.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.203 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 176.2 143.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.425 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -80.76 -48.98 11.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 64' ' ' SER . 2.6 ptp180 -67.16 -33.71 76.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 63' ' ' ARG . 46.9 m -63.65 -27.45 69.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.086 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.774 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 68.9 p -63.29 -48.43 78.13 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.693 0.759 . . . . 0.0 110.08 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.68 -38.64 45.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.29 -52.6 64.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.12 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -43.09 76.85 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.362 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 65' ' ' THR . 90.9 t -61.87 -59.82 3.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.297 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.38 -22.16 66.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.28 -45.67 15.89 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.76 0.314 . . . . 0.0 111.146 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -97.83 -20.41 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.84 110.13 1.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.77 -0.88 56.6 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.495 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -77.58 123.79 27.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -88.99 117.51 28.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.172 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.442 HD13 ' CD2' ' B' ' 218' ' ' LEU . 57.2 mt -121.57 115.77 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.064 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.22 35.28 69.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.716 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.31 13.55 78.51 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.097 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -128.8 130.7 47.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.912 0.356 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.88 133.02 33.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 89.5 mt -79.11 128.04 32.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.596 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -123.93 118.18 26.47 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -107.92 126.43 64.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -123.25 142.87 50.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.975 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -84.79 106.75 16.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.769 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 136.52 21.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.852 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -80.67 156.84 26.14 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.39 137.86 32.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.604 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 80.3 mtp180 -94.5 120.57 64.89 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.731 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 30.0 Cg_exo -62.66 110.57 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.531 2.154 . . . . 0.0 111.481 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.55 140.19 44.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -70.09 -31.05 68.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.416 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 p -79.87 -11.42 59.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 48.9 tp -105.16 8.22 34.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -62.09 -20.1 63.66 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -59.15 -41.62 88.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.631 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 3.5 t80 -69.37 -45.62 68.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -58.08 -50.09 74.67 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.568 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -61.65 -46.34 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.333 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.9 86.42 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.427 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.6 t -74.25 -39.83 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.221 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.76 -45.02 94.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.62 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.83 -29.94 71.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 111.054 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.97 -37.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 70.8 mt -68.82 -39.62 79.94 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.221 -0.405 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.792 179.504 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 68.6 mt -128.51 110.09 20.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.071 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.7 mmt -84.19 118.63 71.72 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.916 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.48 164.98 10.15 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.112 2.542 . . . . 0.0 112.608 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -122.25 94.86 4.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.752 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -84.22 88.62 7.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.321 0.581 . . . . 0.0 110.118 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 23.8 m -109.84 157.08 38.69 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.733 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.39 59.98 2.56 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.911 2.407 . . . . 0.0 112.183 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 215' ' ' SER . . . . . 0.597 ' O ' HD12 ' B' ' 217' ' ' LEU . 73.6 m -78.68 33.24 0.21 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.241 0.616 . . . . 0.0 111.456 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.94 58.84 0.37 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.56 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.597 HD12 ' O ' ' B' ' 215' ' ' SER . 5.0 mp -64.85 -27.86 69.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.0 pp -100.73 -7.63 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.753 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -178.812 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.909 0.385 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 7.0 m-85 -154.23 136.63 14.98 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.209 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 pt -108.42 137.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.899 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 89.4 t80 -94.6 134.76 36.82 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.059 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.56 138.53 45.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.39 -167.62 43.44 Favored Glycine 0 C--N 1.32 -0.312 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.344 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.508 ' OD1' ' HD2' ' A' ' 80' ' ' ARG . 6.3 p30 -48.19 139.42 8.44 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.302 0.572 . . . . 0.0 112.0 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.46 -176.99 3.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.071 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.36 147.67 22.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HD3' ' OE1' ' A' ' 50' ' ' GLU . 75.8 mtt180 -70.89 -15.75 62.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.91 1.61 56.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.407 . . . . 0.0 110.116 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD23 HD12 ' B' ' 217' ' ' LEU . 1.8 tm? -97.77 118.48 34.43 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.6 p -109.95 176.61 5.0 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 111.983 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.5 mp0 -58.16 -31.77 67.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.913 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.69 98.86 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.049 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.96 -45.02 64.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.4 mt -55.72 -46.46 79.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.724 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -41.32 96.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.836 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -56.82 -46.55 81.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.649 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.429 HG22 HD13 ' B' ' 218' ' ' LEU . 53.0 t -57.56 -49.44 80.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.466 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.37 -15.91 58.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -68.41 -15.68 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.07 -33.66 73.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.357 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.26 -0.27 56.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.731 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.22 56.78 23.32 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.559 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 38' ' ' VAL . 8.0 p -151.23 89.7 4.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-O 121.694 0.759 . . . . 0.0 111.381 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.39 100.08 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 112.156 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -131.56 -165.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.555 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.679 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.8 t70 -66.95 131.51 46.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.83 131.47 42.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.551 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.41 108.98 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 tp -94.5 126.93 40.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -77.83 95.43 4.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.435 0.636 . . . . 0.0 111.039 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -104.73 141.56 36.25 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.577 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.97 144.64 11.45 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.173 0.589 . . . . 0.0 111.92 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HA ' HD11 ' B' ' 208' ' ' ILE . 13.5 mp0 -72.75 -26.82 61.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.072 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -74.69 -66.2 0.77 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -115.24 -24.7 8.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.409 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.85 28.14 4.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.623 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 20' ' ' ARG . 18.0 mm-40 -69.6 139.15 53.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.018 0.409 . . . . 0.0 110.519 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 m -56.93 116.65 3.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -74.01 -14.49 61.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.694 0.283 . . . . 0.0 111.673 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 31.41 6.21 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.496 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.53 154.72 4.71 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.647 0.26 . . . . 0.0 110.69 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.55 165.51 34.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -133.83 138.25 45.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.865 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.81 137.17 48.02 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.471 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.659 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.8 ttmt -123.88 121.61 35.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.688 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.4 p90 -136.41 160.98 37.09 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -101.13 104.2 15.29 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 173.99 140.23 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.279 1.432 . . . . 0.0 108.146 172.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -80.21 -46.11 16.86 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -71.22 -35.52 71.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.695 0.283 . . . . 0.0 111.24 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 t -59.02 -26.84 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.49 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.688 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 38.0 p -63.45 -38.52 91.45 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.463 0.649 . . . . 0.0 109.427 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.4 mt -77.3 -33.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.66 -55.44 32.09 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.93 87.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.461 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 65' ' ' THR . 74.7 t -59.54 -54.29 36.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 120.849 0.357 . . . . 0.0 111.308 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -70.2 -31.95 69.64 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.01 -41.23 14.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.497 ' HB2' HG13 ' A' ' 84' ' ' ILE . 3.0 mm? -89.21 -22.92 22.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 39.2 t30 -56.83 112.83 1.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.828 0.347 . . . . 0.0 111.526 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.89 -7.88 55.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.215 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -66.84 130.27 42.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.994 0.397 . . . . 0.0 110.074 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 31.4 mmmt -86.64 119.32 26.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.21 118.17 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.573 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.62 36.17 92.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.947 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.98 51.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.935 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 17' ' ' ASN . 9.5 mmt180 -105.54 156.02 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.633 -0.334 . . . . 0.0 110.726 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.56 128.6 52.58 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 78.6 mt -63.48 106.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.29 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -89.11 105.66 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 72' ' ' LEU . 17.1 mm -114.7 137.93 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.77 -179.3 7.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -90.46 149.51 22.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -159.89 161.26 34.31 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -108.07 119.95 40.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -131.89 141.33 49.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.05 0.452 . . . . 0.0 111.372 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 3.4 mmp_? -117.23 114.48 38.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.5 135.12 54.48 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.915 2.41 . . . . 0.0 111.955 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.447 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 45.8 mmtm -93.52 128.81 39.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.589 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -71.76 -15.76 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.089 0.471 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -72.83 -25.23 61.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.382 0.611 . . . . 0.0 109.677 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.8 mt -102.78 27.98 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -55.4 -33.45 63.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.207 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 28.5 mmtp -59.12 -49.73 76.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 102' ' ' VAL . 12.2 t80 -59.88 -45.91 90.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.582 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 22.9 m-85 -64.0 -46.91 82.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -62.58 -37.52 86.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.598 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.44 85.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 110.477 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 73.7 t -71.87 -40.24 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.196 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -56.8 -48.36 78.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.193 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.71 -27.03 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 111.03 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.473 ' HG2' ' CD1' ' B' ' 212' ' ' PHE . 7.6 tp10 -68.15 -42.24 80.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 84.4 mt -69.24 -34.43 74.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.537 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.001 179.97 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 207' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 13.2 t70 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 46' ' ' GLU . 44.6 mt -123.6 135.27 63.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.987 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.58 135.69 23.77 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.852 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' PRO . . . . . 0.404 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.4 Cg_endo -74.17 152.43 45.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.731 2.287 . . . . 0.0 112.729 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -125.88 103.77 7.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' PHE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 49.8 m-85 -90.21 86.47 6.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.304 0.574 . . . . 0.0 110.09 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 16.8 p -111.85 134.98 21.22 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.576 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 214' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 7.6 Cg_exo -73.27 92.5 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.969 1.779 . . . . 0.0 111.089 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 5.1 m -77.9 -39.94 41.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.51 25.03 61.69 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.427 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 22' ' ' LEU . 17.9 mt -60.79 -32.11 71.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.175 0.488 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.541 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -75.62 -38.58 58.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -177.919 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 120.776 0.322 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 58' ' ' LYS . 36.3 m-85 -149.79 132.49 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.97 0.908 . . . . 0.0 108.715 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.86 128.63 69.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.347 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -91.19 130.98 37.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.286 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 52.0 mt -112.45 143.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.88 -177.15 50.15 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.39 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.6 t-20 -54.64 105.9 0.18 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.897 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.71 -173.07 3.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.519 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -79.2 144.37 34.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -70.41 -22.7 62.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.054 0.454 . . . . 0.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.98 2.47 30.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.45 130.77 38.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 p -109.17 170.49 8.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.294 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.2 -28.75 68.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.146 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.16 99.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.537 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -66.47 -48.13 70.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.12 -45.62 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.073 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.45 -36.93 85.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.062 0.458 . . . . 0.0 110.065 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -60.67 -44.35 96.58 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.81 -47.33 93.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.764 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -75.81 -9.71 58.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.734 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.4 t -70.72 -17.16 62.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -73.51 -21.91 60.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -99.14 -20.45 16.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 83.87 50.47 4.39 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.547 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.52 94.64 28.56 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.597 0.237 . . . . 0.0 111.263 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 26.2 Cg_endo -98.65 30.02 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.416 2.744 . . . . 0.0 111.445 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -92.0 -166.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.519 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -63.58 139.68 58.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -135.8 120.1 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.566 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.86 136.76 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.013 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' PHE . 60.0 tp -128.03 134.15 49.19 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.9 p -65.32 99.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' B' ' 208' ' ' ILE . 22.4 tpp180 -113.63 124.28 51.95 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 48' ' ' THR . 23.5 t70 -71.55 136.79 47.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 110.79 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' HD11 ' B' ' 208' ' ' ILE . 12.8 mt-10 -72.13 -26.67 62.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.15 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.418 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 26.0 m-80 -81.59 -65.59 0.99 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.157 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.56 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.1 t -87.47 -21.22 25.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.619 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 80.83 19.51 67.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.756 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' H ' HG23 ' A' ' 48' ' ' THR . 40.0 mt-10 -101.14 163.43 12.28 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.556 0.217 . . . . 0.0 111.108 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -78.4 141.42 38.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -89.04 -6.84 56.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.74 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 100.59 -7.1 57.68 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.277 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -107.95 148.22 29.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 118.027 0.913 . . . . 0.0 110.574 -177.071 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -135.22 150.5 50.11 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.75 119.38 17.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 tp -106.62 140.76 38.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.551 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 12' ' ' TYR . 7.8 tmtm? -129.42 108.84 10.59 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.755 0.788 . . . . 0.0 112.032 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 4.7 p90 -119.7 156.24 30.87 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.01 105.81 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.562 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 178.22 145.66 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.161 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.01 -45.6 16.33 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.09 -32.96 50.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -55.64 -30.53 61.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.384 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.723 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.1 p -61.39 -52.36 64.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.501 0.667 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.1 mt -63.53 -36.97 78.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.667 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 tt -62.08 -58.68 6.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.221 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.88 86.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.048 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 65.6 t -61.14 -46.57 96.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -78.23 -40.12 38.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -66.94 -50.43 62.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.484 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.64 -4.86 57.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 25.9 t-20 -63.54 109.41 1.64 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.496 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 -2.83 65.33 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.163 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.9 127.15 30.88 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -88.14 115.0 25.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.262 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.6 mt -120.63 109.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.64 25.49 75.63 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 -16.01 59.55 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.461 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -97.11 132.7 42.64 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.837 0.351 . . . . 0.0 111.208 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.83 135.68 35.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.239 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.72 133.22 45.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.423 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 12.7 mptt -107.52 116.78 32.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.405 HG22 HG22 ' A' ' 69' ' ' VAL . 3.4 mm -117.31 138.6 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.53 166.73 30.25 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -88.56 140.14 29.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 15.2 t -153.72 161.55 42.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.661 0.267 . . . . 0.0 110.855 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -116.36 104.69 11.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -115.92 150.04 37.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -125.42 135.57 27.09 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.114 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.87 122.4 10.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.923 2.416 . . . . 0.0 112.214 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -69.21 135.24 50.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.697 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -60.88 3.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -74.14 -22.3 59.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.03 0.443 . . . . 0.0 112.087 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.87 6.06 45.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.333 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.92 -22.36 62.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.553 0.216 . . . . 0.0 111.419 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -58.99 -39.55 82.14 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.652 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.96 -35.96 79.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -66.66 -50.07 64.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.1 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 44.9 mt-10 -65.32 -42.95 92.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.04 -47.49 80.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.547 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.414 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.8 p -71.89 -33.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.571 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -65.81 -39.21 90.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 18.7 mm-40 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.894 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.86 -48.18 77.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 102' ' ' VAL . 11.0 mp -63.12 -45.17 93.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.134 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.082 179.243 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.042 0.449 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 208' ' ' ILE . . . . . 0.488 HG21 ' HG2' ' A' ' 44' ' ' ARG . 62.5 mt -138.46 123.41 22.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.4 mmt -100.84 149.97 36.63 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.172 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.88 163.29 37.38 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.678 2.252 . . . . 0.0 111.714 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -130.17 126.32 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.275 0.559 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -111.2 90.7 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.494 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 72.3 m -110.42 147.58 36.65 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.99 52.54 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.708 2.272 . . . . 0.0 111.257 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.1 m -54.29 -50.15 67.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.938 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.73 47.7 59.93 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.882 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.76 -15.22 59.27 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.405 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' LEU . . . . . 0.518 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.56 -15.82 55.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.909 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.227 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.27 120.78 37.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.413 ' HB2' ' OD1' ' A' ' 5' ' ' ASN . 83.0 mtp -102.43 -6.82 22.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.113 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.73 40.22 6.37 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 3' ' ' MET . 2.1 m-20 -64.12 -23.53 67.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.721 0.408 . . . . 0.0 111.498 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.07 -12.23 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.469 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -99.44 109.84 22.38 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.591 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.84 86.09 1.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.623 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' ALA . 2.9 p-10 -86.01 -22.6 27.21 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 89' ' ' TYR . 5.7 p30 -76.71 21.11 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.765 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . -87.2 142.54 27.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.873 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 4.6 p90 -157.97 -179.59 8.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.219 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -102.65 144.27 13.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 40.4 t80 -101.97 124.96 48.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.525 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 mp -102.38 139.25 23.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.06 -169.78 46.29 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.124 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HB2' ' NH2' ' A' ' 80' ' ' ARG . 11.6 m120 -45.51 112.23 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.63 0.772 . . . . 0.0 112.553 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.4 mt -104.42 168.9 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.201 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.17 140.31 58.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -64.55 -17.24 63.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.896 0.379 . . . . 0.0 110.561 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' B' ' 217' ' ' LEU . 63.9 mm-40 -82.68 -11.6 58.23 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.93 128.27 34.55 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.8 p -110.43 176.56 5.0 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.489 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.8 mp0 -57.42 -30.33 64.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.634 0.373 . . . . 0.0 111.137 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.64 94.96 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.644 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -67.83 -42.39 81.52 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.088 0.471 . . . . 0.0 109.866 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.08 -47.84 88.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.787 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.46 -32.57 74.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 109.874 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -63.71 -41.27 98.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.0 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.65 -46.81 93.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.031 0.443 . . . . 0.0 110.456 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CG ' HD22 ' A' ' 57' ' ' LEU . 60.4 m-85 -73.81 -13.07 60.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.08 -16.48 63.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.395 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.46 -39.56 84.06 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.916 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -85.29 -16.02 41.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.669 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 27.44 73.47 Favored Glycine 0 N--CA 1.454 -0.155 0 CA-C-N 115.877 -0.602 . . . . 0.0 113.327 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.08 97.36 42.15 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.13 101.74 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.079 2.519 . . . . 0.0 112.564 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -137.13 -166.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.4 m-20 -60.2 140.9 56.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.2 p -138.9 128.95 32.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.52 118.62 52.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.784 0.326 . . . . 0.0 111.065 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -109.11 128.69 55.21 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 23.9 m -70.03 108.24 3.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.972 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -126.71 143.3 51.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.693 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 16.2 t70 -53.7 138.47 35.05 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.763 0.665 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' B' ' 208' ' ' ILE . 2.4 mp0 -69.54 -13.93 62.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -110.25 -55.72 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.059 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.517 HG23 ' HG2' ' A' ' 50' ' ' GLU . 3.6 t -101.55 -5.34 25.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.02 18.71 76.6 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.892 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.5 mm-40 -56.28 134.18 53.17 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.916 0.358 . . . . 0.0 111.283 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.0 m -66.2 107.98 2.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -71.33 -19.17 62.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.661 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.88 -0.12 51.95 Favored Glycine 0 C--O 1.221 -0.67 0 C-N-CA 120.747 -0.74 . . . . 0.0 114.452 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 4.0 m-85 -108.99 129.83 55.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.551 0.675 . . . . 0.0 109.592 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -125.83 149.73 48.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.025 0.441 . . . . 0.0 111.365 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 20.3 m-85 -137.9 148.8 45.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.281 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.2 tp -140.66 115.23 9.47 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.531 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 12' ' ' TYR . 1.5 tmtp? -100.25 114.11 27.3 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.265 0.555 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 42.7 p90 -132.06 143.73 50.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.165 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -101.06 106.81 18.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.24 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 65' ' ' THR . 21.0 t70 175.27 109.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.599 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -64.07 -47.18 81.15 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.339 0.59 . . . . 0.0 110.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 m -67.37 -25.42 65.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.534 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.2 p -62.77 -61.2 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.12 -34.98 62.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.59 -61.01 2.83 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.131 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.84 91.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 73.7 t -58.95 -51.59 70.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 120.586 0.231 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.58 -36.77 68.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.828 0.347 . . . . 0.0 111.334 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.56 -43.83 72.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.88 -18.17 31.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 32.9 t-20 -65.06 109.49 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.069 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.9 -2.44 52.04 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -81.13 132.08 35.34 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -88.86 132.26 34.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.146 0.498 . . . . 0.0 112.214 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.1 mm -129.22 101.76 6.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.79 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.43 23.59 77.87 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.458 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 -15.78 60.5 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.043 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.412 ' NH2' ' HB2' ' A' ' 17' ' ' ASN . 30.3 mmm180 -94.86 110.2 22.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.616 0.246 . . . . 0.0 111.596 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 83' ' ' LYS . . . -68.41 127.69 33.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.23 117.88 16.54 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.635 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 81' ' ' ALA . 10.8 mptt -100.84 110.75 22.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 20.5 mm -103.16 121.65 54.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.727 0.298 . . . . 0.0 111.423 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -116.53 166.6 11.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.858 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -96.35 136.43 36.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.3 t -161.24 160.8 30.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.758 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.53 138.99 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.911 0.386 . . . . 0.0 110.175 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 15.6 t80 -149.88 135.24 18.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -96.28 112.32 59.42 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.249 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.54 115.35 2.99 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.564 ' HD3' ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -73.91 144.84 45.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.916 0.388 . . . . 0.0 110.376 178.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -72.94 -13.42 61.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.371 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -68.52 -17.08 64.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.112 0.482 . . . . 0.0 110.063 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 tp -123.01 24.83 8.8 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -58.7 -32.49 69.22 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.172 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.42 -32.63 71.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.531 0.205 . . . . 0.0 111.513 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.55 -55.69 16.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -64.49 -34.5 78.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.73 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 34.0 tt0 -65.6 -41.52 92.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.136 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.61 -30.24 70.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 110.019 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG11 ' H ' ' A' ' 40' ' ' VAL . 86.2 t -68.23 -48.48 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -70.84 -12.74 61.72 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 25.5 mm-40 -61.26 -35.13 76.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -83.23 -26.16 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.508 ' O ' HG12 ' A' ' 110' ' ' ILE . 25.3 mt -85.58 -14.99 44.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.696 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.36 -29.31 63.91 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.29 -26.46 64.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.58 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.48 -37.55 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.394 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 106' ' ' LEU . 47.4 mm -62.69 -22.95 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.43 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.06 -33.62 29.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.833 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.6 t -75.79 102.45 5.47 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.439 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -95.68 153.94 17.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.487 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -66.21 153.31 42.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.048 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 67.62 103.23 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.71 105.5 11.06 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.928 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 45.37 -154.32 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.16 0.984 . . . . 0.0 112.789 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HD2' ' H ' ' A' ' 118' ' ' LYS . 10.6 mptt . . . . . 0 C--O 1.244 0.807 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.262 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 36.8 p -59.75 -37.62 79.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -104.61 11.51 34.11 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.367 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 16.3 t -110.29 -1.22 17.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.169 0.509 . . . . 0.0 110.172 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -104.2 4.5 34.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.91 151.83 21.54 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.37 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.0 101.58 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 121.023 0.44 . . . . 0.0 110.048 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -147.55 119.0 7.89 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.434 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 46' ' ' GLU . 24.4 mt -134.55 117.22 23.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.482 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.1 mmt -114.54 117.95 42.02 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.411 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.2 Cg_exo -50.35 133.65 37.05 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.191 2.594 . . . . 0.0 112.512 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -123.27 108.24 12.56 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.699 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -88.96 88.86 7.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 61.7 m -112.55 155.17 44.22 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.753 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -100.87 112.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.747 2.298 . . . . 0.0 112.044 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.3 p -78.89 -43.41 24.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 109.822 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.18 72.86 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.211 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 21' ' ' GLU . 42.4 mt -58.29 -36.39 73.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.13 -9.59 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.081 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -68.37 -33.63 74.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.29 0.567 . . . . 0.0 110.558 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.04 0.68 17.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.69 12.23 3.17 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.279 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.257 -179.441 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.48 24.06 10.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.945 0.402 . . . . 0.0 111.167 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.86 -24.46 67.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.6 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.05 72.51 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.818 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -92.42 -6.69 49.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.384 0.592 . . . . 0.0 111.152 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.92 -53.87 3.15 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.83 162.08 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -82.39 93.02 7.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.261 0.553 . . . . 0.0 109.813 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.19 -22.31 42.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.664 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -87.16 16.65 4.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.123 0.487 . . . . 0.0 110.186 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 99.5 4.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.742 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 33.4 m-85 -134.74 166.69 22.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 pt -141.92 138.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -85.47 116.81 24.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.477 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.48 130.92 35.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . -86.42 -168.27 44.6 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.25 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 12.4 t30 -39.69 101.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.944 0.898 . . . . 0.0 112.964 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 16' ' ' GLY . 77.3 mt -97.94 -173.8 2.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.345 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.08 139.58 35.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 20' ' ' ARG . 5.7 ptp180 -64.89 -17.39 64.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.654 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.69 -6.38 58.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 0.0 110.517 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.2 tp -90.59 110.7 21.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.1 p -98.27 172.95 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -57.99 -32.18 67.64 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.986 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.16 98.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' O ' ' HB ' ' A' ' 29' ' ' THR . 6.2 t70 -74.83 -38.83 61.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 72.0 mt -58.32 -45.05 89.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.413 0.625 . . . . 0.0 109.581 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 106' ' ' LEU . 83.2 mt -69.06 -26.63 65.06 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.339 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.3 m -57.97 -54.06 51.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.03 -31.19 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 67.8 m-85 -79.26 -20.61 47.7 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.171 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.2 t -70.89 -17.69 62.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 109.892 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.13 -22.13 65.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.701 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.59 2.55 52.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.0 81.38 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.779 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.41 HG12 HG22 ' A' ' 38' ' ' VAL . 32.1 t -127.03 98.72 29.86 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 117.254 0.527 . . . . 0.0 111.687 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.14 120.08 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.936 2.424 . . . . 0.0 110.68 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -124.44 -167.4 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.788 -177.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.77 136.18 39.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 111.802 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.33 134.86 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 41' ' ' ILE . 4.1 mp -124.84 108.61 20.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.0 tp -88.13 139.4 30.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -83.68 109.55 17.55 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.564 ' NE ' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -121.79 145.5 47.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.294 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.11 131.48 50.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.088 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 29.3 mt-10 -75.08 -15.8 60.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.61 -61.39 1.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.1 t -108.06 -22.15 12.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.39 21.58 12.84 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.712 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -71.87 161.37 31.05 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 120.684 0.278 . . . . 0.0 111.162 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 t -81.22 130.97 35.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -80.07 -9.11 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 97.41 13.82 43.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.708 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -158.33 165.48 34.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.169 0.485 . . . . 0.0 110.732 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.73 14.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.983 0.42 . . . . 0.0 111.627 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.81 124.91 27.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.14 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 11.0 tp -110.32 136.52 49.38 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.55 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -114.62 120.38 39.96 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.634 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -140.99 -166.82 2.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.809 -176.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.69 179.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 14.9 m-20 -61.42 -174.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.868 -1.06 . . . . 0.0 113.421 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -49.8 -39.79 39.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.601 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -51.29 -52.79 41.97 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 m -70.81 -30.84 67.4 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.383 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.634 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 32.8 p -61.1 -47.48 86.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 110.757 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.76 -37.53 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.867 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.85 -57.76 10.58 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.147 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.69 82.22 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' THR . 60.4 t -56.47 -52.43 52.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.226 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.47 -37.57 88.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -77.27 -49.22 15.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.47 -29.97 57.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -66.59 110.27 3.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 0.0 109.967 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.76 -19.99 25.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.093 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -74.99 139.02 42.65 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 37.0 ttpt -109.86 135.74 50.27 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.924 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.22 119.29 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' B' ' 221' ' ' GLU . . . 62.64 30.38 76.55 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.626 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.75 1.44 68.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.494 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.572 ' C ' ' HG3' ' A' ' 76' ' ' LYS . 81.6 mtt180 -129.06 119.55 24.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.347 0.574 . . . . 0.0 111.494 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -68.96 137.27 53.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.637 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.93 125.79 30.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.067 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -108.11 105.34 15.04 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -99.21 109.81 25.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.034 0.445 . . . . 0.0 111.11 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -104.61 112.74 25.94 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.1 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.4 124.17 22.01 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.856 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -159.37 136.66 9.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -74.52 155.99 37.36 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HB3' ' CG ' ' A' ' 12' ' ' TYR . 82.9 t80 -150.75 149.89 30.33 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -108.49 121.14 44.32 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.06 129.89 37.75 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.072 2.514 . . . . 0.0 112.442 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.42 128.69 39.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -80.22 -10.18 59.75 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.8 m -76.88 -22.74 53.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.205 0.526 . . . . 0.0 109.886 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 tp -110.9 26.67 10.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.79 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -57.64 -31.32 66.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.956 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -58.66 -38.13 77.5 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.584 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -64.64 -43.89 92.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.6 -47.71 80.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.977 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -59.06 -43.68 91.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.25 86.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.28 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.89 -45.7 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -60.37 -50.39 73.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.499 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.53 -38.64 91.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.69 -51.55 68.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.513 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 28' ' ' LEU . 80.0 mt -67.33 -30.02 69.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.713 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.39 -34.34 77.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.104 0.478 . . . . 0.0 110.313 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -67.88 -38.16 82.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.531 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.22 -26.87 67.58 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.07 -35.41 58.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.255 0.55 . . . . 0.0 110.14 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.18 -42.22 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.034 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.4 t -68.31 109.56 3.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -73.22 89.67 1.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.637 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -61.59 -35.25 77.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.831 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.96 -15.9 60.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.257 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.66 -68.33 0.18 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.453 0.701 . . . . 0.0 111.172 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.53 -179.04 7.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.219 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.807 178.74 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 31.3 m -101.68 39.64 1.42 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.747 0.308 . . . . 0.0 110.449 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -67.68 -18.48 64.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.474 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.6 p -80.62 -17.99 49.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.329 0.585 . . . . 0.0 110.25 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -99.25 -57.05 2.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.559 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -91.27 124.52 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.05 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 57.4 mt -71.4 102.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.486 0.66 . . . . 0.0 110.622 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.92 102.23 5.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.006 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -129.56 129.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.605 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 14.7 mmt -110.18 149.7 40.48 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.445 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.76 146.79 91.27 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.946 2.43 . . . . 0.0 111.557 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -120.14 88.88 3.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.461 0.648 . . . . 0.0 111.348 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.87 96.68 4.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.912 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.6 m -110.22 145.19 31.64 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.91 62.05 3.9 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.472 2.115 . . . . 0.0 111.216 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 34.4 m -59.12 -51.82 68.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.91 37.98 93.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.108 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.594 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 8.5 mp -68.06 -26.62 65.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.23 0.515 . . . . 0.0 111.245 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.98 -22.28 64.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 109.901 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -83.65 -33.81 25.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.516 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.22 0.65 35.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.175 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 11.3 tp10 -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.303 -1.45 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.511 179.18 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.71 80.12 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.286 0.565 . . . . 0.0 111.006 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 mmt -113.07 30.79 6.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.852 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.13 47.92 21.91 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.016 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.36 -24.5 65.12 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.866 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.33 -27.57 62.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.636 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.61 -5.82 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.669 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -100.1 -24.71 14.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.64 -4.72 50.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -80.34 -8.03 59.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.707 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.1 -167.97 2.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.374 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.577 ' CE1' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -55.88 155.83 5.74 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -109.94 152.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.722 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -99.92 137.8 37.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.779 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 51.6 mt -123.63 143.6 36.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.74 -168.76 45.2 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.79 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 9.2 t30 -55.22 117.86 3.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.3 0.572 . . . . 0.0 112.434 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.57 -168.4 1.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.491 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . 56.6 t30 -79.11 154.4 29.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.353 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -70.69 -31.83 68.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.77 -0.5 55.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.8 mt -81.64 109.51 16.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.945 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -98.52 178.74 4.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.915 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 3.3 mp0 -60.06 -25.17 65.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.36 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.35 -51.48 31.99 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 29' ' ' THR . 2.9 m-20 -64.0 -39.64 94.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.784 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.22 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.5 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.23 -35.47 80.91 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 36.9 m -59.01 -48.94 79.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.656 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 HD13 ' B' ' 218' ' ' LEU . 68.9 t -56.38 -51.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.544 ' CG ' HD22 ' A' ' 57' ' ' LEU . 95.7 m-85 -78.26 -17.75 56.25 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -20.0 64.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.07 -24.05 63.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.45 -20.34 40.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.128 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.78 9.68 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.721 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.0 m -127.41 89.23 51.91 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 121.21 0.529 . . . . 0.0 111.95 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 84.32 1.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.88 2.387 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -124.78 -166.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.608 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.0 m-20 -72.58 131.81 42.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.3 p -121.39 133.41 68.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.5 mp -130.43 124.96 58.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.603 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 43' ' ' SER . 2.0 tt -107.79 134.85 50.15 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 42' ' ' LEU . 51.3 p -61.21 114.77 3.34 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 51.4 mtp180 -134.72 137.52 43.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.755 0.312 . . . . 0.0 110.224 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 16.5 m-20 -68.62 156.02 38.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.032 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.92 -35.58 28.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.434 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -71.43 -70.51 0.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.796 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -85.7 -19.9 30.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 73.9 18.59 79.65 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.311 178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 48' ' ' THR . 44.0 mt-10 -93.02 164.55 13.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.739 0.304 . . . . 0.0 111.309 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -72.12 129.07 37.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -80.16 -13.59 59.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.583 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.42 -10.28 30.81 Favored Glycine 0 C--O 1.215 -1.058 0 C-N-CA 120.6 -0.81 . . . . 0.0 114.305 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.16 148.49 28.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.865 0.833 . . . . 0.0 109.853 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -124.77 153.15 42.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.991 0.424 . . . . 0.0 110.836 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.437 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 55.1 m-85 -138.54 136.4 36.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 31' ' ' PHE . 16.5 tp -135.21 122.79 22.09 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.735 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.6 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 55.5 tttp -102.13 117.25 34.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.757 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 50.8 p90 -145.09 145.27 31.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 2.6 mp0 -101.6 107.58 18.88 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.426 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 65' ' ' THR . 28.0 t70 177.22 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.536 0.522 . . . . 0.0 110.783 174.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -51.17 -39.39 56.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -65.25 -54.86 22.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.794 0.33 . . . . 0.0 111.565 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 31.9 p -67.24 -19.93 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.757 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.3 p -61.63 -49.13 77.79 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.757 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -65.23 -38.73 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.788 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 27.4 tp -58.77 -56.89 16.35 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.181 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.07 83.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.489 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 65' ' ' THR . 71.4 t -63.56 -53.06 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.909 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.93 -40.08 63.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.84 -37.81 87.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -95.62 -10.66 28.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 47.8 t-20 -64.84 109.73 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.0 110.578 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.25 3.65 65.06 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.514 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.06 132.78 39.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.0 mmtp -91.88 125.35 36.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.095 0.474 . . . . 0.0 112.221 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mt -134.61 115.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.051 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.44 72.41 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.627 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -3.71 86.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.42 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 mmt180 -102.37 150.13 23.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.94 126.31 51.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 45.4 mt -73.68 128.94 36.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.754 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 75.3 mmtt -122.4 115.14 21.75 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 3.4 mm -114.22 148.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.519 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.09 145.97 23.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.029 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -74.4 136.75 42.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 12' ' ' TYR . 10.2 t -159.24 159.85 34.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.819 0.343 . . . . 0.0 111.128 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -124.27 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 33.6 t80 -136.74 142.8 43.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.65 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -98.14 107.59 42.07 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.446 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.81 119.73 6.47 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.081 2.52 . . . . 0.0 112.839 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.15 150.65 31.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.456 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -70.66 -19.86 62.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.923 0.392 . . . . 0.0 110.73 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.1 m -75.94 -11.16 59.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.373 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp -114.96 18.65 16.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.215 0.531 . . . . 0.0 109.813 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -58.56 -42.12 87.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.942 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB3' ' HE3' ' B' ' 209' ' ' MET . 92.8 mttt -61.78 -29.11 69.92 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.673 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 3.7 t80 -67.94 -52.54 34.97 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.728 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.29 -46.45 73.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.27 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.57 91.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.701 0.286 . . . . 0.0 111.241 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.1 t -64.5 -50.39 76.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.39 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -63.28 -40.61 97.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.884 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 43.6 mm-40 -66.31 -39.64 89.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.49 -35.13 78.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 90.7 mt -63.09 -48.54 78.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -64.59 -31.72 73.06 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.174 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 91.1 mtt180 -62.99 -33.6 75.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.18 -39.59 33.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.688 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 106' ' ' LEU . 44.1 mm -70.14 -32.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.406 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.9 t 74.52 -60.17 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.761 0.824 . . . . 0.0 110.875 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.0 t -162.67 -60.76 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.514 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 tttp 66.78 111.95 0.04 OUTLIER 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.887 0.742 . . . . 0.0 111.453 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -86.14 94.71 9.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -155.39 -156.61 0.67 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.23 20.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.322 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 66.67 16.14 10.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.969 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm . . . . . 0 C--O 1.244 0.782 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.547 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 39.2 m -104.83 3.26 30.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.43 -31.45 72.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.178 0.514 . . . . 0.0 111.232 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 23.1 m -82.17 -11.84 58.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.994 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.87 -62.81 1.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -90.32 121.96 32.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.041 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.45 134.13 28.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.846 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -122.59 98.9 6.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.271 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.99 99.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.145 0.498 . . . . 0.0 109.781 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 17.7 mmt -99.64 125.74 39.64 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.558 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 38.0 Cg_endo -66.37 135.36 39.34 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.632 2.221 . . . . 0.0 112.369 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -109.31 104.37 13.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.35 87.39 6.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.2 m -112.42 117.97 46.3 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.629 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.31 100.85 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.05 1.833 . . . . 0.0 112.184 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -75.27 -44.18 47.24 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.2 27.98 38.43 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.294 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 19' ' ' ASN . 93.4 mt -61.51 -42.01 98.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.564 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 30' ' ' VAL . 2.5 pt? -76.99 -11.58 59.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -92.88 -52.42 4.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.481 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.05 -56.02 4.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.809 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 62.52 86.82 0.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.73 0.644 . . . . 0.0 111.183 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.296 179.664 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.174 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.23 96.58 4.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.52 -29.82 70.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.989 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.07 -17.89 76.02 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.355 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.72 -37.36 9.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.225 0.536 . . . . 0.0 110.031 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.56 -44.07 36.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.806 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.02 71.66 1.28 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.102 0.477 . . . . 0.0 111.699 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.98 -10.79 56.68 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.77 8.5 9.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.992 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -89.81 -17.26 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.265 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.69 98.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 17.2 m-85 -138.48 147.94 43.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.101 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -124.5 137.56 56.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.725 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.2 t80 -91.66 129.97 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.275 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.5 142.39 16.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.97 -169.89 46.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.576 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -63.83 105.66 0.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.9 mt -97.73 -173.02 2.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -72.7 143.09 48.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -59.09 -31.83 69.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -84.91 9.73 13.61 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.617 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tt -96.59 121.03 37.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.107 0.48 . . . . 0.0 109.849 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -100.16 174.72 6.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.8 OUTLIER -67.96 -22.7 65.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.148 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.03 -38.84 94.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.451 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.547 ' O ' ' HB ' ' A' ' 29' ' ' THR . 9.6 t70 -72.89 -38.57 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.36 -46.2 97.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.303 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.6 -34.74 78.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.0 m -56.96 -46.39 82.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.415 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.492 HG22 HD13 ' B' ' 218' ' ' LEU . 84.1 t -64.33 -46.92 91.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -72.52 -19.29 61.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -66.47 -21.34 66.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.459 0.171 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -68.07 -18.4 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.994 0.426 . . . . 0.0 110.587 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.69 3.77 40.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 71.44 44.35 51.25 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.74 89.93 20.52 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 120.821 0.343 . . . . 0.0 111.256 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 97.3 Cg_endo -103.22 47.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.742 2.961 . . . . 0.0 110.949 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.5 t -104.56 -166.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.622 ' H ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -67.07 120.02 12.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -116.78 115.33 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.957 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.8 106.66 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.053 0.454 . . . . 0.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.99 141.17 28.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 78.7 p -73.81 100.23 3.4 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.345 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 44' ' ' ARG . 72.3 mtt-85 -106.38 146.41 30.5 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 48' ' ' THR . 18.7 t70 -58.89 137.53 57.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.94 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.0 mt-10 -72.04 -9.73 58.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.271 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -102.6 -65.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.407 HG22 ' OD2' ' A' ' 45' ' ' ASP . 12.1 t -93.91 -25.67 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.55 35.78 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.688 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.41 154.84 24.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.249 0.524 . . . . 0.0 110.355 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 m -66.34 133.65 50.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.049 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 74.8 mt-30 -89.17 -14.1 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.55 -29.33 8.31 Favored Glycine 0 C--O 1.219 -0.825 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.389 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -108.83 173.44 6.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.011 0.905 . . . . 0.0 111.039 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.44 167.84 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.484 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -131.69 123.36 27.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.945 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 tp -111.45 138.16 48.32 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.712 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 35.0 tttm -122.24 123.09 40.64 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.443 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.743 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.6 p90 -143.7 148.56 35.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.278 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.6 106.08 17.1 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.727 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 65' ' ' THR . 14.7 t70 177.07 126.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.218 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -70.65 -48.12 56.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -63.49 -40.02 95.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -60.94 -32.85 72.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.831 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.743 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.1 p -59.28 -45.73 90.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.347 0.594 . . . . 0.0 110.938 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.78 -38.92 45.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.543 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.17 -56.1 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.604 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.92 78.8 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 88.6 t -65.97 -53.14 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.05 -29.11 66.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -81.25 -48.96 11.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.17 -18.38 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 38.1 t-20 -61.86 112.35 2.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.922 0.391 . . . . 0.0 110.047 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.45 ' HA2' ' HB1' ' A' ' 81' ' ' ALA . . . 105.76 -11.33 45.77 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.755 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -67.13 133.13 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -81.37 115.74 20.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.931 0.395 . . . . 0.0 111.697 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -132.37 112.43 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.82 29.67 67.01 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.749 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.5 16.35 80.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.347 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.5 148.72 51.71 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 122.788 -0.242 . . . . 0.0 110.48 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 74' ' ' GLY . . . -84.87 128.59 34.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.457 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 77.8 mt -62.72 108.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -89.22 99.73 12.66 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.589 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 69' ' ' VAL . 9.8 mm -105.83 138.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -151.41 148.28 27.91 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.194 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -72.06 118.63 15.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.616 0.246 . . . . 0.0 110.428 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -132.15 160.24 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -106.62 136.91 45.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -149.97 136.61 19.2 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 4.3 mpt_? -108.92 127.19 27.77 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.91 104.32 0.17 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.71 2.273 . . . . 0.0 111.901 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.67 134.34 33.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 15.1 ptm180 -60.02 -22.73 62.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -65.31 -19.34 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.118 0.485 . . . . 0.0 110.454 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.9 16.95 6.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 13.7 pt20 -64.94 -20.26 66.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.583 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.08 -41.44 78.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.765 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -62.96 -45.3 93.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.594 -178.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.14 -41.56 92.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.076 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 35.7 tt0 -74.25 -43.15 58.13 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.478 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.1 84.85 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.266 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.563 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.4 m -70.15 -34.6 59.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.858 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.24 -44.11 97.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 5.1 mm-40 -61.27 -41.11 96.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.114 0.483 . . . . 0.0 109.926 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.8 tp10 -70.7 -32.41 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.132 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 102' ' ' VAL . 5.8 mp -84.16 -44.72 13.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.664 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -70.88 -23.98 62.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.912 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 9.5 ptm180 -63.25 -23.64 67.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.932 0.396 . . . . 0.0 110.574 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -78.52 -39.66 37.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.792 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.77 -45.04 98.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.703 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.5 -17.86 14.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.771 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 t 68.78 80.3 0.2 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.35 78.48 1.16 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.705 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -87.75 -59.46 2.24 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 59.94 16.36 5.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.87 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.97 -77.73 0.56 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 60.25 98.76 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 O-C-N 123.656 0.598 . . . . 0.0 112.331 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.207 178.884 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.276 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 16.2 m -93.83 -62.81 1.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -76.12 -17.11 59.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.7 t -68.1 -5.02 15.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.44 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -78.93 -23.55 44.58 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 110.441 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -88.72 166.25 14.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.523 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.2 122.13 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.956 0.407 . . . . 0.0 110.324 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.26 106.55 10.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.046 0.451 . . . . 0.0 111.051 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 53.4 mt -121.7 107.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.714 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.2 mmt -110.37 124.61 32.83 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-O 121.074 0.464 . . . . 0.0 111.907 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 58.9 Cg_endo -72.09 166.29 30.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.105 2.537 . . . . 0.0 112.289 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.74 102.99 4.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.666 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -81.05 85.87 6.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.258 0.551 . . . . 0.0 111.728 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 70.0 m -113.72 119.35 41.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.308 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 98.55 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.151 1.901 . . . . 0.0 111.034 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' B' ' 217' ' ' LEU . 11.3 t -63.86 -40.88 97.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 79.8 20.36 68.43 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.447 ' HG ' ' OG ' ' B' ' 215' ' ' SER . 57.4 mt -65.29 -40.32 93.67 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 30' ' ' VAL . 2.7 pt? -61.55 -27.1 68.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.899 0.381 . . . . 0.0 110.72 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.22 -50.28 8.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.765 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 40.4 mt -74.87 -59.49 2.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.556 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -117.04 90.94 3.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.533 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.645 178.93 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.19 83.86 0.12 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 112.259 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -97.59 -60.07 1.65 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.57 177.52 42.85 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.732 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -79.56 -41.33 27.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.832 0.348 . . . . 0.0 110.658 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.1 -5.42 14.77 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.19 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 69.93 -55.38 0.6 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.902 0.881 . . . . 0.0 112.015 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp 61.5 17.32 8.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.777 0.831 . . . . 0.0 111.726 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -101.68 -7.46 22.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.372 0.606 . . . . 0.0 109.774 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 88' ' ' PHE . 7.0 p30 -120.89 5.25 10.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.336 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.52 130.95 35.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.535 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.1 p90 -159.31 -178.89 7.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.845 0.355 . . . . 0.0 110.835 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -112.91 144.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.471 . . . . 0.0 111.309 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' HB2' HG21 ' A' ' 87' ' ' THR . 83.9 t80 -97.13 131.0 44.32 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 mp -109.7 136.37 45.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.36 -169.4 45.89 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.262 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.24 114.67 0.99 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.369 0.604 . . . . 0.0 112.595 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HB3' HD12 ' A' ' 22' ' ' LEU . 93.4 mt -100.17 -170.87 1.94 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.217 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.442 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.3 m-20 -82.98 151.32 25.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.975 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -66.91 -20.05 65.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.709 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.51 10.59 40.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.812 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 19' ' ' ASN . 25.7 mt -96.27 127.21 42.07 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.9 p -110.3 -179.13 3.69 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 38.1 mt-10 -64.62 -25.26 67.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.983 0.42 . . . . 0.0 110.916 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.96 -42.05 70.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.451 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 29' ' ' THR . 14.3 m-20 -66.08 -42.64 89.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 109.942 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.14 -45.81 95.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.194 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.6 -35.49 81.16 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.049 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 28.1 m -57.49 -47.03 83.01 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.684 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.04 -48.89 86.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -75.53 -17.17 60.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 t -64.74 -32.42 74.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 0.0 110.235 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.05 -22.2 63.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 110.287 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -89.42 0.76 56.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.227 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.78 38.85 97.18 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.62 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.06 88.52 52.53 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.228 0.537 . . . . 0.0 112.266 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -93.57 70.26 0.41 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.133 2.556 . . . . 0.0 110.244 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -117.76 -166.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.043 -177.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -64.27 120.46 12.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.672 0.272 . . . . 0.0 111.431 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.02 138.2 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.7 130.37 49.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 54' ' ' PHE . 49.3 tp -109.95 133.12 53.52 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 26.9 m -67.8 106.62 2.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -117.84 151.95 36.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.481 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 12.9 t70 -66.85 135.89 54.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.648 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.7 mt-10 -81.95 -11.44 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -84.45 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.76 0.314 . . . . 0.0 111.292 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -104.41 -20.4 13.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.024 0.44 . . . . 0.0 111.117 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 91.86 32.3 8.63 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.96 165.22 13.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.996 0.398 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -67.5 128.05 35.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.695 0.283 . . . . 0.0 110.601 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.87 -17.62 27.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.84 -4.41 29.03 Favored Glycine 0 C--O 1.221 -0.69 0 C-N-CA 120.075 -1.059 . . . . 0.0 115.207 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.0 m-85 -114.46 146.84 40.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.049 0.924 . . . . 0.0 109.533 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -133.35 148.37 51.86 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 32.8 m-85 -129.29 138.78 51.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 25.0 tp -138.18 118.68 13.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.177 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -105.43 106.1 16.45 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.711 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 26.9 p90 -124.79 145.93 49.49 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -103.35 106.21 16.67 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.768 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 65' ' ' THR . 33.4 t70 176.46 108.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.557 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.17 -36.39 72.98 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.6 tpt85 -66.99 -49.11 66.38 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p -69.97 -20.72 63.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.711 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 72.4 p -58.36 -46.78 85.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.1 mt -74.26 -36.15 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.044 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 67' ' ' LEU . 6.6 tt -61.97 -54.79 36.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.126 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.66 90.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.867 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 79.4 t -60.92 -52.16 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.03 -38.38 79.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -69.89 -50.02 46.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.931 0.396 . . . . 0.0 111.267 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 94.7 mt -78.13 -12.98 60.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.083 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.91 109.86 1.38 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.35 . . . . 0.0 110.497 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.47 76.85 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.382 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -78.82 129.66 34.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 3.2 tppp? -82.05 116.01 21.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.166 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.4 mm -125.02 101.68 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.468 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.4 42.39 93.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.289 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 20.64 79.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.7 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 51.5 mmm-85 -129.68 144.19 51.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.1 118.7 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.726 0.298 . . . . 0.0 110.242 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 94.7 mt -64.89 140.14 58.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.2 0.524 . . . . 0.0 111.502 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.14 116.51 21.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 5.6 mm -111.7 138.15 41.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.0 145.56 37.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.668 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.36 127.86 32.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 14' ' ' TYR . 1.8 t -147.65 160.37 42.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.575 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.466 ' HB2' ' OD1' ' A' ' 10' ' ' ASN . 6.2 p90 -126.94 135.45 50.92 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -150.48 124.09 9.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.311 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -81.64 128.87 67.76 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.13 142.37 96.65 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.09 2.527 . . . . 0.0 112.602 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -95.47 137.72 34.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.389 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -18.12 58.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.032 0.444 . . . . 0.0 109.833 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -66.81 -27.6 67.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.425 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.34 31.79 5.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.285 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.78 -32.51 67.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.28 -21.13 63.91 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.442 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -70.25 -51.51 30.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -64.15 -30.73 71.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.96 -46.49 71.24 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -60.74 -50.28 74.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.359 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 34.4 m -60.19 -35.0 59.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -58.65 -57.62 12.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.51 -34.91 79.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.508 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 10.7 mm-40 -65.5 -51.46 59.89 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.513 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 89.4 mt -61.17 -40.51 94.16 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.872 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.57 -55.49 34.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -71.9 -20.15 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.038 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.24 -30.06 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 106' ' ' LEU . 81.0 mt -65.63 -46.97 87.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.195 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t 70.63 -45.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -78.42 -2.37 38.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.213 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -75.91 -39.46 56.25 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.602 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.02 -176.95 0.11 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.076 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -38.97 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 62.77 29.4 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.83 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 59.77 -158.41 0.32 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tptt . . . . . 0 N--CA 1.438 -1.058 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.654 177.67 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.142 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 35.6 t 73.06 155.09 0.16 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.434 0.635 . . . . 0.0 111.868 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -70.01 -26.59 64.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.808 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 20.3 m -70.84 -8.98 56.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.819 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.18 -31.38 65.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.092 0.472 . . . . 0.0 110.236 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -85.07 170.42 12.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.17 103.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.57 99.28 5.11 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.811 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mm -93.1 107.04 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.026 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 93.9 mmm -121.72 125.12 26.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.499 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 77.0 Cg_exo -52.66 132.97 48.33 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.227 2.618 . . . . 0.0 113.576 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -126.13 103.69 7.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.863 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -88.63 96.02 10.48 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.391 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 36.1 t -110.56 139.12 21.27 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.932 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.83 79.1 0.41 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.079 1.853 . . . . 0.0 111.908 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -67.74 -39.14 84.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.67 36.0 62.19 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.456 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.417 HD12 ' HG ' ' A' ' 22' ' ' LEU . 62.7 mt -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.715 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.563 HD23 ' H ' ' B' ' 218' ' ' LEU . 1.5 pt? -95.52 -5.88 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.42 -45.9 6.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.521 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 9.4 mp -88.6 -8.98 53.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.492 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -135.18 129.83 34.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.352 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.38 1.05 . . . . 0.0 111.277 177.681 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.283 0 N-CA-C 112.341 -0.304 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.14 -179.7 4.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.649 0.261 . . . . 0.0 110.758 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.3 ttp -69.38 -21.08 63.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.1 0.476 . . . . 0.0 110.268 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.66 -8.8 41.87 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.402 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.63 -39.56 73.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.32 -48.66 15.16 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.845 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.91 89.73 3.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -75.39 106.5 6.96 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.156 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -100.46 -13.87 18.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.135 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.94 19.76 6.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.096 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.36 96.97 4.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.53 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 87' ' ' THR . 99.0 m-85 -154.4 141.2 19.1 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.178 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 pt -116.4 142.13 31.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.407 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -93.16 122.53 35.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 71.7 mt -107.45 138.49 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.85 -169.54 46.0 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.277 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 2.6 m-20 -50.24 119.28 3.54 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 112.489 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 22' ' ' LEU . 57.5 mt -98.87 169.46 9.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.173 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.525 HD22 HD13 ' B' ' 217' ' ' LEU . 56.7 t30 -70.28 149.22 47.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -64.71 -24.93 67.73 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.044 0.449 . . . . 0.0 110.726 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.85 5.33 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.823 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.405 HD22 HD13 ' A' ' 18' ' ' LEU . 3.7 tt -96.7 127.24 42.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -110.73 179.75 3.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.266 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.4 -23.17 66.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.055 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.13 -41.61 96.94 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' B' ' 215' ' ' SER . 6.1 m-20 -65.1 -39.86 93.74 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.24 -49.67 80.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.68 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.87 -35.6 81.09 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.436 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -57.35 -45.43 84.37 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.07 -46.46 45.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.74 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -76.1 -19.61 58.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -19.86 66.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.092 0.473 . . . . 0.0 110.574 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.26 -0.69 15.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.738 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -96.88 -1.21 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.968 0.413 . . . . 0.0 110.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.45 -21.25 24.24 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.819 -0.705 . . . . 0.0 114.563 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.08 129.51 3.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 117.93 0.865 . . . . 0.0 112.29 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.5 112.56 1.07 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.585 2.19 . . . . 0.0 111.458 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.755 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.2 t -103.06 -167.54 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.755 ' H ' HG12 ' A' ' 38' ' ' VAL . 28.4 t70 -68.2 144.47 54.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.02 133.23 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 111.391 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.31 134.89 61.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.828 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.9 tp -132.22 139.6 48.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.715 0.293 . . . . 0.0 111.053 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.6 p -77.06 125.24 28.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.97 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -121.82 142.75 49.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.176 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -74.28 138.52 43.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.181 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.37 -17.12 52.87 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.41 -67.87 0.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.879 0.371 . . . . 0.0 111.171 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 50' ' ' GLU . 9.9 t -115.36 -31.45 5.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.978 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.82 43.65 0.79 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.194 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 48' ' ' THR . 43.1 mt-10 -94.53 168.47 10.84 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -74.99 134.63 41.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -84.05 -9.47 58.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.142 0.496 . . . . 0.0 110.591 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.23 3.45 51.0 Favored Glycine 0 C--O 1.222 -0.635 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.772 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.94 130.0 54.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.494 0.647 . . . . 0.0 110.192 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -131.07 141.2 50.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -128.19 127.98 43.91 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.7 tp -116.91 142.4 46.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.665 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 42.3 tttp -122.66 125.74 46.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.889 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.715 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -146.76 147.47 30.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 105.33 16.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.407 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 30.4 t70 176.04 137.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.416 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -75.91 -45.52 34.89 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.788 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -62.75 -43.07 99.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 33.7 m -58.98 -27.58 65.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.848 -177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.715 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.1 p -63.98 -40.17 95.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.597 0.713 . . . . 0.0 109.942 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.9 mt -76.64 -39.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 43.2 tp -58.12 -58.32 8.95 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.535 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.63 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.592 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 76.7 t -65.4 -59.98 3.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.599 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 -36.66 78.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.97 -51.04 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.71 -8.99 45.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 20.0 t-20 -62.74 109.69 1.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.131 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.59 2.07 76.65 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.682 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -72.51 137.49 46.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -85.64 110.1 19.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.777 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 82' ' ' LEU . 29.0 mm -119.13 108.4 23.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.296 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.97 13.77 80.68 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.693 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.76 -10.42 58.95 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.75 130.95 35.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 77' ' ' ILE . 60.4 mt -84.74 128.3 34.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -104.91 111.43 24.19 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 13.8 mm -105.21 129.33 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -135.92 -179.77 5.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -111.84 129.36 56.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.1 t -155.14 160.96 41.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.123 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -110.52 121.67 45.88 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.86 148.73 41.02 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -113.15 116.01 47.28 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.466 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.13 110.24 0.98 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 112.038 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -94.79 147.24 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.79 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -78.13 -0.66 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.604 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 m -63.5 -22.95 67.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 0.0 110.018 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -122.54 34.36 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.634 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 29.1 pt20 -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.271 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 29.8 mmtp -58.11 -44.53 87.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.018 0.437 . . . . 0.0 110.737 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.8 t80 -62.98 -46.66 86.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.514 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -48.19 82.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.565 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 49.2 mt-10 -57.81 -49.45 76.58 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.081 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -38.23 81.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 68.4 t -63.1 -51.98 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.886 0.374 . . . . 0.0 110.139 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -54.78 -48.67 72.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.91 -30.16 66.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.958 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.65 -47.38 69.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.705 0.288 . . . . 0.0 110.299 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.86 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -63.31 -38.31 90.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -69.0 -24.64 64.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.686 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.4 -44.98 27.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.341 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.79 -55.86 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.9 t 69.5 -65.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.371 0.669 . . . . 0.0 110.436 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.9 p -178.7 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.893 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 62.47 97.39 0.03 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.628 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 62.9 t30 75.98 164.5 0.26 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.59 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.75 83.96 2.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.19 0.519 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.58 -52.06 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.867 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.12 0.91 7.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.218 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.323 -178.783 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.5 m 68.36 102.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.975 0.51 . . . . 0.0 111.581 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.71 -30.07 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 17.7 m -77.75 1.83 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.724 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -89.1 -14.59 35.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.361 0.6 . . . . 0.0 109.602 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -88.92 110.64 21.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.722 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 64.0 mt -85.81 133.34 29.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.326 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ASP . . . . . 0.543 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 17.5 t70 -135.86 110.99 8.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.64 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 58.0 mt -136.78 140.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.576 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.9 mmt -107.73 143.85 28.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -73.1 175.61 10.26 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.728 2.286 . . . . 0.0 111.921 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.03 93.0 2.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 0.0 111.064 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -90.48 86.19 6.36 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.962 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 11.0 p -113.08 141.79 26.25 Favored Pre-proline 0 N--CA 1.435 -1.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.579 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 13.6 Cg_exo -70.25 86.84 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.906 1.737 . . . . 0.0 111.476 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 13.8 t -78.03 -51.25 10.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 72.54 36.71 58.66 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.63 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.525 HD13 HD22 ' A' ' 19' ' ' ASN . 57.1 mt -60.35 -39.91 88.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.12 0.486 . . . . 0.0 111.058 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.497 ' HB3' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.04 -18.13 63.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 178.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.56 -34.74 16.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.961 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 91.2 mt -70.93 -43.06 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.732 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 220' ' ' LEU . 72.9 mm-40 71.81 132.22 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.758 0.661 . . . . 0.0 111.321 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 C--N 1.31 -1.127 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.491 179.578 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.6 153.39 22.42 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.708 0.289 . . . . 0.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.74 -53.08 16.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.155 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.19 30.8 0.43 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.223 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -63.1 -58.81 6.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -99.63 10.52 41.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.779 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 59.37 -156.36 0.34 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.255 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 64.5 mttm -127.73 157.44 40.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.907 0.384 . . . . 0.0 111.072 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.89 -38.82 61.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.738 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' PHE . 30.3 p-10 -75.47 -8.47 56.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.696 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -74.98 109.4 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.701 ' CE1' ' HB2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -157.07 178.76 9.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.226 0.328 . . . . 0.0 110.313 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -118.97 145.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 0.0 111.738 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -94.57 133.77 37.85 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.274 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 62.6 mt -111.59 135.05 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 83' ' ' LYS . . . -87.45 -167.32 43.48 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.933 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 26.2 t-20 -39.69 112.48 0.26 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.372 1.069 . . . . 0.0 113.583 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -107.54 171.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.119 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -87.96 142.52 27.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -60.51 -23.96 64.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.905 0.384 . . . . 0.0 111.396 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB2' HD21 ' B' ' 217' ' ' LEU . 34.2 mm-40 -88.07 -7.6 56.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.75 111.02 22.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.491 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 27' ' ' ILE . 41.0 p -91.87 173.9 7.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HB2' ' CD2' ' B' ' 212' ' ' PHE . 7.5 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.725 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' B' ' 212' ' ' PHE . . . -70.51 -43.1 62.3 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.7 m-20 -63.63 -41.03 98.3 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 24' ' ' GLU . 62.9 mt -58.97 -53.04 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.761 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.28 -33.17 74.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.69 0.281 . . . . 0.0 110.603 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 m -59.89 -45.59 92.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.543 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 26' ' ' ASP . 93.2 t -63.43 -41.36 92.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.639 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 70.5 m-85 -74.79 -22.65 58.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -72.78 -17.62 61.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.324 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.56 -33.52 76.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 121.219 0.533 . . . . 0.0 109.774 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -91.73 -15.42 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.801 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.29 44.99 6.02 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.546 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -137.51 88.28 16.87 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 121.528 0.68 . . . . 0.0 111.596 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -98.44 99.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.502 2.802 . . . . 0.0 111.723 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -130.7 -165.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.537 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.8 m-20 -64.42 116.09 5.76 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.2 129.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.57 106.24 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 57.0 tp -87.21 131.31 34.24 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -74.97 102.44 4.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 19.1 mtp85 -115.7 149.43 38.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 48' ' ' THR . 25.5 t70 -67.72 135.16 52.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.794 0.33 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.99 -28.25 66.18 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.46 -56.23 2.67 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.474 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.3 t -84.82 -23.1 29.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 44' ' ' ARG . . . 82.02 -6.54 66.51 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.698 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 48' ' ' THR . 41.9 mm-40 -71.34 155.34 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.688 -0.301 . . . . 0.0 111.274 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -68.63 138.18 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.3 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -85.25 -5.23 59.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.987 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 106.93 7.63 33.08 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.383 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -152.07 167.97 26.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.785 0.793 . . . . 0.0 110.924 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -150.44 176.28 11.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.27 0.557 . . . . 0.0 111.998 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 50.8 m-85 -136.62 153.02 51.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.932 . . . . 0.0 108.972 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 31' ' ' PHE . 12.4 tp -142.04 125.87 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.1 tmtm? -116.15 113.21 22.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 15.6 p90 -125.18 158.83 33.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.867 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 40.2 mt-10 -103.09 105.54 15.87 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.962 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 14.6 t70 175.7 133.46 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.79 -37.3 30.47 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.654 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -71.32 -40.61 70.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.72 0.295 . . . . 0.0 110.513 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 26.1 t -58.09 -27.83 64.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.695 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.4 p -60.82 -52.52 64.74 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.518 0.675 . . . . 0.0 109.775 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.87 -36.35 63.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.086 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.05 -61.18 2.83 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.367 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.07 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 65' ' ' THR . 54.2 t -64.36 -47.47 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.4 -33.37 60.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.107 0.479 . . . . 0.0 111.154 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.69 -53.19 7.84 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.1 mt -91.43 -23.61 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 t30 -67.76 109.31 3.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.65 -5.05 32.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.673 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -75.05 126.35 30.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -83.72 122.76 29.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.386 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 HD11 ' A' ' 82' ' ' LEU . 41.9 mt -136.5 120.29 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.299 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.77 35.83 87.77 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.408 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.47 3.91 86.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.742 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -133.09 154.5 50.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.546 0.673 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.12 134.82 43.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.727 0.299 . . . . 0.0 111.224 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD11 HD12 ' A' ' 77' ' ' ILE . 75.9 mt -73.22 125.72 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.593 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 56.2 mtpt -108.11 122.42 46.85 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' VAL . 13.5 mm -120.46 129.65 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.621 0.248 . . . . 0.0 110.483 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -138.99 146.22 40.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.127 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.57 130.48 35.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.676 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.658 HG23 ' CE1' ' A' ' 12' ' ' TYR . 3.5 t -156.27 162.52 40.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.825 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ASN . 36.5 p90 -109.68 143.12 39.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.701 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 47.5 t80 -128.65 136.64 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.893 0.378 . . . . 0.0 111.178 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -108.07 96.03 16.83 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.74 146.71 84.49 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.98 2.453 . . . . 0.0 113.506 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.67 136.71 46.96 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.937 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.66 -6.96 44.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.868 0.366 . . . . 0.0 111.41 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -74.74 -27.68 60.45 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 17.26 16.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.987 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -59.04 -28.61 66.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.637 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.39 -40.09 85.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.097 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -72.86 -46.77 51.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.65 -51.82 68.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 36.4 mm-40 -62.27 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.493 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.84 -49.38 77.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.945 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -47.38 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.592 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -56.02 -54.41 45.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.539 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.3 pt-20 -69.89 -26.63 64.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.23 -58.16 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.511 ' O ' HD13 ' A' ' 110' ' ' ILE . 4.1 pp -66.47 -28.33 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.423 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 106' ' ' LEU . 19.0 t70 -59.87 -36.28 76.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.68 -36.11 65.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.733 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.61 -39.46 84.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.125 0.488 . . . . 0.0 110.178 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 106' ' ' LEU . 1.6 mp -63.93 -36.04 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.49 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t 73.72 -60.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 m -85.07 80.49 9.24 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -67.45 -23.25 65.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.866 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -79.6 74.63 6.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.967 0.413 . . . . 0.0 111.326 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -88.99 -33.43 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.2 105.94 1.17 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.403 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.36 112.32 5.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.397 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.8 pttt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.093 -179.816 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 112.081 -0.407 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 36.7 t -161.83 149.65 14.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.938 0.399 . . . . 0.0 110.709 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -7.68 59.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.153 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 62.1 m -92.71 1.98 56.98 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -72.29 -56.95 4.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.189 0.519 . . . . 0.0 110.23 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -90.93 118.66 30.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.367 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 39.6 mm -125.0 98.41 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 CA-C-O 121.437 0.637 . . . . 0.0 110.103 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.03 144.27 30.91 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.943 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 44' ' ' ARG . 46.6 mt -134.22 144.39 35.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.6 mmt -127.19 139.93 36.48 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.854 0.359 . . . . 0.0 111.713 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.61 151.23 41.33 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.435 2.09 . . . . 0.0 111.203 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -158.02 76.22 0.78 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 24' ' ' GLU . 36.8 p90 -110.88 115.72 30.01 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.7 p -110.28 117.96 50.3 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.263 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.84 114.49 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.75 2.3 . . . . 0.0 113.001 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.495 ' HB2' HD12 ' B' ' 217' ' ' LEU . 37.7 m -78.89 -40.48 32.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.69 38.35 8.18 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.386 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.3 mp -63.69 -40.18 96.17 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.428 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.7 pt? -65.15 -20.31 66.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.16 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -80.94 -35.16 32.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.351 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.39 -70.52 0.6 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.971 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 53.56 23.71 3.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.047 0.539 . . . . 0.0 112.268 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.042 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 112.168 -0.373 . . . . 0.0 112.168 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.72 151.33 27.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.637 0.256 . . . . 0.0 110.867 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -13.89 18.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.305 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.5 117.14 5.36 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.494 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.84 -24.63 38.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.076 0.465 . . . . 0.0 110.426 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.99 -44.52 94.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.57 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.412 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 10.0 m-85 -85.13 88.89 7.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -73.39 108.21 6.12 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.363 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' O ' ' HE1' ' A' ' 12' ' ' TYR . 18.8 t70 -90.74 -19.34 23.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.647 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -93.19 -6.67 47.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.832 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.21 97.59 7.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.257 0.551 . . . . 0.0 111.75 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 74.2 m-85 -147.59 156.0 42.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.126 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.21 133.39 69.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.656 0.265 . . . . 0.0 110.498 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -85.49 126.06 33.53 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -105.9 137.02 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.71 -169.5 45.96 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.557 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -53.67 112.39 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.654 0.782 . . . . 0.0 112.239 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 HD23 ' A' ' 22' ' ' LEU . 67.6 mt -102.74 -173.42 2.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.405 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 16.4 m120 -79.31 148.19 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.08 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -65.43 -35.69 81.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.85 7.82 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.803 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 18' ' ' LEU . 26.8 tp -81.67 109.96 16.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -85.17 166.07 16.89 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.615 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 32.1 mt-10 -65.66 -22.4 66.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.53 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -45.76 78.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.581 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -64.26 -40.48 96.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 110.471 178.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.66 -46.39 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.582 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.42 -30.63 70.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.103 0.478 . . . . 0.0 109.733 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 30.8 m -62.57 -41.14 98.75 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 HD13 ' B' ' 218' ' ' LEU . 81.4 t -67.5 -46.86 82.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.26 -21.99 55.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -70.77 -14.31 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.784 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.45 -8.73 55.75 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.391 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.631 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 79.8 m-85 -92.15 -10.9 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.63 10.45 86.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -129.15 89.83 47.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.683 0.278 . . . . 0.0 110.737 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -88.01 114.66 0.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.963 2.442 . . . . 0.0 111.964 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.805 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.6 t -132.31 -167.42 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.805 ' H ' HG12 ' A' ' 38' ' ' VAL . 6.4 m-20 -62.0 144.23 55.43 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.24 140.28 46.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.864 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -137.32 110.33 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.668 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.52 136.42 42.38 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 92.1 p -79.36 112.38 16.53 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.166 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -123.29 149.62 44.58 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.72 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.63 142.45 42.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.557 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.52 -29.3 41.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.819 0.342 . . . . 0.0 111.424 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.74 -58.01 3.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 50' ' ' GLU . 3.7 t -91.79 -40.28 11.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.13 43.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.558 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' H ' HG23 ' A' ' 48' ' ' THR . 42.7 mt-10 -67.49 160.33 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.968 0.507 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.2 m -75.69 141.37 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.03 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 76.8 mt-30 -82.81 -12.96 57.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.03 -30.58 7.9 Favored Glycine 0 C--O 1.216 -0.997 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.969 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -109.36 161.81 14.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.775 0.788 . . . . 0.0 111.575 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.54 26.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -134.09 135.27 43.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.735 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.8 tp -119.15 143.43 47.21 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.624 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 31.6 tttm -124.37 118.54 26.95 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.207 0.527 . . . . 0.0 111.788 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.779 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 12.3 p90 -138.82 144.04 39.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 7' ' ' TYR . 37.0 mt-10 -102.45 104.4 14.85 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.675 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 65' ' ' THR . 25.1 t70 175.46 141.88 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.433 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -80.83 -37.48 29.96 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.02 -43.19 71.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 8.6 p -63.86 -22.72 67.05 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.779 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.1 p -62.23 -50.71 70.66 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.337 0.589 . . . . 0.0 109.762 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mt -64.78 -37.05 79.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.072 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.83 -58.65 7.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.426 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.66 89.23 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 65' ' ' THR . 72.2 t -57.32 -58.98 3.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.44 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.3 -31.38 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -67.23 -46.73 72.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.316 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.631 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 72.5 mt -93.78 -20.49 20.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.12 109.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.52 7.97 58.79 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.061 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.06 138.46 31.5 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -86.32 127.58 34.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG13 HD11 ' A' ' 82' ' ' LEU . 23.7 mm -131.91 110.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.88 20.84 77.96 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.753 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.31 -12.57 65.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.359 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -107.47 150.88 26.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.269 0.534 . . . . 0.0 110.926 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.51 33.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 111.067 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 78.5 mt -80.14 130.62 35.37 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -114.81 108.86 17.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.31 141.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.656 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.26 155.27 38.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.662 0.268 . . . . 0.0 110.95 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -71.68 128.25 35.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.625 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.4 t -153.72 161.26 42.27 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -108.94 159.26 16.95 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -149.48 138.92 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.355 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -112.78 113.73 49.92 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.8 140.34 79.58 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.722 2.282 . . . . 0.0 111.823 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -94.15 128.39 40.53 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -71.8 -15.26 62.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.068 0.461 . . . . 0.0 110.478 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -66.8 -29.63 69.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.6 30.87 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.628 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -53.38 -33.39 53.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.328 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -71.06 -27.09 63.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -68.37 -49.85 57.26 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.431 ' HA ' HG12 ' A' ' 102' ' ' VAL . 64.7 m-85 -64.64 -32.17 73.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.221 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -53.31 48.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.421 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -63.03 -38.39 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.914 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 9.0 p -70.92 -27.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.451 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 tptt -76.68 -42.53 41.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.958 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.76 -26.39 67.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.87 -31.04 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.999 0.428 . . . . 0.0 110.206 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 12.7 tp -63.39 -64.7 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.12 -34.5 72.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.769 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -63.89 -45.2 90.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.516 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.028 0.442 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 106' ' ' LEU . 49.7 mt -69.64 -9.69 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.113 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 111' ' ' VAL . 22.2 t 73.04 4.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.953 0.882 . . . . 0.0 110.002 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.2 t -86.7 88.6 7.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.219 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -151.18 24.42 0.73 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 109.815 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.92 -35.25 78.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.732 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -103.01 -32.06 9.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.947 0.403 . . . . 0.0 110.524 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.2 88.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.516 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -111.95 158.48 19.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 pttp . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.488 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.978 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 37.7 m -115.04 20.9 14.7 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.16 0.505 . . . . 0.0 110.215 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.63 -8.42 56.76 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 31.7 m -79.77 6.13 11.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.715 0.293 . . . . 0.0 111.31 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -72.83 -35.75 67.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.067 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -92.42 116.07 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.174 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.37 132.39 38.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.541 0.686 . . . . 0.0 110.814 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -109.48 120.76 43.48 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.372 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 62.4 mt -108.26 131.09 59.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.797 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.421 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 20.5 mmt -107.22 134.74 19.79 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.431 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 29.6 Cg_endo -62.05 129.59 27.78 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.205 2.603 . . . . 0.0 111.829 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -103.26 102.4 12.36 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.699 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.28 83.38 3.57 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.548 0.689 . . . . 0.0 109.674 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.0 t -113.64 119.41 41.54 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.446 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.31 96.61 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.707 1.605 . . . . 0.0 111.227 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.51 ' HB2' HD12 ' B' ' 217' ' ' LEU . 17.2 m -81.39 -43.79 18.48 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 81.28 38.82 13.84 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.905 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.6 mp -62.72 -37.76 87.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.584 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.537 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.34 -22.7 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.517 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -50.7 49.37 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.848 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.22 -14.95 61.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.6 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -81.39 -29.22 34.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.245 0.837 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.997 179.322 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.55 102.56 13.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.878 0.37 . . . . 0.0 110.19 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.53 -21.91 15.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.489 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.12 95.07 0.56 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.017 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -74.97 -7.1 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.84 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -110.17 -2.01 17.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.855 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 55.49 38.05 29.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.363 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -78.35 52.28 1.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.84 0.829 . . . . 0.0 110.505 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.53 10.36 25.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.466 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -81.8 29.95 0.38 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.732 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.08 98.43 9.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.11 0.481 . . . . 0.0 110.75 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -139.2 137.73 36.26 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.338 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.139 0.495 . . . . 0.0 111.667 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 50.5 t80 -88.42 132.0 34.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.991 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 63.4 mt -106.9 132.69 53.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 83' ' ' LYS . . . -86.44 -168.22 44.55 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.696 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 66.5 t30 -52.12 108.76 0.31 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -175.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.96 -165.6 1.33 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.647 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -101.15 149.03 24.39 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -72.0 -26.53 62.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.72 -19.05 62.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.765 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.475 HD12 HD13 ' B' ' 217' ' ' LEU . 27.1 tp -84.04 109.04 17.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' ILE . 80.4 p -91.12 178.12 6.08 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 120.927 0.394 . . . . 0.0 110.704 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.34 -9.81 58.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.466 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.77 -45.8 56.52 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.33 -39.22 85.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 23' ' ' THR . 46.7 mm -51.11 -51.62 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.636 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -67.7 -36.85 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.8 m -61.95 -42.24 98.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.652 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.47 HG22 HD13 ' B' ' 218' ' ' LEU . 75.4 t -76.04 -45.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -79.34 -21.97 45.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -75.8 -12.57 60.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.954 -0.466 . . . . 0.0 111.069 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.41 -24.53 56.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.878 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -75.2 -1.65 24.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.71 -21.3 45.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.355 -0.45 . . . . 0.0 114.096 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.99 107.2 15.1 Favored Pre-proline 0 C--N 1.313 -0.988 0 O-C-N 122.462 -0.434 . . . . 0.0 110.906 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.8 100.9 1.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.534 2.156 . . . . 0.0 110.718 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -101.05 -166.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.306 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' H ' HG12 ' A' ' 38' ' ' VAL . 34.9 t70 -63.16 129.0 38.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.929 0.395 . . . . 0.0 111.478 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.8 134.87 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.766 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 mt -131.52 106.42 11.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -93.03 127.4 38.54 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.6 t -75.74 91.58 2.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.16 0.505 . . . . 0.0 110.952 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' B' ' 211' ' ' ASP . 4.4 tpt180 -91.44 136.14 33.33 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p30 -80.75 147.16 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.093 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.534 ' HB3' HD11 ' B' ' 208' ' ' ILE . 1.5 pm0 -81.59 -9.59 59.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.042 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -75.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 111.473 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -112.68 -18.93 12.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.216 0.532 . . . . 0.0 110.153 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 90.82 32.05 9.5 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.937 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -103.93 171.29 7.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.806 0.336 . . . . 0.0 111.626 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -73.3 130.85 41.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.59 -8.65 58.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.014 0.435 . . . . 0.0 110.894 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 105.95 -3.55 38.58 Favored Glycine 0 C--O 1.206 -1.63 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.673 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -137.22 163.09 31.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 117.962 0.881 . . . . 0.0 111.292 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.03 175.28 12.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.34 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 84.4 m-85 -138.87 147.99 43.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 tp -137.39 144.11 42.27 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.569 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 31.5 tttt -132.39 123.27 26.42 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 6.2 p90 -134.06 150.91 51.21 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -101.18 103.59 14.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.654 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 174.29 122.87 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.097 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -69.24 -33.36 73.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.04 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -68.04 -41.38 82.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 0.0 111.531 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.3 m -61.9 -26.32 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.669 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.7 p -61.57 -50.78 71.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.568 0.699 . . . . 0.0 109.955 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.6 mt -70.98 -34.77 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.182 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.36 -58.21 8.52 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.831 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.12 75.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 95.7 t -69.01 -30.14 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.154 0.502 . . . . 0.0 111.594 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.41 -31.9 18.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.275 0.56 . . . . 0.0 111.355 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.22 -45.23 9.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.006 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 89.5 mt -96.04 -30.78 13.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 69' ' ' VAL . 8.8 t30 -67.42 109.89 3.37 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.816 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.78 31.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.185 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -72.71 132.22 43.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.21 116.85 21.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.305 0.574 . . . . 0.0 112.334 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.61 109.6 22.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.02 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.89 30.82 77.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.765 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 -13.61 65.43 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.238 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.72 148.7 35.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.925 0.363 . . . . 0.0 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.99 143.46 26.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.691 0.282 . . . . 0.0 111.307 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 87.7 mt -76.74 124.41 27.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.238 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 40.0 ttmt -104.64 117.06 33.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mm -114.96 117.22 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -127.32 146.13 50.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.738 0.304 . . . . 0.0 111.324 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -80.04 125.36 29.69 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 14' ' ' TYR . 13.3 t -154.96 160.65 41.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -100.55 99.63 10.25 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -115.86 132.76 56.55 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.432 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -113.98 132.87 22.47 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.962 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.16 163.24 34.93 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.513 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 60.6 mttp -98.72 129.34 45.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.31 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.36 -11.82 60.13 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.872 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -75.08 -32.73 61.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.18 0.514 . . . . 0.0 110.236 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -89.53 33.46 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -51.4 -36.13 42.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.085 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -60.41 -49.36 77.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 111.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.82 -51.47 69.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.326 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 59.3 m-85 -61.58 -36.3 80.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.287 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 37.7 tt0 -66.5 -51.88 52.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.24 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.7 69.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.194 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.427 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.4 t -69.52 -50.41 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 103' ' ' LYS . 35.8 ttmt -58.1 -44.89 87.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.779 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.5 pt-20 -70.56 -24.42 62.79 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.058 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.1 -41.96 66.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 102' ' ' VAL . 10.6 mp -63.01 -42.17 99.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 111' ' ' VAL . 16.7 t70 -58.1 -45.58 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.005 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -59.08 -38.05 78.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.403 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.19 -29.27 70.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.055 0.455 . . . . 0.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.9 mm -80.77 -45.97 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.317 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 57.5 t -62.86 -34.98 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 p -73.05 -3.14 24.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -86.81 92.82 9.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.23 5.61 4.3 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.348 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.2 t-20 58.96 31.65 21.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.571 0.701 . . . . 0.0 110.084 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.38 -176.16 4.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.808 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.1 -170.0 1.63 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.792 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.9 mttm . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.187 176.454 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 45.4 m -108.97 133.02 53.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.748 0.308 . . . . 0.0 110.438 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.24 -16.38 63.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.584 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 22.7 t -68.2 -13.63 62.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.042 0.449 . . . . 0.0 110.403 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -69.73 -33.91 73.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.9 156.58 17.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.5 99.15 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -132.77 101.95 5.47 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 46' ' ' GLU . 69.3 mt -107.66 126.73 64.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.1 mmt -121.63 145.65 43.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.745 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.3 148.14 54.65 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.838 2.359 . . . . 0.0 112.645 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.49 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 25.4 t70 -117.15 98.41 6.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.44 89.1 5.73 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 33.9 m -110.21 139.88 21.86 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.941 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 3.1 Cg_exo -75.08 84.88 1.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.896 1.731 . . . . 0.0 110.98 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 50.2 m -81.53 -51.12 8.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.186 0.517 . . . . 0.0 110.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.12 43.74 89.29 Favored Glycine 0 N--CA 1.431 -1.666 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.758 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 22' ' ' LEU . 6.9 mp -61.26 -34.73 75.64 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.121 0.46 . . . . 0.0 110.371 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.476 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -79.06 -11.73 60.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.244 0.545 . . . . 0.0 110.563 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.28 -55.38 2.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.209 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 40.4 mt -77.79 -27.57 50.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.43 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 58.15 28.15 16.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.363 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.644 -178.864 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.221 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.1 105.29 10.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.446 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 9' ' ' ASP . 25.7 ttt -118.53 -1.33 11.21 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.905 0.859 . . . . 0.0 108.982 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.22 -4.65 79.46 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.753 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -59.49 -37.2 77.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 0.0 110.538 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -111.55 7.16 20.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.709 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 59.17 23.36 11.64 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.068 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.9 -27.93 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.452 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 8.1 p-10 -97.93 7.37 46.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.396 0.617 . . . . 0.0 109.944 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.21 -16.18 12.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.85 97.89 4.7 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.209 0.528 . . . . 0.0 111.379 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 63.7 m-85 -142.26 139.81 32.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.036 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -116.45 133.48 62.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.038 0.447 . . . . 0.0 110.808 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HG21 ' A' ' 87' ' ' THR . 76.4 t80 -88.01 125.94 34.81 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.857 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.33 143.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.99 -169.37 45.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.119 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.76 133.73 56.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 0.0 111.597 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 mt -125.89 160.33 30.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.02 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.35 146.05 49.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.01 -21.22 65.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.429 . . . . 0.0 110.724 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.75 -13.65 58.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.76 129.58 34.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.434 HG21 ' HB2' ' B' ' 213' ' ' SER . 32.1 p -109.27 179.37 4.18 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.895 0.379 . . . . 0.0 110.681 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.1 pm0 -72.91 -21.07 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 110.049 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.26 -34.22 85.0 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.557 ' O ' ' HB ' ' A' ' 29' ' ' THR . 27.5 m-20 -72.12 -36.76 69.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.69 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.74 -34.64 78.65 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.385 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 53.4 m -59.24 -46.82 87.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.101 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' ASP . 58.3 t -67.52 -50.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.943 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -70.86 -9.34 57.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -22.08 66.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.845 0.355 . . . . 0.0 110.124 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.99 -19.5 64.94 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.213 0.53 . . . . 0.0 110.654 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 39.1 m-85 -83.01 -20.16 35.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.82 17.13 80.16 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.203 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.87 104.57 3.9 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.378 0.608 . . . . 0.0 111.207 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.07 116.3 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.747 2.298 . . . . 0.0 111.961 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -124.83 -166.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.9 m-20 -62.55 120.34 10.93 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.01 111.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.292 0.568 . . . . 0.0 109.938 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 ' CZ ' ' A' ' 99' ' ' TYR . 4.3 mp -108.46 104.48 17.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.57 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.29 120.58 26.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 m -75.14 99.34 3.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.139 0.495 . . . . 0.0 110.964 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.508 ' NH2' ' H ' ' B' ' 211' ' ' ASP . 56.5 mtt180 -103.91 170.16 8.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.762 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.7 p-10 -108.78 149.35 29.18 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.588 ' HA ' HD11 ' B' ' 208' ' ' ILE . 4.6 pt-20 -81.46 -9.95 59.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -78.27 -61.99 1.82 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.944 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -105.49 -28.02 11.06 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.871 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 94.32 24.8 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.833 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.57 169.68 8.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.636 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -68.5 132.13 46.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.48 2.69 21.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.869 0.366 . . . . 0.0 111.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.78 9.66 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.043 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -169.51 163.15 10.32 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.05 0.452 . . . . 0.0 111.349 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.52 161.44 42.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.433 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -133.04 130.84 39.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 8.3 tt -121.15 139.07 53.85 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.912 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 13.5 tmtt? -125.69 121.07 32.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.441 0.639 . . . . 0.0 111.474 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 7.6 p90 -131.8 151.25 51.8 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.587 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.02 104.97 15.66 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.953 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 176.4 137.95 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.134 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -78.36 -40.97 34.75 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.417 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -69.47 -41.04 76.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 111.254 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -58.08 -26.67 62.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.999 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.67 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 53.0 p -62.83 -42.96 99.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.602 0.715 . . . . 0.0 110.401 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.1 mt -75.18 -41.05 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.031 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.87 -52.73 64.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.851 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -57.8 -43.92 85.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.863 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.43 -57.72 10.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.163 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.29 -24.61 67.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -82.54 -54.0 5.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.8 0.333 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.62 -16.1 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.68 109.75 2.13 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -0.36 61.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.523 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -69.13 136.87 52.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.38 122.97 33.73 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.95 118.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.702 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.27 8.52 79.73 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.342 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.89 10.23 46.87 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -129.43 145.38 51.43 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.027 -0.586 . . . . 0.0 110.771 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.19 32.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.872 0.368 . . . . 0.0 111.203 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.44 120.43 22.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.1 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -92.98 113.31 25.55 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.2 mm -118.59 118.89 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.653 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -135.81 149.76 49.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.878 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -76.23 134.76 39.75 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.2 t -160.13 160.58 33.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -91.16 153.09 20.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 44.9 t80 -147.13 119.4 8.34 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.089 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 90' ' ' ARG . 49.0 mtt180 -112.26 99.27 45.98 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.879 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.61 149.52 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -85.13 149.09 25.77 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.04 -8.8 40.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.044 0.45 . . . . 0.0 110.571 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -68.62 -19.06 64.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.221 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.5 mt -118.49 24.43 10.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.58 0.229 . . . . 0.0 111.566 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.1 pt20 -69.97 -25.61 63.71 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.195 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -67.28 -24.42 65.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -69.38 -36.69 77.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CZ ' HG12 ' A' ' 41' ' ' ILE . 53.2 m-85 -69.12 -41.53 77.27 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.077 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 41.8 mm-40 -58.96 -50.64 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.489 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -57.89 -51.21 70.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.734 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 13.1 p -64.1 -37.87 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.02 -49.31 76.54 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.433 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 54.9 mt-10 -64.67 -38.32 90.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.44 -50.17 72.52 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.927 0.394 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 110' ' ' ILE . 85.5 mt -65.99 -41.99 90.39 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.164 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.39 -42.41 77.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 108' ' ' ARG . 45.8 ttm105 -68.94 -39.21 79.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.443 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.93 -39.88 87.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 106' ' ' LEU . 75.7 mt -68.66 -29.96 45.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.255 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 70.7 t 75.32 -61.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.593 0.757 . . . . 0.0 111.837 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.3 m -140.58 90.89 2.38 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.5 95.98 10.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.439 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -97.94 129.41 44.85 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.969 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.0 -43.89 94.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.044 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 64.16 98.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.884 0.74 . . . . 0.0 111.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -62.55 136.1 57.73 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.506 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.789 179.753 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 200' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' B' ' 204' ' ' GLN . . . . . . . . 0 N--CA 1.476 1.339 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 12.6 p -59.05 -37.88 78.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.38 -22.71 62.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.616 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 39.1 t -86.35 -19.32 29.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' B' ' 200' ' ' GLY . 87.0 mt-30 -69.29 -39.03 78.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.275 0.559 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -91.11 123.83 34.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.138 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.51 HG23 ' HB3' ' A' ' 46' ' ' GLU . 62.6 mt -80.71 122.51 36.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.453 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -117.77 98.74 6.51 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.022 0.915 . . . . 0.0 111.003 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 46' ' ' GLU . 66.4 mt -128.74 137.63 56.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.068 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 21.3 mmt -110.09 145.23 31.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 14.6 Cg_exo -70.04 129.05 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.012 2.475 . . . . 0.0 112.295 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.508 ' H ' ' NH2' ' A' ' 44' ' ' ARG . 31.2 m-20 -96.01 82.48 3.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.505 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.17 89.39 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.516 . . . . 0.0 110.912 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 23' ' ' THR . 3.2 m -112.37 129.48 24.3 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.906 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.52 70.32 7.34 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.857 1.704 . . . . 0.0 111.293 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.4 m -65.49 -50.21 66.14 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.62 43.62 96.19 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.691 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.511 ' O ' ' HG3' ' B' ' 221' ' ' GLU . 18.5 mt -56.57 -50.65 71.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -65.38 -31.61 72.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.388 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.17 -37.74 88.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.82 -16.56 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' B' ' 217' ' ' LEU . 43.9 mt-10 -89.16 -23.36 22.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.502 . . . . 0.0 111.32 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.301 -1.536 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.025 -178.928 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.17 -46.99 84.56 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.99 -24.47 66.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.25 -22.49 78.54 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.97 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -55.42 -52.14 64.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.855 0.328 . . . . 0.0 111.186 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.08 11.94 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 64.62 29.41 13.04 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.014 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -63.87 -30.84 71.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.274 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -84.06 0.52 47.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.611 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -114.73 7.34 15.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.486 0.66 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.54 98.73 6.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.596 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 75.5 m-85 -133.48 146.01 50.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.077 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.95 137.15 52.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.342 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 74.8 t80 -85.28 128.89 34.86 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.624 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.18 132.26 61.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.86 -168.59 44.59 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.215 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -49.77 119.99 3.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.517 0.675 . . . . 0.0 112.669 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.29 179.1 4.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 m120 -81.81 151.04 27.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.693 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -73.99 -17.13 61.03 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.056 0.455 . . . . 0.0 111.231 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.23 -14.57 40.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.344 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 19' ' ' ASN . 73.3 mt -84.26 109.32 17.7 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.838 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 27' ' ' ILE . 54.1 p -88.77 176.39 7.09 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.236 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.3 -25.09 67.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.287 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.96 -44.73 54.72 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -63.83 -33.48 75.78 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.755 0.312 . . . . 0.0 110.938 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 23' ' ' THR . 64.5 mt -58.17 -53.09 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.275 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.33 -21.15 62.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.983 0.42 . . . . 0.0 110.673 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.5 m -63.99 -42.89 97.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.533 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.631 HG22 HD13 ' B' ' 218' ' ' LEU . 86.1 t -75.52 -48.46 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.095 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -70.96 -6.97 42.77 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 p -50.87 -44.38 59.64 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.247 0.546 . . . . 0.0 111.631 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -76.32 -6.88 53.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.624 0.726 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.98 26.38 8.62 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.525 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.68 70.09 0.35 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 118.829 -1.653 . . . . 0.0 112.756 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.4 m -44.0 147.52 0.9 Allowed Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.26 1.024 . . . . 0.0 112.634 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -11.34 98.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.7 4.934 . . . . 0.0 117.029 -173.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -128.82 -164.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 26.9 m-20 -70.41 109.54 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.725 -175.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.66 143.35 21.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.2 106.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 55' ' ' ALA . 2.6 tm? -95.11 121.83 37.15 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.2 t -78.42 110.32 13.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.045 0.45 . . . . 0.0 110.51 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -110.45 154.67 23.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.87 139.24 48.75 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HA ' HD11 ' B' ' 208' ' ' ILE . 39.0 mt-10 -74.74 -9.56 58.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -109.75 -60.44 1.78 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.3 t -89.62 -11.22 43.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.16 66.82 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.912 -0.661 . . . . 0.0 114.229 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 48' ' ' THR . 46.3 mm-40 -78.35 156.79 29.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.024 0.412 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.5 p -65.2 128.85 37.51 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.18 -14.73 63.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.804 0.335 . . . . 0.0 111.608 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.69 18.52 8.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.17 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -161.81 159.42 26.98 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 120.922 0.391 . . . . 0.0 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -151.43 170.61 19.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.804 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -136.34 139.2 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.7 tp -126.2 130.63 51.34 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.619 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.1 tttt -116.15 103.58 10.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.585 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 37.4 p90 -118.66 153.45 34.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 tt0 -101.02 105.8 17.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.814 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 13.4 t70 175.48 108.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.058 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -73.59 -8.75 57.21 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 26.6 mtm180 -91.72 -49.23 6.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 0.0 109.911 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -63.84 -26.89 68.82 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.396 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 17.2 p -59.12 -41.32 87.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 110.337 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 mm -69.01 -49.18 65.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.637 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.73 -55.56 28.92 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.252 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.7 74.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 68.0 t -60.48 -48.09 89.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.29 -33.88 42.92 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.192 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.24 -44.95 35.16 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.35 -15.09 58.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 53.2 t30 -68.45 108.72 3.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.79 -8.91 59.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.776 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.96 128.51 35.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.37 134.84 33.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.33 109.88 3.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.583 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.79 22.13 75.3 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.554 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.71 -3.9 81.61 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.473 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.07 123.65 49.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 111.048 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.96 107.68 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.76 143.73 53.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.37 111.7 21.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 8.4 mm -114.74 138.72 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -146.4 146.9 30.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.157 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -72.16 124.8 25.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -147.4 160.8 42.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.01 0.434 . . . . 0.0 110.928 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.6 117.49 34.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 57.2 t80 -102.74 127.6 49.82 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.891 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -100.18 102.08 16.81 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 50.9 Cg_exo -55.85 126.6 22.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.243 2.629 . . . . 0.0 113.706 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -77.13 128.65 34.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -77.28 -12.56 59.96 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.574 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 m -64.42 -23.07 67.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.404 0.621 . . . . 0.0 109.819 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.41 26.29 5.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.459 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -54.16 -46.42 72.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.873 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -71.67 -27.06 62.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 110.722 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -68.15 -48.78 64.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -59.52 -44.42 93.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 35.6 tt0 -60.96 -52.62 64.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.528 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.16 75.48 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 53.7 t -59.0 -49.21 84.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -64.04 -44.09 93.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 36.6 mt-10 -62.36 -43.16 99.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 110.509 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.29 -43.46 83.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.551 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -69.93 -43.06 72.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.064 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.3 -29.53 70.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.959 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.4 mmt85 -83.5 -16.67 44.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 110.846 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.39 -41.08 20.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.687 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.84 -70.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.232 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.2 t 65.93 -74.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 111.762 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m 65.35 -67.79 0.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.746 0.818 . . . . 0.0 110.756 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -113.93 113.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.56 -58.51 2.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.53 81.04 0.16 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.96 100.68 10.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.75 -2.58 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.696 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.049 -179.121 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.427 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.8 t -70.14 -15.0 62.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -66.01 -20.32 66.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 50.6 m -91.75 -3.88 55.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.092 0.473 . . . . 0.0 110.462 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -96.22 30.25 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.257 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -68.84 157.53 36.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.092 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.15 127.67 44.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.55 110.09 13.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.863 0.363 . . . . 0.0 110.763 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 46' ' ' GLU . 48.2 mt -124.66 130.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.01 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.408 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 11.8 mmt -124.29 149.12 60.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.142 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 5.6 Cg_exo -79.92 170.47 16.63 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -147.28 114.65 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -108.37 88.18 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.621 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 19.3 m -111.38 119.59 44.88 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.94 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 24.8 Cg_exo -63.0 110.83 1.23 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.448 2.099 . . . . 0.0 112.536 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 19.8 m -101.64 -50.82 3.61 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.83 41.25 50.18 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.786 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.14 -30.04 69.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.322 0.561 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -64.99 -26.86 68.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.171 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -78.87 -17.87 54.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 0.0 110.987 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.53 -4.19 55.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 58.72 85.47 0.09 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.628 0.58 . . . . 0.0 110.48 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.31 -1.109 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.179 -178.681 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.48 148.13 41.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.755 0.312 . . . . 0.0 110.349 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.6 mmm -89.74 -18.45 26.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.007 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.95 -26.59 15.03 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.731 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -70.01 -10.7 59.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.27 -32.31 64.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -82.3 74.62 9.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 110.113 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -89.52 0.06 57.16 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.731 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.85 9.06 28.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.144 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -84.77 -0.02 52.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.45 97.71 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 21.6 m-85 -147.7 148.07 30.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.07 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.17 136.52 60.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.981 0.419 . . . . 0.0 110.542 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -86.39 131.54 34.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.585 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -113.7 138.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -171.27 47.57 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.422 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.2 t-20 -58.9 104.8 0.26 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.286 0.565 . . . . 0.0 111.735 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -95.41 -172.46 2.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 40.7 t30 -76.37 130.05 37.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -66.14 1.33 1.55 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.43 -10.58 29.53 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.182 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 19' ' ' ASN . 6.5 mp -76.06 140.12 41.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.029 0.442 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.517 HG21 ' HB2' ' B' ' 213' ' ' SER . 44.0 p -110.44 -178.12 3.41 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.785 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' B' ' 210' ' ' PRO . 3.0 mm-40 -62.71 -36.25 82.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.52 95.31 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.492 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 29' ' ' THR . 13.8 m-20 -63.32 -47.83 80.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 110.377 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.68 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.717 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.12 -38.18 90.16 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.318 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.8 m -56.12 -45.22 79.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.716 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.434 HG22 HD13 ' B' ' 218' ' ' LEU . 99.0 t -64.25 -46.39 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.102 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.05 -20.12 33.22 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 t -63.73 -24.72 67.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.648 0.261 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.29 -7.13 28.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.76 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -88.35 -4.09 58.73 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.985 0.421 . . . . 0.0 110.895 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.27 -20.99 27.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.048 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.72 111.03 9.54 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 117.42 0.61 . . . . 0.0 111.582 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.68 110.44 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.789 2.326 . . . . 0.0 111.082 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.9 t -111.03 -167.23 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.716 ' H ' HG12 ' A' ' 38' ' ' VAL . 31.2 m-20 -73.36 147.04 44.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' H ' HG11 ' A' ' 102' ' ' VAL . 14.3 p -135.56 140.73 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.391 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.94 99.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.67 0.271 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 1.3 tt -84.85 122.99 29.95 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 m -67.4 122.25 17.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HD2' ' OH ' ' A' ' 98' ' ' TYR . 81.1 mtt85 -121.34 161.27 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.07 147.07 26.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.042 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HG3' HD11 ' B' ' 208' ' ' ILE . 1.9 mp0 -72.68 -25.12 61.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -93.08 -59.68 1.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 50' ' ' GLU . 5.2 t -81.87 -24.48 35.74 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.462 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.82 77.9 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.026 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 48' ' ' THR . 47.7 mt-10 -80.4 166.61 21.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.819 0.343 . . . . 0.0 110.909 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.7 p -70.15 142.29 52.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.58 3.23 48.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.148 0.499 . . . . 0.0 110.305 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.76 -31.93 8.17 Favored Glycine 0 C--O 1.219 -0.828 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.73 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -109.61 162.36 14.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.164 0.482 . . . . 0.0 111.174 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.81 171.48 16.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.234 0.54 . . . . 0.0 111.587 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -134.39 133.83 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.11 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.9 tp -114.37 144.98 42.4 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.972 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 39.2 tttm -125.51 123.35 38.96 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.244 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.718 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 23.4 p90 -148.15 145.86 28.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -100.95 105.46 16.7 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.805 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' THR . 39.1 t70 175.71 134.15 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.809 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.84 -53.97 22.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.803 0.335 . . . . 0.0 111.179 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -59.31 -39.91 84.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.999 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -61.1 -27.98 68.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.718 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.7 p -69.6 -36.29 76.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.583 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.96 -47.61 54.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.305 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.73 -54.85 40.18 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.76 77.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 86.8 t -60.86 -48.46 88.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.194 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.19 -41.21 81.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -71.85 -53.74 12.29 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 3.0 mm? -80.08 -25.57 39.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 33.9 t-20 -62.37 109.57 1.39 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.071 0.462 . . . . 0.0 111.143 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.65 -4.79 50.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.129 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.52 131.91 43.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 110.382 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 mt -127.2 105.18 13.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.986 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.521 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 69.33 29.65 71.77 Favored Glycine 0 C--N 1.312 -0.784 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.734 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.57 -19.57 43.54 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -89.26 143.93 26.47 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.571 0.224 . . . . 0.0 110.444 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.97 128.29 47.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 55.1 mt -68.77 110.6 4.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.688 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.87 111.66 23.58 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 69' ' ' VAL . 11.4 mm -113.53 141.82 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.479 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -149.78 148.91 29.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.584 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.18 121.16 23.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -133.71 160.11 38.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.649 0.261 . . . . 0.0 110.881 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -106.63 118.41 36.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.55 160.88 43.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.69 155.32 35.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.241 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 99' ' ' TYR . 32.2 Cg_exo -58.74 132.52 48.4 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.84 2.36 . . . . 0.0 113.434 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.28 142.32 34.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.093 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -71.45 -17.05 62.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.881 0.372 . . . . 0.0 111.219 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -74.99 -26.06 59.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.23 0.538 . . . . 0.0 110.371 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.93 28.56 8.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.211 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -53.81 -37.48 63.59 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.952 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.69 -23.93 65.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.424 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.467 ' OH ' ' HD2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.9 -51.73 20.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 91' ' ' PRO . 53.1 m-85 -63.27 -41.2 99.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.58 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.65 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 44.9 mt-10 -64.24 -50.16 69.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.229 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.92 68.37 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.475 HG11 ' H ' ' A' ' 40' ' ' VAL . 91.1 t -68.98 -45.29 80.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.779 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.9 ttmm -63.41 -25.26 68.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.51 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 43.8 mt-10 -59.67 -40.88 89.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.15 -25.81 58.66 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.439 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 103' ' ' LYS . 39.0 mt -74.01 -42.6 60.12 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.17 -25.23 65.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.44 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 108' ' ' ARG . 8.9 tpt180 -61.79 -33.5 74.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.44 -33.95 58.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.12 0.486 . . . . 0.0 110.014 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.447 HG23 ' C ' ' A' ' 113' ' ' LYS . 1.7 mp -62.11 -52.86 55.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t 67.74 -63.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.544 0.738 . . . . 0.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.8 t -154.24 6.5 0.3 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.087 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.447 ' C ' HG23 ' A' ' 110' ' ' ILE . 56.7 tttm -116.56 88.65 2.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -103.14 -160.06 0.76 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.563 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -51.79 -74.71 0.03 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.799 0.44 . . . . 0.0 111.068 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.73 116.93 0.07 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.42 149.63 11.86 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.988 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HB3' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.793 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.426 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 29.3 m -75.68 155.34 35.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 0.0 111.198 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -100.03 10.42 41.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.131 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 27.8 m -57.02 -27.12 61.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.314 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.807 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -90.16 112.03 23.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.992 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 74.9 mt -113.2 126.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.003 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.94 134.97 51.37 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.483 HD11 ' HG3' ' A' ' 46' ' ' GLU . 21.7 mt -137.94 139.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.593 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 2.5 mmt -135.58 133.62 20.39 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.621 0.248 . . . . 0.0 111.494 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.593 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 42.2 Cg_endo -69.91 142.95 48.62 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.313 2.009 . . . . 0.0 110.563 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -104.22 133.41 49.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.074 0.464 . . . . 0.0 111.355 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.25 86.82 2.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.138 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.517 ' HB2' HG21 ' A' ' 23' ' ' THR . 34.2 m -113.74 119.46 41.25 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 175.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 82.59 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.88 1.72 . . . . 0.0 111.178 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.8 m -72.24 -50.53 26.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.349 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.1 32.42 56.33 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 25.5 mt -59.26 -35.19 73.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.378 . . . . 0.0 111.656 -177.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.526 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.8 OUTLIER -70.11 -30.2 67.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 178.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.53 -29.06 63.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 0.0 110.008 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 61.9 mt -72.16 -20.85 61.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.931 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 28.1 mm-40 -93.81 -151.79 0.32 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.104 179.673 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.39 115.77 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.3 ttm -76.46 -14.41 60.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.985 0.422 . . . . 0.0 110.71 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.24 51.52 1.58 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.482 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -66.6 -37.72 85.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.226 0.536 . . . . 0.0 109.858 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.21 -48.0 81.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.187 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.66 -0.65 57.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.66 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.9 mttp 58.37 50.61 9.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.769 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.98 -17.27 63.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.973 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -83.22 2.96 33.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.73 99.26 4.33 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 87' ' ' THR . 89.7 m-85 -134.1 151.73 51.52 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 17.8 pt -121.88 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.952 0.406 . . . . 0.0 110.62 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.6 t80 -75.11 129.63 37.88 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.668 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -115.64 144.53 23.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.58 -169.07 44.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.761 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -54.92 117.29 3.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.545 0.738 . . . . 0.0 110.878 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.39 162.88 12.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.896 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.457 ' H ' HD12 ' A' ' 22' ' ' LEU . 8.6 m120 -64.12 149.68 47.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -71.91 -8.92 57.22 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.382 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 217' ' ' LEU . 46.7 mm-40 -97.71 -3.37 39.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.577 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 19' ' ' ASN . 17.6 mt -87.59 112.9 22.77 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.839 0.352 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.487 HG21 ' HB3' ' B' ' 213' ' ' SER . 30.2 p -98.88 173.33 6.91 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' CD ' HH12 ' A' ' 44' ' ' ARG . 2.0 mp0 -60.22 -27.47 67.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.71 -40.92 85.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 29' ' ' THR . 18.4 m-20 -67.93 -37.32 81.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' THR . 66.8 mt -60.76 -49.0 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.1 -32.5 74.09 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 27.1 m -58.77 -46.09 88.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.432 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG22 HD13 ' B' ' 218' ' ' LEU . 84.5 t -64.38 -40.52 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.89 -14.32 56.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.7 m -63.23 -19.53 64.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.54 -28.91 69.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.38 0.61 . . . . 0.0 109.893 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.28 -14.22 59.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 14.77 69.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.056 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.04 89.55 33.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.3 98.68 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.624 2.216 . . . . 0.0 110.245 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -126.23 -166.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.349 -176.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 22.4 m-20 -60.43 135.17 57.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' H ' HG11 ' A' ' 102' ' ' VAL . 6.3 p -128.44 130.48 69.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.85 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.21 102.52 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.735 0.302 . . . . 0.0 111.327 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.465 HD13 ' NH2' ' A' ' 44' ' ' ARG . 1.7 tt -91.9 124.45 36.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.6 t -74.57 121.8 22.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.078 0.466 . . . . 0.0 111.886 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.465 ' NH2' HD13 ' A' ' 42' ' ' LEU . 5.3 mpt_? -120.1 165.43 14.75 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.69 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -89.59 160.86 16.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.945 0.402 . . . . 0.0 110.05 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -80.97 -9.5 59.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.25 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -93.06 -69.78 0.73 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 t -97.72 -40.33 8.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.94 32.73 2.77 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.796 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 32.6 mm-40 -91.79 153.05 19.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.788 0.327 . . . . 0.0 110.309 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -70.53 130.99 43.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.02 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -75.96 -0.38 21.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.72 16.04 37.86 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.88 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -162.62 156.17 20.38 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.005 0.431 . . . . 0.0 111.172 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.99 171.08 14.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 66.1 m-85 -139.53 140.47 37.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 12.8 tp -120.53 139.25 53.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -125.39 115.41 20.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.0 110.505 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.722 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.8 p90 -134.23 158.21 44.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 50.9 mt-10 -100.26 105.54 17.11 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.587 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 65' ' ' THR . 11.4 t70 175.43 125.63 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.086 0.866 . . . . 0.0 108.935 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -73.04 -54.63 8.06 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.089 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -64.5 -31.41 72.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . 38.4 m -70.06 -19.79 63.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.722 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 65.4 p -67.35 -45.53 76.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.934 0.874 . . . . 0.0 109.002 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.8 mt -70.12 -41.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.28 -55.54 23.92 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.119 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -48.26 65.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 84' ' ' ILE . 90.6 t -63.59 -54.45 32.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.292 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.83 -31.71 73.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.28 -13.98 27.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.06 109.18 2.9 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.403 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.25 52.67 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.09 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -73.91 138.92 44.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 121.6 32.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 111.908 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 HD11 ' A' ' 82' ' ' LEU . 20.9 mm -127.97 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.83 35.69 91.67 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.77 -14.73 55.49 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.144 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -104.22 146.69 28.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.003 0.401 . . . . 0.0 110.527 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.32 129.46 41.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.872 0.368 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 HG13 ' A' ' 77' ' ' ILE . 77.3 mt -74.57 108.2 7.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.35 104.57 17.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 14.9 mm -106.58 141.03 22.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.611 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -150.68 153.14 35.04 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.746 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.8 119.56 22.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.8 t -160.36 161.27 33.09 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -112.32 143.93 42.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -119.4 119.87 35.21 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.845 0.355 . . . . 0.0 110.583 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.65 104.14 54.68 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.13 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.03 -178.56 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.768 2.312 . . . . 0.0 111.859 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.38 151.7 23.87 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 93' ' ' ARG . 51.5 mtm180 -66.81 -9.45 37.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -75.26 -19.4 59.74 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.24 18.29 22.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 13.9 pt20 -63.0 -25.39 68.37 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.907 0.384 . . . . 0.0 110.095 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.558 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 12.7 mptt -52.95 -39.05 62.61 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.336 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.434 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.6 t80 -63.08 -52.02 64.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -64.25 -36.34 83.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.893 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 52.5 mt-10 -65.37 -54.05 34.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.597 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.99 69.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.734 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.497 ' O ' HD13 ' A' ' 106' ' ' LEU . 92.7 t -63.43 -57.62 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.87 -41.83 98.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.838 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.63 -36.83 79.6 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.08 -33.63 65.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 102' ' ' VAL . 6.6 mp -63.78 -48.82 75.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.84 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.78 -33.34 70.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.354 0.597 . . . . 0.0 110.574 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 114' ' ' ASN . 7.7 mtp180 -70.9 -26.26 63.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.989 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.8 -37.9 23.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.4 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 106' ' ' LEU . 70.3 mt -56.99 -48.73 81.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.912 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.36 -31.27 23.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.235 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.6 m 71.23 123.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.634 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 70.03 48.51 0.53 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.715 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 108' ' ' ARG . 90.6 m-20 70.48 171.08 0.31 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.061 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.94 -86.6 0.1 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.29 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 172.15 -65.57 0.01 OUTLIER 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.567 0.747 . . . . 0.0 109.522 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -173.74 143.11 0.96 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.225 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.677 -0.677 . . . . 0.0 110.486 -177.572 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.4 m -88.91 -23.74 22.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.589 0.233 . . . . 0.0 111.15 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' B' ' 205' ' ' TYR . 61.7 mttp -73.71 -6.87 49.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.14 0.495 . . . . 0.0 111.04 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.7 m -72.02 -18.07 61.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.471 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -130.66 -56.52 1.06 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.977 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' B' ' 202' ' ' LYS . 98.6 m-85 -90.9 127.84 36.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.162 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 43.7 mm -77.41 102.16 3.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -108.15 100.53 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.15 102.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.558 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 92.0 mmm -107.73 139.84 20.99 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.976 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.46 155.71 66.15 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.689 2.259 . . . . 0.0 111.856 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.39 124.54 34.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -109.81 87.98 2.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.597 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.487 ' HB3' HG21 ' A' ' 23' ' ' THR . 33.2 t -112.36 117.73 46.83 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 15.8 Cg_exo -69.35 91.33 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.129 1.886 . . . . 0.0 111.794 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 4.2 m -76.66 -41.98 43.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.33 56.33 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.087 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 21' ' ' GLU . 65.8 mt -64.47 -36.73 85.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.343 . . . . 0.0 111.391 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.535 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -79.26 -22.83 44.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.85 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.67 10.75 39.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.755 0.312 . . . . 0.0 110.762 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -50.76 64.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.969 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.59 91.04 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.101 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.309 -1.153 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.761 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.232 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.97 -49.95 18.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.844 0.354 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.9 mtp -102.55 -37.79 7.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.49 112.24 3.81 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.301 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -78.01 -44.75 25.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.134 0.492 . . . . 0.0 110.366 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.44 -33.28 75.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -84.35 98.53 10.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.118 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -112.97 81.29 1.47 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.442 0.639 . . . . 0.0 110.823 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.424 ' O ' ' HE1' ' A' ' 12' ' ' TYR . 8.8 p-10 -88.23 -3.62 58.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.318 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -104.1 0.32 29.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.555 0.693 . . . . 0.0 109.552 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.97 99.81 12.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.144 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.551 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 50.2 m-85 -127.55 139.59 52.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.293 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.02 123.45 62.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.153 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 52.4 t80 -86.53 127.45 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 42.8 mt -109.79 141.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.96 -169.67 46.1 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.514 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -39.62 111.89 0.22 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.436 1.094 . . . . 0.0 113.87 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.52 -178.49 3.61 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.479 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.98 149.54 24.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.19 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.625 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 9.0 mpt_? -76.42 -20.14 57.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.487 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 -10.0 59.12 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.429 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.93 112.15 22.23 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.628 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 p -102.49 -178.85 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.81 0.338 . . . . 0.0 111.047 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.97 -22.41 60.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.371 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.42 53.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.101 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -69.93 -40.55 75.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.723 0.297 . . . . 0.0 110.842 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.91 -43.8 85.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.26 -36.94 82.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 48.6 m -59.69 -36.8 77.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.04 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.76 -38.69 58.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -77.03 -28.16 54.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 p -66.73 -12.72 59.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 111.093 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.06 -21.86 65.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.188 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -2.55 58.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.084 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.61 3.62 90.57 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.204 -0.522 . . . . 0.0 114.152 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -153.66 106.42 2.53 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 117.305 0.553 . . . . 0.0 112.146 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 2.6 Cg_endo -83.28 114.32 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.855 2.37 . . . . 0.0 111.785 176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.3 t -111.89 -165.6 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 18.3 m-20 -61.56 112.19 2.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.36 130.17 65.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.056 0.455 . . . . 0.0 110.618 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 mp -122.37 130.37 74.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.329 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 tp -116.65 139.52 50.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.458 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 37.2 p -73.21 103.89 4.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 7.4 tpp180 -106.89 131.85 53.52 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.78 137.46 57.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' B' ' 208' ' ' ILE . 33.0 mt-10 -80.19 -9.5 59.72 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -111.29 -58.0 2.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.816 0.341 . . . . 0.0 111.598 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 p -81.49 -40.75 22.76 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 95.05 17.64 36.87 Favored Glycine 0 N--CA 1.407 -3.299 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.659 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.95 170.37 11.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 20' ' ' ARG . 5.1 p -86.82 130.46 34.46 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 43' ' ' SER . 87.7 mt-30 -70.9 -20.69 62.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.028 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.28 -2.88 29.66 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.791 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.47 143.04 39.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.459 0.63 . . . . 0.0 110.06 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -130.92 142.52 50.37 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.424 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 119.59 22.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.03 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.5 tp -111.12 136.18 50.54 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 12.6 tmtt? -121.86 121.24 36.72 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.095 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.676 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 16.2 p90 -140.49 156.6 46.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.121 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 mp0 -100.75 105.65 17.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.902 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 12.0 t70 175.33 141.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.943 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -80.54 -51.4 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.238 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.0 -38.72 92.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.321 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 12.3 t -60.73 -28.37 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.969 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.676 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.4 p -63.73 -46.72 84.1 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 121.477 0.656 . . . . 0.0 110.027 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.69 -39.11 68.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.127 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.78 -60.41 3.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.173 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.75 83.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 86' ' ' HIS . 65.9 t -60.18 -55.08 26.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.71 -9.59 59.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -87.69 -53.91 4.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.38 -19.73 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 63.3 t30 -60.78 109.29 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.11 0.481 . . . . 0.0 111.33 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.44 33.79 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.919 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -72.87 132.91 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -93.28 123.16 36.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mt -126.57 112.7 30.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.88 23.84 69.58 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.322 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 -16.39 61.16 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.662 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -96.01 139.74 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 133.87 34.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 85.5 mt -74.72 102.77 4.75 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.05 109.14 21.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 7.1 mm -101.74 131.94 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.14 142.21 47.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.613 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.446 ' CD2' HG21 ' A' ' 69' ' ' VAL . 22.9 m-70 -72.42 112.86 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 14' ' ' TYR . 11.6 t -133.25 161.26 34.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.044 0.449 . . . . 0.0 111.036 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -114.23 99.74 7.84 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.459 0.647 . . . . 0.0 109.848 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.517 ' HB3' ' CD2' ' A' ' 12' ' ' TYR . 87.2 t80 -95.3 139.77 31.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.033 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -110.95 116.86 51.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.272 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.05 129.01 32.59 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.695 2.263 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.19 128.99 42.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.179 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -68.75 -21.12 64.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.32 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -76.1 -6.08 49.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.161 0.505 . . . . 0.0 110.365 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.4 mt -122.72 22.22 9.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -62.32 -26.18 68.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.222 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.02 -38.86 80.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.385 0.612 . . . . 0.0 109.972 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.71 -44.24 64.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.144 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.82 -43.02 97.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.693 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -69.04 -46.62 67.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.13 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.628 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.7 t -61.53 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.062 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.79 -41.8 78.36 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.087 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -65.02 -36.79 85.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.085 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.16 -39.95 68.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.685 0.278 . . . . 0.0 110.423 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -57.66 -53.8 54.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.02 -37.23 76.46 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.451 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -73.54 -36.76 65.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.737 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.12 -36.7 77.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 110.815 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 106' ' ' LEU . 76.1 mt -66.33 -44.22 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.3 t 71.75 -61.66 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.471 0.708 . . . . 0.0 111.758 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 m -90.96 101.55 14.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -71.55 -52.73 16.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.277 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -172.26 152.58 2.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.79 -11.78 58.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.358 . . . . 0.0 110.736 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.59 135.78 40.52 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 171.83 8.27 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.666 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 mttp . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.267 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.259 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 37.4 m -81.08 -1.88 45.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.359 . . . . 0.0 111.561 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -91.46 13.43 17.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.816 0.341 . . . . 0.0 111.69 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 44.9 p -82.03 21.58 0.87 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.079 0.466 . . . . 0.0 110.759 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -70.82 -2.66 15.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.335 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.52 114.99 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.47 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.7 mt -95.6 121.92 46.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -136.7 129.63 30.88 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.551 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 46' ' ' GLU . 38.2 mt -131.76 140.66 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 -177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 8.2 mmt -121.55 144.2 39.76 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.721 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 13.5 Cg_exo -71.15 170.74 17.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.912 2.408 . . . . 0.0 111.984 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -150.25 109.64 3.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.057 0.456 . . . . 0.0 111.457 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.55 89.3 6.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.951 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.6 t -110.28 142.95 27.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.62 92.31 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.81 1.673 . . . . 0.0 111.482 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.597 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 46.3 m -77.82 -48.07 17.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.704 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.96 27.2 73.38 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.69 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 7.8 mp -72.06 -20.64 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.297 0.549 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -93.2 -7.88 43.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.153 0.501 . . . . 0.0 109.902 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.67 -43.85 6.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.149 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.27 -10.14 59.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.059 0.457 . . . . 0.0 111.19 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -86.69 101.33 13.18 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.456 -179.11 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.5 -1.8 54.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.9 mmt -65.58 -42.41 91.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.883 0.373 . . . . 0.0 110.576 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.71 47.49 3.95 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.888 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -71.99 -63.87 1.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.983 0.42 . . . . 0.0 110.408 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.16 -14.54 13.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.098 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.7 p90 40.3 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.133 0.973 . . . . 0.0 113.513 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -113.5 108.1 16.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.224 0.535 . . . . 0.0 111.709 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.08 -14.76 61.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.542 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.53 16.87 2.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.778 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.73 98.48 7.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.047 0.451 . . . . 0.0 111.337 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 96.1 m-85 -141.56 148.7 39.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.956 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 pt -115.92 140.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.48 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HB2' ' CG2' ' A' ' 87' ' ' THR . 86.1 t80 -92.87 131.95 37.45 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.48 132.23 59.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.53 -167.53 43.67 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.824 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -39.74 126.28 1.93 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.517 1.127 . . . . 0.0 112.662 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.56 161.63 24.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.043 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.61 153.91 41.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.591 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -67.76 -37.59 82.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.012 0.434 . . . . 0.0 110.259 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -80.03 1.37 27.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.53 109.57 20.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 27' ' ' ILE . 81.3 p -93.35 176.16 6.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.71 -20.59 66.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.251 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.95 67.24 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' B' ' 215' ' ' SER . 0.7 OUTLIER -66.74 -35.47 80.19 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.591 0.234 . . . . 0.0 110.904 178.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 23' ' ' THR . 64.6 mt -58.32 -46.2 89.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.98 -38.13 82.35 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 55.5 m -54.7 -46.84 74.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.397 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 HD13 ' B' ' 218' ' ' LEU . 55.0 t -62.19 -47.22 94.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.281 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -74.31 -9.64 58.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -71.01 -15.32 62.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.781 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -62.98 -33.98 76.55 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.285 0.564 . . . . 0.0 109.948 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 8.3 m-85 -98.4 -13.78 20.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.962 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 78.25 60.91 2.59 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.362 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 57' ' ' LEU . 61.3 t -111.97 91.65 16.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 14.0 Cg_endo -98.49 31.84 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.503 2.802 . . . . 0.0 110.971 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -94.26 -165.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.581 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 38' ' ' VAL . 64.3 m-20 -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.95 135.97 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.099 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.47 115.5 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.931 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.37 149.13 24.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' SER . 16.8 p -73.02 107.33 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.091 0.472 . . . . 0.0 110.899 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -114.53 129.6 56.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.775 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 17.9 t70 -71.76 139.79 49.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.5 -12.73 60.03 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -102.8 -57.89 1.97 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.44 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.5 t -89.29 -20.1 24.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 74.03 20.31 79.71 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.486 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 48' ' ' THR . 48.9 mt-10 -96.37 170.3 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.861 0.331 . . . . 0.0 111.402 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' SER . 15.1 m -83.29 138.07 33.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.01 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.59 -16.25 35.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.27 23.06 7.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.448 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -156.94 154.35 29.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.18 0.49 . . . . 0.0 109.852 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.44 17.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.237 0.542 . . . . 0.0 112.434 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -134.07 131.94 39.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.526 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 36' ' ' VAL . 16.7 tp -121.66 138.61 54.27 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.804 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 57.6 tttt -120.31 113.97 21.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 33.1 p90 -139.95 148.65 42.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 9.5 tp10 -100.67 105.73 17.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 54.0 t0 174.62 122.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.328 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.34 -12.33 59.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -86.99 -49.48 7.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.091 0.472 . . . . 0.0 110.071 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 t -67.5 -22.65 65.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.062 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.679 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 1.2 p -61.79 -59.1 5.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.872 0.367 . . . . 0.0 111.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.75 -38.06 81.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.963 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 41.3 tp -57.7 -53.89 53.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.267 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.08 84.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 88.3 t -63.41 -60.41 2.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.479 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -63.65 -34.27 77.47 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -69.05 -49.5 56.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.708 0.289 . . . . 0.0 111.021 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 85.9 mt -84.68 -27.68 26.9 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -59.79 108.23 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.03 -5.66 59.54 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.868 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.8 t80 -74.31 130.24 39.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.14 124.32 28.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.568 . . . . 0.0 112.481 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -129.88 105.46 12.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.705 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.97 72.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.602 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.61 59.12 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -111.45 130.31 55.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.583 -0.309 . . . . 0.0 110.524 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -82.28 129.88 34.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.565 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.52 127.63 32.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.335 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 45.4 tptt -110.68 116.46 31.35 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mm -110.13 140.15 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.21 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.13 171.25 16.19 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -101.32 128.95 47.24 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.5 t -153.92 161.8 41.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -114.78 110.41 19.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.931 0.396 . . . . 0.0 111.347 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.0 120.17 30.81 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.321 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -98.79 139.48 21.1 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.131 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.08 138.13 60.54 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.801 2.334 . . . . 0.0 111.887 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -110.31 144.64 38.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.897 0.379 . . . . 0.0 111.694 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -55.3 -31.17 61.42 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.134 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -64.63 -22.1 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.76 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.22 21.32 17.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.108 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -56.9 -38.98 73.57 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.13 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -55.61 -43.17 75.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.853 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 102' ' ' VAL . 49.1 t80 -67.72 -45.82 73.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.506 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.06 -44.39 95.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.138 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.21 -40.88 97.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.76 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -67.96 -41.54 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.311 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 98' ' ' TYR . 72.5 t -64.61 -38.04 81.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.081 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -60.05 -39.19 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.672 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 75.2 mm-40 -61.68 -49.79 75.07 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.773 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.58 -40.67 79.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 110' ' ' ILE . 88.9 mt -65.71 -42.47 91.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 0.0 109.83 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 112' ' ' SER . 27.3 t70 -65.77 -47.92 73.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.082 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.679 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 19.1 mmt180 -63.45 -36.94 85.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.335 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.39 -38.49 84.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.975 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.584 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 70.7 mt -68.49 -50.07 59.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.668 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.584 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 8.9 p 162.05 -13.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.785 0.678 . . . . 0.0 109.833 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.558 ' HA ' ' OD2' ' A' ' 107' ' ' ASP . 10.7 t 83.5 100.35 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.133 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 113' ' ' LYS . 9.0 mtmp? -73.82 96.37 2.56 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.712 -175.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -85.32 -12.51 52.13 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.41 89.5 0.69 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.891 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.64 129.65 40.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.713 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.1 104.0 16.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.721 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm . . . . . 0 C--O 1.245 0.842 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.021 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 179.46 4.7 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -80.87 -13.19 59.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.771 0.32 . . . . 0.0 110.471 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.6 p -70.58 -10.38 59.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.692 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -66.43 -32.52 73.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.365 0.602 . . . . 0.0 109.379 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -91.47 112.54 24.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.57 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -89.74 106.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.17 0.51 . . . . 0.0 111.28 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -116.4 99.35 7.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.671 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 67.0 mt -123.41 131.09 73.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 16.9 mmt -114.31 136.0 22.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.86 169.0 15.6 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.934 2.423 . . . . 0.0 111.95 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -142.78 102.56 4.06 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.702 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -96.99 87.39 4.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.896 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.2 m -111.5 119.53 44.85 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.823 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.21 105.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.823 2.348 . . . . 0.0 112.167 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.504 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 3.6 m -96.28 -50.04 4.96 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.559 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.05 33.82 84.8 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.94 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 11.0 mp -66.94 -33.07 74.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 110.43 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -76.89 -14.24 59.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.794 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.09 -45.44 5.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.197 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.37 -53.19 8.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.861 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -82.89 -47.93 11.29 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' B' ' 218' ' ' LEU . 19.5 m . . . . . 0 C--N 1.294 -1.821 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.867 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.67 -73.53 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.358 0.663 . . . . 0.0 112.465 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.9 ttm -55.1 -53.86 50.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.884 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.16 9.84 76.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.739 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -110.07 -57.29 2.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.906 0.384 . . . . 0.0 110.649 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.3 -46.96 59.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.35 0.595 . . . . 0.0 110.228 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -100.42 35.28 2.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.479 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -61.09 -8.35 3.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.529 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.3 -2.92 14.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.945 0.402 . . . . 0.0 110.854 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 4.9 p30 -83.92 -13.43 53.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.408 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.47 96.15 10.49 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.025 0.441 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.5 m-85 -158.85 136.99 10.59 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.268 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.65 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.158 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -87.08 122.54 31.04 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 26.5 mm -95.29 135.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -168.97 45.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.966 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -40.0 107.83 0.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.152 0.981 . . . . 0.0 113.547 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.55 152.87 23.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.978 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -67.28 138.52 56.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -63.1 -19.78 64.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 0.0 111.473 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -80.59 -4.1 52.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.147 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.8 mt -83.28 139.23 33.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.914 0.387 . . . . 0.0 110.556 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -110.22 168.62 9.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.655 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.84 -27.53 68.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.44 97.73 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.708 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.63 -47.67 83.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 110.781 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.85 -46.63 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.92 -35.96 82.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.031 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.3 m -56.35 -49.29 74.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' CG2' HD22 ' B' ' 218' ' ' LEU . 95.1 t -65.18 -46.51 90.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.724 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -75.15 -22.97 57.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 m -64.6 -24.58 67.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.818 0.342 . . . . 0.0 110.478 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.08 -20.32 66.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -89.75 -2.31 58.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.603 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.44 34.69 44.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.626 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.0 89.81 37.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 111.778 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -89.06 78.27 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.636 2.224 . . . . 0.0 111.116 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -115.86 -166.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.905 -177.492 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' H ' HG12 ' A' ' 38' ' ' VAL . 4.6 p-10 -85.41 144.88 27.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -171.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.02 133.29 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.2 mp -123.68 107.91 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 43' ' ' SER . 5.0 tt -92.27 134.05 35.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 42' ' ' LEU . 19.5 m -67.92 95.52 0.54 Allowed 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -114.2 145.67 41.39 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.483 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 38.1 m-20 -61.52 150.63 35.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.215 0.531 . . . . 0.0 112.062 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB3' HD12 ' B' ' 206' ' ' ILE . 29.9 mp0 -77.13 -41.88 40.09 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.421 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.65 -59.39 2.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -85.79 -15.86 40.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 66.09 31.52 79.58 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.778 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -92.82 155.21 17.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.611 0.206 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -67.04 111.06 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.93 -20.89 60.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.047 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.71 11.12 20.02 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 120.311 -0.947 . . . . 0.0 115.052 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.25 165.51 24.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.878 0.839 . . . . 0.0 109.082 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.499 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.86 121.65 27.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.731 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.77 142.69 46.19 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.117 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -131.72 117.06 18.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.352 0.596 . . . . 0.0 111.701 179.136 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.72 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.0 p90 -129.7 156.01 44.96 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.34 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -102.15 106.15 16.96 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.731 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.2 t70 176.94 139.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.891 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -80.76 -46.56 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -75.41 -29.59 59.82 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 m -68.59 -23.02 64.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.72 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 67.2 p -61.6 -46.87 87.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.557 0.694 . . . . 0.0 109.645 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.59 -33.38 48.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.966 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 67' ' ' LEU . 7.3 tt -61.78 -52.54 63.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.14 89.44 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 79.9 t -63.3 -44.51 99.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.029 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.2 -48.66 56.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.907 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.51 -49.83 65.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.308 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.2 mt -86.57 -2.12 58.22 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.648 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 48.1 t-20 -67.73 108.96 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.93 6.69 61.78 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.421 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -72.16 121.82 19.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -83.65 117.51 23.23 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.03 113.51 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.244 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.64 76.62 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.94 -2.56 88.19 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.969 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.92 145.58 36.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.09 135.9 33.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 80.8 mt -76.06 133.68 40.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.795 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.39 113.09 15.76 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm -103.59 134.5 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.02 157.6 40.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.13 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -92.49 133.14 36.21 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -159.57 157.41 29.81 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CB ' ' HA ' ' A' ' 10' ' ' ASN . 49.6 p90 -107.07 143.08 35.73 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -149.98 138.56 20.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.998 0.428 . . . . 0.0 111.316 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -105.72 138.56 19.65 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.9 136.41 48.68 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 122.649 2.233 . . . . 0.0 113.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -77.29 137.87 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -68.81 -26.0 64.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.995 0.426 . . . . 0.0 110.826 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -77.56 -30.01 52.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.086 0.47 . . . . 0.0 110.596 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.56 18.74 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -65.26 -27.1 68.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.279 0.562 . . . . 0.0 110.132 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.87 -21.15 62.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.746 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.9 t80 -64.16 -46.42 84.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -63.65 -38.05 89.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.752 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.89 -48.09 80.51 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.958 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.6 74.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.356 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.8 t -70.64 -41.48 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.831 0.348 . . . . 0.0 110.119 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -55.54 -48.43 74.73 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.986 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.28 -23.74 67.41 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.766 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -24.66 37.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.012 0.435 . . . . 0.0 110.35 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 69.5 mt -80.93 -44.22 18.57 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.57 -9.71 51.17 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.819 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -62.46 -29.07 70.25 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.019 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.81 -36.31 80.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.597 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -70.47 -45.65 73.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.271 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.0 t 71.93 -70.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.6 t -173.96 -169.74 0.5 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.617 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -132.1 -47.91 0.93 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -151.54 117.78 5.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -134.54 -48.27 0.76 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.39 -173.79 4.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.661 0.267 . . . . 0.0 111.631 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.36 -85.69 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.677 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.315 -0.85 . . . . 0.0 109.777 179.4 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.7 m -125.73 -9.24 6.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.733 0.302 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -78.66 -23.62 45.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.4 p -83.5 3.16 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.198 0.523 . . . . 0.0 110.934 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.82 -24.28 35.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.519 0.676 . . . . 0.0 109.438 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -90.6 172.68 8.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.855 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 46' ' ' GLU . 44.1 mm -59.37 102.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.208 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -136.52 99.86 4.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.648 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 61.3 mt -103.39 123.04 56.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.502 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.2 mmt -101.99 128.61 28.24 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.875 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.51 146.14 88.79 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -120.39 116.97 26.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.522 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -100.33 86.25 3.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.35 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.8 m -113.57 119.1 42.29 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.307 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.44 103.74 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.214 1.943 . . . . 0.0 111.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' B' ' 217' ' ' LEU . 89.9 p -81.35 -32.51 32.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.88 9.25 86.67 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.527 ' HB2' ' OG ' ' B' ' 215' ' ' SER . 0.3 OUTLIER -56.86 -51.58 68.47 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.728 0.811 . . . . 0.0 111.307 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 30' ' ' VAL . 3.9 pp -84.19 -17.25 40.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.578 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.634 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.74 -12.76 58.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.045 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.98 12.89 11.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.614 -0.707 . . . . 0.0 110.211 179.154 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.85 100.78 4.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.736 0.303 . . . . 0.0 110.755 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.5 -39.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.28 125.27 0.77 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -64.48 -27.18 68.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.46 -13.51 58.94 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -123.36 13.96 9.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.189 0.519 . . . . 0.0 109.786 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -114.78 -41.44 3.38 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.9 -39.73 49.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.19 0.11 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.753 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -71.93 96.54 1.71 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -160.63 136.27 8.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.229 1.012 . . . . 0.0 109.142 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 pt -120.01 137.14 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 121.028 0.442 . . . . 0.0 110.848 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -89.4 131.5 35.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.537 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.4 mt -113.84 144.84 20.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.21 -169.16 45.5 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.285 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -65.36 112.37 3.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.788 0.328 . . . . 0.0 110.695 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 74.0 mt -93.95 177.17 6.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 0.0 111.732 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.427 ' H ' HD12 ' A' ' 22' ' ' LEU . 43.9 t-20 -69.13 138.11 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.018 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.75 -20.33 61.08 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.18 2.63 53.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.7 mt -86.67 109.61 19.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -97.41 177.7 5.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.109 0.481 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.44 -27.53 69.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.34 -42.98 89.45 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.428 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.4 m-20 -63.61 -47.24 82.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.23 -47.04 88.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.778 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.23 -41.8 98.74 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 m -60.33 -48.89 79.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.404 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' ASP . 74.9 t -54.7 -47.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.436 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.72 -22.63 37.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -64.76 -26.73 68.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.403 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.66 -16.05 63.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.467 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.87 -4.49 59.18 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.1 0.476 . . . . 0.0 110.249 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.37 17.04 78.74 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.377 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.88 90.18 51.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.716 0.293 . . . . 0.0 110.24 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.89 105.51 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.019 2.479 . . . . 0.0 112.094 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.2 t -132.48 -166.57 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.564 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.9 t70 -70.84 140.21 51.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.07 136.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.35 100.84 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.618 0.246 . . . . 0.0 111.629 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -85.94 112.98 21.69 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.8 t -65.83 118.59 9.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.4 0.619 . . . . 0.0 111.837 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -133.95 155.79 49.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.604 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 48' ' ' THR . 32.3 t70 -73.11 135.41 44.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.873 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' B' ' 208' ' ' ILE . 38.1 mt-10 -69.94 -18.72 63.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -96.36 -61.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.672 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.0 t -84.36 -33.25 23.87 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.65 60.99 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.827 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' H ' HG23 ' A' ' 48' ' ' THR . 12.9 pt-20 -71.21 155.34 40.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.099 0.449 . . . . 0.0 110.367 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 m -68.15 138.69 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.89 -8.89 59.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.099 0.476 . . . . 0.0 111.074 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.43 30.41 7.73 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.329 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -170.61 170.8 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.68 170.82 19.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.72 155.96 49.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.175 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.77 140.26 34.75 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.66 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 49.9 tttp -123.13 115.34 21.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.909 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 8.2 p90 -132.91 143.2 49.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -102.89 107.57 18.45 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.521 -0.871 . . . . 0.0 113.194 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 65' ' ' THR . 29.2 t70 178.61 143.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.883 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.98 -35.01 38.14 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -83.06 -35.52 25.65 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.093 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.8 t -57.6 -29.9 64.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.413 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.605 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 75.4 p -59.43 -52.76 64.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.478 0.656 . . . . 0.0 109.423 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.5 -46.07 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.953 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 tp -50.06 -58.58 5.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.936 0.773 . . . . 0.0 111.562 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.628 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 97.3 t -66.99 -57.85 8.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.527 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.22 -18.04 64.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.561 -0.456 . . . . 0.0 112.15 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -90.5 -55.8 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.989 0.423 . . . . 0.0 111.308 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 92.1 mt -91.34 -17.38 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.79 109.05 2.74 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.436 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.13 2.62 64.12 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.105 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 61.0 t80 -76.87 143.39 39.69 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 1.8 tppp? -94.61 114.23 26.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.901 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 82' ' ' LEU . 16.4 mt -129.6 117.65 42.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.26 35.18 76.45 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.324 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.67 22.26 75.19 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.758 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 24.9 mtp180 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 122.635 -0.332 . . . . 0.0 110.694 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -98.76 135.79 39.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.933 0.397 . . . . 0.0 111.46 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.527 HD11 HD12 ' A' ' 77' ' ' ILE . 41.2 mt -85.54 122.27 29.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.617 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.0 107.45 19.4 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -108.25 124.36 64.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.966 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -136.26 149.99 48.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -77.64 124.39 27.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 t -149.39 162.01 40.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.613 0.244 . . . . 0.0 110.966 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -114.96 108.86 17.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.22 139.8 50.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.297 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -107.47 132.27 21.1 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.74 133.73 46.67 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.969 2.446 . . . . 0.0 112.583 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -76.78 131.98 38.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -70.65 -20.92 62.67 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 p -74.58 -14.46 60.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.786 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.416 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 94.9 mt -113.72 25.12 11.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.855 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -56.79 -35.03 68.24 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 63.3 mmtt -55.76 -46.07 77.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.128 0.49 . . . . 0.0 110.638 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.39 -53.78 50.01 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.066 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 95' ' ' LEU . 77.2 m-85 -59.09 -44.69 91.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -68.52 -32.88 73.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.458 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -67.22 -46.71 73.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.18 -39.79 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.16 0.505 . . . . 0.0 109.946 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -57.02 -54.23 49.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.673 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.24 -28.19 67.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 24.1 mm-40 -64.8 -51.95 59.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.0 110.854 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 -27.01 56.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.1 t70 -58.01 -27.25 63.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -59.52 -27.06 65.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.41 -36.8 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.161 0.505 . . . . 0.0 109.897 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 114' ' ' ASN . 58.2 mt -73.63 -36.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.952 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.6 t -59.47 -30.28 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.427 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.6 t -78.47 88.25 4.44 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 62.51 94.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.205 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 63.9 t30 -123.98 63.1 1.07 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.189 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 70.09 -48.86 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.71 114.71 4.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.953 0.406 . . . . 0.0 111.834 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.71 155.48 50.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 tttp . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.22 179.384 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 22.2 t 73.1 159.2 0.22 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.996 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -117.9 0.11 11.83 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.655 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 25.8 p -68.34 -20.4 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.625 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -61.49 -29.72 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.973 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.77 118.03 18.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.976 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.8 mt -108.76 112.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -140.64 104.37 4.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.791 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 46' ' ' GLU . 63.9 mt -134.85 100.1 2.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.354 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 80.0 mmm -103.87 136.11 19.25 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.4 156.08 62.46 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.921 2.414 . . . . 0.0 113.24 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.85 117.56 7.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -87.47 89.63 8.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.19 0.519 . . . . 0.0 111.142 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 1.0 OUTLIER -91.49 143.24 27.82 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.009 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 214' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 28.4 Cg_endo -96.15 84.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 18.7 t -71.97 -47.04 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 84.97 17.22 63.58 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.828 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 91.4 mt -60.31 -33.21 72.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.502 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -66.42 -35.09 79.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.266 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.07 -27.91 57.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.346 0.593 . . . . 0.0 110.703 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 73.2 mt -76.5 -3.38 37.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.18 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.3 mm-40 -94.17 9.29 38.46 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.75 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.722 179.3 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.424 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.73 83.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.153 0.581 . . . . 0.0 111.632 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.33 -52.6 61.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.474 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.25 -10.53 6.1 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.523 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -64.11 -18.39 64.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.75 4.32 19.89 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 52.47 35.56 17.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.076 0.55 . . . . 0.0 112.164 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -62.71 -26.68 68.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.578 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.99 -22.01 64.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.601 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -97.99 6.19 47.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.485 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.77 99.4 2.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 8.8 m-85 -125.38 154.49 41.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.397 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.58 139.09 52.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.737 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -99.08 123.37 43.33 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.31 141.65 18.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.32 -168.82 45.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.64 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 t30 -48.47 110.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.51 0.724 . . . . 0.0 112.743 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.94 177.62 5.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.24 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' HD13 ' A' ' 22' ' ' LEU . 37.5 t-20 -80.66 142.82 33.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -57.19 -26.39 60.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.585 0.354 . . . . 0.0 111.64 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.99 -10.69 59.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.957 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HD13 ' B' ' 217' ' ' LEU . 6.3 mp -87.28 110.07 19.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.071 0.463 . . . . 0.0 111.018 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.5 p -94.08 172.67 8.08 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.633 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -63.9 -22.59 66.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.289 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.98 -41.03 95.5 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.973 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 29' ' ' THR . 28.8 t70 -75.36 -36.84 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.985 0.421 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.23 -41.04 85.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.633 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.34 -38.94 92.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.303 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 17.4 m -58.02 -45.05 87.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.457 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 26' ' ' ASP . 88.9 t -56.83 -50.14 76.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.29 -16.81 58.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.6 m -72.46 -13.75 61.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.49 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -83.63 -11.03 57.81 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.83 72.94 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.909 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.15 89.63 48.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.58 95.82 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.86 2.373 . . . . 0.0 110.513 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -118.86 -166.7 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.229 -177.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.496 ' H ' HG12 ' A' ' 38' ' ' VAL . 25.0 m-20 -68.13 114.7 6.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.961 0.41 . . . . 0.0 111.997 -172.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.68 127.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.704 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.09 113.19 39.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.488 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' PHE . 59.9 tp -87.26 133.61 33.65 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.497 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 38.6 m -68.73 102.84 1.6 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -123.55 154.57 39.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.968 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 47' ' ' ASN . 5.6 p-10 -84.77 152.09 23.93 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.323 0.582 . . . . 0.0 111.354 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.57 ' HG2' HD12 ' B' ' 206' ' ' ILE . 1.3 mp0 -81.13 -9.88 59.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.413 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 16.4 m120 -83.06 -67.33 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.574 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 t -104.42 -30.55 10.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.56 46.62 4.26 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.62 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.63 164.5 11.71 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.778 0.289 . . . . 0.0 110.693 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -79.55 106.18 11.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.856 0.36 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.3 -33.68 75.79 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.16 31.91 2.95 Favored Glycine 0 C--O 1.218 -0.892 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.997 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.498 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.2 m-85 -135.37 157.32 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.98 29.99 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.997 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -121.07 119.11 31.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.51 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 27.8 tp -115.54 139.77 49.77 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.092 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 1.7 tmtp? -124.14 112.68 17.38 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.183 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.774 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -129.71 150.73 50.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.72 105.34 16.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.203 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 176.2 143.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.425 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -80.76 -48.98 11.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 64' ' ' SER . 2.6 ptp180 -67.16 -33.71 76.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 63' ' ' ARG . 46.9 m -63.65 -27.45 69.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.086 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.774 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 68.9 p -63.29 -48.43 78.13 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.693 0.759 . . . . 0.0 110.08 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.68 -38.64 45.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.29 -52.6 64.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.12 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -43.09 76.85 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.362 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 65' ' ' THR . 90.9 t -61.87 -59.82 3.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.297 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.38 -22.16 66.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.28 -45.67 15.89 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.76 0.314 . . . . 0.0 111.146 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -97.83 -20.41 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.84 110.13 1.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.77 -0.88 56.6 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.495 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -77.58 123.79 27.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -88.99 117.51 28.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.172 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.442 HD13 ' CD2' ' B' ' 218' ' ' LEU . 57.2 mt -121.57 115.77 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.064 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.22 35.28 69.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.716 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.31 13.55 78.51 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.097 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -128.8 130.7 47.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.912 0.356 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.88 133.02 33.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 89.5 mt -79.11 128.04 32.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.596 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -123.93 118.18 26.47 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -107.92 126.43 64.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -123.25 142.87 50.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.975 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -84.79 106.75 16.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.769 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 136.52 21.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.852 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -80.67 156.84 26.14 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.39 137.86 32.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.604 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 80.3 mtp180 -94.5 120.57 64.89 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.731 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 30.0 Cg_exo -62.66 110.57 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.531 2.154 . . . . 0.0 111.481 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.55 140.19 44.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -70.09 -31.05 68.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.416 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 p -79.87 -11.42 59.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 48.9 tp -105.16 8.22 34.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -62.09 -20.1 63.66 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -59.15 -41.62 88.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.631 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 3.5 t80 -69.37 -45.62 68.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -58.08 -50.09 74.67 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.568 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -61.65 -46.34 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.333 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.9 86.42 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.427 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.6 t -74.25 -39.83 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.221 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.76 -45.02 94.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.62 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.83 -29.94 71.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 111.054 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.97 -37.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 70.8 mt -68.82 -39.62 79.94 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.4 -21.34 66.66 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.792 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -65.14 -17.81 64.78 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.504 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.59 -32.54 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.424 0.63 . . . . 0.0 109.719 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.42 -25.9 5.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.914 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.6 t 73.25 -60.7 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.861 0.864 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 p -153.32 -67.2 0.15 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.365 0.602 . . . . 0.0 109.544 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -136.87 17.03 3.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.29 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 63.7 t30 69.12 96.01 0.07 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -74.15 85.16 1.85 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.657 0.742 . . . . 0.0 112.837 -173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.92 12.84 28.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.251 174.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.22 156.16 39.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.22 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.314 179.45 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.227 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -95.37 -28.96 14.7 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.14 -13.41 58.06 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 64.7 m -80.43 -11.33 59.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.686 0.279 . . . . 0.0 111.334 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.6 -3.05 50.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.251 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -86.0 138.4 32.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.947 0.403 . . . . 0.0 110.317 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 46' ' ' GLU . 22.4 mm -90.56 98.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.238 0.542 . . . . 0.0 111.191 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -109.69 98.94 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.534 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 68.6 mt -128.51 110.09 20.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.071 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.7 mmt -84.19 118.63 71.72 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.916 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.48 164.98 10.15 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.112 2.542 . . . . 0.0 112.608 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -122.25 94.86 4.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.752 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -84.22 88.62 7.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.321 0.581 . . . . 0.0 110.118 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 23.8 m -109.84 157.08 38.69 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.733 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.39 59.98 2.56 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.911 2.407 . . . . 0.0 112.183 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' SER . . . . . 0.597 ' O ' HD12 ' B' ' 217' ' ' LEU . 73.6 m -78.68 33.24 0.21 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.241 0.616 . . . . 0.0 111.456 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.94 58.84 0.37 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.56 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.597 HD12 ' O ' ' B' ' 215' ' ' SER . 5.0 mp -64.85 -27.86 69.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.0 pp -100.73 -7.63 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.753 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.18 -53.0 3.25 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.24 0.82 38.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' B' ' 217' ' ' LEU . 26.7 mm-40 61.24 28.48 18.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.16 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.448 -177.831 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.268 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.61 -21.36 59.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.495 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.0 mmm -78.53 -6.97 56.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.25 63.41 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.272 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -65.5 -29.38 70.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.11 6.37 48.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -122.29 10.8 9.98 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.632 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -76.01 -11.5 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.955 0.407 . . . . 0.0 110.924 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.34 -7.83 58.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.59 6.66 44.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.088 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 97.88 4.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.729 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 7.0 m-85 -154.23 136.63 14.98 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.209 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 pt -108.42 137.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.899 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 89.4 t80 -94.6 134.76 36.82 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.059 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.56 138.53 45.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.39 -167.62 43.44 Favored Glycine 0 C--N 1.32 -0.312 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.344 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.508 ' OD1' ' HD2' ' A' ' 80' ' ' ARG . 6.3 p30 -48.19 139.42 8.44 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.302 0.572 . . . . 0.0 112.0 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.46 -176.99 3.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.071 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.36 147.67 22.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HD3' ' OE1' ' A' ' 50' ' ' GLU . 75.8 mtt180 -70.89 -15.75 62.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.91 1.61 56.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.407 . . . . 0.0 110.116 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD23 HD12 ' B' ' 217' ' ' LEU . 1.8 tm? -97.77 118.48 34.43 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.6 p -109.95 176.61 5.0 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 111.983 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.5 mp0 -58.16 -31.77 67.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.913 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.69 98.86 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.049 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.96 -45.02 64.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.4 mt -55.72 -46.46 79.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.724 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -41.32 96.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.836 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -56.82 -46.55 81.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.649 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.429 HG22 HD13 ' B' ' 218' ' ' LEU . 53.0 t -57.56 -49.44 80.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.466 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.37 -15.91 58.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -68.41 -15.68 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.07 -33.66 73.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.357 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.26 -0.27 56.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.731 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.22 56.78 23.32 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.559 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 38' ' ' VAL . 8.0 p -151.23 89.7 4.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-O 121.694 0.759 . . . . 0.0 111.381 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.39 100.08 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 112.156 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -131.56 -165.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.555 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.679 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.8 t70 -66.95 131.51 46.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.83 131.47 42.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.551 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.41 108.98 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 tp -94.5 126.93 40.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -77.83 95.43 4.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.435 0.636 . . . . 0.0 111.039 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -104.73 141.56 36.25 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.577 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.97 144.64 11.45 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.173 0.589 . . . . 0.0 111.92 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HA ' HD11 ' B' ' 208' ' ' ILE . 13.5 mp0 -72.75 -26.82 61.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.072 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -74.69 -66.2 0.77 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -115.24 -24.7 8.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.409 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.85 28.14 4.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.623 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 20' ' ' ARG . 18.0 mm-40 -69.6 139.15 53.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.018 0.409 . . . . 0.0 110.519 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 m -56.93 116.65 3.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -74.01 -14.49 61.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.694 0.283 . . . . 0.0 111.673 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 31.41 6.21 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.496 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.53 154.72 4.71 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.647 0.26 . . . . 0.0 110.69 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.55 165.51 34.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -133.83 138.25 45.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.865 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.81 137.17 48.02 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.471 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.659 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.8 ttmt -123.88 121.61 35.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.688 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.4 p90 -136.41 160.98 37.09 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -101.13 104.2 15.29 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 173.99 140.23 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.279 1.432 . . . . 0.0 108.146 172.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -80.21 -46.11 16.86 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -71.22 -35.52 71.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.695 0.283 . . . . 0.0 111.24 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 t -59.02 -26.84 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.49 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.688 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 38.0 p -63.45 -38.52 91.45 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.463 0.649 . . . . 0.0 109.427 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.4 mt -77.3 -33.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.66 -55.44 32.09 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.93 87.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.461 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 65' ' ' THR . 74.7 t -59.54 -54.29 36.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 120.849 0.357 . . . . 0.0 111.308 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -70.2 -31.95 69.64 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.01 -41.23 14.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.497 ' HB2' HG13 ' A' ' 84' ' ' ILE . 3.0 mm? -89.21 -22.92 22.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 39.2 t30 -56.83 112.83 1.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.828 0.347 . . . . 0.0 111.526 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.89 -7.88 55.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.215 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -66.84 130.27 42.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.994 0.397 . . . . 0.0 110.074 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 31.4 mmmt -86.64 119.32 26.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.21 118.17 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.573 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.62 36.17 92.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.947 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.98 51.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.935 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 17' ' ' ASN . 9.5 mmt180 -105.54 156.02 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.633 -0.334 . . . . 0.0 110.726 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.56 128.6 52.58 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 78.6 mt -63.48 106.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.29 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -89.11 105.66 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 72' ' ' LEU . 17.1 mm -114.7 137.93 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.77 -179.3 7.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -90.46 149.51 22.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -159.89 161.26 34.31 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -108.07 119.95 40.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -131.89 141.33 49.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.05 0.452 . . . . 0.0 111.372 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 3.4 mmp_? -117.23 114.48 38.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.5 135.12 54.48 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.915 2.41 . . . . 0.0 111.955 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.447 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 45.8 mmtm -93.52 128.81 39.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.589 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -71.76 -15.76 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.089 0.471 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -72.83 -25.23 61.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.382 0.611 . . . . 0.0 109.677 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.8 mt -102.78 27.98 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -55.4 -33.45 63.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.207 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 28.5 mmtp -59.12 -49.73 76.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 102' ' ' VAL . 12.2 t80 -59.88 -45.91 90.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.582 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 22.9 m-85 -64.0 -46.91 82.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -62.58 -37.52 86.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.598 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.44 85.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 110.477 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 73.7 t -71.87 -40.24 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.196 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -56.8 -48.36 78.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.193 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.71 -27.03 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 111.03 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 7.6 tp10 -68.15 -42.24 80.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 84.4 mt -69.24 -34.43 74.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.537 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.43 -44.48 89.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 6.1 ppt_? -76.69 -9.89 58.99 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.816 0.341 . . . . 0.0 111.211 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -88.05 -35.99 17.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 106' ' ' LEU . 72.2 mt -66.84 -35.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.161 176.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.07 109.19 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.232 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.1 t -81.21 -173.65 4.45 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.959 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HE2' ' OD1' ' A' ' 115' ' ' ASN . 54.2 mtpt -77.76 137.19 38.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.072 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' HA ' ' HG2' ' A' ' 117' ' ' GLU . 3.2 p-10 -85.31 15.23 4.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' A' ' 113' ' ' LYS . 16.8 m120 -60.28 -34.01 73.14 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.78 -0.93 28.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.387 . . . . 0.0 111.042 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 114' ' ' ASN . 36.8 mm-40 -91.4 -51.01 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.136 0.493 . . . . 0.0 110.432 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.832 -178.864 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 20.1 m 60.22 29.1 18.72 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.946 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.58 -20.14 64.5 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.037 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.5 m -111.5 13.83 21.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.796 0.332 . . . . 0.0 110.967 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -91.29 0.29 57.55 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.555 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -74.11 169.23 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.739 0.304 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.96 112.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 207' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 13.2 t70 -112.09 112.99 25.01 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.085 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 46' ' ' GLU . 44.6 mt -123.6 135.27 63.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.987 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.58 135.69 23.77 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.852 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' PRO . . . . . 0.404 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.4 Cg_endo -74.17 152.43 45.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.731 2.287 . . . . 0.0 112.729 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -125.88 103.77 7.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' PHE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 49.8 m-85 -90.21 86.47 6.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.304 0.574 . . . . 0.0 110.09 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 16.8 p -111.85 134.98 21.22 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.576 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 214' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 7.6 Cg_exo -73.27 92.5 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.969 1.779 . . . . 0.0 111.089 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 5.1 m -77.9 -39.94 41.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.51 25.03 61.69 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.427 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 22' ' ' LEU . 17.9 mt -60.79 -32.11 71.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.175 0.488 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.541 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -75.62 -38.58 58.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.74 -44.67 66.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.9 -8.38 59.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.755 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 58.44 60.45 2.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.215 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.253 1.237 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.426 -179.938 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.98 -24.66 52.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.697 0.284 . . . . 0.0 111.203 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 26.2 mmt -77.14 -48.88 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.53 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.32 157.17 32.16 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -73.42 -40.65 64.08 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.927 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -110.37 10.47 23.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.351 . . . . 0.0 111.345 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 3' ' ' MET . 17.8 m-85 66.95 136.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -103.27 -15.96 15.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.71 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -85.97 3.18 43.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.041 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -94.01 -0.13 55.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.272 0.558 . . . . 0.0 110.323 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -81.22 98.58 8.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.685 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 58' ' ' LYS . 36.3 m-85 -149.79 132.49 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.97 0.908 . . . . 0.0 108.715 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.86 128.63 69.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.347 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -91.19 130.98 37.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.286 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 52.0 mt -112.45 143.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.88 -177.15 50.15 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.39 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.6 t-20 -54.64 105.9 0.18 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.897 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.71 -173.07 3.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.519 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -79.2 144.37 34.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -70.41 -22.7 62.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.054 0.454 . . . . 0.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.98 2.47 30.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.45 130.77 38.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 p -109.17 170.49 8.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.294 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.2 -28.75 68.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.146 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.16 99.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.537 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -66.47 -48.13 70.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.12 -45.62 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.073 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.45 -36.93 85.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.062 0.458 . . . . 0.0 110.065 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -60.67 -44.35 96.58 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.81 -47.33 93.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.764 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -75.81 -9.71 58.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.734 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.4 t -70.72 -17.16 62.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -73.51 -21.91 60.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -99.14 -20.45 16.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 83.87 50.47 4.39 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.547 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.52 94.64 28.56 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.597 0.237 . . . . 0.0 111.263 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 26.2 Cg_endo -98.65 30.02 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.416 2.744 . . . . 0.0 111.445 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -92.0 -166.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.519 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -63.58 139.68 58.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -135.8 120.1 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.566 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.86 136.76 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.013 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' PHE . 60.0 tp -128.03 134.15 49.19 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.9 p -65.32 99.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' B' ' 208' ' ' ILE . 22.4 tpp180 -113.63 124.28 51.95 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 48' ' ' THR . 23.5 t70 -71.55 136.79 47.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 110.79 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' HD11 ' B' ' 208' ' ' ILE . 12.8 mt-10 -72.13 -26.67 62.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.15 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.418 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 26.0 m-80 -81.59 -65.59 0.99 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.157 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.56 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.1 t -87.47 -21.22 25.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.619 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 80.83 19.51 67.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.756 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' H ' HG23 ' A' ' 48' ' ' THR . 40.0 mt-10 -101.14 163.43 12.28 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.556 0.217 . . . . 0.0 111.108 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -78.4 141.42 38.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -89.04 -6.84 56.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.74 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 100.59 -7.1 57.68 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.277 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -107.95 148.22 29.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 118.027 0.913 . . . . 0.0 110.574 -177.071 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -135.22 150.5 50.11 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.75 119.38 17.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 tp -106.62 140.76 38.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.551 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 12' ' ' TYR . 7.8 tmtm? -129.42 108.84 10.59 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.755 0.788 . . . . 0.0 112.032 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 4.7 p90 -119.7 156.24 30.87 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.01 105.81 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.562 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 178.22 145.66 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.161 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.01 -45.6 16.33 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.09 -32.96 50.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -55.64 -30.53 61.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.384 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.723 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.1 p -61.39 -52.36 64.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.501 0.667 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.1 mt -63.53 -36.97 78.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.667 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 tt -62.08 -58.68 6.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.221 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.88 86.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.048 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 65.6 t -61.14 -46.57 96.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -78.23 -40.12 38.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -66.94 -50.43 62.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.484 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.64 -4.86 57.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 25.9 t-20 -63.54 109.41 1.64 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.496 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 -2.83 65.33 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.163 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.9 127.15 30.88 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -88.14 115.0 25.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.262 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.6 mt -120.63 109.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.64 25.49 75.63 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 -16.01 59.55 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.461 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -97.11 132.7 42.64 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.837 0.351 . . . . 0.0 111.208 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.83 135.68 35.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.239 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.72 133.22 45.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.423 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 12.7 mptt -107.52 116.78 32.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.405 HG22 HG22 ' A' ' 69' ' ' VAL . 3.4 mm -117.31 138.6 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.53 166.73 30.25 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -88.56 140.14 29.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 15.2 t -153.72 161.55 42.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.661 0.267 . . . . 0.0 110.855 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -116.36 104.69 11.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -115.92 150.04 37.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -125.42 135.57 27.09 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.114 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.87 122.4 10.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.923 2.416 . . . . 0.0 112.214 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -69.21 135.24 50.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.697 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -60.88 3.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -74.14 -22.3 59.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.03 0.443 . . . . 0.0 112.087 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.87 6.06 45.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.333 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.92 -22.36 62.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.553 0.216 . . . . 0.0 111.419 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -58.99 -39.55 82.14 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.652 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.96 -35.96 79.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -66.66 -50.07 64.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.1 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 44.9 mt-10 -65.32 -42.95 92.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.04 -47.49 80.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.547 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.414 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.8 p -71.89 -33.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.571 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -65.81 -39.21 90.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 18.7 mm-40 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.894 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.86 -48.18 77.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.535 ' O ' HG13 ' A' ' 110' ' ' ILE . 11.0 mp -63.12 -45.17 93.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.134 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.51 -41.64 73.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.082 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -70.14 -41.69 73.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.96 -37.93 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.378 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 106' ' ' LEU . 85.3 mt -56.7 -40.81 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.114 0.483 . . . . 0.0 110.194 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.9 t -73.91 -55.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.65 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.5 m 69.94 169.18 0.3 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.62 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -95.12 158.82 15.3 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.018 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -84.62 94.74 8.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -117.25 100.07 7.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.454 0.645 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.72 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.57 11.35 37.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.335 0.588 . . . . 0.0 109.864 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 117.809 -1.091 . . . . 0.0 108.579 -179.894 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -107.25 35.03 3.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.985 0.422 . . . . 0.0 110.586 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.0 -20.51 65.95 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 32.0 t -110.81 3.0 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.815 0.34 . . . . 0.0 110.5 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -130.74 23.37 5.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.555 0.693 . . . . 0.0 110.134 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -79.29 135.42 36.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.583 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.2 mt -110.32 112.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.346 0.593 . . . . 0.0 110.131 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.09 98.82 3.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.23 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' ILE . . . . . 0.488 HG21 ' HG2' ' A' ' 44' ' ' ARG . 62.5 mt -138.46 123.41 22.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.4 mmt -100.84 149.97 36.63 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.172 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.88 163.29 37.38 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.678 2.252 . . . . 0.0 111.714 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -130.17 126.32 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.275 0.559 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -111.2 90.7 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.494 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 72.3 m -110.42 147.58 36.65 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.99 52.54 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.708 2.272 . . . . 0.0 111.257 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.1 m -54.29 -50.15 67.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.938 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.73 47.7 59.93 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.882 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.76 -15.22 59.27 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.405 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.518 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.56 -15.82 55.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.909 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -9.41 59.06 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.227 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.62 -22.27 63.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.03 80.54 6.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.474 0.654 . . . . 0.0 109.793 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.314 -0.977 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.283 -179.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 4.6 p90 -157.97 -179.59 8.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.219 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -102.65 144.27 13.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 40.4 t80 -101.97 124.96 48.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.525 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 mp -102.38 139.25 23.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.06 -169.78 46.29 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.124 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HB2' ' NH2' ' A' ' 80' ' ' ARG . 11.6 m120 -45.51 112.23 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.63 0.772 . . . . 0.0 112.553 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.4 mt -104.42 168.9 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.201 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.17 140.31 58.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -64.55 -17.24 63.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.896 0.379 . . . . 0.0 110.561 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' B' ' 217' ' ' LEU . 63.9 mm-40 -82.68 -11.6 58.23 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.93 128.27 34.55 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.8 p -110.43 176.56 5.0 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.489 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.8 mp0 -57.42 -30.33 64.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.634 0.373 . . . . 0.0 111.137 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.64 94.96 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.644 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -67.83 -42.39 81.52 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.088 0.471 . . . . 0.0 109.866 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.08 -47.84 88.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.787 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.46 -32.57 74.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 109.874 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -63.71 -41.27 98.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.0 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.65 -46.81 93.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.031 0.443 . . . . 0.0 110.456 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CG ' HD22 ' A' ' 57' ' ' LEU . 60.4 m-85 -73.81 -13.07 60.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.08 -16.48 63.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.395 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.46 -39.56 84.06 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.916 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -85.29 -16.02 41.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.669 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 27.44 73.47 Favored Glycine 0 N--CA 1.454 -0.155 0 CA-C-N 115.877 -0.602 . . . . 0.0 113.327 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.08 97.36 42.15 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.13 101.74 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.079 2.519 . . . . 0.0 112.564 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -137.13 -166.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.4 m-20 -60.2 140.9 56.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.2 p -138.9 128.95 32.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.52 118.62 52.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.784 0.326 . . . . 0.0 111.065 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -109.11 128.69 55.21 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 23.9 m -70.03 108.24 3.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.972 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -126.71 143.3 51.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.693 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 16.2 t70 -53.7 138.47 35.05 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.763 0.665 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' B' ' 208' ' ' ILE . 2.4 mp0 -69.54 -13.93 62.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.25 -55.72 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.059 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.517 HG23 ' HG2' ' A' ' 50' ' ' GLU . 3.6 t -101.55 -5.34 25.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.02 18.71 76.6 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.892 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.5 mm-40 -56.28 134.18 53.17 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.916 0.358 . . . . 0.0 111.283 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.0 m -66.2 107.98 2.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -71.33 -19.17 62.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.661 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.88 -0.12 51.95 Favored Glycine 0 C--O 1.221 -0.67 0 C-N-CA 120.747 -0.74 . . . . 0.0 114.452 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 4.0 m-85 -108.99 129.83 55.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.551 0.675 . . . . 0.0 109.592 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -125.83 149.73 48.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.025 0.441 . . . . 0.0 111.365 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 20.3 m-85 -137.9 148.8 45.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.281 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.2 tp -140.66 115.23 9.47 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.531 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 12' ' ' TYR . 1.5 tmtp? -100.25 114.11 27.3 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.265 0.555 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 42.7 p90 -132.06 143.73 50.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.165 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -101.06 106.81 18.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.24 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 65' ' ' THR . 21.0 t70 175.27 109.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.599 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -64.07 -47.18 81.15 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.339 0.59 . . . . 0.0 110.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 m -67.37 -25.42 65.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.534 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.2 p -62.77 -61.2 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.12 -34.98 62.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.59 -61.01 2.83 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.131 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.84 91.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 73.7 t -58.95 -51.59 70.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 120.586 0.231 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.58 -36.77 68.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.828 0.347 . . . . 0.0 111.334 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.56 -43.83 72.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.88 -18.17 31.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 32.9 t-20 -65.06 109.49 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.069 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.9 -2.44 52.04 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -81.13 132.08 35.34 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -88.86 132.26 34.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.146 0.498 . . . . 0.0 112.214 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.1 mm -129.22 101.76 6.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.79 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.43 23.59 77.87 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.458 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 -15.78 60.5 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.043 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.412 ' NH2' ' HB2' ' A' ' 17' ' ' ASN . 30.3 mmm180 -94.86 110.2 22.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.616 0.246 . . . . 0.0 111.596 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 83' ' ' LYS . . . -68.41 127.69 33.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.23 117.88 16.54 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.635 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 81' ' ' ALA . 10.8 mptt -100.84 110.75 22.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 20.5 mm -103.16 121.65 54.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.727 0.298 . . . . 0.0 111.423 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -116.53 166.6 11.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.858 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -96.35 136.43 36.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.3 t -161.24 160.8 30.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.758 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.53 138.99 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.911 0.386 . . . . 0.0 110.175 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 15.6 t80 -149.88 135.24 18.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -96.28 112.32 59.42 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.249 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.54 115.35 2.99 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.564 ' HD3' ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -73.91 144.84 45.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.916 0.388 . . . . 0.0 110.376 178.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -72.94 -13.42 61.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.371 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -68.52 -17.08 64.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.112 0.482 . . . . 0.0 110.063 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 tp -123.01 24.83 8.8 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -58.7 -32.49 69.22 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.172 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.42 -32.63 71.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.531 0.205 . . . . 0.0 111.513 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.55 -55.69 16.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -64.49 -34.5 78.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.73 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 34.0 tt0 -65.6 -41.52 92.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.136 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.61 -30.24 70.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 110.019 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.418 HG11 ' H ' ' A' ' 40' ' ' VAL . 86.2 t -68.23 -48.48 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -70.84 -12.74 61.72 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 25.5 mm-40 -61.26 -35.13 76.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -83.23 -26.16 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.58 -14.99 44.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.696 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -178.102 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 121.325 0.583 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 46' ' ' GLU . 24.4 mt -134.55 117.22 23.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.482 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.1 mmt -114.54 117.95 42.02 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.411 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.2 Cg_exo -50.35 133.65 37.05 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.191 2.594 . . . . 0.0 112.512 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -123.27 108.24 12.56 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.699 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -88.96 88.86 7.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 61.7 m -112.55 155.17 44.22 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.753 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -100.87 112.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.747 2.298 . . . . 0.0 112.044 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.3 p -78.89 -43.41 24.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 109.822 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.18 72.86 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.211 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 21' ' ' GLU . 42.4 mt -58.29 -36.39 73.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.13 -9.59 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.081 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.29 0.567 . . . . 0.0 110.558 -177.894 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.973 0 CA-C-O 121.123 0.487 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 33.4 m-85 -134.74 166.69 22.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 pt -141.92 138.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -85.47 116.81 24.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.477 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.48 130.92 35.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . -86.42 -168.27 44.6 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.25 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 12.4 t30 -39.69 101.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.944 0.898 . . . . 0.0 112.964 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 16' ' ' GLY . 77.3 mt -97.94 -173.8 2.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.345 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.08 139.58 35.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 20' ' ' ARG . 5.7 ptp180 -64.89 -17.39 64.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.654 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.69 -6.38 58.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 0.0 110.517 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.2 tp -90.59 110.7 21.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.1 p -98.27 172.95 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -57.99 -32.18 67.64 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.986 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.16 98.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.586 ' O ' ' HB ' ' A' ' 29' ' ' THR . 6.2 t70 -74.83 -38.83 61.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 72.0 mt -58.32 -45.05 89.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.413 0.625 . . . . 0.0 109.581 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 106' ' ' LEU . 83.2 mt -69.06 -26.63 65.06 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.339 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.3 m -57.97 -54.06 51.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.03 -31.19 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 67.8 m-85 -79.26 -20.61 47.7 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.171 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.2 t -70.89 -17.69 62.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 109.892 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.13 -22.13 65.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.701 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.59 2.55 52.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.0 81.38 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.779 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.41 HG12 HG22 ' A' ' 38' ' ' VAL . 32.1 t -127.03 98.72 29.86 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 117.254 0.527 . . . . 0.0 111.687 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.14 120.08 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.936 2.424 . . . . 0.0 110.68 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -124.44 -167.4 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.788 -177.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.77 136.18 39.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 111.802 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.33 134.86 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 41' ' ' ILE . 4.1 mp -124.84 108.61 20.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.0 tp -88.13 139.4 30.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -83.68 109.55 17.55 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.564 ' NE ' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -121.79 145.5 47.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.294 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.11 131.48 50.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.088 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 29.3 mt-10 -75.08 -15.8 60.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.61 -61.39 1.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.1 t -108.06 -22.15 12.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.39 21.58 12.84 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.712 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -71.87 161.37 31.05 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 120.684 0.278 . . . . 0.0 111.162 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 t -81.22 130.97 35.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -80.07 -9.11 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 97.41 13.82 43.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.708 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -158.33 165.48 34.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.169 0.485 . . . . 0.0 110.732 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.73 14.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.983 0.42 . . . . 0.0 111.627 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.81 124.91 27.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.14 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 11.0 tp -110.32 136.52 49.38 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.55 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -114.62 120.38 39.96 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.634 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -140.99 -166.82 2.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.809 -176.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.69 179.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 14.9 m-20 -61.42 -174.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.868 -1.06 . . . . 0.0 113.421 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -49.8 -39.79 39.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.601 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -51.29 -52.79 41.97 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 m -70.81 -30.84 67.4 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.383 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.634 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 32.8 p -61.1 -47.48 86.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 110.757 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.76 -37.53 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.867 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.85 -57.76 10.58 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.147 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.69 82.22 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' THR . 60.4 t -56.47 -52.43 52.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.226 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.47 -37.57 88.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -77.27 -49.22 15.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.47 -29.97 57.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -66.59 110.27 3.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 0.0 109.967 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.76 -19.99 25.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.093 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -74.99 139.02 42.65 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 37.0 ttpt -109.86 135.74 50.27 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.924 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.22 119.29 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.64 30.38 76.55 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.626 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.75 1.44 68.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.494 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.572 ' C ' ' HG3' ' A' ' 76' ' ' LYS . 81.6 mtt180 -129.06 119.55 24.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.347 0.574 . . . . 0.0 111.494 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -68.96 137.27 53.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.637 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.93 125.79 30.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.067 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -108.11 105.34 15.04 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -99.21 109.81 25.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.034 0.445 . . . . 0.0 111.11 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -104.61 112.74 25.94 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.1 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.4 124.17 22.01 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.856 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -159.37 136.66 9.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -74.52 155.99 37.36 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HB3' ' CG ' ' A' ' 12' ' ' TYR . 82.9 t80 -150.75 149.89 30.33 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -108.49 121.14 44.32 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.06 129.89 37.75 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.072 2.514 . . . . 0.0 112.442 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.42 128.69 39.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -80.22 -10.18 59.75 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.8 m -76.88 -22.74 53.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.205 0.526 . . . . 0.0 109.886 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 tp -110.9 26.67 10.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.79 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -57.64 -31.32 66.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.956 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -58.66 -38.13 77.5 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.584 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -64.64 -43.89 92.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.6 -47.71 80.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.977 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -59.06 -43.68 91.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.25 86.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.28 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.89 -45.7 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -60.37 -50.39 73.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.499 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.53 -38.64 91.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.69 -51.55 68.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.513 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 28' ' ' LEU . 80.0 mt -67.33 -30.02 69.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.713 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.104 0.478 . . . . 0.0 110.313 179.827 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.038 0.447 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -129.56 129.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.605 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 14.7 mmt -110.18 149.7 40.48 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.445 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.76 146.79 91.27 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.946 2.43 . . . . 0.0 111.557 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -120.14 88.88 3.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.461 0.648 . . . . 0.0 111.348 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.87 96.68 4.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.912 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.6 m -110.22 145.19 31.64 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.91 62.05 3.9 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.472 2.115 . . . . 0.0 111.216 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 34.4 m -59.12 -51.82 68.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.91 37.98 93.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.108 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.594 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 8.5 mp -68.06 -26.62 65.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.23 0.515 . . . . 0.0 111.245 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.98 -22.28 64.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 109.901 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.516 176.831 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.221 0.534 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.577 ' CE1' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -55.88 155.83 5.74 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -109.94 152.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.722 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -99.92 137.8 37.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.779 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 51.6 mt -123.63 143.6 36.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.74 -168.76 45.2 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.79 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 9.2 t30 -55.22 117.86 3.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.3 0.572 . . . . 0.0 112.434 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.57 -168.4 1.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.491 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . 56.6 t30 -79.11 154.4 29.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.353 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -70.69 -31.83 68.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.77 -0.5 55.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.8 mt -81.64 109.51 16.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.945 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -98.52 178.74 4.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.915 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 3.3 mp0 -60.06 -25.17 65.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.36 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.35 -51.48 31.99 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 29' ' ' THR . 2.9 m-20 -64.0 -39.64 94.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.784 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.22 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.5 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.23 -35.47 80.91 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 36.9 m -59.01 -48.94 79.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.656 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 HD13 ' B' ' 218' ' ' LEU . 68.9 t -56.38 -51.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.544 ' CG ' HD22 ' A' ' 57' ' ' LEU . 95.7 m-85 -78.26 -17.75 56.25 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -20.0 64.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.07 -24.05 63.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.45 -20.34 40.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.128 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.78 9.68 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.721 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.0 m -127.41 89.23 51.91 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 121.21 0.529 . . . . 0.0 111.95 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 84.32 1.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.88 2.387 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -124.78 -166.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.608 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.0 m-20 -72.58 131.81 42.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.3 p -121.39 133.41 68.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.5 mp -130.43 124.96 58.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.603 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 43' ' ' SER . 2.0 tt -107.79 134.85 50.15 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 42' ' ' LEU . 51.3 p -61.21 114.77 3.34 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 51.4 mtp180 -134.72 137.52 43.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.755 0.312 . . . . 0.0 110.224 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 16.5 m-20 -68.62 156.02 38.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.032 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.92 -35.58 28.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.434 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -71.43 -70.51 0.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.796 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -85.7 -19.9 30.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 73.9 18.59 79.65 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.311 178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 48' ' ' THR . 44.0 mt-10 -93.02 164.55 13.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.739 0.304 . . . . 0.0 111.309 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -72.12 129.07 37.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -80.16 -13.59 59.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.583 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.42 -10.28 30.81 Favored Glycine 0 C--O 1.215 -1.058 0 C-N-CA 120.6 -0.81 . . . . 0.0 114.305 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.16 148.49 28.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.865 0.833 . . . . 0.0 109.853 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -124.77 153.15 42.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.991 0.424 . . . . 0.0 110.836 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.437 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 55.1 m-85 -138.54 136.4 36.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 31' ' ' PHE . 16.5 tp -135.21 122.79 22.09 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.735 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.6 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 55.5 tttp -102.13 117.25 34.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.757 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 50.8 p90 -145.09 145.27 31.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 2.6 mp0 -101.6 107.58 18.88 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.426 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 65' ' ' THR . 28.0 t70 177.22 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.536 0.522 . . . . 0.0 110.783 174.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -51.17 -39.39 56.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -65.25 -54.86 22.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.794 0.33 . . . . 0.0 111.565 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 31.9 p -67.24 -19.93 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.757 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.3 p -61.63 -49.13 77.79 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.757 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -65.23 -38.73 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.788 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 27.4 tp -58.77 -56.89 16.35 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.181 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.07 83.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.489 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 65' ' ' THR . 71.4 t -63.56 -53.06 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.909 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.93 -40.08 63.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.84 -37.81 87.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -95.62 -10.66 28.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 47.8 t-20 -64.84 109.73 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.0 110.578 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.25 3.65 65.06 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.514 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.06 132.78 39.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.0 mmtp -91.88 125.35 36.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.095 0.474 . . . . 0.0 112.221 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mt -134.61 115.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.051 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.44 72.41 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.627 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -3.71 86.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.42 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 mmt180 -102.37 150.13 23.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.94 126.31 51.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 45.4 mt -73.68 128.94 36.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.754 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 75.3 mmtt -122.4 115.14 21.75 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 3.4 mm -114.22 148.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.519 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.09 145.97 23.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.029 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -74.4 136.75 42.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 12' ' ' TYR . 10.2 t -159.24 159.85 34.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.819 0.343 . . . . 0.0 111.128 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -124.27 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 33.6 t80 -136.74 142.8 43.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.65 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -98.14 107.59 42.07 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.446 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.81 119.73 6.47 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.081 2.52 . . . . 0.0 112.839 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.15 150.65 31.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.456 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -70.66 -19.86 62.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.923 0.392 . . . . 0.0 110.73 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.1 m -75.94 -11.16 59.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.373 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp -114.96 18.65 16.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.215 0.531 . . . . 0.0 109.813 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -58.56 -42.12 87.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.942 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB3' ' HE3' ' B' ' 209' ' ' MET . 92.8 mttt -61.78 -29.11 69.92 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.673 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 3.7 t80 -67.94 -52.54 34.97 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.728 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.29 -46.45 73.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.27 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.57 91.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.701 0.286 . . . . 0.0 111.241 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.1 t -64.5 -50.39 76.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.39 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -63.28 -40.61 97.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.884 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.31 -39.64 89.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.49 -35.13 78.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 90.7 mt -63.09 -48.54 78.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 . . . . . 0 CA--C 1.517 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.174 179.608 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 N--CA 1.443 -0.823 0 CA-C-O 120.877 0.37 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.99 99.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.145 0.498 . . . . 0.0 109.781 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 17.7 mmt -99.64 125.74 39.64 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.558 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 38.0 Cg_endo -66.37 135.36 39.34 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.632 2.221 . . . . 0.0 112.369 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -109.31 104.37 13.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.35 87.39 6.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.2 m -112.42 117.97 46.3 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.629 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.31 100.85 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.05 1.833 . . . . 0.0 112.184 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -75.27 -44.18 47.24 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.2 27.98 38.43 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.294 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 19' ' ' ASN . 93.4 mt -61.51 -42.01 98.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.564 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 30' ' ' VAL . 2.5 pt? -76.99 -11.58 59.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.481 -177.76 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.975 0.417 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 17.2 m-85 -138.48 147.94 43.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.101 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -124.5 137.56 56.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.725 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.2 t80 -91.66 129.97 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.275 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.5 142.39 16.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.97 -169.89 46.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.576 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -63.83 105.66 0.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.9 mt -97.73 -173.02 2.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -72.7 143.09 48.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -59.09 -31.83 69.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -84.91 9.73 13.61 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.617 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tt -96.59 121.03 37.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.107 0.48 . . . . 0.0 109.849 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -100.16 174.72 6.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.8 OUTLIER -67.96 -22.7 65.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.148 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.03 -38.84 94.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.451 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.547 ' O ' ' HB ' ' A' ' 29' ' ' THR . 9.6 t70 -72.89 -38.57 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.36 -46.2 97.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.303 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.6 -34.74 78.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.0 m -56.96 -46.39 82.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.415 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.492 HG22 HD13 ' B' ' 218' ' ' LEU . 84.1 t -64.33 -46.92 91.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -72.52 -19.29 61.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -66.47 -21.34 66.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.459 0.171 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -68.07 -18.4 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.994 0.426 . . . . 0.0 110.587 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.69 3.77 40.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 71.44 44.35 51.25 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.74 89.93 20.52 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 120.821 0.343 . . . . 0.0 111.256 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 97.3 Cg_endo -103.22 47.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.742 2.961 . . . . 0.0 110.949 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.5 t -104.56 -166.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.622 ' H ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -67.07 120.02 12.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -116.78 115.33 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.957 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.8 106.66 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.053 0.454 . . . . 0.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.99 141.17 28.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 78.7 p -73.81 100.23 3.4 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.345 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 44' ' ' ARG . 72.3 mtt-85 -106.38 146.41 30.5 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 48' ' ' THR . 18.7 t70 -58.89 137.53 57.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.94 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.0 mt-10 -72.04 -9.73 58.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.271 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -102.6 -65.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.407 HG22 ' OD2' ' A' ' 45' ' ' ASP . 12.1 t -93.91 -25.67 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.55 35.78 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.688 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.41 154.84 24.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.249 0.524 . . . . 0.0 110.355 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 m -66.34 133.65 50.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.049 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 74.8 mt-30 -89.17 -14.1 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.55 -29.33 8.31 Favored Glycine 0 C--O 1.219 -0.825 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.389 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -108.83 173.44 6.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.011 0.905 . . . . 0.0 111.039 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.44 167.84 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.484 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -131.69 123.36 27.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.945 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 tp -111.45 138.16 48.32 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.712 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 35.0 tttm -122.24 123.09 40.64 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.443 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.743 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.6 p90 -143.7 148.56 35.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.278 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.6 106.08 17.1 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.727 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 65' ' ' THR . 14.7 t70 177.07 126.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.218 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -70.65 -48.12 56.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -63.49 -40.02 95.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -60.94 -32.85 72.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.831 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.743 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.1 p -59.28 -45.73 90.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.347 0.594 . . . . 0.0 110.938 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.78 -38.92 45.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.543 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.17 -56.1 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.604 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.92 78.8 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 88.6 t -65.97 -53.14 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.05 -29.11 66.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -81.25 -48.96 11.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.17 -18.38 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 38.1 t-20 -61.86 112.35 2.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.922 0.391 . . . . 0.0 110.047 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.45 ' HA2' ' HB1' ' A' ' 81' ' ' ALA . . . 105.76 -11.33 45.77 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.755 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -67.13 133.13 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -81.37 115.74 20.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.931 0.395 . . . . 0.0 111.697 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -132.37 112.43 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.82 29.67 67.01 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.749 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.5 16.35 80.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.347 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.5 148.72 51.71 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 122.788 -0.242 . . . . 0.0 110.48 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 74' ' ' GLY . . . -84.87 128.59 34.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.457 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 77.8 mt -62.72 108.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -89.22 99.73 12.66 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.589 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 69' ' ' VAL . 9.8 mm -105.83 138.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -151.41 148.28 27.91 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.194 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 69' ' ' VAL . 16.8 m-70 -72.06 118.63 15.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.616 0.246 . . . . 0.0 110.428 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -132.15 160.24 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -106.62 136.91 45.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -149.97 136.61 19.2 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 4.3 mpt_? -108.92 127.19 27.77 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.91 104.32 0.17 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.71 2.273 . . . . 0.0 111.901 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.67 134.34 33.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 15.1 ptm180 -60.02 -22.73 62.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -65.31 -19.34 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.118 0.485 . . . . 0.0 110.454 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.9 16.95 6.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 13.7 pt20 -64.94 -20.26 66.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.583 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.08 -41.44 78.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.765 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -62.96 -45.3 93.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.594 -178.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.14 -41.56 92.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.076 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 35.7 tt0 -74.25 -43.15 58.13 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.478 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.1 84.85 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.266 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.563 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.4 m -70.15 -34.6 59.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.858 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.24 -44.11 97.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 5.1 mm-40 -61.27 -41.11 96.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.114 0.483 . . . . 0.0 109.926 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -70.7 -32.41 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.132 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 102' ' ' VAL . 5.8 mp -84.16 -44.72 13.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.664 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.912 -176.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 121.046 0.451 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 53.4 mt -121.7 107.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.714 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.2 mmt -110.37 124.61 32.83 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-O 121.074 0.464 . . . . 0.0 111.907 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 58.9 Cg_endo -72.09 166.29 30.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.105 2.537 . . . . 0.0 112.289 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.74 102.99 4.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.666 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -81.05 85.87 6.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.258 0.551 . . . . 0.0 111.728 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 70.0 m -113.72 119.35 41.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.308 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 98.55 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.151 1.901 . . . . 0.0 111.034 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' B' ' 217' ' ' LEU . 11.3 t -63.86 -40.88 97.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.8 20.36 68.43 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.447 ' HG ' ' OG ' ' B' ' 215' ' ' SER . 57.4 mt -65.29 -40.32 93.67 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 30' ' ' VAL . 2.7 pt? -61.55 -27.1 68.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.899 0.381 . . . . 0.0 110.72 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.765 179.8 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.535 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.1 p90 -159.31 -178.89 7.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.845 0.355 . . . . 0.0 110.835 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -112.91 144.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.471 . . . . 0.0 111.309 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' HB2' HG21 ' A' ' 87' ' ' THR . 83.9 t80 -97.13 131.0 44.32 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 mp -109.7 136.37 45.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.36 -169.4 45.89 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.262 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.24 114.67 0.99 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.369 0.604 . . . . 0.0 112.595 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HB3' HD12 ' A' ' 22' ' ' LEU . 93.4 mt -100.17 -170.87 1.94 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.217 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.442 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.3 m-20 -82.98 151.32 25.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.975 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -66.91 -20.05 65.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.709 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.51 10.59 40.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.812 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 19' ' ' ASN . 25.7 mt -96.27 127.21 42.07 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.9 p -110.3 -179.13 3.69 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 38.1 mt-10 -64.62 -25.26 67.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.983 0.42 . . . . 0.0 110.916 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.96 -42.05 70.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.451 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 29' ' ' THR . 14.3 m-20 -66.08 -42.64 89.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 109.942 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.14 -45.81 95.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.194 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.6 -35.49 81.16 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.049 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 28.1 m -57.49 -47.03 83.01 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.684 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.04 -48.89 86.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -75.53 -17.17 60.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 t -64.74 -32.42 74.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 0.0 110.235 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.05 -22.2 63.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 110.287 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -89.42 0.76 56.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.227 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.78 38.85 97.18 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.62 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.06 88.52 52.53 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.228 0.537 . . . . 0.0 112.266 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -93.57 70.26 0.41 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.133 2.556 . . . . 0.0 110.244 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -117.76 -166.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.043 -177.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -64.27 120.46 12.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.672 0.272 . . . . 0.0 111.431 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.02 138.2 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.7 130.37 49.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 54' ' ' PHE . 49.3 tp -109.95 133.12 53.52 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 26.9 m -67.8 106.62 2.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -117.84 151.95 36.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.481 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 12.9 t70 -66.85 135.89 54.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.648 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.7 mt-10 -81.95 -11.44 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -84.45 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.76 0.314 . . . . 0.0 111.292 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -104.41 -20.4 13.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.024 0.44 . . . . 0.0 111.117 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 91.86 32.3 8.63 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.96 165.22 13.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.996 0.398 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -67.5 128.05 35.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.695 0.283 . . . . 0.0 110.601 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.87 -17.62 27.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.84 -4.41 29.03 Favored Glycine 0 C--O 1.221 -0.69 0 C-N-CA 120.075 -1.059 . . . . 0.0 115.207 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.0 m-85 -114.46 146.84 40.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.049 0.924 . . . . 0.0 109.533 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -133.35 148.37 51.86 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 32.8 m-85 -129.29 138.78 51.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 25.0 tp -138.18 118.68 13.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.177 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -105.43 106.1 16.45 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.711 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 26.9 p90 -124.79 145.93 49.49 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -103.35 106.21 16.67 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.768 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 65' ' ' THR . 33.4 t70 176.46 108.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.557 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.17 -36.39 72.98 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.6 tpt85 -66.99 -49.11 66.38 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p -69.97 -20.72 63.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.711 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 72.4 p -58.36 -46.78 85.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.1 mt -74.26 -36.15 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.044 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 67' ' ' LEU . 6.6 tt -61.97 -54.79 36.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.126 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.66 90.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.867 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 79.4 t -60.92 -52.16 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.03 -38.38 79.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -69.89 -50.02 46.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.931 0.396 . . . . 0.0 111.267 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 94.7 mt -78.13 -12.98 60.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.083 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.91 109.86 1.38 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.35 . . . . 0.0 110.497 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.47 76.85 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.382 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -78.82 129.66 34.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 3.2 tppp? -82.05 116.01 21.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.166 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.4 mm -125.02 101.68 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.468 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.4 42.39 93.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.289 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 20.64 79.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.7 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 51.5 mmm-85 -129.68 144.19 51.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.1 118.7 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.726 0.298 . . . . 0.0 110.242 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 94.7 mt -64.89 140.14 58.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.2 0.524 . . . . 0.0 111.502 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.14 116.51 21.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 5.6 mm -111.7 138.15 41.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.0 145.56 37.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.668 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.36 127.86 32.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 14' ' ' TYR . 1.8 t -147.65 160.37 42.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.575 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -126.94 135.45 50.92 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -150.48 124.09 9.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.311 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -81.64 128.87 67.76 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.13 142.37 96.65 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.09 2.527 . . . . 0.0 112.602 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -95.47 137.72 34.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.389 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -18.12 58.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.032 0.444 . . . . 0.0 109.833 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -66.81 -27.6 67.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.425 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.34 31.79 5.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.285 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.78 -32.51 67.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.28 -21.13 63.91 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.442 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -70.25 -51.51 30.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -64.15 -30.73 71.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.96 -46.49 71.24 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -60.74 -50.28 74.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.359 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 34.4 m -60.19 -35.0 59.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -58.65 -57.62 12.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.51 -34.91 79.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.508 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 10.7 mm-40 -65.5 -51.46 59.89 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.513 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 89.4 mt -61.17 -40.51 94.16 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.872 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -178.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 N--CA 1.444 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mm -93.1 107.04 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.026 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 93.9 mmm -121.72 125.12 26.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.499 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 77.0 Cg_exo -52.66 132.97 48.33 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.227 2.618 . . . . 0.0 113.576 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -126.13 103.69 7.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.863 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -88.63 96.02 10.48 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.391 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 36.1 t -110.56 139.12 21.27 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.932 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.83 79.1 0.41 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.079 1.853 . . . . 0.0 111.908 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -67.74 -39.14 84.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.67 36.0 62.19 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.456 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.417 HD12 ' HG ' ' A' ' 22' ' ' LEU . 62.7 mt -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.715 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.563 HD23 ' H ' ' B' ' 218' ' ' LEU . 1.5 pt? -95.52 -5.88 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.521 -176.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 120.999 0.428 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 87' ' ' THR . 99.0 m-85 -154.4 141.2 19.1 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.178 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 pt -116.4 142.13 31.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.407 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -93.16 122.53 35.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 71.7 mt -107.45 138.49 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.85 -169.54 46.0 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.277 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 2.6 m-20 -50.24 119.28 3.54 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 112.489 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 22' ' ' LEU . 57.5 mt -98.87 169.46 9.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.173 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.525 HD22 HD13 ' B' ' 217' ' ' LEU . 56.7 t30 -70.28 149.22 47.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -64.71 -24.93 67.73 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.044 0.449 . . . . 0.0 110.726 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.85 5.33 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.823 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.405 HD22 HD13 ' A' ' 18' ' ' LEU . 3.7 tt -96.7 127.24 42.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -110.73 179.75 3.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.266 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.4 -23.17 66.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.055 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.13 -41.61 96.94 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' B' ' 215' ' ' SER . 6.1 m-20 -65.1 -39.86 93.74 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.24 -49.67 80.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.68 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.87 -35.6 81.09 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.436 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -57.35 -45.43 84.37 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.07 -46.46 45.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.74 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -76.1 -19.61 58.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -19.86 66.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.092 0.473 . . . . 0.0 110.574 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.26 -0.69 15.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.738 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -96.88 -1.21 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.968 0.413 . . . . 0.0 110.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.45 -21.25 24.24 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.819 -0.705 . . . . 0.0 114.563 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.08 129.51 3.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 117.93 0.865 . . . . 0.0 112.29 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.5 112.56 1.07 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.585 2.19 . . . . 0.0 111.458 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.755 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.2 t -103.06 -167.54 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.755 ' H ' HG12 ' A' ' 38' ' ' VAL . 28.4 t70 -68.2 144.47 54.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.02 133.23 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 111.391 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.31 134.89 61.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.828 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.9 tp -132.22 139.6 48.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.715 0.293 . . . . 0.0 111.053 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.6 p -77.06 125.24 28.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.97 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -121.82 142.75 49.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.176 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -74.28 138.52 43.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.181 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.37 -17.12 52.87 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.41 -67.87 0.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.879 0.371 . . . . 0.0 111.171 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 50' ' ' GLU . 9.9 t -115.36 -31.45 5.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.978 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.82 43.65 0.79 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.194 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 48' ' ' THR . 43.1 mt-10 -94.53 168.47 10.84 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -74.99 134.63 41.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -84.05 -9.47 58.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.142 0.496 . . . . 0.0 110.591 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.23 3.45 51.0 Favored Glycine 0 C--O 1.222 -0.635 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.772 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.94 130.0 54.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.494 0.647 . . . . 0.0 110.192 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -131.07 141.2 50.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -128.19 127.98 43.91 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.7 tp -116.91 142.4 46.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.665 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 42.3 tttp -122.66 125.74 46.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.889 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.715 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -146.76 147.47 30.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 105.33 16.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.407 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 30.4 t70 176.04 137.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.416 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -75.91 -45.52 34.89 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.788 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -62.75 -43.07 99.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 33.7 m -58.98 -27.58 65.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.848 -177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.715 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.1 p -63.98 -40.17 95.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.597 0.713 . . . . 0.0 109.942 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.9 mt -76.64 -39.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 43.2 tp -58.12 -58.32 8.95 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.535 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.63 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.592 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 76.7 t -65.4 -59.98 3.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.599 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 -36.66 78.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.97 -51.04 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.71 -8.99 45.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 20.0 t-20 -62.74 109.69 1.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.131 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.59 2.07 76.65 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.682 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -72.51 137.49 46.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -85.64 110.1 19.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.777 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 82' ' ' LEU . 29.0 mm -119.13 108.4 23.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.296 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.97 13.77 80.68 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.693 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.76 -10.42 58.95 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.75 130.95 35.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 77' ' ' ILE . 60.4 mt -84.74 128.3 34.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -104.91 111.43 24.19 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 13.8 mm -105.21 129.33 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -135.92 -179.77 5.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -111.84 129.36 56.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.1 t -155.14 160.96 41.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.123 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -110.52 121.67 45.88 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.86 148.73 41.02 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -113.15 116.01 47.28 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.466 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.13 110.24 0.98 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 112.038 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -94.79 147.24 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.79 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -78.13 -0.66 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.604 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 m -63.5 -22.95 67.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 0.0 110.018 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -122.54 34.36 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.634 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 29.1 pt20 -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.271 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 29.8 mmtp -58.11 -44.53 87.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.018 0.437 . . . . 0.0 110.737 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.8 t80 -62.98 -46.66 86.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.514 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -48.19 82.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.565 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 49.2 mt-10 -57.81 -49.45 76.58 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.081 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -38.23 81.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 68.4 t -63.1 -51.98 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.886 0.374 . . . . 0.0 110.139 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -54.78 -48.67 72.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.91 -30.16 66.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.958 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.65 -47.38 69.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.705 0.288 . . . . 0.0 110.299 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.86 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 178.716 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . 0.543 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 17.5 t70 . . . . . 0 C--O 1.237 0.404 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 58.0 mt -136.78 140.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.576 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.9 mmt -107.73 143.85 28.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -73.1 175.61 10.26 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.728 2.286 . . . . 0.0 111.921 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.03 93.0 2.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 0.0 111.064 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -90.48 86.19 6.36 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.962 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 11.0 p -113.08 141.79 26.25 Favored Pre-proline 0 N--CA 1.435 -1.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.579 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 13.6 Cg_exo -70.25 86.84 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.906 1.737 . . . . 0.0 111.476 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 13.8 t -78.03 -51.25 10.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.54 36.71 58.66 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.63 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.525 HD13 HD22 ' A' ' 19' ' ' ASN . 57.1 mt -60.35 -39.91 88.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.12 0.486 . . . . 0.0 111.058 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.497 ' HB3' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.04 -18.13 63.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 178.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.961 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . . . . . . 0 C--O 1.241 0.621 0 CA-C-O 120.255 0.074 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.701 ' CE1' ' HB2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -157.07 178.76 9.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.226 0.328 . . . . 0.0 110.313 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -118.97 145.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 0.0 111.738 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -94.57 133.77 37.85 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.274 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 62.6 mt -111.59 135.05 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 83' ' ' LYS . . . -87.45 -167.32 43.48 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.933 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 26.2 t-20 -39.69 112.48 0.26 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.372 1.069 . . . . 0.0 113.583 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -107.54 171.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.119 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -87.96 142.52 27.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -60.51 -23.96 64.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.905 0.384 . . . . 0.0 111.396 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB2' HD21 ' B' ' 217' ' ' LEU . 34.2 mm-40 -88.07 -7.6 56.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.75 111.02 22.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.491 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 27' ' ' ILE . 41.0 p -91.87 173.9 7.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HB2' ' CD2' ' B' ' 212' ' ' PHE . 7.5 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.725 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' B' ' 212' ' ' PHE . . . -70.51 -43.1 62.3 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.7 m-20 -63.63 -41.03 98.3 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 24' ' ' GLU . 62.9 mt -58.97 -53.04 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.761 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.28 -33.17 74.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.69 0.281 . . . . 0.0 110.603 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 m -59.89 -45.59 92.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.543 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 26' ' ' ASP . 93.2 t -63.43 -41.36 92.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.639 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 70.5 m-85 -74.79 -22.65 58.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -72.78 -17.62 61.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.324 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.56 -33.52 76.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 121.219 0.533 . . . . 0.0 109.774 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -91.73 -15.42 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.801 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.29 44.99 6.02 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.546 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -137.51 88.28 16.87 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 121.528 0.68 . . . . 0.0 111.596 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -98.44 99.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.502 2.802 . . . . 0.0 111.723 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -130.7 -165.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.537 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.8 m-20 -64.42 116.09 5.76 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.2 129.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.57 106.24 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 57.0 tp -87.21 131.31 34.24 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -74.97 102.44 4.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 19.1 mtp85 -115.7 149.43 38.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 48' ' ' THR . 25.5 t70 -67.72 135.16 52.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.794 0.33 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.99 -28.25 66.18 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.46 -56.23 2.67 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.474 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.3 t -84.82 -23.1 29.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 44' ' ' ARG . . . 82.02 -6.54 66.51 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.698 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 48' ' ' THR . 41.9 mm-40 -71.34 155.34 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.688 -0.301 . . . . 0.0 111.274 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -68.63 138.18 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.3 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -85.25 -5.23 59.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.987 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 106.93 7.63 33.08 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.383 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -152.07 167.97 26.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.785 0.793 . . . . 0.0 110.924 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -150.44 176.28 11.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.27 0.557 . . . . 0.0 111.998 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 50.8 m-85 -136.62 153.02 51.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.932 . . . . 0.0 108.972 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 31' ' ' PHE . 12.4 tp -142.04 125.87 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.1 tmtm? -116.15 113.21 22.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 15.6 p90 -125.18 158.83 33.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.867 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 40.2 mt-10 -103.09 105.54 15.87 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.962 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 14.6 t70 175.7 133.46 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.79 -37.3 30.47 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.654 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -71.32 -40.61 70.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.72 0.295 . . . . 0.0 110.513 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 26.1 t -58.09 -27.83 64.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.695 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.4 p -60.82 -52.52 64.74 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.518 0.675 . . . . 0.0 109.775 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.87 -36.35 63.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.086 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.05 -61.18 2.83 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.367 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.07 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 86' ' ' HIS . 54.2 t -64.36 -47.47 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.4 -33.37 60.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.107 0.479 . . . . 0.0 111.154 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.69 -53.19 7.84 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.1 mt -91.43 -23.61 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 t30 -67.76 109.31 3.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.65 -5.05 32.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.673 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -75.05 126.35 30.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -83.72 122.76 29.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.386 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 HD11 ' A' ' 82' ' ' LEU . 41.9 mt -136.5 120.29 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.299 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.77 35.83 87.77 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.408 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.47 3.91 86.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.742 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -133.09 154.5 50.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.546 0.673 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.12 134.82 43.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.727 0.299 . . . . 0.0 111.224 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD11 HD12 ' A' ' 77' ' ' ILE . 75.9 mt -73.22 125.72 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.593 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 56.2 mtpt -108.11 122.42 46.85 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' VAL . 13.5 mm -120.46 129.65 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.621 0.248 . . . . 0.0 110.483 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -138.99 146.22 40.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.127 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.492 ' CD2' HG21 ' A' ' 69' ' ' VAL . 14.7 m-70 -79.57 130.48 35.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.676 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.658 HG23 ' CE1' ' A' ' 12' ' ' TYR . 3.5 t -156.27 162.52 40.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.825 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -109.68 143.12 39.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.701 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 47.5 t80 -128.65 136.64 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.893 0.378 . . . . 0.0 111.178 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -108.07 96.03 16.83 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.74 146.71 84.49 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.98 2.453 . . . . 0.0 113.506 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.67 136.71 46.96 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.937 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.66 -6.96 44.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.868 0.366 . . . . 0.0 111.41 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -74.74 -27.68 60.45 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 17.26 16.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.987 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -59.04 -28.61 66.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.637 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.39 -40.09 85.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.097 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -72.86 -46.77 51.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.65 -51.82 68.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 36.4 mm-40 -62.27 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.493 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.84 -49.38 77.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.945 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -47.38 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.592 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -56.02 -54.41 45.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.539 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.3 pt-20 -69.89 -26.63 64.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.23 -58.16 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 107' ' ' ASP . 4.1 pp -66.47 -28.33 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.423 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 106' ' ' LEU . 19.0 t70 . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.426 -1.636 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 44' ' ' ARG . 46.6 mt -134.22 144.39 35.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.6 mmt -127.19 139.93 36.48 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.854 0.359 . . . . 0.0 111.713 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.61 151.23 41.33 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.435 2.09 . . . . 0.0 111.203 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -158.02 76.22 0.78 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 24' ' ' GLU . 36.8 p90 -110.88 115.72 30.01 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.7 p -110.28 117.96 50.3 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.263 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.84 114.49 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.75 2.3 . . . . 0.0 113.001 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.495 ' HB2' HD12 ' B' ' 217' ' ' LEU . 37.7 m -78.89 -40.48 32.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.69 38.35 8.18 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.386 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.3 mp -63.69 -40.18 96.17 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.428 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.7 pt? -65.15 -20.31 66.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.16 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.351 179.163 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.257 0.551 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 74.2 m-85 -147.59 156.0 42.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.126 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.21 133.39 69.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.656 0.265 . . . . 0.0 110.498 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -85.49 126.06 33.53 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -105.9 137.02 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.71 -169.5 45.96 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.557 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -53.67 112.39 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.654 0.782 . . . . 0.0 112.239 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 HD23 ' A' ' 22' ' ' LEU . 67.6 mt -102.74 -173.42 2.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.405 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 16.4 m120 -79.31 148.19 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.08 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -65.43 -35.69 81.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.85 7.82 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.803 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 18' ' ' LEU . 26.8 tp -81.67 109.96 16.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -85.17 166.07 16.89 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.615 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 32.1 mt-10 -65.66 -22.4 66.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.53 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -45.76 78.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.581 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -64.26 -40.48 96.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 110.471 178.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.66 -46.39 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.582 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.42 -30.63 70.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.103 0.478 . . . . 0.0 109.733 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 30.8 m -62.57 -41.14 98.75 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 HD13 ' B' ' 218' ' ' LEU . 81.4 t -67.5 -46.86 82.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.26 -21.99 55.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -70.77 -14.31 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.784 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.45 -8.73 55.75 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.391 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.631 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 79.8 m-85 -92.15 -10.9 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.63 10.45 86.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -129.15 89.83 47.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.683 0.278 . . . . 0.0 110.737 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -88.01 114.66 0.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.963 2.442 . . . . 0.0 111.964 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.805 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.6 t -132.31 -167.42 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.805 ' H ' HG12 ' A' ' 38' ' ' VAL . 6.4 m-20 -62.0 144.23 55.43 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.24 140.28 46.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.864 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -137.32 110.33 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.668 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.52 136.42 42.38 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 92.1 p -79.36 112.38 16.53 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.166 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -123.29 149.62 44.58 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.72 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.63 142.45 42.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.557 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.52 -29.3 41.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.819 0.342 . . . . 0.0 111.424 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.74 -58.01 3.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 50' ' ' GLU . 3.7 t -91.79 -40.28 11.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.13 43.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.558 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' H ' HG23 ' A' ' 48' ' ' THR . 42.7 mt-10 -67.49 160.33 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.968 0.507 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.2 m -75.69 141.37 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.03 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 76.8 mt-30 -82.81 -12.96 57.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.03 -30.58 7.9 Favored Glycine 0 C--O 1.216 -0.997 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.969 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -109.36 161.81 14.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.775 0.788 . . . . 0.0 111.575 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.54 26.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -134.09 135.27 43.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.735 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.8 tp -119.15 143.43 47.21 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.624 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 31.6 tttm -124.37 118.54 26.95 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.207 0.527 . . . . 0.0 111.788 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.779 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 12.3 p90 -138.82 144.04 39.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.45 104.4 14.85 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.675 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 65' ' ' THR . 25.1 t70 175.46 141.88 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.433 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -80.83 -37.48 29.96 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.02 -43.19 71.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 8.6 p -63.86 -22.72 67.05 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.779 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.1 p -62.23 -50.71 70.66 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.337 0.589 . . . . 0.0 109.762 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mt -64.78 -37.05 79.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.072 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.83 -58.65 7.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.426 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.66 89.23 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 65' ' ' THR . 72.2 t -57.32 -58.98 3.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.44 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.3 -31.38 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -67.23 -46.73 72.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.316 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.631 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 72.5 mt -93.78 -20.49 20.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.12 109.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.52 7.97 58.79 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.061 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.06 138.46 31.5 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -86.32 127.58 34.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG13 HD11 ' A' ' 82' ' ' LEU . 23.7 mm -131.91 110.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.88 20.84 77.96 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.753 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.31 -12.57 65.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.359 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -107.47 150.88 26.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.269 0.534 . . . . 0.0 110.926 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.51 33.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 111.067 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 78.5 mt -80.14 130.62 35.37 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -114.81 108.86 17.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.31 141.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.656 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.26 155.27 38.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.662 0.268 . . . . 0.0 110.95 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -71.68 128.25 35.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.625 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.4 t -153.72 161.26 42.27 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -108.94 159.26 16.95 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -149.48 138.92 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.355 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -112.78 113.73 49.92 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.8 140.34 79.58 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.722 2.282 . . . . 0.0 111.823 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -94.15 128.39 40.53 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -71.8 -15.26 62.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.068 0.461 . . . . 0.0 110.478 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -66.8 -29.63 69.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.6 30.87 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.628 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -53.38 -33.39 53.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.328 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -71.06 -27.09 63.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -68.37 -49.85 57.26 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.431 ' HA ' HG12 ' A' ' 102' ' ' VAL . 64.7 m-85 -64.64 -32.17 73.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.221 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -53.31 48.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.421 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -63.03 -38.39 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.914 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 9.0 p -70.92 -27.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.451 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 tptt -76.68 -42.53 41.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.958 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.76 -26.39 67.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.87 -31.04 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.999 0.428 . . . . 0.0 110.206 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 12.7 tp -63.39 -64.7 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.467 0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.769 -178.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 62.4 mt -108.26 131.09 59.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.797 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.421 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 20.5 mmt -107.22 134.74 19.79 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.431 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 29.6 Cg_endo -62.05 129.59 27.78 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.205 2.603 . . . . 0.0 111.829 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -103.26 102.4 12.36 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.699 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.28 83.38 3.57 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.548 0.689 . . . . 0.0 109.674 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.0 t -113.64 119.41 41.54 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.446 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.31 96.61 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.707 1.605 . . . . 0.0 111.227 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.51 ' HB2' HD12 ' B' ' 217' ' ' LEU . 17.2 m -81.39 -43.79 18.48 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 81.28 38.82 13.84 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.905 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.6 mp -62.72 -37.76 87.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.584 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.537 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.34 -22.7 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.517 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.224 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.848 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 121.11 0.481 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -139.2 137.73 36.26 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.338 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.139 0.495 . . . . 0.0 111.667 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 50.5 t80 -88.42 132.0 34.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.991 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 63.4 mt -106.9 132.69 53.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 83' ' ' LYS . . . -86.44 -168.22 44.55 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.696 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 66.5 t30 -52.12 108.76 0.31 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -175.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.96 -165.6 1.33 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.647 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -101.15 149.03 24.39 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -72.0 -26.53 62.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.72 -19.05 62.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.765 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.475 HD12 HD13 ' B' ' 217' ' ' LEU . 27.1 tp -84.04 109.04 17.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' ILE . 80.4 p -91.12 178.12 6.08 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 120.927 0.394 . . . . 0.0 110.704 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.34 -9.81 58.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.466 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.77 -45.8 56.52 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.33 -39.22 85.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 23' ' ' THR . 46.7 mm -51.11 -51.62 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.636 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -67.7 -36.85 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.8 m -61.95 -42.24 98.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.652 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.47 HG22 HD13 ' B' ' 218' ' ' LEU . 75.4 t -76.04 -45.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -79.34 -21.97 45.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -75.8 -12.57 60.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.954 -0.466 . . . . 0.0 111.069 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.41 -24.53 56.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.878 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -75.2 -1.65 24.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.71 -21.3 45.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.355 -0.45 . . . . 0.0 114.096 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.99 107.2 15.1 Favored Pre-proline 0 C--N 1.313 -0.988 0 O-C-N 122.462 -0.434 . . . . 0.0 110.906 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.8 100.9 1.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.534 2.156 . . . . 0.0 110.718 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -101.05 -166.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.306 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.559 ' H ' HG12 ' A' ' 38' ' ' VAL . 34.9 t70 -63.16 129.0 38.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.929 0.395 . . . . 0.0 111.478 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.8 134.87 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.766 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 mt -131.52 106.42 11.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -93.03 127.4 38.54 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.6 t -75.74 91.58 2.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.16 0.505 . . . . 0.0 110.952 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' B' ' 211' ' ' ASP . 4.4 tpt180 -91.44 136.14 33.33 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p30 -80.75 147.16 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.093 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.534 ' HB3' HD11 ' B' ' 208' ' ' ILE . 1.5 pm0 -81.59 -9.59 59.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.042 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -75.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 111.473 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -112.68 -18.93 12.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.216 0.532 . . . . 0.0 110.153 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 90.82 32.05 9.5 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.937 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -103.93 171.29 7.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.806 0.336 . . . . 0.0 111.626 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -73.3 130.85 41.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.59 -8.65 58.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.014 0.435 . . . . 0.0 110.894 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 105.95 -3.55 38.58 Favored Glycine 0 C--O 1.206 -1.63 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.673 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -137.22 163.09 31.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 117.962 0.881 . . . . 0.0 111.292 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.03 175.28 12.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.34 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 84.4 m-85 -138.87 147.99 43.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 tp -137.39 144.11 42.27 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.569 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 31.5 tttt -132.39 123.27 26.42 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 6.2 p90 -134.06 150.91 51.21 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -101.18 103.59 14.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.654 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 174.29 122.87 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.097 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -69.24 -33.36 73.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.04 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -68.04 -41.38 82.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 0.0 111.531 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.3 m -61.9 -26.32 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.669 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.7 p -61.57 -50.78 71.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.568 0.699 . . . . 0.0 109.955 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.6 mt -70.98 -34.77 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.182 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.36 -58.21 8.52 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.831 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.12 75.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 95.7 t -69.01 -30.14 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.154 0.502 . . . . 0.0 111.594 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.41 -31.9 18.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.275 0.56 . . . . 0.0 111.355 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.22 -45.23 9.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.006 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 89.5 mt -96.04 -30.78 13.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 69' ' ' VAL . 8.8 t30 -67.42 109.89 3.37 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.816 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.78 31.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.185 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -72.71 132.22 43.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.21 116.85 21.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.305 0.574 . . . . 0.0 112.334 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.61 109.6 22.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.02 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.89 30.82 77.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.765 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 -13.61 65.43 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.238 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.72 148.7 35.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.925 0.363 . . . . 0.0 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.99 143.46 26.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.691 0.282 . . . . 0.0 111.307 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 87.7 mt -76.74 124.41 27.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.238 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 40.0 ttmt -104.64 117.06 33.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mm -114.96 117.22 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -127.32 146.13 50.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.738 0.304 . . . . 0.0 111.324 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -80.04 125.36 29.69 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 14' ' ' TYR . 13.3 t -154.96 160.65 41.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -100.55 99.63 10.25 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -115.86 132.76 56.55 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.432 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -113.98 132.87 22.47 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.962 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.16 163.24 34.93 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.513 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 60.6 mttp -98.72 129.34 45.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.31 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.36 -11.82 60.13 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.872 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -75.08 -32.73 61.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.18 0.514 . . . . 0.0 110.236 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -89.53 33.46 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -51.4 -36.13 42.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.085 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -60.41 -49.36 77.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 111.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.82 -51.47 69.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.326 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 59.3 m-85 -61.58 -36.3 80.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.287 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 37.7 tt0 -66.5 -51.88 52.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.24 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.7 69.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.194 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.427 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.4 t -69.52 -50.41 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 103' ' ' LYS . 35.8 ttmt -58.1 -44.89 87.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.779 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.5 pt-20 -70.56 -24.42 62.79 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.058 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.1 -41.96 66.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 102' ' ' VAL . 10.6 mp -63.01 -42.17 99.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.005 176.823 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 46' ' ' GLU . 69.3 mt -107.66 126.73 64.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.1 mmt -121.63 145.65 43.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.745 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.3 148.14 54.65 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.838 2.359 . . . . 0.0 112.645 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.49 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 25.4 t70 -117.15 98.41 6.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.44 89.1 5.73 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 33.9 m -110.21 139.88 21.86 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.941 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 3.1 Cg_exo -75.08 84.88 1.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.896 1.731 . . . . 0.0 110.98 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 50.2 m -81.53 -51.12 8.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.186 0.517 . . . . 0.0 110.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.12 43.74 89.29 Favored Glycine 0 N--CA 1.431 -1.666 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.758 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 22' ' ' LEU . 6.9 mp -61.26 -34.73 75.64 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.121 0.46 . . . . 0.0 110.371 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.476 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -79.06 -11.73 60.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.244 0.545 . . . . 0.0 110.563 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.443 -0.784 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.209 -178.335 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.209 0.528 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 63.7 m-85 -142.26 139.81 32.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.036 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -116.45 133.48 62.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.038 0.447 . . . . 0.0 110.808 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HG21 ' A' ' 87' ' ' THR . 76.4 t80 -88.01 125.94 34.81 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.857 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.33 143.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.99 -169.37 45.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.119 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.76 133.73 56.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 0.0 111.597 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 mt -125.89 160.33 30.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.02 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.35 146.05 49.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.01 -21.22 65.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.429 . . . . 0.0 110.724 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.75 -13.65 58.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.76 129.58 34.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.434 HG21 ' HB2' ' B' ' 213' ' ' SER . 32.1 p -109.27 179.37 4.18 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.895 0.379 . . . . 0.0 110.681 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.1 pm0 -72.91 -21.07 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 110.049 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.26 -34.22 85.0 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.557 ' O ' ' HB ' ' A' ' 29' ' ' THR . 27.5 m-20 -72.12 -36.76 69.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.69 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.74 -34.64 78.65 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.385 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 53.4 m -59.24 -46.82 87.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.101 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' ASP . 58.3 t -67.52 -50.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.943 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -70.86 -9.34 57.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -22.08 66.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.845 0.355 . . . . 0.0 110.124 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.99 -19.5 64.94 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.213 0.53 . . . . 0.0 110.654 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 39.1 m-85 -83.01 -20.16 35.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.82 17.13 80.16 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.203 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.87 104.57 3.9 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.378 0.608 . . . . 0.0 111.207 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.07 116.3 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.747 2.298 . . . . 0.0 111.961 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -124.83 -166.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.9 m-20 -62.55 120.34 10.93 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.01 111.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.292 0.568 . . . . 0.0 109.938 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 ' CZ ' ' A' ' 99' ' ' TYR . 4.3 mp -108.46 104.48 17.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.57 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.29 120.58 26.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 m -75.14 99.34 3.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.139 0.495 . . . . 0.0 110.964 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.508 ' NH2' ' H ' ' B' ' 211' ' ' ASP . 56.5 mtt180 -103.91 170.16 8.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.762 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.7 p-10 -108.78 149.35 29.18 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.588 ' HA ' HD11 ' B' ' 208' ' ' ILE . 4.6 pt-20 -81.46 -9.95 59.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.27 -61.99 1.82 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.944 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -105.49 -28.02 11.06 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.871 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 94.32 24.8 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.833 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.57 169.68 8.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.636 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -68.5 132.13 46.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.48 2.69 21.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.869 0.366 . . . . 0.0 111.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.78 9.66 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.043 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -169.51 163.15 10.32 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.05 0.452 . . . . 0.0 111.349 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.52 161.44 42.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.433 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -133.04 130.84 39.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 8.3 tt -121.15 139.07 53.85 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.912 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 13.5 tmtt? -125.69 121.07 32.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.441 0.639 . . . . 0.0 111.474 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.67 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 7.6 p90 -131.8 151.25 51.8 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.587 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.02 104.97 15.66 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.953 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 176.4 137.95 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.134 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -78.36 -40.97 34.75 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.417 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -69.47 -41.04 76.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 111.254 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -58.08 -26.67 62.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.999 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.67 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 53.0 p -62.83 -42.96 99.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.602 0.715 . . . . 0.0 110.401 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.1 mt -75.18 -41.05 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.031 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.87 -52.73 64.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.851 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -57.8 -43.92 85.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.863 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.43 -57.72 10.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.163 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.29 -24.61 67.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -82.54 -54.0 5.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.8 0.333 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.62 -16.1 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.68 109.75 2.13 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -0.36 61.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.523 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -69.13 136.87 52.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.38 122.97 33.73 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.95 118.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.702 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.27 8.52 79.73 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.342 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.89 10.23 46.87 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -129.43 145.38 51.43 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.027 -0.586 . . . . 0.0 110.771 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.19 32.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.872 0.368 . . . . 0.0 111.203 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.44 120.43 22.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.1 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -92.98 113.31 25.55 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.2 mm -118.59 118.89 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.653 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -135.81 149.76 49.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.878 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -76.23 134.76 39.75 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.2 t -160.13 160.58 33.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -91.16 153.09 20.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 44.9 t80 -147.13 119.4 8.34 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.089 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 90' ' ' ARG . 49.0 mtt180 -112.26 99.27 45.98 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.879 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.61 149.52 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -85.13 149.09 25.77 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.04 -8.8 40.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.044 0.45 . . . . 0.0 110.571 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -68.62 -19.06 64.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.221 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.5 mt -118.49 24.43 10.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.58 0.229 . . . . 0.0 111.566 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.1 pt20 -69.97 -25.61 63.71 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.195 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -67.28 -24.42 65.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -69.38 -36.69 77.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CZ ' HG12 ' A' ' 41' ' ' ILE . 53.2 m-85 -69.12 -41.53 77.27 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.077 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 41.8 mm-40 -58.96 -50.64 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.489 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -57.89 -51.21 70.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.734 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 13.1 p -64.1 -37.87 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.02 -49.31 76.54 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.433 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 54.9 mt-10 -64.67 -38.32 90.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.44 -50.17 72.52 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.927 0.394 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 85.5 mt -65.99 -41.99 90.39 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.164 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.383 179.349 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 122.022 0.915 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 46' ' ' GLU . 66.4 mt -128.74 137.63 56.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.068 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 21.3 mmt -110.09 145.23 31.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 14.6 Cg_exo -70.04 129.05 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.012 2.475 . . . . 0.0 112.295 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.508 ' H ' ' NH2' ' A' ' 44' ' ' ARG . 31.2 m-20 -96.01 82.48 3.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.505 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.17 89.39 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.516 . . . . 0.0 110.912 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 23' ' ' THR . 3.2 m -112.37 129.48 24.3 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.906 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.52 70.32 7.34 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.857 1.704 . . . . 0.0 111.293 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.4 m -65.49 -50.21 66.14 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.62 43.62 96.19 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.691 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.57 -50.65 71.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -65.38 -31.61 72.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.388 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -178.291 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 121.191 0.52 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 75.5 m-85 -133.48 146.01 50.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.077 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.95 137.15 52.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.342 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 74.8 t80 -85.28 128.89 34.86 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.624 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.18 132.26 61.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.86 -168.59 44.59 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.215 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -49.77 119.99 3.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.517 0.675 . . . . 0.0 112.669 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.29 179.1 4.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 m120 -81.81 151.04 27.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.693 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -73.99 -17.13 61.03 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.056 0.455 . . . . 0.0 111.231 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.23 -14.57 40.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.344 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 19' ' ' ASN . 73.3 mt -84.26 109.32 17.7 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.838 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 27' ' ' ILE . 54.1 p -88.77 176.39 7.09 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.236 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.3 -25.09 67.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.287 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.96 -44.73 54.72 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -63.83 -33.48 75.78 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.755 0.312 . . . . 0.0 110.938 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 23' ' ' THR . 64.5 mt -58.17 -53.09 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.275 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.33 -21.15 62.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.983 0.42 . . . . 0.0 110.673 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.5 m -63.99 -42.89 97.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.533 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.631 HG22 HD13 ' B' ' 218' ' ' LEU . 86.1 t -75.52 -48.46 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.095 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -70.96 -6.97 42.77 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 p -50.87 -44.38 59.64 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.247 0.546 . . . . 0.0 111.631 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -76.32 -6.88 53.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.624 0.726 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.98 26.38 8.62 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.525 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.68 70.09 0.35 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 118.829 -1.653 . . . . 0.0 112.756 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.4 m -44.0 147.52 0.9 Allowed Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.26 1.024 . . . . 0.0 112.634 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -11.34 98.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.7 4.934 . . . . 0.0 117.029 -173.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -128.82 -164.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 26.9 m-20 -70.41 109.54 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.725 -175.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.66 143.35 21.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.2 106.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 55' ' ' ALA . 2.6 tm? -95.11 121.83 37.15 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.2 t -78.42 110.32 13.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.045 0.45 . . . . 0.0 110.51 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -110.45 154.67 23.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.87 139.24 48.75 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HA ' HD11 ' B' ' 208' ' ' ILE . 39.0 mt-10 -74.74 -9.56 58.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -109.75 -60.44 1.78 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.3 t -89.62 -11.22 43.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.16 66.82 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.912 -0.661 . . . . 0.0 114.229 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 48' ' ' THR . 46.3 mm-40 -78.35 156.79 29.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.024 0.412 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.5 p -65.2 128.85 37.51 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.18 -14.73 63.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.804 0.335 . . . . 0.0 111.608 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.69 18.52 8.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.17 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -161.81 159.42 26.98 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 120.922 0.391 . . . . 0.0 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -151.43 170.61 19.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.804 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -136.34 139.2 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.7 tp -126.2 130.63 51.34 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.619 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.1 tttt -116.15 103.58 10.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.585 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 37.4 p90 -118.66 153.45 34.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 tt0 -101.02 105.8 17.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.814 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 13.4 t70 175.48 108.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.058 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -73.59 -8.75 57.21 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 26.6 mtm180 -91.72 -49.23 6.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 0.0 109.911 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -63.84 -26.89 68.82 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.396 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 17.2 p -59.12 -41.32 87.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 110.337 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 mm -69.01 -49.18 65.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.637 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.73 -55.56 28.92 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.252 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.7 74.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 68.0 t -60.48 -48.09 89.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.29 -33.88 42.92 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.192 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.24 -44.95 35.16 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.35 -15.09 58.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 53.2 t30 -68.45 108.72 3.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.79 -8.91 59.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.776 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.96 128.51 35.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.37 134.84 33.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.33 109.88 3.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.583 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.79 22.13 75.3 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.554 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.71 -3.9 81.61 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.473 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.07 123.65 49.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 111.048 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.96 107.68 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.76 143.73 53.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.37 111.7 21.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 8.4 mm -114.74 138.72 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -146.4 146.9 30.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.157 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -72.16 124.8 25.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -147.4 160.8 42.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.01 0.434 . . . . 0.0 110.928 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.6 117.49 34.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 57.2 t80 -102.74 127.6 49.82 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.891 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -100.18 102.08 16.81 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 50.9 Cg_exo -55.85 126.6 22.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.243 2.629 . . . . 0.0 113.706 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -77.13 128.65 34.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -77.28 -12.56 59.96 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.574 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 m -64.42 -23.07 67.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.404 0.621 . . . . 0.0 109.819 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.41 26.29 5.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.459 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -54.16 -46.42 72.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.873 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -71.67 -27.06 62.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 110.722 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -68.15 -48.78 64.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -59.52 -44.42 93.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 35.6 tt0 -60.96 -52.62 64.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.528 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.16 75.48 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 53.7 t -59.0 -49.21 84.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -64.04 -44.09 93.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 36.6 mt-10 -62.36 -43.16 99.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 110.509 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.29 -43.46 83.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.551 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -69.93 -43.06 72.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.064 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.959 -179.817 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.238 0.474 0 CA-C-O 120.863 0.363 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 46' ' ' GLU . 48.2 mt -124.66 130.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.01 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.408 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 11.8 mmt -124.29 149.12 60.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.142 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 5.6 Cg_exo -79.92 170.47 16.63 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -147.28 114.65 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -108.37 88.18 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.621 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 19.3 m -111.38 119.59 44.88 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.94 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 24.8 Cg_exo -63.0 110.83 1.23 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.448 2.099 . . . . 0.0 112.536 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 19.8 m -101.64 -50.82 3.61 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.83 41.25 50.18 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.786 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.14 -30.04 69.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.322 0.561 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -64.99 -26.86 68.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.171 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 0.0 110.987 -177.332 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 21.6 m-85 -147.7 148.07 30.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.07 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.17 136.52 60.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.981 0.419 . . . . 0.0 110.542 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -86.39 131.54 34.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.585 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -113.7 138.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -171.27 47.57 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.422 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.2 t-20 -58.9 104.8 0.26 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.286 0.565 . . . . 0.0 111.735 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -95.41 -172.46 2.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 40.7 t30 -76.37 130.05 37.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -66.14 1.33 1.55 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.43 -10.58 29.53 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.182 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 19' ' ' ASN . 6.5 mp -76.06 140.12 41.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.029 0.442 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.517 HG21 ' HB2' ' B' ' 213' ' ' SER . 44.0 p -110.44 -178.12 3.41 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.785 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' B' ' 210' ' ' PRO . 3.0 mm-40 -62.71 -36.25 82.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.52 95.31 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.492 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 29' ' ' THR . 13.8 m-20 -63.32 -47.83 80.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 110.377 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.68 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.717 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.12 -38.18 90.16 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.318 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.8 m -56.12 -45.22 79.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.716 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.434 HG22 HD13 ' B' ' 218' ' ' LEU . 99.0 t -64.25 -46.39 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.102 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.05 -20.12 33.22 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 t -63.73 -24.72 67.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.648 0.261 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.29 -7.13 28.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.76 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -88.35 -4.09 58.73 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.985 0.421 . . . . 0.0 110.895 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.27 -20.99 27.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.048 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.72 111.03 9.54 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 117.42 0.61 . . . . 0.0 111.582 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.68 110.44 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.789 2.326 . . . . 0.0 111.082 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.9 t -111.03 -167.23 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.716 ' H ' HG12 ' A' ' 38' ' ' VAL . 31.2 m-20 -73.36 147.04 44.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' H ' HG11 ' A' ' 102' ' ' VAL . 14.3 p -135.56 140.73 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.391 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.94 99.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.67 0.271 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 1.3 tt -84.85 122.99 29.95 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 m -67.4 122.25 17.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HD2' ' OH ' ' A' ' 98' ' ' TYR . 81.1 mtt85 -121.34 161.27 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.07 147.07 26.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.042 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HG3' HD11 ' B' ' 208' ' ' ILE . 1.9 mp0 -72.68 -25.12 61.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -93.08 -59.68 1.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 50' ' ' GLU . 5.2 t -81.87 -24.48 35.74 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.462 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.82 77.9 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.026 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 48' ' ' THR . 47.7 mt-10 -80.4 166.61 21.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.819 0.343 . . . . 0.0 110.909 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.7 p -70.15 142.29 52.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.58 3.23 48.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.148 0.499 . . . . 0.0 110.305 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.76 -31.93 8.17 Favored Glycine 0 C--O 1.219 -0.828 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.73 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -109.61 162.36 14.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.164 0.482 . . . . 0.0 111.174 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.81 171.48 16.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.234 0.54 . . . . 0.0 111.587 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -134.39 133.83 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.11 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.9 tp -114.37 144.98 42.4 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.972 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 39.2 tttm -125.51 123.35 38.96 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.244 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.718 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 23.4 p90 -148.15 145.86 28.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -100.95 105.46 16.7 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.805 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' THR . 39.1 t70 175.71 134.15 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.809 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.84 -53.97 22.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.803 0.335 . . . . 0.0 111.179 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -59.31 -39.91 84.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.999 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -61.1 -27.98 68.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.718 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.7 p -69.6 -36.29 76.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.583 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.96 -47.61 54.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.305 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.73 -54.85 40.18 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.76 77.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 86.8 t -60.86 -48.46 88.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.194 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.19 -41.21 81.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -71.85 -53.74 12.29 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 3.0 mm? -80.08 -25.57 39.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 33.9 t-20 -62.37 109.57 1.39 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.071 0.462 . . . . 0.0 111.143 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.65 -4.79 50.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.129 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.52 131.91 43.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 110.382 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 mt -127.2 105.18 13.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.986 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.33 29.65 71.77 Favored Glycine 0 C--N 1.312 -0.784 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.734 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.57 -19.57 43.54 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -89.26 143.93 26.47 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.571 0.224 . . . . 0.0 110.444 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.97 128.29 47.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 55.1 mt -68.77 110.6 4.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.688 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.87 111.66 23.58 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 69' ' ' VAL . 11.4 mm -113.53 141.82 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.479 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -149.78 148.91 29.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.584 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.18 121.16 23.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -133.71 160.11 38.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.649 0.261 . . . . 0.0 110.881 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -106.63 118.41 36.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.55 160.88 43.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.69 155.32 35.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.241 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 99' ' ' TYR . 32.2 Cg_exo -58.74 132.52 48.4 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.84 2.36 . . . . 0.0 113.434 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.28 142.32 34.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.093 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -71.45 -17.05 62.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.881 0.372 . . . . 0.0 111.219 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -74.99 -26.06 59.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.23 0.538 . . . . 0.0 110.371 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.93 28.56 8.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.211 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -53.81 -37.48 63.59 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.952 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.69 -23.93 65.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.424 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.467 ' OH ' ' HD2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.9 -51.73 20.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 91' ' ' PRO . 53.1 m-85 -63.27 -41.2 99.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.58 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.65 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 44.9 mt-10 -64.24 -50.16 69.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.229 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.92 68.37 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.475 HG11 ' H ' ' A' ' 40' ' ' VAL . 91.1 t -68.98 -45.29 80.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.779 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.9 ttmm -63.41 -25.26 68.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.51 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 43.8 mt-10 -59.67 -40.88 89.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.15 -25.81 58.66 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.439 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 103' ' ' LYS . 39.0 mt -74.01 -42.6 60.12 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.44 178.87 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.483 HD11 ' HG3' ' A' ' 46' ' ' GLU . 21.7 mt -137.94 139.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.593 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 2.5 mmt -135.58 133.62 20.39 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.621 0.248 . . . . 0.0 111.494 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.593 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 42.2 Cg_endo -69.91 142.95 48.62 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.313 2.009 . . . . 0.0 110.563 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -104.22 133.41 49.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.074 0.464 . . . . 0.0 111.355 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.25 86.82 2.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.138 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.517 ' HB2' HG21 ' A' ' 23' ' ' THR . 34.2 m -113.74 119.46 41.25 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 175.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 82.59 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.88 1.72 . . . . 0.0 111.178 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.8 m -72.24 -50.53 26.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.349 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.1 32.42 56.33 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.26 -35.19 73.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.378 . . . . 0.0 111.656 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.526 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.8 OUTLIER -70.11 -30.2 67.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 178.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 0.0 110.008 -179.889 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.886 0 CA-C-O 121.192 0.52 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 87' ' ' THR . 89.7 m-85 -134.1 151.73 51.52 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 17.8 pt -121.88 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.952 0.406 . . . . 0.0 110.62 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.6 t80 -75.11 129.63 37.88 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.668 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -115.64 144.53 23.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.58 -169.07 44.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.761 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -54.92 117.29 3.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.545 0.738 . . . . 0.0 110.878 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.39 162.88 12.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.896 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.457 ' H ' HD12 ' A' ' 22' ' ' LEU . 8.6 m120 -64.12 149.68 47.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -71.91 -8.92 57.22 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.382 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 217' ' ' LEU . 46.7 mm-40 -97.71 -3.37 39.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.577 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 19' ' ' ASN . 17.6 mt -87.59 112.9 22.77 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.839 0.352 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.487 HG21 ' HB3' ' B' ' 213' ' ' SER . 30.2 p -98.88 173.33 6.91 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' CD ' HH12 ' A' ' 44' ' ' ARG . 2.0 mp0 -60.22 -27.47 67.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.71 -40.92 85.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 29' ' ' THR . 18.4 m-20 -67.93 -37.32 81.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' THR . 66.8 mt -60.76 -49.0 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.1 -32.5 74.09 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 27.1 m -58.77 -46.09 88.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.432 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG22 HD13 ' B' ' 218' ' ' LEU . 84.5 t -64.38 -40.52 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.89 -14.32 56.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.7 m -63.23 -19.53 64.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.54 -28.91 69.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.38 0.61 . . . . 0.0 109.893 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.28 -14.22 59.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 14.77 69.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.056 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.04 89.55 33.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.3 98.68 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.624 2.216 . . . . 0.0 110.245 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -126.23 -166.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.349 -176.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 22.4 m-20 -60.43 135.17 57.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' H ' HG11 ' A' ' 102' ' ' VAL . 6.3 p -128.44 130.48 69.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.85 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.21 102.52 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.735 0.302 . . . . 0.0 111.327 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.465 HD13 ' NH2' ' A' ' 44' ' ' ARG . 1.7 tt -91.9 124.45 36.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.6 t -74.57 121.8 22.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.078 0.466 . . . . 0.0 111.886 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.465 ' NH2' HD13 ' A' ' 42' ' ' LEU . 5.3 mpt_? -120.1 165.43 14.75 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.69 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -89.59 160.86 16.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.945 0.402 . . . . 0.0 110.05 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -80.97 -9.5 59.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.25 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -93.06 -69.78 0.73 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 t -97.72 -40.33 8.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.94 32.73 2.77 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.796 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 32.6 mm-40 -91.79 153.05 19.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.788 0.327 . . . . 0.0 110.309 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -70.53 130.99 43.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.02 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -75.96 -0.38 21.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.72 16.04 37.86 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.88 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -162.62 156.17 20.38 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.005 0.431 . . . . 0.0 111.172 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.99 171.08 14.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 66.1 m-85 -139.53 140.47 37.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 12.8 tp -120.53 139.25 53.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -125.39 115.41 20.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.0 110.505 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.722 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.8 p90 -134.23 158.21 44.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 50.9 mt-10 -100.26 105.54 17.11 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.587 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 65' ' ' THR . 11.4 t70 175.43 125.63 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.086 0.866 . . . . 0.0 108.935 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -73.04 -54.63 8.06 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.089 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -64.5 -31.41 72.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . 38.4 m -70.06 -19.79 63.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.722 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 65.4 p -67.35 -45.53 76.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.934 0.874 . . . . 0.0 109.002 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.8 mt -70.12 -41.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.28 -55.54 23.92 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.119 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -48.26 65.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 84' ' ' ILE . 90.6 t -63.59 -54.45 32.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.292 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.83 -31.71 73.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.28 -13.98 27.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.06 109.18 2.9 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.403 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.25 52.67 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.09 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -73.91 138.92 44.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 121.6 32.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 111.908 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 HD11 ' A' ' 82' ' ' LEU . 20.9 mm -127.97 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.83 35.69 91.67 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.77 -14.73 55.49 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.144 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -104.22 146.69 28.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.003 0.401 . . . . 0.0 110.527 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.32 129.46 41.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.872 0.368 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 HG13 ' A' ' 77' ' ' ILE . 77.3 mt -74.57 108.2 7.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.35 104.57 17.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 14.9 mm -106.58 141.03 22.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.611 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -150.68 153.14 35.04 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.746 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.456 ' CD2' HG21 ' A' ' 69' ' ' VAL . 43.8 m-70 -78.8 119.56 22.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.8 t -160.36 161.27 33.09 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -112.32 143.93 42.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -119.4 119.87 35.21 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.845 0.355 . . . . 0.0 110.583 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.65 104.14 54.68 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.13 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.03 -178.56 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.768 2.312 . . . . 0.0 111.859 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.38 151.7 23.87 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 93' ' ' ARG . 51.5 mtm180 -66.81 -9.45 37.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -75.26 -19.4 59.74 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.24 18.29 22.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 13.9 pt20 -63.0 -25.39 68.37 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.907 0.384 . . . . 0.0 110.095 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.558 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 12.7 mptt -52.95 -39.05 62.61 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.336 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.434 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.6 t80 -63.08 -52.02 64.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -64.25 -36.34 83.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.893 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 52.5 mt-10 -65.37 -54.05 34.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.597 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.99 69.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.734 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.497 ' O ' HD13 ' A' ' 106' ' ' LEU . 92.7 t -63.43 -57.62 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.87 -41.83 98.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.838 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.63 -36.83 79.6 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.08 -33.63 65.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 102' ' ' VAL . 6.6 mp -63.78 -48.82 75.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.84 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 121.354 0.597 . . . . 0.0 110.574 178.015 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.452 -0.351 0 CA-C-O 120.914 0.387 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.15 102.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.558 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 92.0 mmm -107.73 139.84 20.99 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.976 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.46 155.71 66.15 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.689 2.259 . . . . 0.0 111.856 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.39 124.54 34.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -109.81 87.98 2.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.597 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.487 ' HB3' HG21 ' A' ' 23' ' ' THR . 33.2 t -112.36 117.73 46.83 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 15.8 Cg_exo -69.35 91.33 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.129 1.886 . . . . 0.0 111.794 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 4.2 m -76.66 -41.98 43.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.33 56.33 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.087 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 21' ' ' GLU . 65.8 mt -64.47 -36.73 85.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.343 . . . . 0.0 111.391 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.535 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -79.26 -22.83 44.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.85 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--N 1.324 -0.528 0 CA-C-O 120.755 0.312 . . . . 0.0 110.762 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.551 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 50.2 m-85 -127.55 139.59 52.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.293 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.02 123.45 62.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.153 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 52.4 t80 -86.53 127.45 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 42.8 mt -109.79 141.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.96 -169.67 46.1 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.514 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -39.62 111.89 0.22 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.436 1.094 . . . . 0.0 113.87 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.52 -178.49 3.61 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.479 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.98 149.54 24.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.19 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.625 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 9.0 mpt_? -76.42 -20.14 57.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.487 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 -10.0 59.12 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.429 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.93 112.15 22.23 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.628 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 p -102.49 -178.85 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.81 0.338 . . . . 0.0 111.047 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.97 -22.41 60.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.371 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.42 53.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.101 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -69.93 -40.55 75.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.723 0.297 . . . . 0.0 110.842 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.91 -43.8 85.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.26 -36.94 82.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 48.6 m -59.69 -36.8 77.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.04 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.76 -38.69 58.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -77.03 -28.16 54.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 p -66.73 -12.72 59.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 111.093 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.06 -21.86 65.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.188 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -2.55 58.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.084 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.61 3.62 90.57 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.204 -0.522 . . . . 0.0 114.152 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -153.66 106.42 2.53 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 117.305 0.553 . . . . 0.0 112.146 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 2.6 Cg_endo -83.28 114.32 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.855 2.37 . . . . 0.0 111.785 176.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.3 t -111.89 -165.6 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 18.3 m-20 -61.56 112.19 2.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.36 130.17 65.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.056 0.455 . . . . 0.0 110.618 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 mp -122.37 130.37 74.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.329 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 tp -116.65 139.52 50.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.458 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 37.2 p -73.21 103.89 4.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 7.4 tpp180 -106.89 131.85 53.52 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.78 137.46 57.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' B' ' 208' ' ' ILE . 33.0 mt-10 -80.19 -9.5 59.72 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -111.29 -58.0 2.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.816 0.341 . . . . 0.0 111.598 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 p -81.49 -40.75 22.76 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 95.05 17.64 36.87 Favored Glycine 0 N--CA 1.407 -3.299 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.659 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.95 170.37 11.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 20' ' ' ARG . 5.1 p -86.82 130.46 34.46 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 43' ' ' SER . 87.7 mt-30 -70.9 -20.69 62.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.028 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.28 -2.88 29.66 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.791 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.47 143.04 39.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.459 0.63 . . . . 0.0 110.06 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -130.92 142.52 50.37 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.424 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 119.59 22.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.03 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.5 tp -111.12 136.18 50.54 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 12.6 tmtt? -121.86 121.24 36.72 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.095 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.676 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 16.2 p90 -140.49 156.6 46.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.121 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 mp0 -100.75 105.65 17.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.902 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 12.0 t70 175.33 141.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.943 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -80.54 -51.4 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.238 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.0 -38.72 92.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.321 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 12.3 t -60.73 -28.37 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.969 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.676 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.4 p -63.73 -46.72 84.1 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 121.477 0.656 . . . . 0.0 110.027 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.69 -39.11 68.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.127 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.78 -60.41 3.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.173 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.75 83.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 86' ' ' HIS . 65.9 t -60.18 -55.08 26.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.71 -9.59 59.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -87.69 -53.91 4.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.38 -19.73 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 63.3 t30 -60.78 109.29 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.11 0.481 . . . . 0.0 111.33 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.44 33.79 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.919 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -72.87 132.91 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -93.28 123.16 36.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mt -126.57 112.7 30.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.88 23.84 69.58 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.322 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 -16.39 61.16 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.662 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -96.01 139.74 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 133.87 34.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 85.5 mt -74.72 102.77 4.75 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.05 109.14 21.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 7.1 mm -101.74 131.94 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.14 142.21 47.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.613 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.446 ' CD2' HG21 ' A' ' 69' ' ' VAL . 22.9 m-70 -72.42 112.86 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 14' ' ' TYR . 11.6 t -133.25 161.26 34.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.044 0.449 . . . . 0.0 111.036 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -114.23 99.74 7.84 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.459 0.647 . . . . 0.0 109.848 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.517 ' HB3' ' CD2' ' A' ' 12' ' ' TYR . 87.2 t80 -95.3 139.77 31.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.033 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -110.95 116.86 51.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.272 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.05 129.01 32.59 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.695 2.263 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.19 128.99 42.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.179 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -68.75 -21.12 64.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.32 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -76.1 -6.08 49.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.161 0.505 . . . . 0.0 110.365 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.4 mt -122.72 22.22 9.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -62.32 -26.18 68.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.222 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.02 -38.86 80.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.385 0.612 . . . . 0.0 109.972 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.71 -44.24 64.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.144 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.82 -43.02 97.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.693 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -69.04 -46.62 67.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.13 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.628 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.7 t -61.53 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.062 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.79 -41.8 78.36 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.087 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -65.02 -36.79 85.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.085 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.16 -39.95 68.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.685 0.278 . . . . 0.0 110.423 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -57.66 -53.8 54.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.451 -177.885 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.5 t70 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 46' ' ' GLU . 38.2 mt -131.76 140.66 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 -177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 8.2 mmt -121.55 144.2 39.76 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.721 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 13.5 Cg_exo -71.15 170.74 17.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.912 2.408 . . . . 0.0 111.984 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -150.25 109.64 3.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.057 0.456 . . . . 0.0 111.457 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.55 89.3 6.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.951 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.6 t -110.28 142.95 27.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.62 92.31 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.81 1.673 . . . . 0.0 111.482 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.597 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 46.3 m -77.82 -48.07 17.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.704 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.96 27.2 73.38 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.69 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 7.8 mp -72.06 -20.64 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.297 0.549 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -93.2 -7.88 43.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.153 0.501 . . . . 0.0 109.902 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.149 -178.19 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 96.1 m-85 -141.56 148.7 39.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.956 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 pt -115.92 140.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.48 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HB2' ' CG2' ' A' ' 87' ' ' THR . 86.1 t80 -92.87 131.95 37.45 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.48 132.23 59.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.53 -167.53 43.67 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.824 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -39.74 126.28 1.93 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.517 1.127 . . . . 0.0 112.662 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.56 161.63 24.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.043 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.61 153.91 41.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.591 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -67.76 -37.59 82.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.012 0.434 . . . . 0.0 110.259 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -80.03 1.37 27.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.53 109.57 20.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 27' ' ' ILE . 81.3 p -93.35 176.16 6.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.71 -20.59 66.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.251 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.95 67.24 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' B' ' 215' ' ' SER . 0.7 OUTLIER -66.74 -35.47 80.19 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.591 0.234 . . . . 0.0 110.904 178.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 23' ' ' THR . 64.6 mt -58.32 -46.2 89.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.98 -38.13 82.35 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 55.5 m -54.7 -46.84 74.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.397 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 HD13 ' B' ' 218' ' ' LEU . 55.0 t -62.19 -47.22 94.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.281 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -74.31 -9.64 58.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -71.01 -15.32 62.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.781 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -62.98 -33.98 76.55 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.285 0.564 . . . . 0.0 109.948 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.419 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 8.3 m-85 -98.4 -13.78 20.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.962 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 78.25 60.91 2.59 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.362 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 57' ' ' LEU . 61.3 t -111.97 91.65 16.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 14.0 Cg_endo -98.49 31.84 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.503 2.802 . . . . 0.0 110.971 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -94.26 -165.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.581 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 38' ' ' VAL . 64.3 m-20 -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.95 135.97 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.099 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.47 115.5 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.931 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.37 149.13 24.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' SER . 16.8 p -73.02 107.33 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.091 0.472 . . . . 0.0 110.899 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -114.53 129.6 56.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.775 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 17.9 t70 -71.76 139.79 49.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.5 -12.73 60.03 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.8 -57.89 1.97 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.44 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.5 t -89.29 -20.1 24.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 74.03 20.31 79.71 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.486 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 48' ' ' THR . 48.9 mt-10 -96.37 170.3 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.861 0.331 . . . . 0.0 111.402 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' SER . 15.1 m -83.29 138.07 33.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.01 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.59 -16.25 35.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.27 23.06 7.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.448 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -156.94 154.35 29.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.18 0.49 . . . . 0.0 109.852 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.44 17.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.237 0.542 . . . . 0.0 112.434 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -134.07 131.94 39.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.526 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 36' ' ' VAL . 16.7 tp -121.66 138.61 54.27 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.804 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 57.6 tttt -120.31 113.97 21.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 33.1 p90 -139.95 148.65 42.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 9.5 tp10 -100.67 105.73 17.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 54.0 t0 174.62 122.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.328 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.34 -12.33 59.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -86.99 -49.48 7.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.091 0.472 . . . . 0.0 110.071 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 t -67.5 -22.65 65.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.062 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.679 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 1.2 p -61.79 -59.1 5.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.872 0.367 . . . . 0.0 111.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.75 -38.06 81.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.963 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 41.3 tp -57.7 -53.89 53.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.267 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.08 84.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 88.3 t -63.41 -60.41 2.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.479 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -63.65 -34.27 77.47 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -69.05 -49.5 56.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.708 0.289 . . . . 0.0 111.021 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 85.9 mt -84.68 -27.68 26.9 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -59.79 108.23 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.03 -5.66 59.54 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.868 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.8 t80 -74.31 130.24 39.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.14 124.32 28.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.568 . . . . 0.0 112.481 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -129.88 105.46 12.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.705 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.97 72.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.602 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.61 59.12 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -111.45 130.31 55.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.583 -0.309 . . . . 0.0 110.524 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -82.28 129.88 34.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.565 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.52 127.63 32.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.335 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 45.4 tptt -110.68 116.46 31.35 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mm -110.13 140.15 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.21 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.13 171.25 16.19 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -101.32 128.95 47.24 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.5 t -153.92 161.8 41.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -114.78 110.41 19.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.931 0.396 . . . . 0.0 111.347 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.0 120.17 30.81 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.321 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -98.79 139.48 21.1 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.131 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.08 138.13 60.54 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.801 2.334 . . . . 0.0 111.887 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -110.31 144.64 38.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.897 0.379 . . . . 0.0 111.694 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -55.3 -31.17 61.42 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.134 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -64.63 -22.1 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.76 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.22 21.32 17.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.108 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -56.9 -38.98 73.57 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.13 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -55.61 -43.17 75.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.853 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 102' ' ' VAL . 49.1 t80 -67.72 -45.82 73.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.506 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.06 -44.39 95.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.138 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.21 -40.88 97.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.76 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -67.96 -41.54 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.311 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 98' ' ' TYR . 72.5 t -64.61 -38.04 81.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.081 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -60.05 -39.19 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.672 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -61.68 -49.79 75.07 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.773 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.58 -40.67 79.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.71 -42.47 91.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 0.0 109.83 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.082 179.738 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 67.0 mt -123.41 131.09 73.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 16.9 mmt -114.31 136.0 22.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.86 169.0 15.6 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.934 2.423 . . . . 0.0 111.95 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -142.78 102.56 4.06 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.702 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -96.99 87.39 4.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.896 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.2 m -111.5 119.53 44.85 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.823 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.21 105.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.823 2.348 . . . . 0.0 112.167 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.504 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 3.6 m -96.28 -50.04 4.96 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.559 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.05 33.82 84.8 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.94 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 11.0 mp -66.94 -33.07 74.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 110.43 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -76.89 -14.24 59.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.794 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.197 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.956 0 CA-C-O 121.025 0.441 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.5 m-85 -158.85 136.99 10.59 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.268 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.65 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.158 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -87.08 122.54 31.04 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 26.5 mm -95.29 135.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -168.97 45.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.966 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -40.0 107.83 0.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.152 0.981 . . . . 0.0 113.547 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.55 152.87 23.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.978 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.537 HD22 HD11 ' B' ' 217' ' ' LEU . 48.9 t30 -67.28 138.52 56.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -63.1 -19.78 64.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 0.0 111.473 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 57.6 mm-40 -80.59 -4.1 52.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.147 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.8 mt -83.28 139.23 33.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.914 0.387 . . . . 0.0 110.556 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -110.22 168.62 9.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.655 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.84 -27.53 68.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.44 97.73 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.708 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.63 -47.67 83.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 110.781 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.85 -46.63 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.92 -35.96 82.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.031 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.3 m -56.35 -49.29 74.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' CG2' HD22 ' B' ' 218' ' ' LEU . 95.1 t -65.18 -46.51 90.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.724 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -75.15 -22.97 57.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 m -64.6 -24.58 67.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.818 0.342 . . . . 0.0 110.478 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.08 -20.32 66.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -89.75 -2.31 58.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.603 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.44 34.69 44.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.626 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.0 89.81 37.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 111.778 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -89.06 78.27 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.636 2.224 . . . . 0.0 111.116 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -115.86 -166.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.905 -177.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' H ' HG12 ' A' ' 38' ' ' VAL . 4.6 p-10 -85.41 144.88 27.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -171.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.02 133.29 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.2 mp -123.68 107.91 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 43' ' ' SER . 5.0 tt -92.27 134.05 35.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 42' ' ' LEU . 19.5 m -67.92 95.52 0.54 Allowed 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -114.2 145.67 41.39 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.483 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 38.1 m-20 -61.52 150.63 35.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.215 0.531 . . . . 0.0 112.062 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -77.13 -41.88 40.09 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.421 -176.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.65 -59.39 2.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -85.79 -15.86 40.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 66.09 31.52 79.58 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.778 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -92.82 155.21 17.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.611 0.206 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -67.04 111.06 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.93 -20.89 60.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.047 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.71 11.12 20.02 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 120.311 -0.947 . . . . 0.0 115.052 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.25 165.51 24.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.878 0.839 . . . . 0.0 109.082 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.499 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.86 121.65 27.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.731 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.77 142.69 46.19 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.117 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -131.72 117.06 18.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.352 0.596 . . . . 0.0 111.701 179.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.72 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.0 p90 -129.7 156.01 44.96 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.34 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -102.15 106.15 16.96 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.731 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.2 t70 176.94 139.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.891 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -80.76 -46.56 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -75.41 -29.59 59.82 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 m -68.59 -23.02 64.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.72 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 67.2 p -61.6 -46.87 87.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.557 0.694 . . . . 0.0 109.645 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.59 -33.38 48.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.966 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 67' ' ' LEU . 7.3 tt -61.78 -52.54 63.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.14 89.44 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 79.9 t -63.3 -44.51 99.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.029 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.2 -48.66 56.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.907 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.51 -49.83 65.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.308 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.2 mt -86.57 -2.12 58.22 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.648 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 48.1 t-20 -67.73 108.96 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.93 6.69 61.78 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.421 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -72.16 121.82 19.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -83.65 117.51 23.23 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.03 113.51 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.244 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.64 76.62 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.94 -2.56 88.19 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.969 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.92 145.58 36.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.09 135.9 33.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 80.8 mt -76.06 133.68 40.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.795 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.39 113.09 15.76 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm -103.59 134.5 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.02 157.6 40.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.13 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -92.49 133.14 36.21 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -159.57 157.41 29.81 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -107.07 143.08 35.73 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -149.98 138.56 20.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.998 0.428 . . . . 0.0 111.316 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -105.72 138.56 19.65 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.9 136.41 48.68 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 122.649 2.233 . . . . 0.0 113.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -77.29 137.87 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -68.81 -26.0 64.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.995 0.426 . . . . 0.0 110.826 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -77.56 -30.01 52.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.086 0.47 . . . . 0.0 110.596 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.56 18.74 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -65.26 -27.1 68.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.279 0.562 . . . . 0.0 110.132 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.87 -21.15 62.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.746 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.9 t80 -64.16 -46.42 84.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -63.65 -38.05 89.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.752 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.89 -48.09 80.51 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.958 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.6 74.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.356 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.8 t -70.64 -41.48 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.831 0.348 . . . . 0.0 110.119 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -55.54 -48.43 74.73 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.986 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.28 -23.74 67.41 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.766 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -24.66 37.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.012 0.435 . . . . 0.0 110.35 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 69.5 mt -80.93 -44.22 18.57 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--O 1.236 0.38 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.819 177.711 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 61.3 mt -103.39 123.04 56.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.502 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.2 mmt -101.99 128.61 28.24 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.875 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.51 146.14 88.79 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -120.39 116.97 26.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.522 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -100.33 86.25 3.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.35 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.8 m -113.57 119.1 42.29 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.307 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.44 103.74 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.214 1.943 . . . . 0.0 111.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' B' ' 217' ' ' LEU . 89.9 p -81.35 -32.51 32.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.88 9.25 86.67 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.537 HD11 HD22 ' A' ' 19' ' ' ASN . 0.3 OUTLIER -56.86 -51.58 68.47 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.728 0.811 . . . . 0.0 111.307 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 30' ' ' VAL . 3.9 pp -84.19 -17.25 40.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.578 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.634 -176.825 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.84 0.352 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -160.63 136.27 8.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.229 1.012 . . . . 0.0 109.142 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 pt -120.01 137.14 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 121.028 0.442 . . . . 0.0 110.848 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -89.4 131.5 35.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.537 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.4 mt -113.84 144.84 20.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.21 -169.16 45.5 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.285 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.36 112.37 3.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.788 0.328 . . . . 0.0 110.695 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 74.0 mt -93.95 177.17 6.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 0.0 111.732 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.427 ' H ' HD12 ' A' ' 22' ' ' LEU . 43.9 t-20 -69.13 138.11 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.018 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.75 -20.33 61.08 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.18 2.63 53.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.7 mt -86.67 109.61 19.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -97.41 177.7 5.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.109 0.481 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.44 -27.53 69.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.34 -42.98 89.45 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.428 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.4 m-20 -63.61 -47.24 82.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.23 -47.04 88.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.778 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.23 -41.8 98.74 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 m -60.33 -48.89 79.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.404 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' ASP . 74.9 t -54.7 -47.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.436 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.72 -22.63 37.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -64.76 -26.73 68.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.403 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.66 -16.05 63.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.467 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.87 -4.49 59.18 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.1 0.476 . . . . 0.0 110.249 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.37 17.04 78.74 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.377 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.88 90.18 51.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.716 0.293 . . . . 0.0 110.24 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.89 105.51 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.019 2.479 . . . . 0.0 112.094 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.2 t -132.48 -166.57 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.564 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.9 t70 -70.84 140.21 51.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.07 136.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.35 100.84 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.618 0.246 . . . . 0.0 111.629 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -85.94 112.98 21.69 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.8 t -65.83 118.59 9.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.4 0.619 . . . . 0.0 111.837 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -133.95 155.79 49.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.604 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 48' ' ' THR . 32.3 t70 -73.11 135.41 44.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.873 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' B' ' 208' ' ' ILE . 38.1 mt-10 -69.94 -18.72 63.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -96.36 -61.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.672 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.0 t -84.36 -33.25 23.87 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.65 60.99 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.827 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' H ' HG23 ' A' ' 48' ' ' THR . 12.9 pt-20 -71.21 155.34 40.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.099 0.449 . . . . 0.0 110.367 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 m -68.15 138.69 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.89 -8.89 59.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.099 0.476 . . . . 0.0 111.074 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.43 30.41 7.73 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.329 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -170.61 170.8 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.68 170.82 19.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.72 155.96 49.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.175 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.77 140.26 34.75 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.66 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 49.9 tttp -123.13 115.34 21.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.909 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 8.2 p90 -132.91 143.2 49.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -102.89 107.57 18.45 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.521 -0.871 . . . . 0.0 113.194 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 65' ' ' THR . 29.2 t70 178.61 143.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.883 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -79.98 -35.01 38.14 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -83.06 -35.52 25.65 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.093 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.8 t -57.6 -29.9 64.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.413 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.605 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 75.4 p -59.43 -52.76 64.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.478 0.656 . . . . 0.0 109.423 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.5 -46.07 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.953 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 tp -50.06 -58.58 5.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.936 0.773 . . . . 0.0 111.562 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.628 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 97.3 t -66.99 -57.85 8.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.527 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.22 -18.04 64.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.561 -0.456 . . . . 0.0 112.15 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -90.5 -55.8 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.989 0.423 . . . . 0.0 111.308 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 92.1 mt -91.34 -17.38 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.79 109.05 2.74 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.436 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.13 2.62 64.12 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.105 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 61.0 t80 -76.87 143.39 39.69 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 1.8 tppp? -94.61 114.23 26.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.901 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 82' ' ' LEU . 16.4 mt -129.6 117.65 42.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.26 35.18 76.45 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.324 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.67 22.26 75.19 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.758 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 24.9 mtp180 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 122.635 -0.332 . . . . 0.0 110.694 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -98.76 135.79 39.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.933 0.397 . . . . 0.0 111.46 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.527 HD11 HD12 ' A' ' 77' ' ' ILE . 41.2 mt -85.54 122.27 29.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.617 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.0 107.45 19.4 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -108.25 124.36 64.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.966 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -136.26 149.99 48.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -77.64 124.39 27.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 t -149.39 162.01 40.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.613 0.244 . . . . 0.0 110.966 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -114.96 108.86 17.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.22 139.8 50.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.297 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -107.47 132.27 21.1 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.74 133.73 46.67 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.969 2.446 . . . . 0.0 112.583 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -76.78 131.98 38.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -70.65 -20.92 62.67 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 p -74.58 -14.46 60.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.786 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.416 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 94.9 mt -113.72 25.12 11.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.855 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -56.79 -35.03 68.24 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 63.3 mmtt -55.76 -46.07 77.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.128 0.49 . . . . 0.0 110.638 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.39 -53.78 50.01 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.066 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 95' ' ' LEU . 77.2 m-85 -59.09 -44.69 91.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -68.52 -32.88 73.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.458 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -67.22 -46.71 73.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.18 -39.79 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.16 0.505 . . . . 0.0 109.946 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -57.02 -54.23 49.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.673 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.24 -28.19 67.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 24.1 mm-40 -64.8 -51.95 59.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.0 110.854 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 -27.01 56.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 177.748 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 120.971 0.415 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 46' ' ' GLU . 63.9 mt -134.85 100.1 2.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.354 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 80.0 mmm -103.87 136.11 19.25 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.4 156.08 62.46 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.921 2.414 . . . . 0.0 113.24 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.85 117.56 7.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -87.47 89.63 8.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.19 0.519 . . . . 0.0 111.142 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 1.0 OUTLIER -91.49 143.24 27.82 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.009 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 28.4 Cg_endo -96.15 84.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 18.7 t -71.97 -47.04 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.22 63.58 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.828 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.409 HD12 ' HG ' ' A' ' 22' ' ' LEU . 91.4 mt -60.31 -33.21 72.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.502 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -66.42 -35.09 79.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.266 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.346 0.593 . . . . 0.0 110.703 -177.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.272 0.558 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 8.8 m-85 -125.38 154.49 41.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.397 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.58 139.09 52.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.737 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -99.08 123.37 43.33 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.31 141.65 18.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.32 -168.82 45.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.64 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 3.7 t-20 -48.47 110.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.51 0.724 . . . . 0.0 112.743 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.94 177.62 5.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.24 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' HD13 ' A' ' 22' ' ' LEU . 37.5 t-20 -80.66 142.82 33.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -57.19 -26.39 60.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.585 0.354 . . . . 0.0 111.64 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.99 -10.69 59.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.957 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HD13 ' B' ' 217' ' ' LEU . 6.3 mp -87.28 110.07 19.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.071 0.463 . . . . 0.0 111.018 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.5 p -94.08 172.67 8.08 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.633 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -63.9 -22.59 66.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.289 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.98 -41.03 95.5 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.973 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 29' ' ' THR . 28.8 t70 -75.36 -36.84 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.985 0.421 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.23 -41.04 85.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.633 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.34 -38.94 92.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.303 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 17.4 m -58.02 -45.05 87.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.457 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 26' ' ' ASP . 88.9 t -56.83 -50.14 76.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.29 -16.81 58.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.6 m -72.46 -13.75 61.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.49 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -83.63 -11.03 57.81 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.83 72.94 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.909 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.15 89.63 48.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.58 95.82 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.86 2.373 . . . . 0.0 110.513 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -118.86 -166.7 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.229 -177.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.496 ' H ' HG12 ' A' ' 38' ' ' VAL . 25.0 m-20 -68.13 114.7 6.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.961 0.41 . . . . 0.0 111.997 -172.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.68 127.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.704 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.09 113.19 39.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.488 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' PHE . 59.9 tp -87.26 133.61 33.65 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.497 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 38.6 m -68.73 102.84 1.6 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -123.55 154.57 39.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.968 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 47' ' ' ASN . 5.6 p-10 -84.77 152.09 23.93 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.323 0.582 . . . . 0.0 111.354 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.13 -9.88 59.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.413 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.433 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 16.4 m120 -83.06 -67.33 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.574 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 t -104.42 -30.55 10.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.56 46.62 4.26 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.62 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.63 164.5 11.71 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.778 0.289 . . . . 0.0 110.693 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -79.55 106.18 11.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.856 0.36 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.3 -33.68 75.79 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.16 31.91 2.95 Favored Glycine 0 C--O 1.218 -0.892 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.997 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.498 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.2 m-85 -135.37 157.32 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.98 29.99 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.997 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -121.07 119.11 31.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.51 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 27.8 tp -115.54 139.77 49.77 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.092 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 1.7 tmtp? -124.14 112.68 17.38 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.183 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.774 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -129.71 150.73 50.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.72 105.34 16.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.203 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 176.2 143.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.425 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -80.76 -48.98 11.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 64' ' ' SER . 2.6 ptp180 -67.16 -33.71 76.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 63' ' ' ARG . 46.9 m -63.65 -27.45 69.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.086 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.774 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 68.9 p -63.29 -48.43 78.13 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.693 0.759 . . . . 0.0 110.08 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.68 -38.64 45.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.29 -52.6 64.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.12 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -43.09 76.85 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.362 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 65' ' ' THR . 90.9 t -61.87 -59.82 3.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.297 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.38 -22.16 66.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.28 -45.67 15.89 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.76 0.314 . . . . 0.0 111.146 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -97.83 -20.41 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.84 110.13 1.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.77 -0.88 56.6 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.495 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -77.58 123.79 27.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -88.99 117.51 28.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.172 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.442 HD13 ' CD2' ' B' ' 218' ' ' LEU . 57.2 mt -121.57 115.77 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.064 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.22 35.28 69.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.716 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.31 13.55 78.51 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.097 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -128.8 130.7 47.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.912 0.356 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.88 133.02 33.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 89.5 mt -79.11 128.04 32.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.596 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -123.93 118.18 26.47 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -107.92 126.43 64.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -123.25 142.87 50.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.975 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -84.79 106.75 16.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.769 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 136.52 21.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.852 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -80.67 156.84 26.14 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.39 137.86 32.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.604 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 80.3 mtp180 -94.5 120.57 64.89 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.731 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 30.0 Cg_exo -62.66 110.57 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.531 2.154 . . . . 0.0 111.481 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.55 140.19 44.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -70.09 -31.05 68.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.416 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 p -79.87 -11.42 59.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 48.9 tp -105.16 8.22 34.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -62.09 -20.1 63.66 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -59.15 -41.62 88.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.631 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 3.5 t80 -69.37 -45.62 68.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -58.08 -50.09 74.67 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.568 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -61.65 -46.34 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.333 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.9 86.42 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.427 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.6 t -74.25 -39.83 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.221 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.76 -45.02 94.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.62 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.83 -29.94 71.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 111.054 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.97 -37.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 70.8 mt -68.82 -39.62 79.94 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.221 -0.405 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.792 179.504 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 68.6 mt -128.51 110.09 20.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.071 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.7 mmt -84.19 118.63 71.72 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.916 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.48 164.98 10.15 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.112 2.542 . . . . 0.0 112.608 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -122.25 94.86 4.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.752 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -84.22 88.62 7.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.321 0.581 . . . . 0.0 110.118 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 23.8 m -109.84 157.08 38.69 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.733 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.39 59.98 2.56 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.911 2.407 . . . . 0.0 112.183 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . 0.597 ' O ' HD12 ' B' ' 217' ' ' LEU . 73.6 m -78.68 33.24 0.21 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.241 0.616 . . . . 0.0 111.456 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.94 58.84 0.37 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.56 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.597 HD12 ' O ' ' B' ' 215' ' ' SER . 5.0 mp -64.85 -27.86 69.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.0 pp -100.73 -7.63 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.753 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -178.812 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.909 0.385 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 7.0 m-85 -154.23 136.63 14.98 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.209 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 pt -108.42 137.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.899 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 89.4 t80 -94.6 134.76 36.82 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.059 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.56 138.53 45.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.39 -167.62 43.44 Favored Glycine 0 C--N 1.32 -0.312 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.344 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.508 ' OD1' ' HD2' ' A' ' 80' ' ' ARG . 6.3 p30 -48.19 139.42 8.44 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.302 0.572 . . . . 0.0 112.0 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.46 -176.99 3.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.071 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.36 147.67 22.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HD3' ' OE1' ' A' ' 50' ' ' GLU . 75.8 mtt180 -70.89 -15.75 62.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.91 1.61 56.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.407 . . . . 0.0 110.116 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD23 HD12 ' B' ' 217' ' ' LEU . 1.8 tm? -97.77 118.48 34.43 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.6 p -109.95 176.61 5.0 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 111.983 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.5 mp0 -58.16 -31.77 67.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.913 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.69 98.86 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.049 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.96 -45.02 64.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.4 mt -55.72 -46.46 79.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.724 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -41.32 96.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.836 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -56.82 -46.55 81.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.649 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.429 HG22 HD13 ' B' ' 218' ' ' LEU . 53.0 t -57.56 -49.44 80.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.466 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.37 -15.91 58.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -68.41 -15.68 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.07 -33.66 73.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.357 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.26 -0.27 56.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.731 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.22 56.78 23.32 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.559 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 38' ' ' VAL . 8.0 p -151.23 89.7 4.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-O 121.694 0.759 . . . . 0.0 111.381 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.39 100.08 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 112.156 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -131.56 -165.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.555 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.679 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.8 t70 -66.95 131.51 46.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.83 131.47 42.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.551 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.41 108.98 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 tp -94.5 126.93 40.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -77.83 95.43 4.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.435 0.636 . . . . 0.0 111.039 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -104.73 141.56 36.25 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.577 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.97 144.64 11.45 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.173 0.589 . . . . 0.0 111.92 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HA ' HD11 ' B' ' 208' ' ' ILE . 13.5 mp0 -72.75 -26.82 61.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.072 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -74.69 -66.2 0.77 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -115.24 -24.7 8.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.409 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.85 28.14 4.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.623 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 20' ' ' ARG . 18.0 mm-40 -69.6 139.15 53.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.018 0.409 . . . . 0.0 110.519 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 m -56.93 116.65 3.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -74.01 -14.49 61.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.694 0.283 . . . . 0.0 111.673 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 31.41 6.21 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.496 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.53 154.72 4.71 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.647 0.26 . . . . 0.0 110.69 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.55 165.51 34.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -133.83 138.25 45.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.865 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.81 137.17 48.02 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.471 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.659 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.8 ttmt -123.88 121.61 35.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.688 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.4 p90 -136.41 160.98 37.09 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -101.13 104.2 15.29 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 173.99 140.23 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.279 1.432 . . . . 0.0 108.146 172.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -80.21 -46.11 16.86 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -71.22 -35.52 71.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.695 0.283 . . . . 0.0 111.24 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 t -59.02 -26.84 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.49 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.688 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 38.0 p -63.45 -38.52 91.45 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.463 0.649 . . . . 0.0 109.427 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.4 mt -77.3 -33.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.66 -55.44 32.09 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.93 87.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.461 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 65' ' ' THR . 74.7 t -59.54 -54.29 36.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 120.849 0.357 . . . . 0.0 111.308 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -70.2 -31.95 69.64 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.01 -41.23 14.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.497 ' HB2' HG13 ' A' ' 84' ' ' ILE . 3.0 mm? -89.21 -22.92 22.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 39.2 t30 -56.83 112.83 1.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.828 0.347 . . . . 0.0 111.526 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.89 -7.88 55.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.215 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -66.84 130.27 42.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.994 0.397 . . . . 0.0 110.074 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 31.4 mmmt -86.64 119.32 26.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.21 118.17 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.573 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.62 36.17 92.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.947 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.98 51.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.935 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 17' ' ' ASN . 9.5 mmt180 -105.54 156.02 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.633 -0.334 . . . . 0.0 110.726 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.56 128.6 52.58 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 78.6 mt -63.48 106.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.29 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -89.11 105.66 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 72' ' ' LEU . 17.1 mm -114.7 137.93 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.77 -179.3 7.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -90.46 149.51 22.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -159.89 161.26 34.31 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -108.07 119.95 40.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -131.89 141.33 49.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.05 0.452 . . . . 0.0 111.372 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 3.4 mmp_? -117.23 114.48 38.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.5 135.12 54.48 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.915 2.41 . . . . 0.0 111.955 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.447 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 45.8 mmtm -93.52 128.81 39.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.589 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -71.76 -15.76 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.089 0.471 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -72.83 -25.23 61.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.382 0.611 . . . . 0.0 109.677 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.8 mt -102.78 27.98 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -55.4 -33.45 63.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.207 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 28.5 mmtp -59.12 -49.73 76.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 102' ' ' VAL . 12.2 t80 -59.88 -45.91 90.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.582 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 22.9 m-85 -64.0 -46.91 82.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -62.58 -37.52 86.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.598 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.44 85.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 110.477 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 73.7 t -71.87 -40.24 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.196 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -56.8 -48.36 78.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.193 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.71 -27.03 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 111.03 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.473 ' HG2' ' CD1' ' B' ' 212' ' ' PHE . 7.6 tp10 -68.15 -42.24 80.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 84.4 mt -69.24 -34.43 74.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.537 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.001 179.97 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 13.2 t70 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 46' ' ' GLU . 44.6 mt -123.6 135.27 63.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.987 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.58 135.69 23.77 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.852 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . 0.404 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.4 Cg_endo -74.17 152.43 45.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.731 2.287 . . . . 0.0 112.729 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -125.88 103.77 7.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 49.8 m-85 -90.21 86.47 6.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.304 0.574 . . . . 0.0 110.09 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 16.8 p -111.85 134.98 21.22 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.576 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 7.6 Cg_exo -73.27 92.5 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.969 1.779 . . . . 0.0 111.089 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 5.1 m -77.9 -39.94 41.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.51 25.03 61.69 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.427 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 22' ' ' LEU . 17.9 mt -60.79 -32.11 71.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.175 0.488 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.541 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -75.62 -38.58 58.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -177.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 120.776 0.322 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 58' ' ' LYS . 36.3 m-85 -149.79 132.49 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.97 0.908 . . . . 0.0 108.715 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.86 128.63 69.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.347 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -91.19 130.98 37.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.286 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 52.0 mt -112.45 143.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.88 -177.15 50.15 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.39 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.6 t-20 -54.64 105.9 0.18 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.897 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.71 -173.07 3.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.519 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -79.2 144.37 34.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -70.41 -22.7 62.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.054 0.454 . . . . 0.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.98 2.47 30.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.45 130.77 38.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 p -109.17 170.49 8.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.294 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.2 -28.75 68.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.146 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.16 99.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.537 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -66.47 -48.13 70.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.12 -45.62 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.073 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.45 -36.93 85.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.062 0.458 . . . . 0.0 110.065 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -60.67 -44.35 96.58 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.81 -47.33 93.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.764 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -75.81 -9.71 58.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.734 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.4 t -70.72 -17.16 62.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -73.51 -21.91 60.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -99.14 -20.45 16.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 83.87 50.47 4.39 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.547 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.52 94.64 28.56 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.597 0.237 . . . . 0.0 111.263 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 26.2 Cg_endo -98.65 30.02 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.416 2.744 . . . . 0.0 111.445 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -92.0 -166.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.519 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -63.58 139.68 58.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -135.8 120.1 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.566 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.86 136.76 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.013 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' PHE . 60.0 tp -128.03 134.15 49.19 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.9 p -65.32 99.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' B' ' 208' ' ' ILE . 22.4 tpp180 -113.63 124.28 51.95 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 48' ' ' THR . 23.5 t70 -71.55 136.79 47.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 110.79 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' HD11 ' B' ' 208' ' ' ILE . 12.8 mt-10 -72.13 -26.67 62.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.15 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.418 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 26.0 m-80 -81.59 -65.59 0.99 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.157 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.56 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.1 t -87.47 -21.22 25.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.619 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 80.83 19.51 67.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.756 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' H ' HG23 ' A' ' 48' ' ' THR . 40.0 mt-10 -101.14 163.43 12.28 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.556 0.217 . . . . 0.0 111.108 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -78.4 141.42 38.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -89.04 -6.84 56.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.74 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 100.59 -7.1 57.68 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.277 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -107.95 148.22 29.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 118.027 0.913 . . . . 0.0 110.574 -177.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -135.22 150.5 50.11 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.75 119.38 17.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 tp -106.62 140.76 38.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.551 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 12' ' ' TYR . 7.8 tmtm? -129.42 108.84 10.59 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.755 0.788 . . . . 0.0 112.032 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 4.7 p90 -119.7 156.24 30.87 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.01 105.81 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.562 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 178.22 145.66 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.161 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -81.01 -45.6 16.33 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.09 -32.96 50.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -55.64 -30.53 61.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.384 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.723 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.1 p -61.39 -52.36 64.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.501 0.667 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.1 mt -63.53 -36.97 78.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.667 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 tt -62.08 -58.68 6.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.221 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.88 86.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.048 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 65.6 t -61.14 -46.57 96.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -78.23 -40.12 38.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -66.94 -50.43 62.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.484 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.64 -4.86 57.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 25.9 t-20 -63.54 109.41 1.64 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.496 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 -2.83 65.33 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.163 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.9 127.15 30.88 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -88.14 115.0 25.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.262 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.6 mt -120.63 109.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.64 25.49 75.63 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 -16.01 59.55 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.461 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -97.11 132.7 42.64 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.837 0.351 . . . . 0.0 111.208 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.83 135.68 35.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.239 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.72 133.22 45.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.423 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 12.7 mptt -107.52 116.78 32.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.405 HG22 HG22 ' A' ' 69' ' ' VAL . 3.4 mm -117.31 138.6 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.53 166.73 30.25 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -88.56 140.14 29.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 15.2 t -153.72 161.55 42.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.661 0.267 . . . . 0.0 110.855 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -116.36 104.69 11.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -115.92 150.04 37.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -125.42 135.57 27.09 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.114 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.87 122.4 10.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.923 2.416 . . . . 0.0 112.214 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -69.21 135.24 50.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.697 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -60.88 3.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -74.14 -22.3 59.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.03 0.443 . . . . 0.0 112.087 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.87 6.06 45.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.333 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.92 -22.36 62.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.553 0.216 . . . . 0.0 111.419 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -58.99 -39.55 82.14 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.652 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.96 -35.96 79.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -66.66 -50.07 64.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.1 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 44.9 mt-10 -65.32 -42.95 92.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.04 -47.49 80.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.547 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.414 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.8 p -71.89 -33.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.571 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -65.81 -39.21 90.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 18.7 mm-40 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.894 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.86 -48.18 77.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 102' ' ' VAL . 11.0 mp -63.12 -45.17 93.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.134 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.082 179.243 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.042 0.449 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . 0.488 HG21 ' HG2' ' A' ' 44' ' ' ARG . 62.5 mt -138.46 123.41 22.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.4 mmt -100.84 149.97 36.63 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.172 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.88 163.29 37.38 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.678 2.252 . . . . 0.0 111.714 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -130.17 126.32 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.275 0.559 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -111.2 90.7 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.494 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 72.3 m -110.42 147.58 36.65 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.99 52.54 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.708 2.272 . . . . 0.0 111.257 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.1 m -54.29 -50.15 67.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.938 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.73 47.7 59.93 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.882 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.76 -15.22 59.27 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.405 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . 0.518 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.56 -15.82 55.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.909 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.227 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.27 120.78 37.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.413 ' HB2' ' OD1' ' A' ' 5' ' ' ASN . 83.0 mtp -102.43 -6.82 22.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.113 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.73 40.22 6.37 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 3' ' ' MET . 2.1 m-20 -64.12 -23.53 67.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.721 0.408 . . . . 0.0 111.498 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.07 -12.23 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.469 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -99.44 109.84 22.38 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.591 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.84 86.09 1.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.623 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' ALA . 2.9 p-10 -86.01 -22.6 27.21 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 89' ' ' TYR . 5.7 p30 -76.71 21.11 0.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.765 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' ASP . . . -87.2 142.54 27.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.873 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 4.6 p90 -157.97 -179.59 8.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.219 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 pt -102.65 144.27 13.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 40.4 t80 -101.97 124.96 48.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.525 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 mp -102.38 139.25 23.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.06 -169.78 46.29 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.124 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' HB2' ' NH2' ' A' ' 80' ' ' ARG . 11.6 m120 -45.51 112.23 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.63 0.772 . . . . 0.0 112.553 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.4 mt -104.42 168.9 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.201 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.17 140.31 58.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -64.55 -17.24 63.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.896 0.379 . . . . 0.0 110.561 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' B' ' 217' ' ' LEU . 63.9 mm-40 -82.68 -11.6 58.23 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.7 mt -84.93 128.27 34.55 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.53 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.8 p -110.43 176.56 5.0 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.489 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.8 mp0 -57.42 -30.33 64.88 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.634 0.373 . . . . 0.0 111.137 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -40.64 94.96 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.644 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -67.83 -42.39 81.52 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.088 0.471 . . . . 0.0 109.866 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.08 -47.84 88.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.787 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -65.46 -32.57 74.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 109.874 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 m -63.71 -41.27 98.12 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.0 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.65 -46.81 93.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.031 0.443 . . . . 0.0 110.456 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CG ' HD22 ' A' ' 57' ' ' LEU . 60.4 m-85 -73.81 -13.07 60.87 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.844 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.08 -16.48 63.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.395 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.46 -39.56 84.06 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.916 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -85.29 -16.02 41.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.669 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.51 27.44 73.47 Favored Glycine 0 N--CA 1.454 -0.155 0 CA-C-N 115.877 -0.602 . . . . 0.0 113.327 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.08 97.36 42.15 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.13 101.74 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.079 2.519 . . . . 0.0 112.564 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -137.13 -166.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 38' ' ' VAL . 17.4 m-20 -60.2 140.9 56.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.2 p -138.9 128.95 32.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.52 118.62 52.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.784 0.326 . . . . 0.0 111.065 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.5 tp -109.11 128.69 55.21 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 23.9 m -70.03 108.24 3.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.972 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -126.71 143.3 51.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.693 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 16.2 t70 -53.7 138.47 35.05 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.763 0.665 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' B' ' 208' ' ' ILE . 2.4 mp0 -69.54 -13.93 62.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.25 -55.72 2.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.059 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.517 HG23 ' HG2' ' A' ' 50' ' ' GLU . 3.6 t -101.55 -5.34 25.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.02 18.71 76.6 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.892 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.5 mm-40 -56.28 134.18 53.17 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.916 0.358 . . . . 0.0 111.283 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.0 m -66.2 107.98 2.13 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -71.33 -19.17 62.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.661 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.88 -0.12 51.95 Favored Glycine 0 C--O 1.221 -0.67 0 C-N-CA 120.747 -0.74 . . . . 0.0 114.452 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 4.0 m-85 -108.99 129.83 55.46 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.551 0.675 . . . . 0.0 109.592 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -125.83 149.73 48.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.025 0.441 . . . . 0.0 111.365 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 20.3 m-85 -137.9 148.8 45.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.281 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.2 tp -140.66 115.23 9.47 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.531 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 12' ' ' TYR . 1.5 tmtp? -100.25 114.11 27.3 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.265 0.555 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 42.7 p90 -132.06 143.73 50.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.165 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -101.06 106.81 18.12 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.24 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.571 ' O ' HG23 ' A' ' 65' ' ' THR . 21.0 t70 175.27 109.96 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.599 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -64.07 -47.18 81.15 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.339 0.59 . . . . 0.0 110.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 m -67.37 -25.42 65.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.534 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.654 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.2 p -62.77 -61.2 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.12 -34.98 62.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.59 -61.01 2.83 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.131 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.84 91.94 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 73.7 t -58.95 -51.59 70.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-O 120.586 0.231 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.58 -36.77 68.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.828 0.347 . . . . 0.0 111.334 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.56 -43.83 72.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.88 -18.17 31.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 32.9 t-20 -65.06 109.49 2.17 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.069 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.9 -2.44 52.04 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -81.13 132.08 35.34 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -88.86 132.26 34.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.146 0.498 . . . . 0.0 112.214 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.1 mm -129.22 101.76 6.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.79 174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.43 23.59 77.87 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.458 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.67 -15.78 60.5 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.043 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.412 ' NH2' ' HB2' ' A' ' 17' ' ' ASN . 30.3 mmm180 -94.86 110.2 22.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.616 0.246 . . . . 0.0 111.596 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 83' ' ' LYS . . . -68.41 127.69 33.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.23 117.88 16.54 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.635 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 81' ' ' ALA . 10.8 mptt -100.84 110.75 22.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 20.5 mm -103.16 121.65 54.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.727 0.298 . . . . 0.0 111.423 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -116.53 166.6 11.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.858 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -96.35 136.43 36.85 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.3 t -161.24 160.8 30.38 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.758 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.53 138.99 43.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.911 0.386 . . . . 0.0 110.175 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 15.6 t80 -149.88 135.24 18.19 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -96.28 112.32 59.42 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.249 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.54 115.35 2.99 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.564 ' HD3' ' H ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -73.91 144.84 45.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.916 0.388 . . . . 0.0 110.376 178.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -72.94 -13.42 61.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.371 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 t -68.52 -17.08 64.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.112 0.482 . . . . 0.0 110.063 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 tp -123.01 24.83 8.8 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -58.7 -32.49 69.22 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.172 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -60.42 -32.63 71.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.531 0.205 . . . . 0.0 111.513 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.55 -55.69 16.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -64.49 -34.5 78.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.73 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 34.0 tt0 -65.6 -41.52 92.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.136 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.61 -30.24 70.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 110.019 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG11 ' H ' ' A' ' 40' ' ' VAL . 86.2 t -68.23 -48.48 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -70.84 -12.74 61.72 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 25.5 mm-40 -61.26 -35.13 76.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -83.23 -26.16 31.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.508 ' O ' HG12 ' A' ' 110' ' ' ILE . 25.3 mt -85.58 -14.99 44.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.696 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.36 -29.31 63.91 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.503 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -59.29 -26.46 64.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.58 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.48 -37.55 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.394 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 106' ' ' LEU . 47.4 mm -62.69 -22.95 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.43 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.06 -33.62 29.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.833 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.6 t -75.79 102.45 5.47 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.439 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -95.68 153.94 17.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.487 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -66.21 153.31 42.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.048 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 67.62 103.23 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.71 105.5 11.06 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.928 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 45.37 -154.32 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.16 0.984 . . . . 0.0 112.789 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HD2' ' H ' ' A' ' 118' ' ' LYS . 10.6 mptt . . . . . 0 C--O 1.244 0.807 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.262 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 112.089 -0.404 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 36.8 p -59.75 -37.62 79.5 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -104.61 11.51 34.11 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.367 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 16.3 t -110.29 -1.22 17.36 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.169 0.509 . . . . 0.0 110.172 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -104.2 4.5 34.01 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.91 151.83 21.54 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.37 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.0 101.58 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 121.023 0.44 . . . . 0.0 110.048 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -147.55 119.0 7.89 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.434 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 46' ' ' GLU . 24.4 mt -134.55 117.22 23.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.482 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 3.1 mmt -114.54 117.95 42.02 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.411 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.2 Cg_exo -50.35 133.65 37.05 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.191 2.594 . . . . 0.0 112.512 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -123.27 108.24 12.56 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.699 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -88.96 88.86 7.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 61.7 m -112.55 155.17 44.22 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.753 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -100.87 112.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.747 2.298 . . . . 0.0 112.044 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 95.3 p -78.89 -43.41 24.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 109.822 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.18 72.86 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.211 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 21' ' ' GLU . 42.4 mt -58.29 -36.39 73.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.13 -9.59 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.081 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -68.37 -33.63 74.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.29 0.567 . . . . 0.0 110.558 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.04 0.68 17.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.69 12.23 3.17 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.279 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.257 -179.441 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.234 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.48 24.06 10.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.945 0.402 . . . . 0.0 111.167 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptm -63.86 -24.46 67.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.6 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.05 72.51 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.818 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -92.42 -6.69 49.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.384 0.592 . . . . 0.0 111.152 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.92 -53.87 3.15 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.83 162.08 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -82.39 93.02 7.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.261 0.553 . . . . 0.0 109.813 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.19 -22.31 42.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.664 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -87.16 16.65 4.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.123 0.487 . . . . 0.0 110.186 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 99.5 4.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.742 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 33.4 m-85 -134.74 166.69 22.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 pt -141.92 138.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.166 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -85.47 116.81 24.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.477 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -86.48 130.92 35.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 18' ' ' LEU . . . -86.42 -168.27 44.6 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.25 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 12.4 t30 -39.69 101.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.944 0.898 . . . . 0.0 112.964 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 16' ' ' GLY . 77.3 mt -97.94 -173.8 2.7 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.345 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -100.08 139.58 35.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 20' ' ' ARG . 5.7 ptp180 -64.89 -17.39 64.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.826 0.346 . . . . 0.0 111.654 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.69 -6.38 58.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 0.0 110.517 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.2 tp -90.59 110.7 21.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.1 p -98.27 172.95 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -57.99 -32.18 67.64 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.986 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.16 98.86 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.586 ' O ' ' HB ' ' A' ' 29' ' ' THR . 6.2 t70 -74.83 -38.83 61.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 ' O ' ' HD1' ' A' ' 31' ' ' PHE . 72.0 mt -58.32 -45.05 89.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.413 0.625 . . . . 0.0 109.581 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 106' ' ' LEU . 83.2 mt -69.06 -26.63 65.06 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.339 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.3 m -57.97 -54.06 51.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.03 -31.19 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' HD1' ' O ' ' A' ' 27' ' ' ILE . 67.8 m-85 -79.26 -20.61 47.7 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.171 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.2 t -70.89 -17.69 62.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 109.892 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.13 -22.13 65.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.701 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.59 2.55 52.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.0 81.38 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.779 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.41 HG12 HG22 ' A' ' 38' ' ' VAL . 32.1 t -127.03 98.72 29.86 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 117.254 0.527 . . . . 0.0 111.687 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.14 120.08 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.936 2.424 . . . . 0.0 110.68 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -124.44 -167.4 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.788 -177.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.77 136.18 39.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 111.802 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.33 134.86 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 41' ' ' ILE . 4.1 mp -124.84 108.61 20.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.0 tp -88.13 139.4 30.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.919 0.39 . . . . 0.0 110.242 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -83.68 109.55 17.55 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.564 ' NE ' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -121.79 145.5 47.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.294 -176.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.11 131.48 50.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.088 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HA ' HD11 ' B' ' 208' ' ' ILE . 29.3 mt-10 -75.08 -15.8 60.6 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.61 -61.39 1.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.1 t -108.06 -22.15 12.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.39 21.58 12.84 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.712 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -71.87 161.37 31.05 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 120.684 0.278 . . . . 0.0 111.162 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 t -81.22 130.97 35.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -80.07 -9.11 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 97.41 13.82 43.53 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.708 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -158.33 165.48 34.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.169 0.485 . . . . 0.0 110.732 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.73 14.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.983 0.42 . . . . 0.0 111.627 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.81 124.91 27.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.14 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 11.0 tp -110.32 136.52 49.38 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.55 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -114.62 120.38 39.96 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.634 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -140.99 -166.82 2.24 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.809 -176.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.69 179.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 14.9 m-20 -61.42 -174.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.868 -1.06 . . . . 0.0 113.421 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -49.8 -39.79 39.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.601 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -51.29 -52.79 41.97 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 m -70.81 -30.84 67.4 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.383 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.634 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 32.8 p -61.1 -47.48 86.1 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 110.757 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.76 -37.53 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.867 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.85 -57.76 10.58 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.147 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.69 82.22 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' THR . 60.4 t -56.47 -52.43 52.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.226 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.47 -37.57 88.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -77.27 -49.22 15.51 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.47 -29.97 57.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -66.59 110.27 3.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 0.0 109.967 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.76 -19.99 25.14 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.093 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -74.99 139.02 42.65 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 37.0 ttpt -109.86 135.74 50.27 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.924 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.4 mt -127.22 119.29 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' B' ' 221' ' ' GLU . . . 62.64 30.38 76.55 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.626 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.75 1.44 68.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.494 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.572 ' C ' ' HG3' ' A' ' 76' ' ' LYS . 81.6 mtt180 -129.06 119.55 24.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.347 0.574 . . . . 0.0 111.494 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . . . -68.96 137.27 53.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.637 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.93 125.79 30.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.067 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -108.11 105.34 15.04 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -99.21 109.81 25.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.034 0.445 . . . . 0.0 111.11 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -104.61 112.74 25.94 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.1 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.4 124.17 22.01 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.856 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -159.37 136.66 9.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -74.52 155.99 37.36 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.54 ' HB3' ' CG ' ' A' ' 12' ' ' TYR . 82.9 t80 -150.75 149.89 30.33 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -108.49 121.14 44.32 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.06 129.89 37.75 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.072 2.514 . . . . 0.0 112.442 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.42 128.69 39.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -80.22 -10.18 59.75 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.951 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.8 m -76.88 -22.74 53.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.205 0.526 . . . . 0.0 109.886 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 tp -110.9 26.67 10.45 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.79 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -57.64 -31.32 66.15 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.956 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -58.66 -38.13 77.5 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.584 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -64.64 -43.89 92.23 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -63.6 -47.71 80.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.977 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -59.06 -43.68 91.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.825 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.24 -46.25 86.28 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.28 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.89 -45.7 83.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -60.37 -50.39 73.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.499 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.53 -38.64 91.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.69 -51.55 68.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.513 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 28' ' ' LEU . 80.0 mt -67.33 -30.02 69.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.713 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.39 -34.34 77.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.104 0.478 . . . . 0.0 110.313 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -67.88 -38.16 82.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.531 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.22 -26.87 67.58 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.07 -35.41 58.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.255 0.55 . . . . 0.0 110.14 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.18 -42.22 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.034 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.4 t -68.31 109.56 3.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 0.0 110.548 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -73.22 89.67 1.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.637 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -61.59 -35.25 77.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.831 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.96 -15.9 60.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.257 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.66 -68.33 0.18 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.453 0.701 . . . . 0.0 111.172 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.53 -179.04 7.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.219 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.807 178.74 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 31.3 m -101.68 39.64 1.42 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.747 0.308 . . . . 0.0 110.449 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -67.68 -18.48 64.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.474 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.6 p -80.62 -17.99 49.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.329 0.585 . . . . 0.0 110.25 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -99.25 -57.05 2.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.559 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -91.27 124.52 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.05 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 57.4 mt -71.4 102.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.486 0.66 . . . . 0.0 110.622 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -130.92 102.23 5.97 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.006 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.574 HD11 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -129.56 129.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.605 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 14.7 mmt -110.18 149.7 40.48 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.445 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.76 146.79 91.27 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.946 2.43 . . . . 0.0 111.557 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -120.14 88.88 3.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.461 0.648 . . . . 0.0 111.348 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -76.87 96.68 4.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.912 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 14.6 m -110.22 145.19 31.64 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.91 62.05 3.9 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.472 2.115 . . . . 0.0 111.216 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.594 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 34.4 m -59.12 -51.82 68.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.91 37.98 93.41 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.108 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.594 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 8.5 mp -68.06 -26.62 65.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 117.23 0.515 . . . . 0.0 111.245 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.98 -22.28 64.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 109.901 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -83.65 -33.81 25.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.516 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.22 0.65 35.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.175 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 11.3 tp10 -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.303 -1.45 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.511 179.18 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.069 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.71 80.12 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.286 0.565 . . . . 0.0 111.006 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 mmt -113.07 30.79 6.91 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.852 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.13 47.92 21.91 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.016 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -60.36 -24.5 65.12 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.866 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.33 -27.57 62.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.636 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -92.61 -5.82 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.669 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -100.1 -24.71 14.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.64 -4.72 50.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -80.34 -8.03 59.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.707 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.1 -167.97 2.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.374 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.577 ' CE1' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -55.88 155.83 5.74 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -109.94 152.85 11.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.722 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -99.92 137.8 37.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.779 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 51.6 mt -123.63 143.6 36.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.74 -168.76 45.2 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.79 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 9.2 t30 -55.22 117.86 3.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.3 0.572 . . . . 0.0 112.434 -176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 63.8 mt -100.57 -168.4 1.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.981 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.491 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . 56.6 t30 -79.11 154.4 29.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.353 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -70.69 -31.83 68.85 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.77 -0.5 55.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.8 mt -81.64 109.51 16.14 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.945 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.4 p -98.52 178.74 4.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.915 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 3.3 mp0 -60.06 -25.17 65.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.36 176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.35 -51.48 31.99 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HB ' ' A' ' 29' ' ' THR . 2.9 m-20 -64.0 -39.64 94.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.784 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.22 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.5 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.23 -35.47 80.91 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 36.9 m -59.01 -48.94 79.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.656 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG22 HD13 ' B' ' 218' ' ' LEU . 68.9 t -56.38 -51.74 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.544 ' CG ' HD22 ' A' ' 57' ' ' LEU . 95.7 m-85 -78.26 -17.75 56.25 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -176.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -68.39 -20.0 64.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -70.07 -24.05 63.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.043 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.45 -20.34 40.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.128 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.78 9.68 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.721 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.0 m -127.41 89.23 51.91 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 121.21 0.529 . . . . 0.0 111.95 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 84.32 1.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.88 2.387 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -124.78 -166.59 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.608 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.0 m-20 -72.58 131.81 42.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' H ' HG11 ' A' ' 102' ' ' VAL . 7.3 p -121.39 133.41 68.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.5 mp -130.43 124.96 58.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 120.716 0.293 . . . . 0.0 110.603 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 43' ' ' SER . 2.0 tt -107.79 134.85 50.15 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.407 ' N ' HD23 ' A' ' 42' ' ' LEU . 51.3 p -61.21 114.77 3.34 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 51.4 mtp180 -134.72 137.52 43.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.755 0.312 . . . . 0.0 110.224 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.587 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 16.5 m-20 -68.62 156.02 38.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.032 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.92 -35.58 28.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.434 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -71.43 -70.51 0.31 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.796 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -85.7 -19.9 30.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.76 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.587 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 73.9 18.59 79.65 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.311 178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 48' ' ' THR . 44.0 mt-10 -93.02 164.55 13.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.739 0.304 . . . . 0.0 111.309 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -72.12 129.07 37.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.499 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -80.16 -13.59 59.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.583 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.42 -10.28 30.81 Favored Glycine 0 C--O 1.215 -1.058 0 C-N-CA 120.6 -0.81 . . . . 0.0 114.305 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.16 148.49 28.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.865 0.833 . . . . 0.0 109.853 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -124.77 153.15 42.89 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.991 0.424 . . . . 0.0 110.836 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.437 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 55.1 m-85 -138.54 136.4 36.03 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 31' ' ' PHE . 16.5 tp -135.21 122.79 22.09 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.735 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.6 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 55.5 tttp -102.13 117.25 34.39 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.757 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 50.8 p90 -145.09 145.27 31.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 2.6 mp0 -101.6 107.58 18.88 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.426 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 65' ' ' THR . 28.0 t70 177.22 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.536 0.522 . . . . 0.0 110.783 174.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -51.17 -39.39 56.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -65.25 -54.86 22.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.794 0.33 . . . . 0.0 111.565 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.426 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 31.9 p -67.24 -19.93 65.59 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.757 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.3 p -61.63 -49.13 77.79 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.757 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.9 mt -65.23 -38.73 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.788 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 27.4 tp -58.77 -56.89 16.35 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.181 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.07 83.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.489 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 65' ' ' THR . 71.4 t -63.56 -53.06 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.909 -178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.93 -40.08 63.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.84 -37.81 87.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -95.62 -10.66 28.87 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 47.8 t-20 -64.84 109.73 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.057 0.456 . . . . 0.0 110.578 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.25 3.65 65.06 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.514 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -77.06 132.78 39.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.0 mmtp -91.88 125.35 36.55 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.095 0.474 . . . . 0.0 112.221 -176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mt -134.61 115.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.051 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.26 27.44 72.41 Favored Glycine 0 C--N 1.315 -0.6 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.627 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -3.71 86.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.42 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 18.0 mmt180 -102.37 150.13 23.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.94 126.31 51.87 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.862 0.363 . . . . 0.0 110.57 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 45.4 mt -73.68 128.94 36.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.754 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 75.3 mmtt -122.4 115.14 21.75 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 3.4 mm -114.22 148.39 17.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.519 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -154.09 145.97 23.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.029 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -74.4 136.75 42.41 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 12' ' ' TYR . 10.2 t -159.24 159.85 34.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.819 0.343 . . . . 0.0 111.128 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -124.27 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 33.6 t80 -136.74 142.8 43.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.65 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -98.14 107.59 42.07 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.446 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.81 119.73 6.47 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.081 2.52 . . . . 0.0 112.839 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.15 150.65 31.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.456 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -70.66 -19.86 62.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.923 0.392 . . . . 0.0 110.73 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.1 m -75.94 -11.16 59.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.373 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp -114.96 18.65 16.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.215 0.531 . . . . 0.0 109.813 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -58.56 -42.12 87.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.942 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB3' ' HE3' ' B' ' 209' ' ' MET . 92.8 mttt -61.78 -29.11 69.92 Favored 'General case' 0 C--O 1.22 -0.447 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.673 -177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 3.7 t80 -67.94 -52.54 34.97 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.728 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.29 -46.45 73.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.27 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.57 91.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.701 0.286 . . . . 0.0 111.241 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.1 t -64.5 -50.39 76.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.39 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -63.28 -40.61 97.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.884 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 43.6 mm-40 -66.31 -39.64 89.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.639 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.49 -35.13 78.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.732 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 90.7 mt -63.09 -48.54 78.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.325 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -64.59 -31.72 73.06 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.174 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 91.1 mtt180 -62.99 -33.6 75.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.18 -39.59 33.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.688 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 106' ' ' LEU . 44.1 mm -70.14 -32.59 51.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.406 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.9 t 74.52 -60.17 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 123.761 0.824 . . . . 0.0 110.875 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.0 t -162.67 -60.76 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.514 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 tttp 66.78 111.95 0.04 OUTLIER 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.887 0.742 . . . . 0.0 111.453 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -86.14 94.71 9.34 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -155.39 -156.61 0.67 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.23 20.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.798 0.332 . . . . 0.0 111.322 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 66.67 16.14 10.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.969 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm . . . . . 0 C--O 1.244 0.782 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.547 -179.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 39.2 m -104.83 3.26 30.88 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.43 -31.45 72.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.178 0.514 . . . . 0.0 111.232 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 23.1 m -82.17 -11.84 58.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.994 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.87 -62.81 1.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -90.32 121.96 32.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.041 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.45 134.13 28.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.846 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -122.59 98.9 6.13 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.271 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.99 99.11 7.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.145 0.498 . . . . 0.0 109.781 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 17.7 mmt -99.64 125.74 39.64 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.558 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 38.0 Cg_endo -66.37 135.36 39.34 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.632 2.221 . . . . 0.0 112.369 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -109.31 104.37 13.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.35 87.39 6.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.147 0.499 . . . . 0.0 110.658 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.2 m -112.42 117.97 46.3 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.629 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.31 100.85 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.05 1.833 . . . . 0.0 112.184 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -75.27 -44.18 47.24 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 83.2 27.98 38.43 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.294 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 19' ' ' ASN . 93.4 mt -61.51 -42.01 98.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.996 0.426 . . . . 0.0 110.564 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 30' ' ' VAL . 2.5 pt? -76.99 -11.58 59.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.956 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -92.88 -52.42 4.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.481 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.05 -56.02 4.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.809 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 62.52 86.82 0.11 Allowed 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.73 0.644 . . . . 0.0 111.183 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.296 179.664 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.174 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.23 96.58 4.58 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.52 -29.82 70.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.989 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.07 -17.89 76.02 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.355 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.72 -37.36 9.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.225 0.536 . . . . 0.0 110.031 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.56 -44.07 36.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.806 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.02 71.66 1.28 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.102 0.477 . . . . 0.0 111.699 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.98 -10.79 56.68 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.77 8.5 9.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.992 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -89.81 -17.26 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.265 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.69 98.92 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.843 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 17.2 m-85 -138.48 147.94 43.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.101 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -124.5 137.56 56.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.725 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 90.2 t80 -91.66 129.97 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.275 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.5 142.39 16.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.97 -169.89 46.31 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.576 -175.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -63.83 105.66 0.87 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.9 mt -97.73 -173.02 2.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -72.7 143.09 48.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -59.09 -31.83 69.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -84.91 9.73 13.61 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.617 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tt -96.59 121.03 37.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.107 0.48 . . . . 0.0 109.849 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.9 p -100.16 174.72 6.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.859 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 0.8 OUTLIER -67.96 -22.7 65.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.148 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.03 -38.84 94.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.451 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.547 ' O ' ' HB ' ' A' ' 29' ' ' THR . 9.6 t70 -72.89 -38.57 66.89 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.8 mt -61.36 -46.2 97.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.303 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.6 -34.74 78.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.0 m -56.96 -46.39 82.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.415 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.492 HG22 HD13 ' B' ' 218' ' ' LEU . 84.1 t -64.33 -46.92 91.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -72.52 -19.29 61.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 m -66.47 -21.34 66.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.459 0.171 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -68.07 -18.4 64.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.994 0.426 . . . . 0.0 110.587 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -101.69 3.77 40.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.89 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 71.44 44.35 51.25 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.779 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.74 89.93 20.52 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 120.821 0.343 . . . . 0.0 111.256 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 97.3 Cg_endo -103.22 47.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.742 2.961 . . . . 0.0 110.949 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.5 t -104.56 -166.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.681 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.622 ' H ' HG12 ' A' ' 38' ' ' VAL . 10.0 m-20 -67.07 120.02 12.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -171.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 p -116.78 115.33 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.957 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.8 106.66 21.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.053 0.454 . . . . 0.0 111.069 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.99 141.17 28.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 78.7 p -73.81 100.23 3.4 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.345 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 44' ' ' ARG . 72.3 mtt-85 -106.38 146.41 30.5 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 48' ' ' THR . 18.7 t70 -58.89 137.53 57.76 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.94 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 36.0 mt-10 -72.04 -9.73 58.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.271 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -102.6 -65.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.407 HG22 ' OD2' ' A' ' 45' ' ' ASP . 12.1 t -93.91 -25.67 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.94 21.55 35.78 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.688 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.41 154.84 24.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.249 0.524 . . . . 0.0 110.355 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 m -66.34 133.65 50.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.049 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 74.8 mt-30 -89.17 -14.1 36.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.55 -29.33 8.31 Favored Glycine 0 C--O 1.219 -0.825 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.389 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -108.83 173.44 6.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.011 0.905 . . . . 0.0 111.039 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.44 167.84 29.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.484 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -131.69 123.36 27.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.945 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.1 tp -111.45 138.16 48.32 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.712 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 35.0 tttm -122.24 123.09 40.64 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.443 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.743 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.6 p90 -143.7 148.56 35.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.278 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -101.6 106.08 17.1 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.727 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 65' ' ' THR . 14.7 t70 177.07 126.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.218 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -70.65 -48.12 56.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -63.49 -40.02 95.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.812 0.339 . . . . 0.0 111.13 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.9 t -60.94 -32.85 72.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.831 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.743 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.1 p -59.28 -45.73 90.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.347 0.594 . . . . 0.0 110.938 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.9 mt -74.78 -38.92 45.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.543 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.17 -56.1 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.604 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.92 78.8 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 88.6 t -65.97 -53.14 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.05 -29.11 66.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -81.25 -48.96 11.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.17 -18.38 55.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 38.1 t-20 -61.86 112.35 2.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.922 0.391 . . . . 0.0 110.047 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.45 ' HA2' ' HB1' ' A' ' 81' ' ' ALA . . . 105.76 -11.33 45.77 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.755 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -67.13 133.13 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -81.37 115.74 20.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.931 0.395 . . . . 0.0 111.697 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -132.37 112.43 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.82 29.67 67.01 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.749 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.5 16.35 80.8 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.347 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.5 148.72 51.71 Favored 'General case' 0 CA--C 1.51 -0.589 0 O-C-N 122.788 -0.242 . . . . 0.0 110.48 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB1' ' HA2' ' A' ' 74' ' ' GLY . . . -84.87 128.59 34.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.457 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 77.8 mt -62.72 108.17 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -89.22 99.73 12.66 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.589 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 69' ' ' VAL . 9.8 mm -105.83 138.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -151.41 148.28 27.91 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.194 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 69' ' ' VAL . 16.8 m-70 -72.06 118.63 15.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.616 0.246 . . . . 0.0 110.428 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -132.15 160.24 36.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.788 0.328 . . . . 0.0 110.648 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -106.62 136.91 45.6 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -149.97 136.61 19.2 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 90' ' ' ARG . 4.3 mpt_? -108.92 127.19 27.77 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.91 104.32 0.17 Allowed 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.71 2.273 . . . . 0.0 111.901 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.67 134.34 33.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 15.1 ptm180 -60.02 -22.73 62.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -65.31 -19.34 65.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.118 0.485 . . . . 0.0 110.454 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.0 mt -127.9 16.95 6.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.04 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 13.7 pt20 -64.94 -20.26 66.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.583 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.08 -41.44 78.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.765 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.489 ' O ' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -62.96 -45.3 93.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.594 -178.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.14 -41.56 92.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.076 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 35.7 tt0 -74.25 -43.15 58.13 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.478 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.1 84.85 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.266 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.563 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.4 m -70.15 -34.6 59.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.858 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.24 -44.11 97.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.382 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 5.1 mm-40 -61.27 -41.11 96.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.114 0.483 . . . . 0.0 109.926 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 4.8 tp10 -70.7 -32.41 69.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.132 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 102' ' ' VAL . 5.8 mp -84.16 -44.72 13.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.664 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -70.88 -23.98 62.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.912 -176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 9.5 ptm180 -63.25 -23.64 67.51 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.932 0.396 . . . . 0.0 110.574 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -78.52 -39.66 37.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.792 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.77 -45.04 98.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.703 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.5 -17.86 14.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.771 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 t 68.78 80.3 0.2 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.35 78.48 1.16 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.705 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -87.75 -59.46 2.24 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 59.94 16.36 5.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.87 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.97 -77.73 0.56 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 60.25 98.76 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 O-C-N 123.656 0.598 . . . . 0.0 112.331 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.207 178.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.276 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 16.2 m -93.83 -62.81 1.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -76.12 -17.11 59.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 12.7 t -68.1 -5.02 15.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.44 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -78.93 -23.55 44.58 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.136 0.493 . . . . 0.0 110.441 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -88.72 166.25 14.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.523 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.2 122.13 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.956 0.407 . . . . 0.0 110.324 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.26 106.55 10.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.046 0.451 . . . . 0.0 111.051 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 53.4 mt -121.7 107.66 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.714 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.2 mmt -110.37 124.61 32.83 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-O 121.074 0.464 . . . . 0.0 111.907 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 58.9 Cg_endo -72.09 166.29 30.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.105 2.537 . . . . 0.0 112.289 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -142.74 102.99 4.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.666 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -81.05 85.87 6.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.258 0.551 . . . . 0.0 111.728 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 70.0 m -113.72 119.35 41.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.308 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 98.55 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.151 1.901 . . . . 0.0 111.034 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG ' ' B' ' 217' ' ' LEU . 11.3 t -63.86 -40.88 97.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 79.8 20.36 68.43 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.447 ' HG ' ' OG ' ' B' ' 215' ' ' SER . 57.4 mt -65.29 -40.32 93.67 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 30' ' ' VAL . 2.7 pt? -61.55 -27.1 68.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.899 0.381 . . . . 0.0 110.72 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.22 -50.28 8.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.765 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 40.4 mt -74.87 -59.49 2.71 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.556 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -117.04 90.94 3.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.533 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.645 178.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.19 83.86 0.12 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 112.259 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -97.59 -60.07 1.65 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.57 177.52 42.85 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.732 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -79.56 -41.33 27.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.832 0.348 . . . . 0.0 110.658 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -111.1 -5.42 14.77 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.19 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 69.93 -55.38 0.6 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.902 0.881 . . . . 0.0 112.015 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp 61.5 17.32 8.37 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.777 0.831 . . . . 0.0 111.726 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -101.68 -7.46 22.64 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.372 0.606 . . . . 0.0 109.774 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 88' ' ' PHE . 7.0 p30 -120.89 5.25 10.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.336 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.52 130.95 35.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.691 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.535 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 2.1 p90 -159.31 -178.89 7.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.845 0.355 . . . . 0.0 110.835 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -112.91 144.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.471 . . . . 0.0 111.309 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' HB2' HG21 ' A' ' 87' ' ' THR . 83.9 t80 -97.13 131.0 44.32 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 mp -109.7 136.37 45.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.36 -169.4 45.89 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.262 -175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.24 114.67 0.99 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.369 0.604 . . . . 0.0 112.595 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HB3' HD12 ' A' ' 22' ' ' LEU . 93.4 mt -100.17 -170.87 1.94 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.217 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.442 ' H ' HD12 ' A' ' 22' ' ' LEU . 61.3 m-20 -82.98 151.32 25.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.975 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -66.91 -20.05 65.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.709 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -100.51 10.59 40.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.812 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 19' ' ' ASN . 25.7 mt -96.27 127.21 42.07 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.9 p -110.3 -179.13 3.69 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.499 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 38.1 mt-10 -64.62 -25.26 67.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.983 0.42 . . . . 0.0 110.916 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.96 -42.05 70.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.451 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 29' ' ' THR . 14.3 m-20 -66.08 -42.64 89.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 109.942 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.8 mt -60.14 -45.81 95.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.194 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.6 -35.49 81.16 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.049 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 28.1 m -57.49 -47.03 83.01 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.684 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -62.04 -48.89 86.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -75.53 -17.17 60.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 t -64.74 -32.42 74.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 0.0 110.235 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.05 -22.2 63.1 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 110.287 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -89.42 0.76 56.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.227 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.78 38.85 97.18 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.62 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.06 88.52 52.53 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.228 0.537 . . . . 0.0 112.266 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -93.57 70.26 0.41 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.133 2.556 . . . . 0.0 110.244 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -117.76 -166.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.043 -177.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.507 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -64.27 120.46 12.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.672 0.272 . . . . 0.0 111.431 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.02 138.2 53.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.7 130.37 49.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 54' ' ' PHE . 49.3 tp -109.95 133.12 53.52 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 26.9 m -67.8 106.62 2.32 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -117.84 151.95 36.33 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.481 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 12.9 t70 -66.85 135.89 54.57 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.648 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.402 ' HA ' HD11 ' B' ' 208' ' ' ILE . 31.7 mt-10 -81.95 -11.44 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -84.45 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.76 0.314 . . . . 0.0 111.292 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -104.41 -20.4 13.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.024 0.44 . . . . 0.0 111.117 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 91.86 32.3 8.63 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -91.96 165.22 13.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.996 0.398 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 m -67.5 128.05 35.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.695 0.283 . . . . 0.0 110.601 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.87 -17.62 27.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.84 -4.41 29.03 Favored Glycine 0 C--O 1.221 -0.69 0 C-N-CA 120.075 -1.059 . . . . 0.0 115.207 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.0 m-85 -114.46 146.84 40.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.049 0.924 . . . . 0.0 109.533 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -133.35 148.37 51.86 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 32.8 m-85 -129.29 138.78 51.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.707 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 25.0 tp -138.18 118.68 13.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.177 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -105.43 106.1 16.45 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.711 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.711 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 26.9 p90 -124.79 145.93 49.49 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -103.35 106.21 16.67 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.768 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.603 ' O ' HG23 ' A' ' 65' ' ' THR . 33.4 t70 176.46 108.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.557 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.17 -36.39 72.98 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.6 tpt85 -66.99 -49.11 66.38 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 p -69.97 -20.72 63.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.711 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 72.4 p -58.36 -46.78 85.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.459 0.647 . . . . 0.0 110.01 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.1 mt -74.26 -36.15 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.044 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 67' ' ' LEU . 6.6 tt -61.97 -54.79 36.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.126 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.77 -44.66 90.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.867 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 79.4 t -60.92 -52.16 64.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.03 -38.38 79.14 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -69.89 -50.02 46.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.931 0.396 . . . . 0.0 111.267 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 94.7 mt -78.13 -12.98 60.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.083 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.91 109.86 1.38 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.836 0.35 . . . . 0.0 110.497 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.47 76.85 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.382 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -78.82 129.66 34.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 3.2 tppp? -82.05 116.01 21.45 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.166 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.4 mm -125.02 101.68 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.468 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.4 42.39 93.9 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.289 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 20.64 79.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.7 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 51.5 mmm-85 -129.68 144.19 51.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.1 118.7 35.3 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.726 0.298 . . . . 0.0 110.242 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 94.7 mt -64.89 140.14 58.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.2 0.524 . . . . 0.0 111.502 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.14 116.51 21.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 5.6 mm -111.7 138.15 41.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.808 0.337 . . . . 0.0 110.449 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.0 145.56 37.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.668 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -78.36 127.86 32.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.542 HG21 ' HB2' ' A' ' 14' ' ' TYR . 1.8 t -147.65 160.37 42.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.575 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.466 ' HB2' ' OD1' ' A' ' 10' ' ' ASN . 6.2 p90 -126.94 135.45 50.92 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -150.48 124.09 9.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.311 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -81.64 128.87 67.76 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.13 142.37 96.65 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.09 2.527 . . . . 0.0 112.602 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -95.47 137.72 34.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.389 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -18.12 58.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.032 0.444 . . . . 0.0 109.833 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 m -66.81 -27.6 67.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.425 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.34 31.79 5.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.285 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.78 -32.51 67.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.28 -21.13 63.91 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.442 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -70.25 -51.51 30.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -64.15 -30.73 71.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.96 -46.49 71.24 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -60.74 -50.28 74.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.359 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 34.4 m -60.19 -35.0 59.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.682 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -58.65 -57.62 12.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.809 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.51 -34.91 79.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.508 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 10.7 mm-40 -65.5 -51.46 59.89 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.513 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 89.4 mt -61.17 -40.51 94.16 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.872 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.57 -55.49 34.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -71.9 -20.15 61.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.038 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.24 -30.06 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.487 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 106' ' ' LEU . 81.0 mt -65.63 -46.97 87.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.195 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t 70.63 -45.54 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -78.42 -2.37 38.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.213 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -75.91 -39.46 56.25 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.602 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.02 -176.95 0.11 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.076 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -38.97 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 62.77 29.4 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.83 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 59.77 -158.41 0.32 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.0 tptt . . . . . 0 N--CA 1.438 -1.058 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.654 177.67 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.142 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 35.6 t 73.06 155.09 0.16 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.434 0.635 . . . . 0.0 111.868 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -70.01 -26.59 64.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.808 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 20.3 m -70.84 -8.98 56.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.819 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.18 -31.38 65.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.092 0.472 . . . . 0.0 110.236 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -85.07 170.42 12.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.602 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.17 103.12 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.57 99.28 5.11 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.811 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' GLU . 7.4 mm -93.1 107.04 18.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.026 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 93.9 mmm -121.72 125.12 26.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.499 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 77.0 Cg_exo -52.66 132.97 48.33 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.227 2.618 . . . . 0.0 113.576 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -126.13 103.69 7.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.863 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -88.63 96.02 10.48 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.391 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 36.1 t -110.56 139.12 21.27 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.932 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.83 79.1 0.41 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 122.079 1.853 . . . . 0.0 111.908 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -67.74 -39.14 84.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.67 36.0 62.19 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.456 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.417 HD12 ' HG ' ' A' ' 22' ' ' LEU . 62.7 mt -62.85 -32.81 74.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.715 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.563 HD23 ' H ' ' B' ' 218' ' ' LEU . 1.5 pt? -95.52 -5.88 41.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -97.42 -45.9 6.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.521 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 9.4 mp -88.6 -8.98 53.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.492 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -135.18 129.83 34.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.352 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.38 1.05 . . . . 0.0 111.277 177.681 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.283 0 N-CA-C 112.341 -0.304 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.14 -179.7 4.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.649 0.261 . . . . 0.0 110.758 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.3 ttp -69.38 -21.08 63.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.1 0.476 . . . . 0.0 110.268 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.66 -8.8 41.87 Favored Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.402 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.63 -39.56 73.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -78.32 -48.66 15.16 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.845 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.91 89.73 3.95 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -75.39 106.5 6.96 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.156 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -100.46 -13.87 18.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.135 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.94 19.76 6.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.096 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.36 96.97 4.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.53 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 87' ' ' THR . 99.0 m-85 -154.4 141.2 19.1 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.178 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.1 pt -116.4 142.13 31.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.407 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -93.16 122.53 35.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 71.7 mt -107.45 138.49 33.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.85 -169.54 46.0 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.277 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 2.6 m-20 -50.24 119.28 3.54 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 112.489 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 22' ' ' LEU . 57.5 mt -98.87 169.46 9.44 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.173 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.525 HD22 HD13 ' B' ' 217' ' ' LEU . 56.7 t30 -70.28 149.22 47.64 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -64.71 -24.93 67.73 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.044 0.449 . . . . 0.0 110.726 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.85 5.33 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.823 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.405 HD22 HD13 ' A' ' 18' ' ' LEU . 3.7 tt -96.7 127.24 42.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.6 p -110.73 179.75 3.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.266 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -65.4 -23.17 66.89 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.055 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.13 -41.61 96.94 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' B' ' 215' ' ' SER . 6.1 m-20 -65.1 -39.86 93.74 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -58.24 -49.67 80.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.68 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.87 -35.6 81.09 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.436 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -57.35 -45.43 84.37 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.8 t -74.07 -46.46 45.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.74 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -76.1 -19.61 58.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -19.86 66.05 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.092 0.473 . . . . 0.0 110.574 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.26 -0.69 15.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.738 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -96.88 -1.21 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.968 0.413 . . . . 0.0 110.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.45 -21.25 24.24 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.819 -0.705 . . . . 0.0 114.563 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.08 129.51 3.87 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 117.93 0.865 . . . . 0.0 112.29 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.5 112.56 1.07 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.585 2.19 . . . . 0.0 111.458 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.755 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.2 t -103.06 -167.54 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.67 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.755 ' H ' HG12 ' A' ' 38' ' ' VAL . 28.4 t70 -68.2 144.47 54.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.02 133.23 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 111.391 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.31 134.89 61.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.828 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.9 tp -132.22 139.6 48.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.715 0.293 . . . . 0.0 111.053 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.6 p -77.06 125.24 28.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.97 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -121.82 142.75 49.91 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.176 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -74.28 138.52 43.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.181 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.37 -17.12 52.87 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.41 -67.87 0.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.879 0.371 . . . . 0.0 111.171 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 50' ' ' GLU . 9.9 t -115.36 -31.45 5.94 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.978 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.82 43.65 0.79 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.194 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 48' ' ' THR . 43.1 mt-10 -94.53 168.47 10.84 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.5 t -74.99 134.63 41.42 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -84.05 -9.47 58.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.142 0.496 . . . . 0.0 110.591 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.23 3.45 51.0 Favored Glycine 0 C--O 1.222 -0.635 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.772 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -119.94 130.0 54.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.494 0.647 . . . . 0.0 110.192 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -131.07 141.2 50.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.038 0.447 . . . . 0.0 110.684 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -128.19 127.98 43.91 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.7 tp -116.91 142.4 46.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.665 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 42.3 tttp -122.66 125.74 46.21 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.889 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.715 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -146.76 147.47 30.95 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 105.33 16.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.57 -0.852 . . . . 0.0 112.407 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 65' ' ' THR . 30.4 t70 176.04 137.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.416 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -75.91 -45.52 34.89 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.788 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -62.75 -43.07 99.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 33.7 m -58.98 -27.58 65.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.848 -177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.715 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.1 p -63.98 -40.17 95.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.597 0.713 . . . . 0.0 109.942 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.9 mt -76.64 -39.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.603 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 43.2 tp -58.12 -58.32 8.95 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.535 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.63 68.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.592 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 76.7 t -65.4 -59.98 3.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.599 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 -36.66 78.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -74.97 -51.04 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -91.71 -8.99 45.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 20.0 t-20 -62.74 109.69 1.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.131 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.59 2.07 76.65 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.682 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -72.51 137.49 46.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -85.64 110.1 19.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.777 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.551 HG13 HD11 ' A' ' 82' ' ' LEU . 29.0 mm -119.13 108.4 23.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.296 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.97 13.77 80.68 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.693 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.76 -10.42 58.95 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.75 130.95 35.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.551 HD11 HG13 ' A' ' 77' ' ' ILE . 60.4 mt -84.74 128.3 34.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -104.91 111.43 24.19 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 13.8 mm -105.21 129.33 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -135.92 -179.77 5.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -111.84 129.36 56.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 10.1 t -155.14 160.96 41.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.123 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -110.52 121.67 45.88 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.86 148.73 41.02 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.315 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -113.15 116.01 47.28 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.466 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.13 110.24 0.98 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 112.038 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -94.79 147.24 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.79 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -78.13 -0.66 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.604 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 m -63.5 -22.95 67.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 0.0 110.018 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.8 mt -122.54 34.36 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.634 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.545 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 29.1 pt20 -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.271 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 29.8 mmtp -58.11 -44.53 87.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.018 0.437 . . . . 0.0 110.737 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.471 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.8 t80 -62.98 -46.66 86.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.514 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -48.19 82.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.565 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 49.2 mt-10 -57.81 -49.45 76.58 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.081 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.96 -38.23 81.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 98' ' ' TYR . 68.4 t -63.1 -51.98 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.886 0.374 . . . . 0.0 110.139 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -54.78 -48.67 72.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.91 -30.16 66.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.958 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.65 -47.38 69.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.705 0.288 . . . . 0.0 110.299 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.86 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.67 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -63.31 -38.31 90.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -69.0 -24.64 64.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.686 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.4 -44.98 27.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.341 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.79 -55.86 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.087 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.9 t 69.5 -65.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.371 0.669 . . . . 0.0 110.436 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.9 p -178.7 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.893 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 62.47 97.39 0.03 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.628 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 62.9 t30 75.98 164.5 0.26 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.59 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -74.75 83.96 2.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.19 0.519 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.58 -52.06 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.867 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.12 0.91 7.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.218 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.2 tttt . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.323 -178.783 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.5 m 68.36 102.29 0.05 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.975 0.51 . . . . 0.0 111.581 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.71 -30.07 71.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 17.7 m -77.75 1.83 18.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.724 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -89.1 -14.59 35.91 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.361 0.6 . . . . 0.0 109.602 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -88.92 110.64 21.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.722 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 64.0 mt -85.81 133.34 29.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.326 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . 0.543 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 17.5 t70 -135.86 110.99 8.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.64 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 58.0 mt -136.78 140.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 110.576 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 2.9 mmt -107.73 143.85 28.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -73.1 175.61 10.26 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.728 2.286 . . . . 0.0 111.921 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.03 93.0 2.54 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.005 0.431 . . . . 0.0 111.064 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -90.48 86.19 6.36 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.962 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 11.0 p -113.08 141.79 26.25 Favored Pre-proline 0 N--CA 1.435 -1.208 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.579 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 13.6 Cg_exo -70.25 86.84 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.906 1.737 . . . . 0.0 111.476 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 13.8 t -78.03 -51.25 10.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 72.54 36.71 58.66 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.63 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.525 HD13 HD22 ' A' ' 19' ' ' ASN . 57.1 mt -60.35 -39.91 88.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.12 0.486 . . . . 0.0 111.058 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.497 ' HB3' HG23 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.04 -18.13 63.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 178.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.56 -34.74 16.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.961 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 91.2 mt -70.93 -43.06 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.732 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 220' ' ' LEU . 72.9 mm-40 71.81 132.22 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.758 0.661 . . . . 0.0 111.321 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 C--N 1.31 -1.127 0 CA-C-O 118.568 -0.73 . . . . 0.0 110.491 179.578 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.6 153.39 22.42 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.708 0.289 . . . . 0.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.74 -53.08 16.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.155 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.19 30.8 0.43 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.223 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -63.1 -58.81 6.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 110.38 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -99.63 10.52 41.21 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.779 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 59.37 -156.36 0.34 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.255 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 10' ' ' ASN . 64.5 mttm -127.73 157.44 40.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.907 0.384 . . . . 0.0 111.072 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.89 -38.82 61.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.738 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' PHE . 30.3 p-10 -75.47 -8.47 56.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.696 -178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -74.98 109.4 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.701 ' CE1' ' HB2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -157.07 178.76 9.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.226 0.328 . . . . 0.0 110.313 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -118.97 145.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.139 0.495 . . . . 0.0 111.738 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 87' ' ' THR . 39.2 t80 -94.57 133.77 37.85 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.274 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 62.6 mt -111.59 135.05 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 83' ' ' LYS . . . -87.45 -167.32 43.48 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.933 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 26.2 t-20 -39.69 112.48 0.26 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.372 1.069 . . . . 0.0 113.583 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.0 mt -107.54 171.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.119 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -87.96 142.52 27.72 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -60.51 -23.96 64.95 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.905 0.384 . . . . 0.0 111.396 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HB2' HD21 ' B' ' 217' ' ' LEU . 34.2 mm-40 -88.07 -7.6 56.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.75 111.02 22.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.491 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 27' ' ' ILE . 41.0 p -91.87 173.9 7.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HB2' ' CD2' ' B' ' 212' ' ' PHE . 7.5 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.725 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' B' ' 212' ' ' PHE . . . -70.51 -43.1 62.3 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.7 m-20 -63.63 -41.03 98.3 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 24' ' ' GLU . 62.9 mt -58.97 -53.04 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.761 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.28 -33.17 74.92 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 120.69 0.281 . . . . 0.0 110.603 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 m -59.89 -45.59 92.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.543 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 26' ' ' ASP . 93.2 t -63.43 -41.36 92.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.639 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CZ ' HD22 ' A' ' 57' ' ' LEU . 70.5 m-85 -74.79 -22.65 58.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.5 m -72.78 -17.62 61.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.324 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.56 -33.52 76.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 121.219 0.533 . . . . 0.0 109.774 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -91.73 -15.42 28.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.801 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.29 44.99 6.02 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.546 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -137.51 88.28 16.87 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 121.528 0.68 . . . . 0.0 111.596 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -98.44 99.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 123.502 2.802 . . . . 0.0 111.723 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -130.7 -165.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.537 ' H ' HG12 ' A' ' 38' ' ' VAL . 7.8 m-20 -64.42 116.09 5.76 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -110.2 129.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.57 106.24 18.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 57.0 tp -87.21 131.31 34.24 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -74.97 102.44 4.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.935 0.397 . . . . 0.0 109.998 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 19.1 mtp85 -115.7 149.43 38.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 48' ' ' THR . 25.5 t70 -67.72 135.16 52.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.794 0.33 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.99 -28.25 66.18 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.46 -56.23 2.67 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.474 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.3 t -84.82 -23.1 29.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 44' ' ' ARG . . . 82.02 -6.54 66.51 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.698 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' H ' HG23 ' A' ' 48' ' ' THR . 41.9 mm-40 -71.34 155.34 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.688 -0.301 . . . . 0.0 111.274 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.7 t -68.63 138.18 54.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.3 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -85.25 -5.23 59.33 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.987 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 106.93 7.63 33.08 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.383 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -152.07 167.97 26.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.785 0.793 . . . . 0.0 110.924 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -150.44 176.28 11.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.27 0.557 . . . . 0.0 111.998 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB3' ' CE2' ' A' ' 12' ' ' TYR . 50.8 m-85 -136.62 153.02 51.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.932 . . . . 0.0 108.972 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 31' ' ' PHE . 12.4 tp -142.04 125.87 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.1 tmtm? -116.15 113.21 22.78 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.184 0.516 . . . . 0.0 110.538 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 15.6 p90 -125.18 158.83 33.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.867 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 40.2 mt-10 -103.09 105.54 15.87 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.962 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 14.6 t70 175.7 133.46 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -80.79 -37.3 30.47 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.654 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -71.32 -40.61 70.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.72 0.295 . . . . 0.0 110.513 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 26.1 t -58.09 -27.83 64.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.85 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.695 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.4 p -60.82 -52.52 64.74 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.518 0.675 . . . . 0.0 109.775 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.3 mt -70.87 -36.35 63.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.086 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.05 -61.18 2.83 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.367 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.07 79.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 86' ' ' HIS . 54.2 t -64.36 -47.47 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.4 -33.37 60.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.107 0.479 . . . . 0.0 111.154 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -77.69 -53.19 7.84 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.1 mt -91.43 -23.61 19.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 t30 -67.76 109.31 3.29 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.65 -5.05 32.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.673 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -75.05 126.35 30.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -83.72 122.76 29.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.386 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 HD11 ' A' ' 82' ' ' LEU . 41.9 mt -136.5 120.29 23.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.299 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.77 35.83 87.77 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.408 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.47 3.91 86.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.742 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -133.09 154.5 50.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 117.546 0.673 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.12 134.82 43.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.727 0.299 . . . . 0.0 111.224 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD11 HD12 ' A' ' 77' ' ' ILE . 75.9 mt -73.22 125.72 28.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.593 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 56.2 mtpt -108.11 122.42 46.85 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG22 HG22 ' A' ' 69' ' ' VAL . 13.5 mm -120.46 129.65 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.621 0.248 . . . . 0.0 110.483 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -138.99 146.22 40.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.127 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.492 ' CD2' HG21 ' A' ' 69' ' ' VAL . 14.7 m-70 -79.57 130.48 35.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.676 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.658 HG23 ' CE1' ' A' ' 12' ' ' TYR . 3.5 t -156.27 162.52 40.12 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.825 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ASN . 36.5 p90 -109.68 143.12 39.9 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.701 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 47.5 t80 -128.65 136.64 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.893 0.378 . . . . 0.0 111.178 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -108.07 96.03 16.83 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.74 146.71 84.49 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.98 2.453 . . . . 0.0 113.506 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.67 136.71 46.96 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.937 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.66 -6.96 44.9 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.868 0.366 . . . . 0.0 111.41 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.7 t -74.74 -27.68 60.45 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 17.26 16.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.987 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -59.04 -28.61 66.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.637 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.39 -40.09 85.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.097 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -72.86 -46.77 51.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.65 -51.82 68.3 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 36.4 mm-40 -62.27 -43.3 99.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.493 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.84 -49.38 77.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.945 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.03 -47.38 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.592 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -56.02 -54.41 45.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.539 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.3 pt-20 -69.89 -26.63 64.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.23 -58.16 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.511 ' O ' HD13 ' A' ' 110' ' ' ILE . 4.1 pp -66.47 -28.33 68.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.038 0.447 . . . . 0.0 110.423 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 106' ' ' LEU . 19.0 t70 -59.87 -36.28 76.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.387 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.68 -36.11 65.27 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.733 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.61 -39.46 84.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.125 0.488 . . . . 0.0 110.178 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 106' ' ' LEU . 1.6 mp -63.93 -36.04 75.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.49 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t 73.72 -60.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.5 m -85.07 80.49 9.24 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -67.45 -23.25 65.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.866 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -79.6 74.63 6.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.967 0.413 . . . . 0.0 111.326 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -88.99 -33.43 17.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -162.2 105.94 1.17 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.403 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -68.36 112.32 5.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.397 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.8 pttt . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.093 -179.816 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.26 0 N-CA-C 112.081 -0.407 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 36.7 t -161.83 149.65 14.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.938 0.399 . . . . 0.0 110.709 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -7.68 59.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.153 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 62.1 m -92.71 1.98 56.98 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.023 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -72.29 -56.95 4.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.189 0.519 . . . . 0.0 110.23 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -90.93 118.66 30.5 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.367 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 39.6 mm -125.0 98.41 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 CA-C-O 121.437 0.637 . . . . 0.0 110.103 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.03 144.27 30.91 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.943 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 44' ' ' ARG . 46.6 mt -134.22 144.39 35.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 11.6 mmt -127.19 139.93 36.48 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.854 0.359 . . . . 0.0 111.713 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.61 151.23 41.33 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.435 2.09 . . . . 0.0 111.203 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -158.02 76.22 0.78 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 24' ' ' GLU . 36.8 p90 -110.88 115.72 30.01 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 12.7 p -110.28 117.96 50.3 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.263 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.84 114.49 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.75 2.3 . . . . 0.0 113.001 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.495 ' HB2' HD12 ' B' ' 217' ' ' LEU . 37.7 m -78.89 -40.48 32.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.332 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 86.69 38.35 8.18 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.386 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.3 mp -63.69 -40.18 96.17 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.428 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.7 pt? -65.15 -20.31 66.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.16 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -80.94 -35.16 32.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.351 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.39 -70.52 0.6 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.971 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 53.56 23.71 3.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.047 0.539 . . . . 0.0 112.268 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.042 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 112.168 -0.373 . . . . 0.0 112.168 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.72 151.33 27.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.637 0.256 . . . . 0.0 110.867 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.02 -13.89 18.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.305 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.5 117.14 5.36 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.494 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.84 -24.63 38.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.076 0.465 . . . . 0.0 110.426 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.99 -44.52 94.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.57 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.412 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 10.0 m-85 -85.13 88.89 7.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -73.39 108.21 6.12 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.363 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' O ' ' HE1' ' A' ' 12' ' ' TYR . 18.8 t70 -90.74 -19.34 23.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.647 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -93.19 -6.67 47.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.832 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.21 97.59 7.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.257 0.551 . . . . 0.0 111.75 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 74.2 m-85 -147.59 156.0 42.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.126 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 pt -125.21 133.39 69.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 120.656 0.265 . . . . 0.0 110.498 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -85.49 126.06 33.53 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.796 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -105.9 137.02 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.71 -169.5 45.96 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.557 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -53.67 112.39 0.91 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.654 0.782 . . . . 0.0 112.239 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 HD23 ' A' ' 22' ' ' LEU . 67.6 mt -102.74 -173.42 2.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.405 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 16.4 m120 -79.31 148.19 32.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.08 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -65.43 -35.69 81.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.85 7.82 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.803 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 18' ' ' LEU . 26.8 tp -81.67 109.96 16.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 p -85.17 166.07 16.89 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.615 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 32.1 mt-10 -65.66 -22.4 66.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.53 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -45.76 78.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.581 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -64.26 -40.48 96.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 110.471 178.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.1 mt -58.66 -46.39 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.582 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.42 -30.63 70.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.103 0.478 . . . . 0.0 109.733 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 30.8 m -62.57 -41.14 98.75 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.552 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG22 HD13 ' B' ' 218' ' ' LEU . 81.4 t -67.5 -46.86 82.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.303 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.26 -21.99 55.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -70.77 -14.31 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.784 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.45 -8.73 55.75 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.391 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.631 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 79.8 m-85 -92.15 -10.9 37.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.63 10.45 86.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.399 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -129.15 89.83 47.05 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 120.683 0.278 . . . . 0.0 110.737 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -88.01 114.66 0.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.963 2.442 . . . . 0.0 111.964 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.805 HG12 ' H ' ' A' ' 39' ' ' ASP . 2.6 t -132.31 -167.42 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.805 ' H ' HG12 ' A' ' 38' ' ' VAL . 6.4 m-20 -62.0 144.23 55.43 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.24 140.28 46.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.864 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.9 mt -137.32 110.33 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.668 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.5 tp -102.52 136.42 42.38 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.408 ' OG ' ' HB2' ' A' ' 52' ' ' GLN . 92.1 p -79.36 112.38 16.53 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.166 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -123.29 149.62 44.58 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.72 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.63 142.45 42.61 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.557 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.52 -29.3 41.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.819 0.342 . . . . 0.0 111.424 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -76.74 -58.01 3.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 50' ' ' GLU . 3.7 t -91.79 -40.28 11.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.93 -9.13 43.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.558 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' H ' HG23 ' A' ' 48' ' ' THR . 42.7 mt-10 -67.49 160.33 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.968 0.507 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.2 m -75.69 141.37 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.03 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 76.8 mt-30 -82.81 -12.96 57.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.03 -30.58 7.9 Favored Glycine 0 C--O 1.216 -0.997 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.969 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -109.36 161.81 14.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.775 0.788 . . . . 0.0 111.575 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.33 166.54 26.82 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.127 0.489 . . . . 0.0 111.828 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -134.09 135.27 43.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.735 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.8 tp -119.15 143.43 47.21 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.624 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 31.6 tttm -124.37 118.54 26.95 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.207 0.527 . . . . 0.0 111.788 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.779 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 12.3 p90 -138.82 144.04 39.13 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 7' ' ' TYR . 37.0 mt-10 -102.45 104.4 14.85 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.675 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 65' ' ' THR . 25.1 t70 175.46 141.88 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.433 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -80.83 -37.48 29.96 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.02 -43.19 71.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 61' ' ' ASP . 8.6 p -63.86 -22.72 67.05 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.779 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 44.1 p -62.23 -50.71 70.66 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.337 0.589 . . . . 0.0 109.762 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mt -64.78 -37.05 79.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.072 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.83 -58.65 7.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.426 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.66 89.23 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 65' ' ' THR . 72.2 t -57.32 -58.98 3.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.44 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.3 -31.38 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -67.23 -46.73 72.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.316 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.631 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 72.5 mt -93.78 -20.49 20.05 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -63.12 109.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.52 7.97 58.79 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.061 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.06 138.46 31.5 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -86.32 127.58 34.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG13 HD11 ' A' ' 82' ' ' LEU . 23.7 mm -131.91 110.76 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.88 20.84 77.96 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.753 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.31 -12.57 65.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.359 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -107.47 150.88 26.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.269 0.534 . . . . 0.0 110.926 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.64 133.51 33.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 111.067 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 78.5 mt -80.14 130.62 35.37 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.68 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -114.81 108.86 17.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mm -112.31 141.34 28.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.656 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.26 155.27 38.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.662 0.268 . . . . 0.0 110.95 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -71.68 128.25 35.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.625 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.4 t -153.72 161.26 42.27 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -108.94 159.26 16.95 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -149.48 138.92 21.54 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.355 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -112.78 113.73 49.92 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.8 140.34 79.58 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.722 2.282 . . . . 0.0 111.823 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -94.15 128.39 40.53 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -71.8 -15.26 62.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.068 0.461 . . . . 0.0 110.478 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -66.8 -29.63 69.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.6 30.87 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.628 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -53.38 -33.39 53.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.328 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -71.06 -27.09 63.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -68.37 -49.85 57.26 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.431 ' HA ' HG12 ' A' ' 102' ' ' VAL . 64.7 m-85 -64.64 -32.17 73.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.221 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -53.31 48.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.421 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -63.03 -38.39 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.914 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 9.0 p -70.92 -27.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.451 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 tptt -76.68 -42.53 41.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.958 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.76 -26.39 67.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.87 -31.04 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.999 0.428 . . . . 0.0 110.206 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 102' ' ' VAL . 12.7 tp -63.39 -64.7 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.273 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.12 -34.5 72.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.769 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -63.89 -45.2 90.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.516 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.028 0.442 . . . . 0.0 110.658 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 106' ' ' LEU . 49.7 mt -69.64 -9.69 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.113 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 111' ' ' VAL . 22.2 t 73.04 4.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.953 0.882 . . . . 0.0 110.002 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.2 t -86.7 88.6 7.7 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.219 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -151.18 24.42 0.73 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.099 0.476 . . . . 0.0 109.815 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.92 -35.25 78.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.732 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -103.01 -32.06 9.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.947 0.403 . . . . 0.0 110.524 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.57 -39.2 88.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.516 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -111.95 158.48 19.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 pttp . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.488 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.978 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 37.7 m -115.04 20.9 14.7 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.16 0.505 . . . . 0.0 110.215 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.63 -8.42 56.76 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 31.7 m -79.77 6.13 11.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.715 0.293 . . . . 0.0 111.31 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -72.83 -35.75 67.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.067 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -92.42 116.07 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.174 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.37 132.39 38.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.541 0.686 . . . . 0.0 110.814 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -109.48 120.76 43.48 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.372 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 62.4 mt -108.26 131.09 59.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.797 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.421 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 20.5 mmt -107.22 134.74 19.79 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.431 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 29.6 Cg_endo -62.05 129.59 27.78 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.205 2.603 . . . . 0.0 111.829 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -103.26 102.4 12.36 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.699 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.28 83.38 3.57 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.548 0.689 . . . . 0.0 109.674 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.0 t -113.64 119.41 41.54 Favored Pre-proline 0 N--CA 1.433 -1.316 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.446 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.31 96.61 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.707 1.605 . . . . 0.0 111.227 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.51 ' HB2' HD12 ' B' ' 217' ' ' LEU . 17.2 m -81.39 -43.79 18.48 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 81.28 38.82 13.84 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.905 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' B' ' 215' ' ' SER . 5.6 mp -62.72 -37.76 87.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.584 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.537 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.34 -22.7 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.517 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 -50.7 49.37 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.848 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.22 -14.95 61.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.12 0.486 . . . . 0.0 110.6 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -81.39 -29.22 34.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.245 0.837 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.997 179.322 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.55 102.56 13.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.878 0.37 . . . . 0.0 110.19 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 ttt -99.53 -21.91 15.71 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.489 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.12 95.07 0.56 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.017 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -74.97 -7.1 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.84 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -110.17 -2.01 17.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.855 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 55.49 38.05 29.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.363 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -78.35 52.28 1.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.84 0.829 . . . . 0.0 110.505 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.53 10.36 25.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.466 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -81.8 29.95 0.38 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.732 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.08 98.43 9.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.11 0.481 . . . . 0.0 110.75 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -139.2 137.73 36.26 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.338 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.97 135.4 61.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.139 0.495 . . . . 0.0 111.667 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HD1' ' CE1' ' A' ' 56' ' ' TYR . 50.5 t80 -88.42 132.0 34.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.991 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 63.4 mt -106.9 132.69 53.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 83' ' ' LYS . . . -86.44 -168.22 44.55 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.696 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 66.5 t30 -52.12 108.76 0.31 Allowed 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -175.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.96 -165.6 1.33 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.647 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -101.15 149.03 24.39 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -72.0 -26.53 62.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.72 -19.05 62.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.765 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.475 HD12 HD13 ' B' ' 217' ' ' LEU . 27.1 tp -84.04 109.04 17.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 27' ' ' ILE . 80.4 p -91.12 178.12 6.08 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 120.927 0.394 . . . . 0.0 110.704 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.34 -9.81 58.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.466 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.77 -45.8 56.52 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.33 -39.22 85.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 23' ' ' THR . 46.7 mm -51.11 -51.62 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.636 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -67.7 -36.85 81.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.425 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.8 m -61.95 -42.24 98.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.652 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.47 HG22 HD13 ' B' ' 218' ' ' LEU . 75.4 t -76.04 -45.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -79.34 -21.97 45.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -75.8 -12.57 60.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.954 -0.466 . . . . 0.0 111.069 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -57.41 -24.53 56.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.878 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -75.2 -1.65 24.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.71 -21.3 45.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.355 -0.45 . . . . 0.0 114.096 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.99 107.2 15.1 Favored Pre-proline 0 C--N 1.313 -0.988 0 O-C-N 122.462 -0.434 . . . . 0.0 110.906 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.8 100.9 1.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.534 2.156 . . . . 0.0 110.718 175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -101.05 -166.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.306 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' H ' HG12 ' A' ' 38' ' ' VAL . 34.9 t70 -63.16 129.0 38.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.929 0.395 . . . . 0.0 111.478 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.8 134.87 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.766 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.3 mt -131.52 106.42 11.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -93.03 127.4 38.54 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.6 t -75.74 91.58 2.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.16 0.505 . . . . 0.0 110.952 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' B' ' 211' ' ' ASP . 4.4 tpt180 -91.44 136.14 33.33 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p30 -80.75 147.16 30.66 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.093 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.534 ' HB3' HD11 ' B' ' 208' ' ' ILE . 1.5 pm0 -81.59 -9.59 59.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.042 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -75.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 111.473 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.8 t -112.68 -18.93 12.22 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.216 0.532 . . . . 0.0 110.153 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 90.82 32.05 9.5 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.937 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -103.93 171.29 7.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.806 0.336 . . . . 0.0 111.626 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.0 t -73.3 130.85 41.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.59 -8.65 58.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.014 0.435 . . . . 0.0 110.894 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 105.95 -3.55 38.58 Favored Glycine 0 C--O 1.206 -1.63 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.673 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -137.22 163.09 31.74 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 117.962 0.881 . . . . 0.0 111.292 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.03 175.28 12.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.34 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CE1' ' HD1' ' A' ' 14' ' ' TYR . 84.4 m-85 -138.87 147.99 43.1 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 tp -137.39 144.11 42.27 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.569 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 31.5 tttt -132.39 123.27 26.42 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.689 177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 6.2 p90 -134.06 150.91 51.21 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -101.18 103.59 14.64 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.654 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 174.29 122.87 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.097 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -69.24 -33.36 73.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.04 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -68.04 -41.38 82.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.98 0.419 . . . . 0.0 111.531 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.3 m -61.9 -26.32 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.669 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 41.7 p -61.57 -50.78 71.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.568 0.699 . . . . 0.0 109.955 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.6 mt -70.98 -34.77 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.182 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.36 -58.21 8.52 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.831 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.12 75.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 73' ' ' ASN . 95.7 t -69.01 -30.14 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.154 0.502 . . . . 0.0 111.594 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.41 -31.9 18.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.275 0.56 . . . . 0.0 111.355 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.22 -45.23 9.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.006 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 89.5 mt -96.04 -30.78 13.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 69' ' ' VAL . 8.8 t30 -67.42 109.89 3.37 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.816 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.78 31.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.185 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -72.71 132.22 43.39 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.21 116.85 21.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.305 0.574 . . . . 0.0 112.334 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.61 109.6 22.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.02 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.89 30.82 77.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.765 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 -13.61 65.43 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.238 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -113.72 148.7 35.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.925 0.363 . . . . 0.0 110.448 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.99 143.46 26.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.691 0.282 . . . . 0.0 111.307 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 87.7 mt -76.74 124.41 27.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.238 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 40.0 ttmt -104.64 117.06 33.18 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mm -114.96 117.22 54.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.799 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -127.32 146.13 50.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.738 0.304 . . . . 0.0 111.324 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -80.04 125.36 29.69 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 14' ' ' TYR . 13.3 t -154.96 160.65 41.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -100.55 99.63 10.25 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -115.86 132.76 56.55 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.432 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -113.98 132.87 22.47 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.962 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.16 163.24 34.93 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.513 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 60.6 mttp -98.72 129.34 45.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.31 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -75.36 -11.82 60.13 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.872 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -75.08 -32.73 61.55 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.18 0.514 . . . . 0.0 110.236 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 99.0 mt -89.53 33.46 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -51.4 -36.13 42.15 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.085 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -60.41 -49.36 77.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.857 0.36 . . . . 0.0 111.366 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -59.82 -51.47 69.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.326 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.513 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 59.3 m-85 -61.58 -36.3 80.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.287 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 37.7 tt0 -66.5 -51.88 52.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.24 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.7 69.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.194 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.427 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.4 t -69.52 -50.41 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 103' ' ' LYS . 35.8 ttmt -58.1 -44.89 87.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.779 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 11.5 pt-20 -70.56 -24.42 62.79 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.058 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.1 -41.96 66.67 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 102' ' ' VAL . 10.6 mp -63.01 -42.17 99.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 111' ' ' VAL . 16.7 t70 -58.1 -45.58 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.005 176.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -59.08 -38.05 78.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.403 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -63.19 -29.27 70.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.055 0.455 . . . . 0.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.9 mm -80.77 -45.97 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.317 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 57.5 t -62.86 -34.98 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 p -73.05 -3.14 24.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -86.81 92.82 9.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.23 5.61 4.3 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.348 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.2 t-20 58.96 31.65 21.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.571 0.701 . . . . 0.0 110.084 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.38 -176.16 4.52 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.808 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.1 -170.0 1.63 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.792 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.9 mttm . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.187 176.454 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 45.4 m -108.97 133.02 53.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.748 0.308 . . . . 0.0 110.438 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.24 -16.38 63.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.584 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 22.7 t -68.2 -13.63 62.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.042 0.449 . . . . 0.0 110.403 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -69.73 -33.91 73.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.9 156.58 17.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.5 99.15 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -132.77 101.95 5.47 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 46' ' ' GLU . 69.3 mt -107.66 126.73 64.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 12.1 mmt -121.63 145.65 43.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.745 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.3 148.14 54.65 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.838 2.359 . . . . 0.0 112.645 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.49 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 25.4 t70 -117.15 98.41 6.44 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.672 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.44 89.1 5.73 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 33.9 m -110.21 139.88 21.86 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.941 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 3.1 Cg_exo -75.08 84.88 1.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.896 1.731 . . . . 0.0 110.98 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 50.2 m -81.53 -51.12 8.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.186 0.517 . . . . 0.0 110.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.12 43.74 89.29 Favored Glycine 0 N--CA 1.431 -1.666 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.758 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 22' ' ' LEU . 6.9 mp -61.26 -34.73 75.64 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 117.121 0.46 . . . . 0.0 110.371 177.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.476 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -79.06 -11.73 60.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.244 0.545 . . . . 0.0 110.563 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.28 -55.38 2.96 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.209 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 40.4 mt -77.79 -27.57 50.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.43 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 58.15 28.15 16.05 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.363 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.644 -178.864 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.221 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.1 105.29 10.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.446 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 9' ' ' ASP . 25.7 ttt -118.53 -1.33 11.21 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.905 0.859 . . . . 0.0 108.982 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.22 -4.65 79.46 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.753 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.52 ' ND2' ' HG3' ' A' ' 6' ' ' GLU . 5.9 p-10 -59.49 -37.2 77.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 0.0 110.538 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' HG3' ' ND2' ' A' ' 5' ' ' ASN . 77.0 mt-10 -111.55 7.16 20.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.709 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 59.17 23.36 11.64 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.068 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.9 -27.93 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.452 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 8.1 p-10 -97.93 7.37 46.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.396 0.617 . . . . 0.0 109.944 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.21 -16.18 12.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.957 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.85 97.89 4.7 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.209 0.528 . . . . 0.0 111.379 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 63.7 m-85 -142.26 139.81 32.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.036 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.0 pt -116.45 133.48 62.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.038 0.447 . . . . 0.0 110.808 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HG21 ' A' ' 87' ' ' THR . 76.4 t80 -88.01 125.94 34.81 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.857 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.0 mt -106.33 143.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.99 -169.37 45.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.119 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.76 133.73 56.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 0.0 111.597 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 mt -125.89 160.33 30.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.02 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -61.35 146.05 49.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.453 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.01 -21.22 65.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.002 0.429 . . . . 0.0 110.724 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.75 -13.65 58.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.895 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.76 129.58 34.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.434 HG21 ' HB2' ' B' ' 213' ' ' SER . 32.1 p -109.27 179.37 4.18 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.895 0.379 . . . . 0.0 110.681 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.1 pm0 -72.91 -21.07 60.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 110.049 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.26 -34.22 85.0 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.557 ' O ' ' HB ' ' A' ' 29' ' ' THR . 27.5 m-20 -72.12 -36.76 69.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.69 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.74 -34.64 78.65 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.385 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 53.4 m -59.24 -46.82 87.47 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.101 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 26' ' ' ASP . 58.3 t -67.52 -50.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.943 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -70.86 -9.34 57.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -22.08 66.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.845 0.355 . . . . 0.0 110.124 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.99 -19.5 64.94 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.213 0.53 . . . . 0.0 110.654 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' OH ' ' HA ' ' A' ' 68' ' ' ALA . 39.1 m-85 -83.01 -20.16 35.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.82 17.13 80.16 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.203 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.87 104.57 3.9 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.378 0.608 . . . . 0.0 111.207 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -85.07 116.3 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.747 2.298 . . . . 0.0 111.961 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -124.83 -166.53 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.9 m-20 -62.55 120.34 10.93 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.01 111.15 30.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.292 0.568 . . . . 0.0 109.938 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 ' CZ ' ' A' ' 99' ' ' TYR . 4.3 mp -108.46 104.48 17.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.57 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.9 tp -84.29 120.58 26.41 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 m -75.14 99.34 3.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.139 0.495 . . . . 0.0 110.964 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.508 ' NH2' ' H ' ' B' ' 211' ' ' ASP . 56.5 mtt180 -103.91 170.16 8.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.762 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 2.7 p-10 -108.78 149.35 29.18 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.588 ' HA ' HD11 ' B' ' 208' ' ' ILE . 4.6 pt-20 -81.46 -9.95 59.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.27 -61.99 1.82 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.944 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -105.49 -28.02 11.06 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.871 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 94.32 24.8 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.833 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -101.57 169.68 8.68 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.636 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -68.5 132.13 46.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -79.48 2.69 21.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.869 0.366 . . . . 0.0 111.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.06 22.78 9.66 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.043 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -169.51 163.15 10.32 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 121.05 0.452 . . . . 0.0 111.349 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.52 161.44 42.24 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.433 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -133.04 130.84 39.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 8.3 tt -121.15 139.07 53.85 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.912 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 13.5 tmtt? -125.69 121.07 32.42 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.441 0.639 . . . . 0.0 111.474 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.67 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 7.6 p90 -131.8 151.25 51.8 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.587 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.02 104.97 15.66 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.953 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 176.4 137.95 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.134 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -78.36 -40.97 34.75 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.417 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -69.47 -41.04 76.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 111.254 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -58.08 -26.67 62.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.999 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.67 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 53.0 p -62.83 -42.96 99.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.602 0.715 . . . . 0.0 110.401 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.1 mt -75.18 -41.05 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.031 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.2 tp -59.87 -52.73 64.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.851 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' ' OH ' ' A' ' 34' ' ' TYR . . . -57.8 -43.92 85.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.863 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.43 -57.72 10.81 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.163 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -62.29 -24.61 67.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -82.54 -54.0 5.52 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.8 0.333 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.0 mt -93.62 -16.1 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.68 109.75 2.13 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.988 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -0.36 61.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.523 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -69.13 136.87 52.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.38 122.97 33.73 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.95 118.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.702 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.27 8.52 79.73 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.342 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.89 10.23 46.87 Favored Glycine 0 CA--C 1.489 -1.532 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -129.43 145.38 51.43 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 115.027 -0.586 . . . . 0.0 110.771 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.19 32.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.872 0.368 . . . . 0.0 111.203 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.44 120.43 22.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.1 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -92.98 113.31 25.55 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.2 mm -118.59 118.89 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.653 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -135.81 149.76 49.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.878 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -76.23 134.76 39.75 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.2 t -160.13 160.58 33.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -91.16 153.09 20.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 12' ' ' TYR . 44.9 t80 -147.13 119.4 8.34 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.089 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 90' ' ' ARG . 49.0 mtt180 -112.26 99.27 45.98 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.879 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.61 149.52 38.79 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -85.13 149.09 25.77 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.04 -8.8 40.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.044 0.45 . . . . 0.0 110.571 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -68.62 -19.06 64.42 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.221 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.5 mt -118.49 24.43 10.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.58 0.229 . . . . 0.0 111.566 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 11.1 pt20 -69.97 -25.61 63.71 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.195 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -67.28 -24.42 65.78 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.951 0.405 . . . . 0.0 110.616 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -69.38 -36.69 77.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CZ ' HG12 ' A' ' 41' ' ' ILE . 53.2 m-85 -69.12 -41.53 77.27 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.077 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 41.8 mm-40 -58.96 -50.64 73.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.489 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -57.89 -51.21 70.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.734 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 13.1 p -64.1 -37.87 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.17 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.02 -49.31 76.54 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.433 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 54.9 mt-10 -64.67 -38.32 90.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.44 -50.17 72.52 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.927 0.394 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 110' ' ' ILE . 85.5 mt -65.99 -41.99 90.39 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.164 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -56.39 -42.41 77.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 108' ' ' ARG . 45.8 ttm105 -68.94 -39.21 79.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.443 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -66.93 -39.88 87.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 106' ' ' LEU . 75.7 mt -68.66 -29.96 45.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.255 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 70.7 t 75.32 -61.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.593 0.757 . . . . 0.0 111.837 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 64.3 m -140.58 90.89 2.38 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.19 0.519 . . . . 0.0 110.54 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.5 95.98 10.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.439 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -97.94 129.41 44.85 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.969 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.0 -43.89 94.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.044 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 64.16 98.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.884 0.74 . . . . 0.0 111.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -62.55 136.1 57.73 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.506 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt . . . . . 0 C--N 1.311 -1.077 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.789 179.753 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' B' ' 204' ' ' GLN . . . . . . . . 0 N--CA 1.476 1.339 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 12.6 p -59.05 -37.88 78.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.38 -22.71 62.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.616 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 39.1 t -86.35 -19.32 29.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.956 0.408 . . . . 0.0 110.558 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' B' ' 200' ' ' GLY . 18.8 mt-30 -69.29 -39.03 78.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.275 0.559 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -91.11 123.83 34.87 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.138 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.51 HG23 ' HB3' ' A' ' 46' ' ' GLU . 62.6 mt -80.71 122.51 36.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.453 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -117.77 98.74 6.51 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.022 0.915 . . . . 0.0 111.003 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 46' ' ' GLU . 66.4 mt -128.74 137.63 56.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.068 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 21.3 mmt -110.09 145.23 31.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 14.6 Cg_exo -70.04 129.05 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.012 2.475 . . . . 0.0 112.295 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.508 ' H ' ' NH2' ' A' ' 44' ' ' ARG . 31.2 m-20 -96.01 82.48 3.51 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.505 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.17 89.39 0.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.516 . . . . 0.0 110.912 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 23' ' ' THR . 3.2 m -112.37 129.48 24.3 Favored Pre-proline 0 N--CA 1.436 -1.149 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.906 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.52 70.32 7.34 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.857 1.704 . . . . 0.0 111.293 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.4 m -65.49 -50.21 66.14 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.62 43.62 96.19 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.691 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.511 ' O ' ' HG3' ' B' ' 221' ' ' GLU . 18.5 mt -56.57 -50.65 71.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -65.38 -31.61 72.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.388 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.17 -37.74 88.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.82 -16.56 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.384 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' B' ' 217' ' ' LEU . 43.9 mt-10 -89.16 -23.36 22.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.502 . . . . 0.0 111.32 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.301 -1.536 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.025 -178.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.17 -46.99 84.56 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.99 -24.47 66.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.25 -22.49 78.54 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.97 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -55.42 -52.14 64.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.855 0.328 . . . . 0.0 111.186 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.08 11.94 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 64.62 29.41 13.04 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.014 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -63.87 -30.84 71.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.274 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -84.06 0.52 47.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.611 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -114.73 7.34 15.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.486 0.66 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.54 98.73 6.97 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.596 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 75.5 m-85 -133.48 146.01 50.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.077 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.95 137.15 52.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.342 175.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 74.8 t80 -85.28 128.89 34.86 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.624 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.18 132.26 61.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.86 -168.59 44.59 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.215 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -49.77 119.99 3.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.517 0.675 . . . . 0.0 112.669 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.29 179.1 4.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' H ' HD12 ' A' ' 22' ' ' LEU . 17.7 m120 -81.81 151.04 27.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.693 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -73.99 -17.13 61.03 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.056 0.455 . . . . 0.0 111.231 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.23 -14.57 40.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.344 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 19' ' ' ASN . 73.3 mt -84.26 109.32 17.7 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.838 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 27' ' ' ILE . 54.1 p -88.77 176.39 7.09 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.236 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.3 -25.09 67.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.287 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.96 -44.73 54.72 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -63.83 -33.48 75.78 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.755 0.312 . . . . 0.0 110.938 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 23' ' ' THR . 64.5 mt -58.17 -53.09 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.275 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.33 -21.15 62.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.983 0.42 . . . . 0.0 110.673 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 51.5 m -63.99 -42.89 97.07 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.533 176.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.631 HG22 HD13 ' B' ' 218' ' ' LEU . 86.1 t -75.52 -48.46 30.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.095 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -70.96 -6.97 42.77 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 p -50.87 -44.38 59.64 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.247 0.546 . . . . 0.0 111.631 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -76.32 -6.88 53.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.624 0.726 . . . . 0.0 110.637 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.98 26.38 8.62 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.525 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.68 70.09 0.35 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 118.829 -1.653 . . . . 0.0 112.756 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.4 m -44.0 147.52 0.9 Allowed Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 124.26 1.024 . . . . 0.0 112.634 -178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -11.34 98.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.7 4.934 . . . . 0.0 117.029 -173.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -128.82 -164.52 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 26.9 m-20 -70.41 109.54 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.725 -175.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.66 143.35 21.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.438 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.2 106.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.402 HD22 ' HB2' ' A' ' 55' ' ' ALA . 2.6 tm? -95.11 121.83 37.15 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.2 t -78.42 110.32 13.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.045 0.45 . . . . 0.0 110.51 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -110.45 154.67 23.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.87 139.24 48.75 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HA ' HD11 ' B' ' 208' ' ' ILE . 39.0 mt-10 -74.74 -9.56 58.68 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -109.75 -60.44 1.78 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.3 t -89.62 -11.22 43.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.16 66.82 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.912 -0.661 . . . . 0.0 114.229 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 48' ' ' THR . 46.3 mm-40 -78.35 156.79 29.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.024 0.412 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.5 p -65.2 128.85 37.51 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.18 -14.73 63.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.804 0.335 . . . . 0.0 111.608 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.69 18.52 8.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.17 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -161.81 159.42 26.98 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 120.922 0.391 . . . . 0.0 111.1 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -151.43 170.61 19.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.804 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -136.34 139.2 42.39 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.7 tp -126.2 130.63 51.34 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.619 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.1 tttt -116.15 103.58 10.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.585 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 37.4 p90 -118.66 153.45 34.3 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 tt0 -101.02 105.8 17.03 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.814 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 13.4 t70 175.48 108.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.058 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -73.59 -8.75 57.21 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 63' ' ' ARG . 26.6 mtm180 -91.72 -49.23 6.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.542 0.687 . . . . 0.0 109.911 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -63.84 -26.89 68.82 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.396 -178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 17.2 p -59.12 -41.32 87.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 110.337 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 mm -69.01 -49.18 65.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.637 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tt -61.73 -55.56 28.92 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.252 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.7 74.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 68.0 t -60.48 -48.09 89.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -79.29 -33.88 42.92 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.192 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.24 -44.95 35.16 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.35 -15.09 58.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 53.2 t30 -68.45 108.72 3.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.79 -8.91 59.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.776 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.96 128.51 35.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.37 134.84 33.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.33 109.88 3.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.583 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.79 22.13 75.3 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.554 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.71 -3.9 81.61 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.473 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -109.07 123.65 49.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.635 0.255 . . . . 0.0 111.048 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.96 107.68 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.76 143.73 53.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.37 111.7 21.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 8.4 mm -114.74 138.72 44.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -146.4 146.9 30.79 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.157 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -72.16 124.8 25.77 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -147.4 160.8 42.14 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.01 0.434 . . . . 0.0 110.928 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.6 117.49 34.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 91' ' ' PRO . 57.2 t80 -102.74 127.6 49.82 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.891 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -100.18 102.08 16.81 Favored Pre-proline 0 C--N 1.317 -0.842 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HA ' ' CE2' ' A' ' 89' ' ' TYR . 50.9 Cg_exo -55.85 126.6 22.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.243 2.629 . . . . 0.0 113.706 -175.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -77.13 128.65 34.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -77.28 -12.56 59.96 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.574 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 m -64.42 -23.07 67.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.404 0.621 . . . . 0.0 109.819 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.41 26.29 5.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.459 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -54.16 -46.42 72.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.873 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -71.67 -27.06 62.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.681 0.277 . . . . 0.0 110.722 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -68.15 -48.78 64.44 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -59.52 -44.42 93.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.319 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 35.6 tt0 -60.96 -52.62 64.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.528 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.16 75.48 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.181 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 53.7 t -59.0 -49.21 84.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -64.04 -44.09 93.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.339 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 36.6 mt-10 -62.36 -43.16 99.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 110.509 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.29 -43.46 83.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.551 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -69.93 -43.06 72.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.064 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.3 -29.53 70.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.959 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 21.4 mmt85 -83.5 -16.67 44.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 110.846 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -82.39 -41.08 20.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.687 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.84 -70.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.232 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 73.2 t 65.93 -74.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 111.762 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 m 65.35 -67.79 0.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.746 0.818 . . . . 0.0 110.756 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -113.93 113.37 24.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.56 -58.51 2.46 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.53 81.04 0.16 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.647 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.96 100.68 10.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.75 -2.58 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.696 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.049 -179.121 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.427 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 5.8 t -70.14 -15.0 62.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.717 0.294 . . . . 0.0 111.346 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -66.01 -20.32 66.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.839 0.352 . . . . 0.0 111.194 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 50.6 m -91.75 -3.88 55.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.092 0.473 . . . . 0.0 110.462 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -96.22 30.25 2.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.257 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -68.84 157.53 36.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.092 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 64.7 mt -92.15 127.67 44.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -125.55 110.09 13.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.863 0.363 . . . . 0.0 110.763 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 46' ' ' GLU . 48.2 mt -124.66 130.25 73.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.01 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.408 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 11.8 mmt -124.29 149.12 60.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.142 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 5.6 Cg_exo -79.92 170.47 16.63 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.295 2.663 . . . . 0.0 112.836 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -147.28 114.65 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -108.37 88.18 2.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.621 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 19.3 m -111.38 119.59 44.88 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.94 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 24.8 Cg_exo -63.0 110.83 1.23 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.448 2.099 . . . . 0.0 112.536 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 19.8 m -101.64 -50.82 3.61 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.83 41.25 50.18 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.786 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.14 -30.04 69.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.322 0.561 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -64.99 -26.86 68.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.171 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -78.87 -17.87 54.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 0.0 110.987 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.53 -4.19 55.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.085 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 58.72 85.47 0.09 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.628 0.58 . . . . 0.0 110.48 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.31 -1.109 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.179 -178.681 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.48 148.13 41.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.755 0.312 . . . . 0.0 110.349 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.6 mmm -89.74 -18.45 26.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.007 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.95 -26.59 15.03 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.731 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -70.01 -10.7 59.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -73.27 -32.31 64.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -82.3 74.62 9.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.251 0.548 . . . . 0.0 110.113 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -89.52 0.06 57.16 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.731 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.85 9.06 28.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.144 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -84.77 -0.02 52.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.45 97.71 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.138 0.494 . . . . 0.0 111.233 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 21.6 m-85 -147.7 148.07 30.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.07 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.17 136.52 60.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.981 0.419 . . . . 0.0 110.542 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -86.39 131.54 34.18 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.585 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -113.7 138.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -171.27 47.57 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.422 -175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.2 t-20 -58.9 104.8 0.26 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.286 0.565 . . . . 0.0 111.735 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -95.41 -172.46 2.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.166 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 40.7 t30 -76.37 130.05 37.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -66.14 1.33 1.55 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.43 -10.58 29.53 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.182 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 19' ' ' ASN . 6.5 mp -76.06 140.12 41.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.029 0.442 . . . . 0.0 111.313 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.517 HG21 ' HB2' ' B' ' 213' ' ' SER . 44.0 p -110.44 -178.12 3.41 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.785 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG3' ' HB2' ' B' ' 210' ' ' PRO . 3.0 mm-40 -62.71 -36.25 82.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.52 95.31 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.492 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 29' ' ' THR . 13.8 m-20 -63.32 -47.83 80.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.917 0.389 . . . . 0.0 110.377 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.68 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.717 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.12 -38.18 90.16 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.318 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 22.8 m -56.12 -45.22 79.58 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.716 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.434 HG22 HD13 ' B' ' 218' ' ' LEU . 99.0 t -64.25 -46.39 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.102 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -84.05 -20.12 33.22 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.4 t -63.73 -24.72 67.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.648 0.261 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.29 -7.13 28.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.76 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -88.35 -4.09 58.73 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.985 0.421 . . . . 0.0 110.895 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.27 -20.99 27.44 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.048 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.72 111.03 9.54 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 117.42 0.61 . . . . 0.0 111.582 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.68 110.44 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.789 2.326 . . . . 0.0 111.082 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.9 t -111.03 -167.23 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.716 ' H ' HG12 ' A' ' 38' ' ' VAL . 31.2 m-20 -73.36 147.04 44.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' H ' HG11 ' A' ' 102' ' ' VAL . 14.3 p -135.56 140.73 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.391 177.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.94 99.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.67 0.271 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB3' ' NH1' ' A' ' 44' ' ' ARG . 1.3 tt -84.85 122.99 29.95 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 m -67.4 122.25 17.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.852 0.358 . . . . 0.0 111.22 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HD2' ' OH ' ' A' ' 98' ' ' TYR . 81.1 mtt85 -121.34 161.27 22.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -86.07 147.07 26.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.042 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HG3' HD11 ' B' ' 208' ' ' ILE . 1.9 mp0 -72.68 -25.12 61.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -93.08 -59.68 1.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 50' ' ' GLU . 5.2 t -81.87 -24.48 35.74 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.462 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.82 77.9 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.026 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 48' ' ' THR . 47.7 mt-10 -80.4 166.61 21.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.819 0.343 . . . . 0.0 110.909 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.7 p -70.15 142.29 52.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.769 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -87.58 3.23 48.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.148 0.499 . . . . 0.0 110.305 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 102.76 -31.93 8.17 Favored Glycine 0 C--O 1.219 -0.828 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.73 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -109.61 162.36 14.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 117.164 0.482 . . . . 0.0 111.174 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.81 171.48 16.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.234 0.54 . . . . 0.0 111.587 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -134.39 133.83 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.11 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.9 tp -114.37 144.98 42.4 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.972 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 39.2 tttm -125.51 123.35 38.96 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.244 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.718 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 23.4 p90 -148.15 145.86 28.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -100.95 105.46 16.7 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.206 -0.998 . . . . 0.0 112.805 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' THR . 39.1 t70 175.71 134.15 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.809 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.84 -53.97 22.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.803 0.335 . . . . 0.0 111.179 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -59.31 -39.91 84.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.999 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 m -61.1 -27.98 68.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.718 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 47.7 p -69.6 -36.29 76.08 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.583 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mm -71.96 -47.61 54.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.305 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 tt -60.73 -54.85 40.18 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.02 -47.76 77.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 86.8 t -60.86 -48.46 88.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.194 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -68.19 -41.21 81.75 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -71.85 -53.74 12.29 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 3.0 mm? -80.08 -25.57 39.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 33.9 t-20 -62.37 109.57 1.39 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.071 0.462 . . . . 0.0 111.143 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.65 -4.79 50.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.129 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.52 131.91 43.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 110.382 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -87.02 117.88 26.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 mt -127.2 105.18 13.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.986 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.521 ' H ' ' HG3' ' B' ' 221' ' ' GLU . . . 69.33 29.65 71.77 Favored Glycine 0 C--N 1.312 -0.784 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.734 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.57 -19.57 43.54 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -89.26 143.93 26.47 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.571 0.224 . . . . 0.0 110.444 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.97 128.29 47.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 55.1 mt -68.77 110.6 4.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.688 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.87 111.66 23.58 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 69' ' ' VAL . 11.4 mm -113.53 141.82 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.479 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -149.78 148.91 29.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.584 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -77.18 121.16 23.25 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -133.71 160.11 38.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.649 0.261 . . . . 0.0 110.881 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -106.63 118.41 36.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -150.55 160.88 43.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.69 155.32 35.84 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.241 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 99' ' ' TYR . 32.2 Cg_exo -58.74 132.52 48.4 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.84 2.36 . . . . 0.0 113.434 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.28 142.32 34.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.093 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -71.45 -17.05 62.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.881 0.372 . . . . 0.0 111.219 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -74.99 -26.06 59.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.23 0.538 . . . . 0.0 110.371 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.93 28.56 8.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.211 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -53.81 -37.48 63.59 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.952 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -67.69 -23.93 65.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.424 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.467 ' OH ' ' HD2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.9 -51.73 20.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 91' ' ' PRO . 53.1 m-85 -63.27 -41.2 99.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.58 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.65 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 44.9 mt-10 -64.24 -50.16 69.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.229 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.92 68.37 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.475 HG11 ' H ' ' A' ' 40' ' ' VAL . 91.1 t -68.98 -45.29 80.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.779 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.9 ttmm -63.41 -25.26 68.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.51 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 43.8 mt-10 -59.67 -40.88 89.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.15 -25.81 58.66 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.439 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 103' ' ' LYS . 39.0 mt -74.01 -42.6 60.12 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.17 -25.23 65.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.44 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 108' ' ' ARG . 8.9 tpt180 -61.79 -33.5 74.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.426 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -76.44 -33.95 58.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.12 0.486 . . . . 0.0 110.014 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.447 HG23 ' C ' ' A' ' 113' ' ' LYS . 1.7 mp -62.11 -52.86 55.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.5 t 67.74 -63.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.544 0.738 . . . . 0.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.8 t -154.24 6.5 0.3 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.087 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.447 ' C ' HG23 ' A' ' 110' ' ' ILE . 56.7 tttm -116.56 88.65 2.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.162 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -103.14 -160.06 0.76 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.563 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -51.79 -74.71 0.03 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.799 0.44 . . . . 0.0 111.068 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.73 116.93 0.07 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.363 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.42 149.63 11.86 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.988 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HB3' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.793 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.426 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 29.3 m -75.68 155.34 35.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 0.0 111.198 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -100.03 10.42 41.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.131 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 27.8 m -57.02 -27.12 61.34 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.314 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -57.68 -37.81 74.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.807 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -90.16 112.03 23.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.992 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 74.9 mt -113.2 126.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.003 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.94 134.97 51.37 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.483 HD11 ' HG3' ' A' ' 46' ' ' GLU . 21.7 mt -137.94 139.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.593 ' SD ' ' HD2' ' B' ' 210' ' ' PRO . 2.5 mmt -135.58 133.62 20.39 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.621 0.248 . . . . 0.0 111.494 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.593 ' HD2' ' SD ' ' B' ' 209' ' ' MET . 42.2 Cg_endo -69.91 142.95 48.62 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.313 2.009 . . . . 0.0 110.563 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -104.22 133.41 49.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.074 0.464 . . . . 0.0 111.355 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.25 86.82 2.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.138 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.517 ' HB2' HG21 ' A' ' 23' ' ' THR . 34.2 m -113.74 119.46 41.25 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 175.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.95 82.59 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.88 1.72 . . . . 0.0 111.178 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.8 m -72.24 -50.53 26.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.349 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.1 32.42 56.33 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 25.5 mt -59.26 -35.19 73.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.443 -0.378 . . . . 0.0 111.656 -177.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.526 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.8 OUTLIER -70.11 -30.2 67.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 178.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.53 -29.06 63.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 0.0 110.008 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 61.9 mt -72.16 -20.85 61.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.931 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 78' ' ' GLY . 28.1 mm-40 -93.81 -151.79 0.32 Allowed 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.104 179.673 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.39 115.77 21.57 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.3 ttm -76.46 -14.41 60.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.985 0.422 . . . . 0.0 110.71 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.24 51.52 1.58 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.482 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -66.6 -37.72 85.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.226 0.536 . . . . 0.0 109.858 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.21 -48.0 81.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.187 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.66 -0.65 57.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.66 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.9 mttp 58.37 50.61 9.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.769 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.98 -17.27 63.29 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.973 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -83.22 2.96 33.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.73 99.26 4.33 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 87' ' ' THR . 89.7 m-85 -134.1 151.73 51.52 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 17.8 pt -121.88 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.952 0.406 . . . . 0.0 110.62 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 34.6 t80 -75.11 129.63 37.88 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.668 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.7 mt -115.64 144.53 23.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.58 -169.07 44.63 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.761 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -54.92 117.29 3.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.545 0.738 . . . . 0.0 110.878 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -102.39 162.88 12.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.896 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.457 ' H ' HD12 ' A' ' 22' ' ' LEU . 8.6 m120 -64.12 149.68 47.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -71.91 -8.92 57.22 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.382 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 217' ' ' LEU . 46.7 mm-40 -97.71 -3.37 39.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.577 177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 19' ' ' ASN . 17.6 mt -87.59 112.9 22.77 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 120.839 0.352 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.487 HG21 ' HB3' ' B' ' 213' ' ' SER . 30.2 p -98.88 173.33 6.91 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' CD ' HH12 ' A' ' 44' ' ' ARG . 2.0 mp0 -60.22 -27.47 67.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.71 -40.92 85.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' HB ' ' A' ' 29' ' ' THR . 18.4 m-20 -67.93 -37.32 81.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' THR . 66.8 mt -60.76 -49.0 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.1 -32.5 74.09 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 27.1 m -58.77 -46.09 88.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.432 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG22 HD13 ' B' ' 218' ' ' LEU . 84.5 t -64.38 -40.52 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -81.89 -14.32 56.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.7 m -63.23 -19.53 64.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.799 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.54 -28.91 69.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.38 0.61 . . . . 0.0 109.893 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -78.28 -14.22 59.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.545 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 14.77 69.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.056 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.04 89.55 33.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -82.3 98.68 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.624 2.216 . . . . 0.0 110.245 174.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -126.23 -166.02 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.349 -176.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 22.4 m-20 -60.43 135.17 57.66 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' H ' HG11 ' A' ' 102' ' ' VAL . 6.3 p -128.44 130.48 69.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.85 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.21 102.52 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.735 0.302 . . . . 0.0 111.327 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.465 HD13 ' NH2' ' A' ' 44' ' ' ARG . 1.7 tt -91.9 124.45 36.03 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.6 t -74.57 121.8 22.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.078 0.466 . . . . 0.0 111.886 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.465 ' NH2' HD13 ' A' ' 42' ' ' LEU . 5.3 mpt_? -120.1 165.43 14.75 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.69 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -89.59 160.86 16.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.945 0.402 . . . . 0.0 110.05 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -80.97 -9.5 59.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.25 -176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -93.06 -69.78 0.73 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 t -97.72 -40.33 8.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.94 32.73 2.77 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.796 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ARG . 32.6 mm-40 -91.79 153.05 19.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.788 0.327 . . . . 0.0 110.309 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -70.53 130.99 43.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.02 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -75.96 -0.38 21.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.72 16.04 37.86 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.88 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -162.62 156.17 20.38 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.005 0.431 . . . . 0.0 111.172 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.99 171.08 14.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 66.1 m-85 -139.53 140.47 37.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 12.8 tp -120.53 139.25 53.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 1.4 tmtp? -125.39 115.41 20.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.0 110.505 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.722 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 25.8 p90 -134.23 158.21 44.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 50.9 mt-10 -100.26 105.54 17.11 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.587 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 65' ' ' THR . 11.4 t70 175.43 125.63 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.086 0.866 . . . . 0.0 108.935 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -73.04 -54.63 8.06 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.089 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -64.5 -31.41 72.62 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 61' ' ' ASP . 38.4 m -70.06 -19.79 63.26 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.722 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 65.4 p -67.35 -45.53 76.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.934 0.874 . . . . 0.0 109.002 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.8 mt -70.12 -41.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.28 -55.54 23.92 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.119 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -48.26 65.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 84' ' ' ILE . 90.6 t -63.59 -54.45 32.21 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.292 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.83 -31.71 73.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.28 -13.98 27.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.06 109.18 2.9 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.403 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.79 -3.25 52.67 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.09 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -73.91 138.92 44.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 121.6 32.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 111.908 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 HD11 ' A' ' 82' ' ' LEU . 20.9 mm -127.97 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.83 35.69 91.67 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.77 -14.73 55.49 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.144 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -104.22 146.69 28.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.003 0.401 . . . . 0.0 110.527 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.32 129.46 41.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.872 0.368 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD11 HG13 ' A' ' 77' ' ' ILE . 77.3 mt -74.57 108.2 7.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.35 104.57 17.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 14.9 mm -106.58 141.03 22.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.611 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -150.68 153.14 35.04 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.746 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.456 ' CD2' HG21 ' A' ' 69' ' ' VAL . 43.8 m-70 -78.8 119.56 22.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 14.8 t -160.36 161.27 33.09 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -112.32 143.93 42.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -119.4 119.87 35.21 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.845 0.355 . . . . 0.0 110.583 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.65 104.14 54.68 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.13 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.03 -178.56 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.768 2.312 . . . . 0.0 111.859 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.38 151.7 23.87 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 93' ' ' ARG . 51.5 mtm180 -66.81 -9.45 37.4 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -75.26 -19.4 59.74 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.24 18.29 22.55 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 13.9 pt20 -63.0 -25.39 68.37 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.907 0.384 . . . . 0.0 110.095 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.558 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 12.7 mptt -52.95 -39.05 62.61 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.336 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.434 ' O ' HG23 ' A' ' 102' ' ' VAL . 3.6 t80 -63.08 -52.02 64.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.738 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -64.25 -36.34 83.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.893 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 52.5 mt-10 -65.37 -54.05 34.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.597 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.28 -41.99 69.52 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.734 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.497 ' O ' HD13 ' A' ' 106' ' ' LEU . 92.7 t -63.43 -57.62 11.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.944 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.87 -41.83 98.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.838 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.63 -36.83 79.6 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.08 -33.63 65.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 102' ' ' VAL . 6.6 mp -63.78 -48.82 75.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.84 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.78 -33.34 70.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.354 0.597 . . . . 0.0 110.574 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 114' ' ' ASN . 7.7 mtp180 -70.9 -26.26 63.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.989 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.8 -37.9 23.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.7 0.286 . . . . 0.0 110.4 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 106' ' ' LEU . 70.3 mt -56.99 -48.73 81.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.912 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.36 -31.27 23.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.235 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.6 m 71.23 123.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.634 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 70.03 48.51 0.53 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.715 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 108' ' ' ARG . 90.6 m-20 70.48 171.08 0.31 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.061 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -81.94 -86.6 0.1 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.29 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 172.15 -65.57 0.01 OUTLIER 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.567 0.747 . . . . 0.0 109.522 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -173.74 143.11 0.96 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.225 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.677 -0.677 . . . . 0.0 110.486 -177.572 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 24.4 m -88.91 -23.74 22.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.589 0.233 . . . . 0.0 111.15 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' B' ' 205' ' ' TYR . 61.7 mttp -73.71 -6.87 49.52 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.14 0.495 . . . . 0.0 111.04 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.7 m -72.02 -18.07 61.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.471 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -130.66 -56.52 1.06 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.977 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' B' ' 202' ' ' LYS . 98.6 m-85 -90.9 127.84 36.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.162 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 43.7 mm -77.41 102.16 3.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -108.15 100.53 9.84 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.034 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.15 102.26 7.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.558 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 92.0 mmm -107.73 139.84 20.99 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.976 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.46 155.71 66.15 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.689 2.259 . . . . 0.0 111.856 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.39 124.54 34.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -109.81 87.98 2.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.597 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.487 ' HB3' HG21 ' A' ' 23' ' ' THR . 33.2 t -112.36 117.73 46.83 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 15.8 Cg_exo -69.35 91.33 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.129 1.886 . . . . 0.0 111.794 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 4.2 m -76.66 -41.98 43.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.0 109.709 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.33 56.33 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.087 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 21' ' ' GLU . 65.8 mt -64.47 -36.73 85.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.343 . . . . 0.0 111.391 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.535 HD23 ' H ' ' B' ' 218' ' ' LEU . 0.9 OUTLIER -79.26 -22.83 44.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.85 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.67 10.75 39.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.755 0.312 . . . . 0.0 110.762 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -50.76 64.81 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.969 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.59 91.04 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.101 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.309 -1.153 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.761 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.232 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.97 -49.95 18.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.844 0.354 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.9 mtp -102.55 -37.79 7.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.49 112.24 3.81 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.301 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -78.01 -44.75 25.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.134 0.492 . . . . 0.0 110.366 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.44 -33.28 75.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.793 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -84.35 98.53 10.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.118 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -112.97 81.29 1.47 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.442 0.639 . . . . 0.0 110.823 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.424 ' O ' ' HE1' ' A' ' 12' ' ' TYR . 8.8 p-10 -88.23 -3.62 58.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.318 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -104.1 0.32 29.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.555 0.693 . . . . 0.0 109.552 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.97 99.81 12.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.144 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.551 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 50.2 m-85 -127.55 139.59 52.67 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.293 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.02 123.45 62.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.153 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 52.4 t80 -86.53 127.45 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 42.8 mt -109.79 141.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.96 -169.67 46.1 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.514 -175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -39.62 111.89 0.22 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.436 1.094 . . . . 0.0 113.87 -174.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.52 -178.49 3.61 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.479 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.98 149.54 24.7 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.19 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.625 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 9.0 mpt_? -76.42 -20.14 57.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.23 0.538 . . . . 0.0 110.487 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 -10.0 59.12 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.429 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.93 112.15 22.23 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.628 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.9 p -102.49 -178.85 3.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.81 0.338 . . . . 0.0 111.047 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.97 -22.41 60.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.371 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.42 53.36 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.101 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 29' ' ' THR . 1.0 OUTLIER -69.93 -40.55 75.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.723 0.297 . . . . 0.0 110.842 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.3 mt -57.91 -43.8 85.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.26 -36.94 82.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 48.6 m -59.69 -36.8 77.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.04 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.76 -38.69 58.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.715 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -77.03 -28.16 54.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 p -66.73 -12.72 59.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 0.0 111.093 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.06 -21.86 65.88 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.188 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -2.55 58.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.084 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.61 3.62 90.57 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.204 -0.522 . . . . 0.0 114.152 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -153.66 106.42 2.53 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 117.305 0.553 . . . . 0.0 112.146 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 2.6 Cg_endo -83.28 114.32 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.855 2.37 . . . . 0.0 111.785 176.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.3 t -111.89 -165.6 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 18.3 m-20 -61.56 112.19 2.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.36 130.17 65.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.056 0.455 . . . . 0.0 110.618 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 mp -122.37 130.37 74.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.329 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.5 tp -116.65 139.52 50.44 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.458 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . 37.2 p -73.21 103.89 4.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 49' ' ' GLY . 7.4 tpp180 -106.89 131.85 53.52 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -65.78 137.46 57.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' B' ' 208' ' ' ILE . 33.0 mt-10 -80.19 -9.5 59.72 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -111.29 -58.0 2.17 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.816 0.341 . . . . 0.0 111.598 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 p -81.49 -40.75 22.76 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.604 0.716 . . . . 0.0 110.271 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 95.05 17.64 36.87 Favored Glycine 0 N--CA 1.407 -3.299 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.659 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.95 170.37 11.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 20' ' ' ARG . 5.1 p -86.82 130.46 34.46 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' A' ' 43' ' ' SER . 87.7 mt-30 -70.9 -20.69 62.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.028 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.28 -2.88 29.66 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.791 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.47 143.04 39.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.459 0.63 . . . . 0.0 110.06 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -130.92 142.52 50.37 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.424 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.05 119.59 22.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.03 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.5 tp -111.12 136.18 50.54 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 12.6 tmtt? -121.86 121.24 36.72 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.095 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.676 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 16.2 p90 -140.49 156.6 46.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.121 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 1.6 mp0 -100.75 105.65 17.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.902 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 64' ' ' SER . 12.0 t70 175.33 141.26 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.943 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -80.54 -51.4 8.81 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.238 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.0 -38.72 92.33 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.321 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 12.3 t -60.73 -28.37 68.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.969 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.676 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 64.4 p -63.73 -46.72 84.1 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 121.477 0.656 . . . . 0.0 110.027 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.69 -39.11 68.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.127 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.78 -60.41 3.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.173 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.25 -45.75 83.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 86' ' ' HIS . 65.9 t -60.18 -55.08 26.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -77.71 -9.59 59.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -87.69 -53.91 4.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.38 -19.73 49.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 63.3 t30 -60.78 109.29 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.11 0.481 . . . . 0.0 111.33 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.44 33.79 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.919 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -72.87 132.91 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -93.28 123.16 36.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mt -126.57 112.7 30.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.88 23.84 69.58 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.322 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.32 -16.39 61.16 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.662 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -96.01 139.74 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.741 0.305 . . . . 0.0 110.772 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.68 133.87 34.82 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 85.5 mt -74.72 102.77 4.75 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.05 109.14 21.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 14' ' ' TYR . 7.1 mm -101.74 131.94 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.14 142.21 47.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.613 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.446 ' CD2' HG21 ' A' ' 69' ' ' VAL . 22.9 m-70 -72.42 112.86 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 ' HB2' ' A' ' 14' ' ' TYR . 11.6 t -133.25 161.26 34.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.044 0.449 . . . . 0.0 111.036 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -114.23 99.74 7.84 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.459 0.647 . . . . 0.0 109.848 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.517 ' HB3' ' CD2' ' A' ' 12' ' ' TYR . 87.2 t80 -95.3 139.77 31.13 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.033 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -110.95 116.86 51.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.272 179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.05 129.01 32.59 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.695 2.263 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -95.19 128.99 42.47 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.179 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -68.75 -21.12 64.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.32 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -76.1 -6.08 49.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.161 0.505 . . . . 0.0 110.365 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.4 mt -122.72 22.22 9.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -62.32 -26.18 68.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.222 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.02 -38.86 80.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.385 0.612 . . . . 0.0 109.972 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.71 -44.24 64.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.144 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.82 -43.02 97.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.693 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -69.04 -46.62 67.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.15 -44.91 92.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.13 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.628 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.7 t -61.53 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.062 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.79 -41.8 78.36 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.087 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -65.02 -36.79 85.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.085 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -72.16 -39.95 68.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.685 0.278 . . . . 0.0 110.423 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 77.5 mt -57.66 -53.8 54.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.02 -37.23 76.46 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.451 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -73.54 -36.76 65.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.737 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.12 -36.7 77.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 110.815 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 106' ' ' LEU . 76.1 mt -66.33 -44.22 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.5 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.3 t 71.75 -61.66 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.471 0.708 . . . . 0.0 111.758 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 m -90.96 101.55 14.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.405 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -71.55 -52.73 16.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.277 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -172.26 152.58 2.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.79 -11.78 58.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.358 . . . . 0.0 110.736 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.59 135.78 40.52 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.5 171.83 8.27 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.666 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 mttp . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.267 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.259 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 37.4 m -81.08 -1.88 45.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.359 . . . . 0.0 111.561 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -91.46 13.43 17.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.816 0.341 . . . . 0.0 111.69 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 44.9 p -82.03 21.58 0.87 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.079 0.466 . . . . 0.0 110.759 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -70.82 -2.66 15.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.335 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.52 114.99 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.47 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.7 mt -95.6 121.92 46.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.062 0.458 . . . . 0.0 110.361 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -136.7 129.63 30.88 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.551 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 46' ' ' GLU . 38.2 mt -131.76 140.66 47.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 -177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' B' ' 210' ' ' PRO . 8.2 mmt -121.55 144.2 39.76 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.721 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 209' ' ' MET . 13.5 Cg_exo -71.15 170.74 17.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.912 2.408 . . . . 0.0 111.984 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -150.25 109.64 3.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.057 0.456 . . . . 0.0 111.457 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.55 89.3 6.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.951 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.6 t -110.28 142.95 27.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.62 92.31 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.81 1.673 . . . . 0.0 111.482 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.597 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 46.3 m -77.82 -48.07 17.38 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.704 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.96 27.2 73.38 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.69 175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.597 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 7.8 mp -72.06 -20.64 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.297 0.549 . . . . 0.0 110.941 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -93.2 -7.88 43.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.153 0.501 . . . . 0.0 109.902 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.67 -43.85 6.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.149 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.27 -10.14 59.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.059 0.457 . . . . 0.0 111.19 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -86.69 101.33 13.18 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.543 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.456 -179.11 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.5 -1.8 54.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.9 mmt -65.58 -42.41 91.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.883 0.373 . . . . 0.0 110.576 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.71 47.49 3.95 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.888 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -71.99 -63.87 1.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.983 0.42 . . . . 0.0 110.408 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.16 -14.54 13.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.098 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.7 p90 40.3 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.133 0.973 . . . . 0.0 113.513 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -113.5 108.1 16.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.224 0.535 . . . . 0.0 111.709 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.08 -14.76 61.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.542 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -84.53 16.87 2.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.778 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.73 98.48 7.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.047 0.451 . . . . 0.0 111.337 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 58' ' ' LYS . 96.1 m-85 -141.56 148.7 39.74 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.956 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 pt -115.92 140.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.48 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' HB2' ' CG2' ' A' ' 87' ' ' THR . 86.1 t80 -92.87 131.95 37.45 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.803 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.48 132.23 59.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.208 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.53 -167.53 43.67 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.824 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -39.74 126.28 1.93 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.517 1.127 . . . . 0.0 112.662 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.56 161.63 24.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.043 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -71.61 153.91 41.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.591 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -67.76 -37.59 82.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.012 0.434 . . . . 0.0 110.259 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -80.03 1.37 27.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.169 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -88.53 109.57 20.17 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 27' ' ' ILE . 81.3 p -93.35 176.16 6.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -66.71 -20.59 66.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.251 178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.95 67.24 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' B' ' 215' ' ' SER . 0.7 OUTLIER -66.74 -35.47 80.19 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.591 0.234 . . . . 0.0 110.904 178.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 23' ' ' THR . 64.6 mt -58.32 -46.2 89.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.0 tp -67.98 -38.13 82.35 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 55.5 m -54.7 -46.84 74.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.397 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.48 HG22 HD13 ' B' ' 218' ' ' LEU . 55.0 t -62.19 -47.22 94.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.281 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -74.31 -9.64 58.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -71.01 -15.32 62.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.781 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -62.98 -33.98 76.55 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.285 0.564 . . . . 0.0 109.948 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' OH ' ' HG ' ' A' ' 72' ' ' LEU . 8.3 m-85 -98.4 -13.78 20.45 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.962 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 78.25 60.91 2.59 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.362 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 57' ' ' LEU . 61.3 t -111.97 91.65 16.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 14.0 Cg_endo -98.49 31.84 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.503 2.802 . . . . 0.0 110.971 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -94.26 -165.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.581 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 38' ' ' VAL . 64.3 m-20 -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.95 135.97 50.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.099 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.47 115.5 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.931 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -102.37 149.13 24.66 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' SER . 16.8 p -73.02 107.33 5.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.091 0.472 . . . . 0.0 110.899 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmm-85 -114.53 129.6 56.68 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.775 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 17.9 t70 -71.76 139.79 49.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.266 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.5 -12.73 60.03 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.8 -57.89 1.97 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.833 0.349 . . . . 0.0 111.44 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.5 t -89.29 -20.1 24.5 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.15 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 74.03 20.31 79.71 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.486 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 48' ' ' THR . 48.9 mt-10 -96.37 170.3 9.33 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.861 0.331 . . . . 0.0 111.402 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' SER . 15.1 m -83.29 138.07 33.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.01 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.59 -16.25 35.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.27 23.06 7.16 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.056 -1.068 . . . . 0.0 114.448 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -156.94 154.35 29.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.18 0.49 . . . . 0.0 109.852 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.44 17.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.237 0.542 . . . . 0.0 112.434 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -134.07 131.94 39.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.526 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.425 HD21 HG11 ' A' ' 36' ' ' VAL . 16.7 tp -121.66 138.61 54.27 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.804 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 12' ' ' TYR . 57.6 tttt -120.31 113.97 21.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 33.1 p90 -139.95 148.65 42.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 9.5 tp10 -100.67 105.73 17.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 54.0 t0 174.62 122.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.328 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -80.34 -12.33 59.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.022 0.439 . . . . 0.0 110.589 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -86.99 -49.48 7.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.091 0.472 . . . . 0.0 110.071 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 67' ' ' LEU . 15.9 t -67.5 -22.65 65.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.062 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.679 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 1.2 p -61.79 -59.1 5.65 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.872 0.367 . . . . 0.0 111.23 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.75 -38.06 81.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.963 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 64' ' ' SER . 41.3 tp -57.7 -53.89 53.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.267 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.08 84.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 65' ' ' THR . 88.3 t -63.41 -60.41 2.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.479 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -63.65 -34.27 77.47 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -69.05 -49.5 56.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.708 0.289 . . . . 0.0 111.021 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HG ' ' OH ' ' A' ' 34' ' ' TYR . 85.9 mt -84.68 -27.68 26.9 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -59.79 108.23 0.72 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.03 -5.66 59.54 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.868 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 47.8 t80 -74.31 130.24 39.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.14 124.32 28.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.294 0.568 . . . . 0.0 112.481 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -129.88 105.46 12.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.705 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.97 72.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.602 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.61 59.12 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -111.45 130.31 55.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.583 -0.309 . . . . 0.0 110.524 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -82.28 129.88 34.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.565 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.52 127.63 32.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.335 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 83' ' ' LYS . 45.4 tptt -110.68 116.46 31.35 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mm -110.13 140.15 30.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.21 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.13 171.25 16.19 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -101.32 128.95 47.24 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 13.5 t -153.92 161.8 41.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -114.78 110.41 19.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.931 0.396 . . . . 0.0 111.347 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -125.0 120.17 30.81 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.321 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -98.79 139.48 21.1 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.131 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.08 138.13 60.54 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.801 2.334 . . . . 0.0 111.887 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -110.31 144.64 38.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.897 0.379 . . . . 0.0 111.694 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -55.3 -31.17 61.42 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.134 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -64.63 -22.1 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.76 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.22 21.32 17.52 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.108 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -56.9 -38.98 73.57 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.13 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -55.61 -43.17 75.83 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 110.853 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 102' ' ' VAL . 49.1 t80 -67.72 -45.82 73.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.506 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.06 -44.39 95.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.138 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.21 -40.88 97.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.76 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HB2' ' SD ' ' B' ' 209' ' ' MET . . . -67.96 -41.54 82.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.311 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 98' ' ' TYR . 72.5 t -64.61 -38.04 81.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.081 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -60.05 -39.19 85.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.672 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 75.2 mm-40 -61.68 -49.79 75.07 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.773 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -57.58 -40.67 79.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 110' ' ' ILE . 88.9 mt -65.71 -42.47 91.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.181 0.515 . . . . 0.0 109.83 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 112' ' ' SER . 27.3 t70 -65.77 -47.92 73.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.082 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.679 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 19.1 mmt180 -63.45 -36.94 85.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.335 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.39 -38.49 84.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.975 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.584 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 70.7 mt -68.49 -50.07 59.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.668 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.584 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 8.9 p 162.05 -13.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.785 0.678 . . . . 0.0 109.833 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.558 ' HA ' ' OD2' ' A' ' 107' ' ' ASP . 10.7 t 83.5 100.35 0.05 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.133 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.458 ' NZ ' ' HB2' ' A' ' 113' ' ' LYS . 9.0 mtmp? -73.82 96.37 2.56 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.712 -175.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -85.32 -12.51 52.13 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.41 89.5 0.69 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.891 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.64 129.65 40.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.713 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.1 104.0 16.27 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.721 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm . . . . . 0 C--O 1.245 0.842 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.021 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 179.46 4.7 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -80.87 -13.19 59.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.771 0.32 . . . . 0.0 110.471 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.6 p -70.58 -10.38 59.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.692 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -66.43 -32.52 73.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.365 0.602 . . . . 0.0 109.379 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -91.47 112.54 24.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.57 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -89.74 106.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.17 0.51 . . . . 0.0 111.28 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -116.4 99.35 7.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.671 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 67.0 mt -123.41 131.09 73.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 101' ' ' ALA . 16.9 mmt -114.31 136.0 22.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.86 169.0 15.6 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.934 2.423 . . . . 0.0 111.95 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -142.78 102.56 4.06 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.702 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -96.99 87.39 4.23 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.896 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.2 m -111.5 119.53 44.85 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.823 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.21 105.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.823 2.348 . . . . 0.0 112.167 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.504 ' HB3' ' CD1' ' B' ' 217' ' ' LEU . 3.6 m -96.28 -50.04 4.96 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.559 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.05 33.82 84.8 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.94 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' B' ' 215' ' ' SER . 11.0 mp -66.94 -33.07 74.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 110.43 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 30' ' ' VAL . 2.6 pt? -76.89 -14.24 59.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.794 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.09 -45.44 5.39 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.197 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.37 -53.19 8.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.861 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -82.89 -47.93 11.29 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' B' ' 218' ' ' LEU . 19.5 m . . . . . 0 C--N 1.294 -1.821 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.867 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.67 -73.53 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.358 0.663 . . . . 0.0 112.465 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.9 ttm -55.1 -53.86 50.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.884 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.16 9.84 76.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.739 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -110.07 -57.29 2.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.906 0.384 . . . . 0.0 110.649 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.3 -46.96 59.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.35 0.595 . . . . 0.0 110.228 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -100.42 35.28 2.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.479 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -61.09 -8.35 3.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.529 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.3 -2.92 14.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.945 0.402 . . . . 0.0 110.854 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 88' ' ' PHE . 2.1 p-10 -83.92 -13.43 53.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.408 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.47 96.15 10.49 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.025 0.441 . . . . 0.0 110.221 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.611 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.5 m-85 -158.85 136.99 10.59 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.268 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.65 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.158 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -87.08 122.54 31.04 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 55' ' ' ALA . 26.5 mm -95.29 135.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.78 -168.97 45.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.966 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -40.0 107.83 0.08 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.152 0.981 . . . . 0.0 113.547 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.55 152.87 23.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.978 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.537 HD22 HD11 ' B' ' 217' ' ' LEU . 48.9 t30 -67.28 138.52 56.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -63.1 -19.78 64.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.909 0.385 . . . . 0.0 111.473 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 57.6 mm-40 -80.59 -4.1 52.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.147 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.8 mt -83.28 139.23 33.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.914 0.387 . . . . 0.0 110.556 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.6 p -110.22 168.62 9.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.655 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.84 -27.53 68.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.45 -40.44 97.73 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.708 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -58.63 -47.67 83.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 110.781 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.85 -46.63 93.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.92 -35.96 82.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.031 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.3 m -56.35 -49.29 74.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' CG2' HD22 ' B' ' 218' ' ' LEU . 95.1 t -65.18 -46.51 90.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.724 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -75.15 -22.97 57.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.5 m -64.6 -24.58 67.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.818 0.342 . . . . 0.0 110.478 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.08 -20.32 66.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -89.75 -2.31 58.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.603 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.44 34.69 44.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.626 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.0 89.81 37.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 111.778 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -89.06 78.27 1.09 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.636 2.224 . . . . 0.0 111.116 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -115.86 -166.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.905 -177.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' H ' HG12 ' A' ' 38' ' ' VAL . 4.6 p-10 -85.41 144.88 27.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -171.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.02 133.29 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.31 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 98' ' ' TYR . 4.2 mp -123.68 107.91 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 43' ' ' SER . 5.0 tt -92.27 134.05 35.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 42' ' ' LEU . 19.5 m -67.92 95.52 0.54 Allowed 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -114.2 145.67 41.39 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.483 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 38.1 m-20 -61.52 150.63 35.27 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.215 0.531 . . . . 0.0 112.062 -178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB3' HD12 ' B' ' 206' ' ' ILE . 29.9 mp0 -77.13 -41.88 40.09 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.421 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.65 -59.39 2.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -85.79 -15.86 40.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 45' ' ' ASP . . . 66.09 31.52 79.58 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.778 177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -92.82 155.21 17.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.611 0.206 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 m -67.04 111.06 3.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.93 -20.89 60.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.047 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.71 11.12 20.02 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 120.311 -0.947 . . . . 0.0 115.052 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.25 165.51 24.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 117.878 0.839 . . . . 0.0 109.082 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.499 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.86 121.65 27.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.731 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.77 142.69 46.19 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.117 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.611 ' HB2' ' CE1' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -131.72 117.06 18.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.352 0.596 . . . . 0.0 111.701 179.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.72 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.0 p90 -129.7 156.01 44.96 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.34 175.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -102.15 106.15 16.96 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.731 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.2 t70 176.94 139.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.891 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -80.76 -46.56 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -75.41 -29.59 59.82 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 m -68.59 -23.02 64.42 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.72 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 67.2 p -61.6 -46.87 87.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.557 0.694 . . . . 0.0 109.645 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.59 -33.38 48.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.966 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 67' ' ' LEU . 7.3 tt -61.78 -52.54 63.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.14 89.44 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 79.9 t -63.3 -44.51 99.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.029 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.2 -48.66 56.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.877 0.37 . . . . 0.0 111.907 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -66.51 -49.83 65.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.308 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 85.2 mt -86.57 -2.12 58.22 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.648 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 48.1 t-20 -67.73 108.96 3.13 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.93 6.69 61.78 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.421 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -72.16 121.82 19.95 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -83.65 117.51 23.23 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 mt -133.03 113.51 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.244 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.46 20.64 76.62 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.94 -2.56 88.19 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.969 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.92 145.58 36.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.09 135.9 33.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.872 0.368 . . . . 0.0 111.364 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 80.8 mt -76.06 133.68 40.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.795 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -127.39 113.09 15.76 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm -103.59 134.5 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.02 157.6 40.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.13 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -92.49 133.14 36.21 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -159.57 157.41 29.81 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CB ' ' HA ' ' A' ' 10' ' ' ASN . 49.6 p90 -107.07 143.08 35.73 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -149.98 138.56 20.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.998 0.428 . . . . 0.0 111.316 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -105.72 138.56 19.65 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.9 136.41 48.68 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 122.649 2.233 . . . . 0.0 113.33 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -77.29 137.87 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 ttp85 -68.81 -26.0 64.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.995 0.426 . . . . 0.0 110.826 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 m -77.56 -30.01 52.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.086 0.47 . . . . 0.0 110.596 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.56 18.74 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -65.26 -27.1 68.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.279 0.562 . . . . 0.0 110.132 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.87 -21.15 62.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.746 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.9 t80 -64.16 -46.42 84.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -63.65 -38.05 89.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.752 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.89 -48.09 80.51 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.958 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.6 74.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.356 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.8 t -70.64 -41.48 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.831 0.348 . . . . 0.0 110.119 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -55.54 -48.43 74.73 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.986 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.28 -23.74 67.41 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.766 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -24.66 37.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.012 0.435 . . . . 0.0 110.35 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 69.5 mt -80.93 -44.22 18.57 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.57 -9.71 51.17 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.819 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -62.46 -29.07 70.25 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.019 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.81 -36.31 80.19 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.597 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.9 mt -70.47 -45.65 73.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.271 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.0 t 71.93 -70.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.6 t -173.96 -169.74 0.5 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.617 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -132.1 -47.91 0.93 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -151.54 117.78 5.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.36 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -134.54 -48.27 0.76 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.39 -173.79 4.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.661 0.267 . . . . 0.0 111.631 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.36 -85.69 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.677 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.315 -0.85 . . . . 0.0 109.777 179.4 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 25.7 m -125.73 -9.24 6.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.733 0.302 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -78.66 -23.62 45.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.4 p -83.5 3.16 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.198 0.523 . . . . 0.0 110.934 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -81.82 -24.28 35.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.519 0.676 . . . . 0.0 109.438 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -90.6 172.68 8.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.855 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 46' ' ' GLU . 44.1 mm -59.37 102.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.208 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -136.52 99.86 4.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.648 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 61.3 mt -103.39 123.04 56.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.502 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.2 mmt -101.99 128.61 28.24 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.875 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.51 146.14 88.79 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -120.39 116.97 26.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.522 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -100.33 86.25 3.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.35 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.8 m -113.57 119.1 42.29 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.307 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.44 103.74 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.214 1.943 . . . . 0.0 111.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' B' ' 217' ' ' LEU . 89.9 p -81.35 -32.51 32.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.218 0.532 . . . . 0.0 110.145 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.88 9.25 86.67 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.537 HD11 HD22 ' A' ' 19' ' ' ASN . 0.3 OUTLIER -56.86 -51.58 68.47 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.728 0.811 . . . . 0.0 111.307 -177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 30' ' ' VAL . 3.9 pp -84.19 -17.25 40.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.578 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.634 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.74 -12.76 58.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.045 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -120.98 12.89 11.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.614 -0.707 . . . . 0.0 110.211 179.154 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.85 100.78 4.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.736 0.303 . . . . 0.0 110.755 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.5 -39.11 1.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.28 125.27 0.77 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -64.48 -27.18 68.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.46 -13.51 58.94 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -123.36 13.96 9.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.189 0.519 . . . . 0.0 109.786 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -114.78 -41.44 3.38 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.73 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.9 -39.73 49.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.978 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.19 0.11 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.753 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -71.93 96.54 1.71 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -160.63 136.27 8.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.229 1.012 . . . . 0.0 109.142 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 pt -120.01 137.14 54.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 121.028 0.442 . . . . 0.0 110.848 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -89.4 131.5 35.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.537 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.4 mt -113.84 144.84 20.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.21 -169.16 45.5 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.285 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -65.36 112.37 3.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.788 0.328 . . . . 0.0 110.695 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 74.0 mt -93.95 177.17 6.07 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 0.0 111.732 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.427 ' H ' HD12 ' A' ' 22' ' ' LEU . 43.9 t-20 -69.13 138.11 53.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.018 177.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.75 -20.33 61.08 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.18 2.63 53.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.427 HD12 ' H ' ' A' ' 19' ' ' ASN . 16.7 mt -86.67 109.61 19.31 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.6 p -97.41 177.7 5.45 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.109 0.481 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.44 -27.53 69.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.34 -42.98 89.45 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.428 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.4 m-20 -63.61 -47.24 82.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.23 -47.04 88.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.778 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 tp -62.23 -41.8 98.74 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 m -60.33 -48.89 79.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.404 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' ASP . 74.9 t -54.7 -47.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.436 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.72 -22.63 37.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -64.76 -26.73 68.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.403 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.66 -16.05 63.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.467 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.87 -4.49 59.18 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.1 0.476 . . . . 0.0 110.249 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.37 17.04 78.74 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.377 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.88 90.18 51.39 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.716 0.293 . . . . 0.0 110.24 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -89.89 105.51 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.019 2.479 . . . . 0.0 112.094 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 58' ' ' LYS . 1.2 t -132.48 -166.57 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.564 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.9 t70 -70.84 140.21 51.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.07 136.03 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.35 100.84 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.618 0.246 . . . . 0.0 111.629 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -85.94 112.98 21.69 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.8 t -65.83 118.59 9.89 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.4 0.619 . . . . 0.0 111.837 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -133.95 155.79 49.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.604 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' OD2' HG22 ' A' ' 48' ' ' THR . 32.3 t70 -73.11 135.41 44.75 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.873 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' B' ' 208' ' ' ILE . 38.1 mt-10 -69.94 -18.72 63.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -96.36 -61.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.672 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' OD2' ' A' ' 45' ' ' ASP . 5.0 t -84.36 -33.25 23.87 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.58 -6.65 60.99 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.827 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' H ' HG23 ' A' ' 48' ' ' THR . 12.9 pt-20 -71.21 155.34 40.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.099 0.449 . . . . 0.0 110.367 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.9 m -68.15 138.69 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.89 -8.89 59.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.099 0.476 . . . . 0.0 111.074 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.43 30.41 7.73 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.329 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -170.61 170.8 6.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.68 170.82 19.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.959 0.409 . . . . 0.0 111.297 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.72 155.96 49.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.175 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.77 140.26 34.75 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.66 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 49.9 tttp -123.13 115.34 21.63 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.909 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 8.2 p90 -132.91 143.2 49.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -102.89 107.57 18.45 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.521 -0.871 . . . . 0.0 113.194 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 65' ' ' THR . 29.2 t70 178.61 143.57 0.12 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.883 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -79.98 -35.01 38.14 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -83.06 -35.52 25.65 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.093 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.8 t -57.6 -29.9 64.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.413 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.605 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 75.4 p -59.43 -52.76 64.24 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.478 0.656 . . . . 0.0 109.423 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.5 -46.07 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.953 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 tp -50.06 -58.58 5.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.936 0.773 . . . . 0.0 111.562 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.628 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 65' ' ' THR . 97.3 t -66.99 -57.85 8.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.527 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.22 -18.04 64.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.561 -0.456 . . . . 0.0 112.15 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -90.5 -55.8 3.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.989 0.423 . . . . 0.0 111.308 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 92.1 mt -91.34 -17.38 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.79 109.05 2.74 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.436 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.13 2.62 64.12 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.105 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' ALA . 61.0 t80 -76.87 143.39 39.69 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 1.8 tppp? -94.61 114.23 26.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.901 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.527 HD12 HD11 ' A' ' 82' ' ' LEU . 16.4 mt -129.6 117.65 42.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.26 35.18 76.45 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.324 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.67 22.26 75.19 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.758 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' LYS . 24.9 mtp180 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 122.635 -0.332 . . . . 0.0 110.694 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -98.76 135.79 39.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.933 0.397 . . . . 0.0 111.46 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.527 HD11 HD12 ' A' ' 77' ' ' ILE . 41.2 mt -85.54 122.27 29.43 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.617 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.0 107.45 19.4 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -108.25 124.36 64.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.966 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -136.26 149.99 48.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -77.64 124.39 27.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 t -149.39 162.01 40.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.613 0.244 . . . . 0.0 110.966 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -114.96 108.86 17.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.22 139.8 50.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.297 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -107.47 132.27 21.1 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.74 133.73 46.67 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.969 2.446 . . . . 0.0 112.583 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -76.78 131.98 38.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -70.65 -20.92 62.67 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 p -74.58 -14.46 60.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.786 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.416 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 94.9 mt -113.72 25.12 11.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.855 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -56.79 -35.03 68.24 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.544 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' SD ' ' B' ' 209' ' ' MET . 63.3 mmtt -55.76 -46.07 77.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.128 0.49 . . . . 0.0 110.638 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.39 -53.78 50.01 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.066 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 95' ' ' LEU . 77.2 m-85 -59.09 -44.69 91.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -68.52 -32.88 73.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.458 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 105' ' ' GLU . . . -67.22 -46.71 73.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.18 -39.79 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.16 0.505 . . . . 0.0 109.946 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -57.02 -54.23 49.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.673 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.24 -28.19 67.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 24.1 mm-40 -64.8 -51.95 59.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.0 110.854 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.24 -27.01 56.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 111' ' ' VAL . 12.1 t70 -58.01 -27.25 63.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -59.52 -27.06 65.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.828 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.41 -36.8 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.161 0.505 . . . . 0.0 109.897 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 114' ' ' ASN . 58.2 mt -73.63 -36.42 47.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.952 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.6 t -59.47 -30.28 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.427 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.6 t -78.47 88.25 4.44 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 62.51 94.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.205 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 110' ' ' ILE . 63.9 t30 -123.98 63.1 1.07 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.189 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 70.09 -48.86 0.64 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.71 114.71 4.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.953 0.406 . . . . 0.0 111.834 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -135.71 155.48 50.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 tttp . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.22 179.384 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.303 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 22.2 t 73.1 159.2 0.22 Allowed 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.996 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -117.9 0.11 11.83 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.655 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 25.8 p -68.34 -20.4 64.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.625 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -61.49 -29.72 70.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.973 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -75.77 118.03 18.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.976 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.8 mt -108.76 112.01 38.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.093 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -140.64 104.37 4.72 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.791 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 46' ' ' GLU . 63.9 mt -134.85 100.1 2.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.354 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . 0.406 ' SD ' ' HB3' ' A' ' 97' ' ' LYS . 80.0 mmm -103.87 136.11 19.25 Favored Pre-proline 0 C--N 1.314 -0.952 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.4 156.08 62.46 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.921 2.414 . . . . 0.0 113.24 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.85 117.56 7.58 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.071 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -87.47 89.63 8.07 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.19 0.519 . . . . 0.0 111.142 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 1.0 OUTLIER -91.49 143.24 27.82 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.009 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 28.4 Cg_endo -96.15 84.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 18.7 t -71.97 -47.04 55.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' B' ' 220' ' ' LEU . . . 84.97 17.22 63.58 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.828 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' B' ' 221' ' ' GLU . 91.4 mt -60.31 -33.21 72.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.502 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -66.42 -35.09 79.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.266 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.07 -27.91 57.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.346 0.593 . . . . 0.0 110.703 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 216' ' ' GLY . 73.2 mt -76.5 -3.38 37.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.18 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' B' ' 217' ' ' LEU . 7.3 mm-40 -94.17 9.29 38.46 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.75 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.722 179.3 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.424 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.73 83.59 0.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.153 0.581 . . . . 0.0 111.632 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.0 mmm -63.33 -52.6 61.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.474 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.25 -10.53 6.1 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.523 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -64.11 -18.39 64.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.75 4.32 19.89 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.207 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 52.47 35.56 17.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.076 0.55 . . . . 0.0 112.164 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -62.71 -26.68 68.79 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.578 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -68.99 -22.01 64.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.601 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -97.99 6.19 47.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.485 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.77 99.4 2.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 58' ' ' LYS . 8.8 m-85 -125.38 154.49 41.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.397 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.3 pt -129.58 139.09 52.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.737 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -99.08 123.37 43.33 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.31 141.65 18.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.32 -168.82 45.26 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.64 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 3.7 t-20 -48.47 110.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.51 0.724 . . . . 0.0 112.743 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.94 177.62 5.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.24 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' HD13 ' A' ' 22' ' ' LEU . 37.5 t-20 -80.66 142.82 33.58 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -57.19 -26.39 60.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.585 0.354 . . . . 0.0 111.64 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.99 -10.69 59.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.957 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HD13 ' B' ' 217' ' ' LEU . 6.3 mp -87.28 110.07 19.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.071 0.463 . . . . 0.0 111.018 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 46.5 p -94.08 172.67 8.08 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.633 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -63.9 -22.59 66.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.289 . . . . 0.0 111.123 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.98 -41.03 95.5 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.973 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 29' ' ' THR . 28.8 t70 -75.36 -36.84 60.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.985 0.421 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.23 -41.04 85.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.633 176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.34 -38.94 92.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.303 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' ASP . 17.4 m -58.02 -45.05 87.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.457 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 26' ' ' ASP . 88.9 t -56.83 -50.14 76.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.29 -16.81 58.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.6 m -72.46 -13.75 61.51 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.95 -27.59 63.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.49 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -83.63 -11.03 57.81 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.83 72.94 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.909 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.15 89.63 48.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.58 95.82 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.86 2.373 . . . . 0.0 110.513 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -118.86 -166.7 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.229 -177.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.496 ' H ' HG12 ' A' ' 38' ' ' VAL . 25.0 m-20 -68.13 114.7 6.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.961 0.41 . . . . 0.0 111.997 -172.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.68 127.6 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.704 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.09 113.19 39.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.488 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' PHE . 59.9 tp -87.26 133.61 33.65 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.497 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 38.6 m -68.73 102.84 1.6 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -123.55 154.57 39.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.968 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 47' ' ' ASN . 5.6 p-10 -84.77 152.09 23.93 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.323 0.582 . . . . 0.0 111.354 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.57 ' HG2' HD12 ' B' ' 206' ' ' ILE . 1.3 mp0 -81.13 -9.88 59.74 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.413 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 16.4 m120 -83.06 -67.33 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.574 -176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.1 t -104.42 -30.55 10.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.56 46.62 4.26 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.62 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.63 164.5 11.71 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.778 0.289 . . . . 0.0 110.693 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -79.55 106.18 11.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.856 0.36 . . . . 0.0 111.022 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -67.3 -33.68 75.79 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 110.16 31.91 2.95 Favored Glycine 0 C--O 1.218 -0.892 0 C-N-CA 120.096 -1.049 . . . . 0.0 113.997 177.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.498 ' O ' HD12 ' A' ' 42' ' ' LEU . 5.2 m-85 -135.37 157.32 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.43 141.98 29.99 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.997 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -121.07 119.11 31.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.51 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' TYR . 27.8 tp -115.54 139.77 49.77 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.092 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 1.7 tmtp? -124.14 112.68 17.38 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.183 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.774 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 18.6 p90 -129.71 150.73 50.9 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.72 105.34 16.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.203 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.0 t70 176.2 143.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.425 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -80.76 -48.98 11.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 64' ' ' SER . 2.6 ptp180 -67.16 -33.71 76.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 63' ' ' ARG . 46.9 m -63.65 -27.45 69.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.086 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.774 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 68.9 p -63.29 -48.43 78.13 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.693 0.759 . . . . 0.0 110.08 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.68 -38.64 45.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt -61.29 -52.6 64.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.12 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -43.09 76.85 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.362 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 65' ' ' THR . 90.9 t -61.87 -59.82 3.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.297 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -63.38 -22.16 66.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.28 -45.67 15.89 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.76 0.314 . . . . 0.0 111.146 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 97.6 mt -97.83 -20.41 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.84 110.13 1.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.035 0.445 . . . . 0.0 111.15 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.77 -0.88 56.6 Favored Glycine 0 C--N 1.317 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.495 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -77.58 123.79 27.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -88.99 117.51 28.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.172 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.442 HD13 ' CD2' ' B' ' 218' ' ' LEU . 57.2 mt -121.57 115.77 47.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.064 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.22 35.28 69.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.716 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.31 13.55 78.51 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.097 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -128.8 130.7 47.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.912 0.356 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.88 133.02 33.66 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.222 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 89.5 mt -79.11 128.04 32.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.596 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -123.93 118.18 26.47 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.7 mm -107.92 126.43 64.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.663 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -123.25 142.87 50.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.975 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -84.79 106.75 16.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.769 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 136.52 21.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.852 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -80.67 156.84 26.14 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.602 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.39 137.86 32.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.604 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 80.3 mtp180 -94.5 120.57 64.89 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.731 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 30.0 Cg_exo -62.66 110.57 1.13 Allowed 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.531 2.154 . . . . 0.0 111.481 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.55 140.19 44.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -70.09 -31.05 68.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.416 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.6 p -79.87 -11.42 59.81 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 48.9 tp -105.16 8.22 34.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -62.09 -20.1 63.66 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -59.15 -41.62 88.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.631 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.497 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 3.5 t80 -69.37 -45.62 68.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -58.08 -50.09 74.67 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.568 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -61.65 -46.34 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.333 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.9 86.42 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.427 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 76.6 t -74.25 -39.83 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.221 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -62.76 -45.02 94.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.62 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -62.83 -29.94 71.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 111.054 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.97 -37.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 70.8 mt -68.82 -39.62 79.94 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.4 -21.34 66.66 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.792 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -65.14 -17.81 64.78 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.504 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.59 -32.54 60.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.424 0.63 . . . . 0.0 109.719 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.3 mt -90.42 -25.9 5.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.914 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.6 t 73.25 -60.7 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.861 0.864 . . . . 0.0 110.924 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 p -153.32 -67.2 0.15 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.365 0.602 . . . . 0.0 109.544 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -136.87 17.03 3.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.29 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 63.7 t30 69.12 96.01 0.07 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -74.15 85.16 1.85 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.657 0.742 . . . . 0.0 112.837 -173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.92 12.84 28.36 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.251 174.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.22 156.16 39.19 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.22 -177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.314 179.45 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.227 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 6.3 p -95.37 -28.96 14.7 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -65.14 -13.41 58.06 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 64.7 m -80.43 -11.33 59.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.686 0.279 . . . . 0.0 111.334 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.6 -3.05 50.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.251 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -86.0 138.4 32.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.947 0.403 . . . . 0.0 110.317 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.57 HD12 ' HG2' ' A' ' 46' ' ' GLU . 22.4 mm -90.56 98.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.238 0.542 . . . . 0.0 111.191 -176.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -109.69 98.94 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.534 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 68.6 mt -128.51 110.09 20.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.071 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.7 mmt -84.19 118.63 71.72 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.916 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.48 164.98 10.15 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.112 2.542 . . . . 0.0 112.608 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -122.25 94.86 4.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.752 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -84.22 88.62 7.23 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.321 0.581 . . . . 0.0 110.118 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 23.8 m -109.84 157.08 38.69 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.733 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.39 59.98 2.56 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.911 2.407 . . . . 0.0 112.183 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . 0.597 ' O ' HD12 ' B' ' 217' ' ' LEU . 73.6 m -78.68 33.24 0.21 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.241 0.616 . . . . 0.0 111.456 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.94 58.84 0.37 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.56 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.597 HD12 ' O ' ' B' ' 215' ' ' SER . 5.0 mp -64.85 -27.86 69.16 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 77' ' ' ILE . 4.0 pp -100.73 -7.63 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.753 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.18 -53.0 3.25 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.24 0.82 38.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.536 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' B' ' 217' ' ' LEU . 26.7 mm-40 61.24 28.48 18.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.16 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.448 -177.831 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.268 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.61 -21.36 59.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.495 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.0 mmm -78.53 -6.97 56.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.21 4.25 63.41 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.272 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -65.5 -29.38 70.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.11 6.37 48.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -122.29 10.8 9.98 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.632 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -76.01 -11.5 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.955 0.407 . . . . 0.0 110.924 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -85.34 -7.83 58.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.59 6.66 44.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.088 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 97.88 4.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.729 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 7.0 m-85 -154.23 136.63 14.98 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.209 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.4 pt -108.42 137.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.899 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 89.4 t80 -94.6 134.76 36.82 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.059 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.8 mt -115.56 138.53 45.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.39 -167.62 43.44 Favored Glycine 0 C--N 1.32 -0.312 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.344 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.508 ' OD1' ' HD2' ' A' ' 80' ' ' ARG . 6.3 p30 -48.19 139.42 8.44 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.302 0.572 . . . . 0.0 112.0 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.46 -176.99 3.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.071 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -91.36 147.67 22.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HD3' ' OE1' ' A' ' 50' ' ' GLU . 75.8 mtt180 -70.89 -15.75 62.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.91 1.61 56.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.407 . . . . 0.0 110.116 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD23 HD12 ' B' ' 217' ' ' LEU . 1.8 tm? -97.77 118.48 34.43 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.6 p -109.95 176.61 5.0 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.173 0.511 . . . . 0.0 111.983 -175.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' B' ' 210' ' ' PRO . 2.5 mp0 -58.16 -31.77 67.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.913 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.69 98.86 Favored Glycine 0 CA--C 1.506 -0.496 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.049 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.96 -45.02 64.86 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.4 mt -55.72 -46.46 79.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.724 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -64.47 -41.32 96.56 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.836 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -56.82 -46.55 81.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.649 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.429 HG22 HD13 ' B' ' 218' ' ' LEU . 53.0 t -57.56 -49.44 80.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.466 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.37 -15.91 58.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -68.41 -15.68 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.07 -33.66 73.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.357 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -88.26 -0.27 56.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.731 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.22 56.78 23.32 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.559 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 38' ' ' VAL . 8.0 p -151.23 89.7 4.2 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-O 121.694 0.759 . . . . 0.0 111.381 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.39 100.08 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 112.156 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 39' ' ' ASP . 1.8 t -131.56 -165.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.555 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.679 ' H ' HG12 ' A' ' 38' ' ' VAL . 20.8 t70 -66.95 131.51 46.03 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.83 131.47 42.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.551 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.41 108.98 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.5 tp -94.5 126.93 40.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -77.83 95.43 4.71 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.435 0.636 . . . . 0.0 111.039 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -104.73 141.56 36.25 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.577 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.97 144.64 11.45 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.173 0.589 . . . . 0.0 111.92 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HA ' HD11 ' B' ' 208' ' ' ILE . 13.5 mp0 -72.75 -26.82 61.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.072 -175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -74.69 -66.2 0.77 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 t -115.24 -24.7 8.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.409 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.85 28.14 4.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.623 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 20' ' ' ARG . 18.0 mm-40 -69.6 139.15 53.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.018 0.409 . . . . 0.0 110.519 178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 m -56.93 116.65 3.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -74.01 -14.49 61.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.694 0.283 . . . . 0.0 111.673 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 31.41 6.21 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.496 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.53 154.72 4.71 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.647 0.26 . . . . 0.0 110.69 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.55 165.51 34.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -133.83 138.25 45.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.865 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 tp -131.81 137.17 48.02 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.471 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.659 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 15.8 ttmt -123.88 121.61 35.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.688 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 10.4 p90 -136.41 160.98 37.09 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -101.13 104.2 15.29 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 173.99 140.23 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.279 1.432 . . . . 0.0 108.146 172.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -80.21 -46.11 16.86 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -71.22 -35.52 71.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.695 0.283 . . . . 0.0 111.24 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 t -59.02 -26.84 64.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.49 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.688 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 38.0 p -63.45 -38.52 91.45 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.463 0.649 . . . . 0.0 109.427 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.4 mt -77.3 -33.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.66 -55.44 32.09 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.699 175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.93 87.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.461 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 65' ' ' THR . 74.7 t -59.54 -54.29 36.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 120.849 0.357 . . . . 0.0 111.308 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -70.2 -31.95 69.64 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.01 -41.23 14.04 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.497 ' HB2' HG13 ' A' ' 84' ' ' ILE . 3.0 mm? -89.21 -22.92 22.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 39.2 t30 -56.83 112.83 1.43 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.828 0.347 . . . . 0.0 111.526 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.89 -7.88 55.53 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.215 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -66.84 130.27 42.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.994 0.397 . . . . 0.0 110.074 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 31.4 mmmt -86.64 119.32 26.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.21 118.17 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.573 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.62 36.17 92.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.947 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.34 -8.98 51.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.935 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 17' ' ' ASN . 9.5 mmt180 -105.54 156.02 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.633 -0.334 . . . . 0.0 110.726 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.56 128.6 52.58 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 73' ' ' ASN . 78.6 mt -63.48 106.57 0.95 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.29 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -89.11 105.66 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 72' ' ' LEU . 17.1 mm -114.7 137.93 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.659 0.266 . . . . 0.0 110.821 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -158.77 -179.3 7.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -90.46 149.51 22.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -159.89 161.26 34.31 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -108.07 119.95 40.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -131.89 141.33 49.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.05 0.452 . . . . 0.0 111.372 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 3.4 mmp_? -117.23 114.48 38.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.5 135.12 54.48 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.915 2.41 . . . . 0.0 111.955 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.447 ' O ' ' HE2' ' A' ' 99' ' ' TYR . 45.8 mmtm -93.52 128.81 39.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.589 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -71.76 -15.76 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.089 0.471 . . . . 0.0 110.78 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -72.83 -25.23 61.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.382 0.611 . . . . 0.0 109.677 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.8 mt -102.78 27.98 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.354 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -55.4 -33.45 63.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.207 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' B' ' 207' ' ' ASP . 28.5 mmtp -59.12 -49.73 76.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 102' ' ' VAL . 12.2 t80 -59.88 -45.91 90.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.582 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 22.9 m-85 -64.0 -46.91 82.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.334 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -62.58 -37.52 86.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.598 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.44 85.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 110.477 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 73.7 t -71.87 -40.24 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.196 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -56.8 -48.36 78.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.193 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.71 -27.03 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 111.03 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 7.6 tp10 -68.15 -42.24 80.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 102' ' ' VAL . 84.4 mt -69.24 -34.43 74.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.537 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.43 -44.48 89.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 6.1 ppt_? -76.69 -9.89 58.99 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.816 0.341 . . . . 0.0 111.211 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -88.05 -35.99 17.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 106' ' ' LEU . 72.2 mt -66.84 -35.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.089 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.161 176.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.07 109.19 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.232 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.1 t -81.21 -173.65 4.45 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.959 -177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HE2' ' OD1' ' A' ' 115' ' ' ASN . 54.2 mtpt -77.76 137.19 38.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.072 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' HA ' ' HG2' ' A' ' 117' ' ' GLU . 3.2 p-10 -85.31 15.23 4.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' OD1' ' HE2' ' A' ' 113' ' ' LYS . 16.8 m120 -60.28 -34.01 73.14 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.78 -0.93 28.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.387 . . . . 0.0 111.042 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 114' ' ' ASN . 36.8 mm-40 -91.4 -51.01 5.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.136 0.493 . . . . 0.0 110.432 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.832 -178.864 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 20.1 m 60.22 29.1 18.72 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.971 0.415 . . . . 0.0 110.946 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.58 -20.14 64.5 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.037 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.5 m -111.5 13.83 21.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.796 0.332 . . . . 0.0 110.967 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -91.29 0.29 57.55 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.555 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -74.11 169.23 17.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.739 0.304 . . . . 0.0 111.139 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.96 112.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 97' ' ' LYS . 13.2 t70 -112.09 112.99 25.01 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.085 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 46' ' ' GLU . 44.6 mt -123.6 135.27 63.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.987 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.58 135.69 23.77 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.852 178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . 0.404 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 71.4 Cg_endo -74.17 152.43 45.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.731 2.287 . . . . 0.0 112.729 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -125.88 103.77 7.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 49.8 m-85 -90.21 86.47 6.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.304 0.574 . . . . 0.0 110.09 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' B' ' 214' ' ' PRO . 16.8 p -111.85 134.98 21.22 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.576 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 213' ' ' SER . 7.6 Cg_exo -73.27 92.5 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.969 1.779 . . . . 0.0 111.089 176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 5.1 m -77.9 -39.94 41.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.51 25.03 61.69 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.427 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 22' ' ' LEU . 17.9 mt -60.79 -32.11 71.46 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.175 0.488 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.541 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -75.62 -38.58 58.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.74 -44.67 66.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.9 -8.38 59.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.755 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 58.44 60.45 2.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.215 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--O 1.253 1.237 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.426 -179.938 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.98 -24.66 52.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.697 0.284 . . . . 0.0 111.203 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' TYR . 26.2 mmt -77.14 -48.88 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.53 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.32 157.17 32.16 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -73.42 -40.65 64.08 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.927 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -110.37 10.47 23.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.836 0.351 . . . . 0.0 111.345 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 3' ' ' MET . 17.8 m-85 66.95 136.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -103.27 -15.96 15.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.71 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -85.97 3.18 43.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.041 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -94.01 -0.13 55.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.272 0.558 . . . . 0.0 110.323 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -81.22 98.58 8.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.685 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 58' ' ' LYS . 36.3 m-85 -149.79 132.49 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.97 0.908 . . . . 0.0 108.715 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.86 128.63 69.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.347 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -91.19 130.98 37.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.286 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 83' ' ' LYS . 52.0 mt -112.45 143.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.88 -177.15 50.15 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.493 -0.861 . . . . 0.0 113.39 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.6 t-20 -54.64 105.9 0.18 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.897 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 mt -93.71 -173.07 3.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.519 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -79.2 144.37 34.48 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -70.41 -22.7 62.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.054 0.454 . . . . 0.0 110.032 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.98 2.47 30.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.45 130.77 38.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 p -109.17 170.49 8.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.294 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.2 -28.75 68.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.146 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.16 99.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.537 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -66.47 -48.13 70.9 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.1 mt -57.12 -45.62 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.073 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.45 -36.93 85.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.062 0.458 . . . . 0.0 110.065 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -60.67 -44.35 96.58 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.81 -47.33 93.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.764 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -75.81 -9.71 58.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.734 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.4 t -70.72 -17.16 62.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -73.51 -21.91 60.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.632 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -99.14 -20.45 16.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 83.87 50.47 4.39 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.547 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.52 94.64 28.56 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.597 0.237 . . . . 0.0 111.263 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 26.2 Cg_endo -98.65 30.02 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.416 2.744 . . . . 0.0 111.445 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -92.0 -166.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.519 ' H ' HG12 ' A' ' 38' ' ' VAL . 5.6 m-20 -63.58 139.68 58.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 p -135.8 120.1 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.566 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.86 136.76 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.013 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' PHE . 60.0 tp -128.03 134.15 49.19 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.9 p -65.32 99.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.488 ' HG2' HG21 ' B' ' 208' ' ' ILE . 22.4 tpp180 -113.63 124.28 51.95 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 48' ' ' THR . 23.5 t70 -71.55 136.79 47.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 110.79 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HA ' HD11 ' B' ' 208' ' ' ILE . 12.8 mt-10 -72.13 -26.67 62.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.15 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.418 ' HB2' ' OD2' ' A' ' 45' ' ' ASP . 26.0 m-80 -81.59 -65.59 0.99 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.157 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.56 HG22 ' OD2' ' A' ' 45' ' ' ASP . 10.1 t -87.47 -21.22 25.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.619 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 80.83 19.51 67.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.756 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' H ' HG23 ' A' ' 48' ' ' THR . 40.0 mt-10 -101.14 163.43 12.28 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.556 0.217 . . . . 0.0 111.108 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.9 t -78.4 141.42 38.36 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -89.04 -6.84 56.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.74 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 17' ' ' ASN . . . 100.59 -7.1 57.68 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.277 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.443 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -107.95 148.22 29.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 118.027 0.913 . . . . 0.0 110.574 -177.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . . . -135.22 150.5 50.11 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.75 119.38 17.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.2 tp -106.62 140.76 38.99 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.551 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.603 ' HG3' ' CZ ' ' A' ' 12' ' ' TYR . 7.8 tmtm? -129.42 108.84 10.59 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.755 0.788 . . . . 0.0 112.032 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 65' ' ' THR . 4.7 p90 -119.7 156.24 30.87 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.01 105.81 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.839 -1.144 . . . . 0.0 112.562 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 178.22 145.66 0.13 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.161 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -81.01 -45.6 16.33 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.09 -32.96 50.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -55.64 -30.53 61.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.384 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.723 ' HA ' ' OH ' ' A' ' 59' ' ' TYR . 71.1 p -61.39 -52.36 64.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.501 0.667 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.1 mt -63.53 -36.97 78.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.667 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 tt -62.08 -58.68 6.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.221 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.88 86.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.048 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 65.6 t -61.14 -46.57 96.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -78.23 -40.12 38.27 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -66.94 -50.43 62.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.484 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.64 -4.86 57.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 25.9 t-20 -63.54 109.41 1.64 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.496 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 -2.83 65.33 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.163 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -65.9 127.15 30.88 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -88.14 115.0 25.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.262 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.6 mt -120.63 109.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.64 25.49 75.63 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.98 -16.01 59.55 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.461 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -97.11 132.7 42.64 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.837 0.351 . . . . 0.0 111.208 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.83 135.68 35.98 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.239 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.72 133.22 45.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.423 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 12.7 mptt -107.52 116.78 32.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.405 HG22 HG22 ' A' ' 69' ' ' VAL . 3.4 mm -117.31 138.6 47.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -151.53 166.73 30.25 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -88.56 140.14 29.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 15.2 t -153.72 161.55 42.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.661 0.267 . . . . 0.0 110.855 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -116.36 104.69 11.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -115.92 150.04 37.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.438 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -125.42 135.57 27.09 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.114 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.87 122.4 10.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.923 2.416 . . . . 0.0 112.214 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -69.21 135.24 50.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.697 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.31 -60.88 3.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -74.14 -22.3 59.5 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.03 0.443 . . . . 0.0 112.087 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.9 tp -90.87 6.06 45.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.333 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -59.92 -22.36 62.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.553 0.216 . . . . 0.0 111.419 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -58.99 -39.55 82.14 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.652 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.96 -35.96 79.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -66.66 -50.07 64.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.1 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 44.9 mt-10 -65.32 -42.95 92.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.04 -47.49 80.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.547 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.414 ' O ' HD13 ' A' ' 106' ' ' LEU . 10.8 p -71.89 -33.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.571 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -65.81 -39.21 90.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 100' ' ' GLU . 18.7 mm-40 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.894 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.86 -48.18 77.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.535 ' O ' HG13 ' A' ' 110' ' ' ILE . 11.0 mp -63.12 -45.17 93.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.134 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.51 -41.64 73.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.082 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -70.14 -41.69 73.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.96 -37.93 89.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.378 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 106' ' ' LEU . 85.3 mt -56.7 -40.81 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.114 0.483 . . . . 0.0 110.194 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.9 t -73.91 -55.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.65 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.5 m 69.94 169.18 0.3 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.62 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -95.12 158.82 15.3 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.018 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -84.62 94.74 8.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.461 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -117.25 100.07 7.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.454 0.645 . . . . 0.0 110.842 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.72 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.57 11.35 37.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.335 0.588 . . . . 0.0 109.864 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt . . . . . 0 N--CA 1.433 -1.296 0 CA-C-O 117.809 -1.091 . . . . 0.0 108.579 -179.894 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' SER . . . . . . . . . . . . . 19.9 m -107.25 35.03 3.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.985 0.422 . . . . 0.0 110.586 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.0 -20.51 65.95 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 32.0 t -110.81 3.0 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.815 0.34 . . . . 0.0 110.5 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -130.74 23.37 5.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.555 0.693 . . . . 0.0 110.134 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -79.29 135.42 36.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.583 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 66.2 mt -110.32 112.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.346 0.593 . . . . 0.0 110.131 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -141.09 98.82 3.45 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.23 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . 0.488 HG21 ' HG2' ' A' ' 44' ' ' ARG . 62.5 mt -138.46 123.41 22.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' MET . . . . . . . . . . . . . 32.4 mmt -100.84 149.97 36.63 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.172 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.88 163.29 37.38 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 122.678 2.252 . . . . 0.0 111.714 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -130.17 126.32 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.275 0.559 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -111.2 90.7 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.494 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 72.3 m -110.42 147.58 36.65 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.99 52.54 4.39 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.708 2.272 . . . . 0.0 111.257 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' SER . . . . . . . . . . . . . 1.1 m -54.29 -50.15 67.96 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.938 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.73 47.7 59.93 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.882 174.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.76 -15.22 59.27 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.405 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.518 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -80.56 -15.82 55.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.909 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -9.41 59.06 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.227 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.62 -22.27 63.5 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.03 80.54 6.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.474 0.654 . . . . 0.0 109.793 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.314 -0.977 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.283 -179.178 . . . . . . . . 0 0 . 1 stop_ save_